"PROJ_ID"	"SITE_ID"	"SUBID"	"STATE"	"EVENT_NO"	"EVENT_ID"	"ID"	"AETERM"	"AESTDT_"	"AEENDT_"	"AEONGO"	"AETOXGR"	"AEPACN"	"AEPACN_A"	"AEPACN_B"	"AEACN"	"AEACN_A"	"AEACN_B"	"AEDACN"	"AEDACN_A"	"AEDACN_B"	"AEACOTH"	"AEACOTH1"	"AEACOTH2"	"AEACOTH3"	"AEACO3OT"	"AEOUT"	"AERELP"	"AERELA"	"AERELD"	"AESER"	"AESCONG"	"AESDISAB"	"AESDTH"	"AESHOSP"	"AESLIFE"	"AESINTER"	"AESOTH"	"AESOTHC"	"SAEIRDT_"	"SAEDDT_"	"SAEAUTOP"	"SAEHADT_"	"SAEHDDT_"	"SAECOM1"	"SAECOM2"	"SAECOM3"	"SAEPRED"	"SAEDRED"	"SAEPST"	"SAEST"	"SAEDST"	"SAEPRR"	"SAERR"	"SAEDRR"	"SAEDESC1"	"SAEDESC2"	"SAEDESC3"	"SAEDESC4"	"SAEDESC5"	"SAEDESC6"	"M_HLGT"	"M_LLT"	"M_USER"	"M_PT"	"M_SOURCE"	"M_SCORE"	"M_MTIME"	"M_SOC"	"M_TIME"	"M_DICT"	"M_HLT"	"M_PROD"	"M_IS_P"	"llt"	"SOC"	"HLGT"	"HLT"	"PT"	"Level_5_Type"	"Level_5_Text"	"Level_6_Type"	"Level_6_Text"	"Level_7_Type"	"Level_7_Text"	"Level_8_Type"	"Level_8_Text"	"Level_9_Type"	"Level_9_Text"	"Level_10_Type"	"Level_10_Text"
"1"	"DN-101 Protocol No. 011-007"	"001"	"001-0003"	5	9	"Adverse Event/Serious Adverse Event"	2603014003	"anemia"	35	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471792346	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2"	"DN-101 Protocol No. 011-007"	"001"	"001-0003"	3	9	"Adverse Event/Serious Adverse Event"	2822916001	"anemia"	119	126	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"2 units packed red blood cells given ,"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481663560	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3"	"DN-101 Protocol No. 011-007"	"001"	"001-0003"	3	9	"Adverse Event/Serious Adverse Event"	2680725001	"arthralgia knees"	37	187	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473883911	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"4"	"DN-101 Protocol No. 011-007"	"001"	"001-0003"	3	9	"Adverse Event/Serious Adverse Event"	2645865001	"fatigue"	15	248	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471791774	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5"	"DN-101 Protocol No. 011-007"	"001"	"001-0003"	3	9	"Adverse Event/Serious Adverse Event"	2682100001	"hot flashes"	14	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473961741	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"6"	"DN-101 Protocol No. 011-007"	"001"	"001-0003"	3	9	"Adverse Event/Serious Adverse Event"	2823244001	"hyperglycemia"	14	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481666275	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"7"	"DN-101 Protocol No. 011-007"	"001"	"001-0003"	3	9	"Adverse Event/Serious Adverse Event"	2823258001	"hyperglycemia"	77	98	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481666380	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"8"	"DN-101 Protocol No. 011-007"	"001"	"001-0003"	3	9	"Adverse Event/Serious Adverse Event"	2680743001	"numbness tingling fingertips"	36	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473884062	""	""	""	NA	"Numbness in fingers"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"9"	"DN-101 Protocol No. 011-007"	"001"	"001-0003"	3	9	"Adverse Event/Serious Adverse Event"	2823222001	"numbness tingling fingertips"	162	NA	1	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481666063	""	""	""	NA	"Numbness in fingers"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"10"	"DN-101 Protocol No. 011-007"	"001"	"001-0004"	5	9	"Adverse Event/Serious Adverse Event"	2642913003	"alopecia"	19	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474297127	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"11"	"DN-101 Protocol No. 011-007"	"001"	"001-0004"	3	9	"Adverse Event/Serious Adverse Event"	2685693001	"indigestion"	8	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474297274	""	""	""	NA	"Indigestion"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"12"	"DN-101 Protocol No. 011-007"	"001"	"001-0005"	5	9	"Adverse Event/Serious Adverse Event"	2683452003	"edema lower legs"	109	167	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484161298	""	""	""	NA	"Edema legs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"13"	"DN-101 Protocol No. 011-007"	"001"	"001-0005"	3	9	"Adverse Event/Serious Adverse Event"	2925802001	"hemorrhage GI"	153	167	NA	4	1	1	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	4	0	NA	0	28	NA	NA	1	1	1	NA	NA	""	154	167	2	153	167	"CT scan of abdomen on day of admission 2/7/07 shows evidence of sigmoid diverticulosis, no evidence to suggest abcess or free air."	""	""	2	2	0	NA	0	2	NA	2	"I have very little information today, patient is on a ventilator in ICU. I have been verbally told the patient had a GI hemorrhage, had severely low BP, cardiac arrest. Now he is comatose on a"	"ventilator with possible congestive heart failure. I will be able to get more information over the next few days.;2/14/07 Update- The patient has been extubated and is eating. He has been undergoing"	"dialysis for renal failure.;2/21/07 The patient developed a bowel perforation from his diverticulosis and expired on 2/21/07. He did not undergo any surgical procedure for the bowel perforation."	""	""	""	""	""	""	""	""	NA	NA	""	1486581002	""	""	""	NA	"GI hemorrhage"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Non-site specific gastrointestinal haemorrhages"	"Gastrointestinal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"14"	"DN-101 Protocol No. 011-007"	"001"	"001-0005"	3	9	"Adverse Event/Serious Adverse Event"	2866454001	"insomnia"	54	167	NA	1	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484161120	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"15"	"DN-101 Protocol No. 011-007"	"001"	"001-0005"	3	9	"Adverse Event/Serious Adverse Event"	2866476001	"low hemoglobin"	98	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484161428	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"16"	"DN-101 Protocol No. 011-007"	"001"	"001-0008"	5	9	"Adverse Event/Serious Adverse Event"	2746568003	"alopecia"	34	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481056500	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"17"	"DN-101 Protocol No. 011-007"	"001"	"001-0008"	3	9	"Adverse Event/Serious Adverse Event"	2806329001	"anemia"	20	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481056679	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"18"	"DN-101 Protocol No. 011-007"	"001"	"001-0008"	3	9	"Adverse Event/Serious Adverse Event"	2806402001	"anxiety"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481057261	""	""	""	NA	"Anxiety"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Anxiety"	""	""	""	""	""	""	""	""	""	""	""	""
"19"	"DN-101 Protocol No. 011-007"	"001"	"001-0008"	3	9	"Adverse Event/Serious Adverse Event"	2806314001	"fever"	29	30	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481056570	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"20"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	5	9	"Adverse Event/Serious Adverse Event"	2752143003	"abdomenal pain/cramping"	178	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495478651	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"21"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	3	9	"Adverse Event/Serious Adverse Event"	3231929001	"alopecia"	17	155	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495478362	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"22"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	3	9	"Adverse Event/Serious Adverse Event"	3232046001	"arthalgia"	165	NA	1	2	1	1	NA	NA	NA	NA	1	1	NA	4	NA	NA	1	"study tretment terminated"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495479110	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"23"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	3	9	"Adverse Event/Serious Adverse Event"	3231904001	"diarrhea"	178	180	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495478199	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"24"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	3	9	"Adverse Event/Serious Adverse Event"	2903581001	"dyspena"	51	74	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485881315	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"25"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	3	9	"Adverse Event/Serious Adverse Event"	3231851001	"dysphasia/ pt now reporting as part of med hx"	-78	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495477916	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"26"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	3	9	"Adverse Event/Serious Adverse Event"	3232033001	"fatigu"	164	NA	1	3	1	1	NA	NA	NA	NA	1	1	NA	4	NA	NA	1	"study treatment terminated"	NA	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495479021	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"27"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	3	9	"Adverse Event/Serious Adverse Event"	2903587001	"fatigue"	53	74	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485881571	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"28"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	3	9	"Adverse Event/Serious Adverse Event"	2903593001	"weakness"	53	NA	1	3	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485881732	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"29"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	3	9	"Adverse Event/Serious Adverse Event"	3231986001	"weakness"	178	NA	1	3	1	1	NA	NA	NA	NA	1	1	NA	4	NA	NA	1	"Study treatment terminated"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495478817	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"30"	"DN-101 Protocol No. 011-007"	"001"	"001-0012"	5	9	"Adverse Event/Serious Adverse Event"	2799091003	"anemia"	32	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485894933	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"31"	"DN-101 Protocol No. 011-007"	"001"	"001-0012"	3	9	"Adverse Event/Serious Adverse Event"	3087981001	"bone pain"	129	136	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492353779	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"32"	"DN-101 Protocol No. 011-007"	"001"	"001-0012"	3	9	"Adverse Event/Serious Adverse Event"	3088043001	"diarrhea"	14	32	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492354370	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"33"	"DN-101 Protocol No. 011-007"	"001"	"001-0012"	3	9	"Adverse Event/Serious Adverse Event"	2903854001	"fatigue"	31	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485894652	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"34"	"DN-101 Protocol No. 011-007"	"001"	"001-0012"	3	9	"Adverse Event/Serious Adverse Event"	3088005001	"nausea"	14	32	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492354069	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"35"	"DN-101 Protocol No. 011-007"	"001"	"001-0012"	3	9	"Adverse Event/Serious Adverse Event"	2903872001	"olfactory alteration"	32	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485894853	""	""	""	NA	"Smell alteration"	"Nervous system disorders"	"Cranial nerve disorders (excl neoplasms)"	"Olfactory nerve disorders"	"Parosmia"	""	""	""	""	""	""	""	""	""	""	""	""
"36"	"DN-101 Protocol No. 011-007"	"001"	"001-0012"	3	9	"Adverse Event/Serious Adverse Event"	3088059001	"spinal cord compression"	93	106	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	4	NA	NA	1	"radiation therapy to involved area"	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492354663	""	""	""	NA	"Spinal cord compression"	"Nervous system disorders"	"Spinal cord and nerve root disorders"	"Spinal cord and nerve root disorders NEC"	"Spinal cord compression"	""	""	""	""	""	""	""	""	""	""	""	""
"37"	"DN-101 Protocol No. 011-007"	"001"	"001-0012"	3	9	"Adverse Event/Serious Adverse Event"	3088049001	"taste alterations"	39	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492354513	""	""	""	NA	"Taste altered"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"38"	"DN-101 Protocol No. 011-007"	"001"	"001-0013"	5	9	"Adverse Event/Serious Adverse Event"	2958069003	"community acquired pneumonia with sepsis syndrome"	86	NA	1	3	NA	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	2	0	NA	NA	8	NA	NA	NA	1	NA	NA	NA	""	95	NA	NA	86	NA	"5/13/07 CXR SHOWED PNEUMONIA IN LEFT MID LUNG FIELD; 5/13/07 BLOOD CULTURE WAS POSITIVE FOR STREPTOCOCCUS PNEUMONIAE"	""	""	2	2	2	NA	2	2	NA	2	"ON 5/13/07 THE PT PRESENTED TO THE ER WITH 1 WEEK HX OF CHILLS AND LOW GRADE FEVER (99.5F), AND 3 DAY HX OF WORSENINF SHORTNESS OF BREATH.  CXR SHOWED MID LEFT LUNG OPACITY CONSISTENT WITH PNEUMONIA."	"PT WAS ADMITTED AND TREATED WITH IV FLUIDS, IV ANTIBIOTICS, LEVOPHED INFUSION, BIPAP AT NIGHT.  AS OF 5/22/05 THE PT CONTINUES HOSPITALIZED WHILE RECOVERING."	""	""	""	""	""	""	""	""	""	NA	NA	""	1495476477	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"39"	"DN-101 Protocol No. 011-007"	"001"	"001-0013"	3	9	"Adverse Event/Serious Adverse Event"	3016926001	"hyperglycemia"	7	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490128001	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"40"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3026850003	"anemia"	34	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492635352	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"41"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	3	9	"Adverse Event/Serious Adverse Event"	3107993001	"dizziness with movements"	41	42	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492635239	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"42"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	3	9	"Adverse Event/Serious Adverse Event"	3183621001	"dry skin"	35	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494535860	""	""	""	NA	"Dry skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Dry skin"	""	""	""	""	""	""	""	""	""	""	""	""
"43"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	3	9	"Adverse Event/Serious Adverse Event"	3107986001	"facial rash"	42	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492635114	""	""	""	NA	"Facial rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"44"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	3	9	"Adverse Event/Serious Adverse Event"	3183602001	"fatigue"	43	50	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494535615	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"45"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	3	9	"Adverse Event/Serious Adverse Event"	3107978001	"fatigue"	21	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492634994	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"46"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	3	9	"Adverse Event/Serious Adverse Event"	3107939001	"hot flashes"	21	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492634633	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"47"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	3	9	"Adverse Event/Serious Adverse Event"	3107959001	"hyperglycemia"	34	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492634782	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"48"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	3	9	"Adverse Event/Serious Adverse Event"	3107814001	"right buttock pain"	21	21	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492633309	""	""	""	NA	"Buttock pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Buttock pain"	""	""	""	""	""	""	""	""	""	""	""	""
"49"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	3	9	"Adverse Event/Serious Adverse Event"	3107966001	"right hip pain"	24	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492634873	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"50"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	3	9	"Adverse Event/Serious Adverse Event"	3183616001	"taste alteration"	43	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494535788	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"51"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	2558403003	"Alopecia"	24	243	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463518017	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"52"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	3	9	"Adverse Event/Serious Adverse Event"	2581139001	"Altered taste"	40	213	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1464808155	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"53"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	3	9	"Adverse Event/Serious Adverse Event"	2660380001	"Cold sore outer aspect right side of mouth"	76	92	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472659411	""	""	""	NA	"Cold sore mouth"	"Infections and infestations"	"Viral infectious disorders"	"Herpes viral infections"	"Herpes simplex"	""	""	""	""	""	""	""	""	""	""	""	""
"54"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	3	9	"Adverse Event/Serious Adverse Event"	2778490001	"Constipation"	147	149	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479312447	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"55"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	3	9	"Adverse Event/Serious Adverse Event"	2660389001	"Cushingoid appearance"	124	285	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472659602	""	""	""	NA	"Cushingoid"	"Endocrine disorders"	"Adrenal gland disorders"	"Adrenal cortical hyperfunctions"	"Cushingoid"	""	""	""	""	""	""	""	""	""	""	""	""
"56"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	3	9	"Adverse Event/Serious Adverse Event"	2601739001	"Eye tearing"	61	212	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1467654399	""	""	""	NA	"Eyes tearing"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"57"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	3	9	"Adverse Event/Serious Adverse Event"	2878561001	"Eyes tearing"	213	285	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484686122	""	""	""	NA	"Eyes tearing"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"58"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	3	9	"Adverse Event/Serious Adverse Event"	2878492001	"Fatigue"	82	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484685541	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"59"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	3	9	"Adverse Event/Serious Adverse Event"	2640162001	"Fingernail changes"	103	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471289037	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"60"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	3	9	"Adverse Event/Serious Adverse Event"	2707601001	"Fingernail changes"	162	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475612204	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"61"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	3	9	"Adverse Event/Serious Adverse Event"	3057233001	"Intermittent lower abdominal pain"	331	NA	1	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491323599	""	""	""	NA	"Lower abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain lower"	""	""	""	""	""	""	""	""	""	""	""	""
"62"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	3	9	"Adverse Event/Serious Adverse Event"	2878511001	"Knee pain"	NA	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484685766	""	""	""	NA	"Knee pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"63"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	3	9	"Adverse Event/Serious Adverse Event"	2877411001	"Left eyelid blepharitis"	194	245	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484668672	""	""	""	NA	"Blepharitis"	"Eye disorders"	"Ocular infections, irritations and inflammations"	"Lid, lash and lacrimal infections, irritations and inflammations"	"Blepharitis"	""	""	""	""	""	""	""	""	""	""	""	""
"64"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	3	9	"Adverse Event/Serious Adverse Event"	3057260001	"Lower back pain with ambulation"	320	NA	1	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491323947	""	""	""	NA	"Low back ache"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"65"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	3	9	"Adverse Event/Serious Adverse Event"	2601733001	"Neuropathy"	54	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1467653983	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"66"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	3	9	"Adverse Event/Serious Adverse Event"	2878533001	"Numbness in fingertips"	NA	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484685942	""	""	""	NA	"Numbness in fingers"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"67"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	3	9	"Adverse Event/Serious Adverse Event"	2660365001	"Pain in fingertips with pressure"	117	213	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472659293	""	""	""	NA	"Pain in fingers"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"68"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	3	9	"Adverse Event/Serious Adverse Event"	2880172001	"Right eye catract"	194	278	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484757677	""	""	""	NA	"Right cataract"	"Eye disorders"	"Anterior eye structural change, deposit and degeneration"	"Cataract conditions"	"Cataract"	""	""	""	""	""	""	""	""	""	""	""	""
"69"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	3	9	"Adverse Event/Serious Adverse Event"	2660386001	"Right eye red-from rubbing"	111	125	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472659517	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"70"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	3	9	"Adverse Event/Serious Adverse Event"	2707631001	"Right middle finger infected"	175	184	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475613224	""	""	""	NA	"Infected finger"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Localised infection"	""	""	""	""	""	""	""	""	""	""	""	""
"71"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	5	9	"Adverse Event/Serious Adverse Event"	2777567003	"Alopecia"	41	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484175855	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"72"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	3	9	"Adverse Event/Serious Adverse Event"	3002455001	"Bruising on forearms"	83	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489605071	""	""	""	NA	"Bruising"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"73"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	3	9	"Adverse Event/Serious Adverse Event"	2821506001	"Constipation"	10	10	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481651062	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"74"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	3	9	"Adverse Event/Serious Adverse Event"	3002470001	"Cracked skin of fingers"	83	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489605198	""	""	""	NA	"Chapped skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Skin injuries and mechanical dermatoses"	"Skin chapped"	""	""	""	""	""	""	""	""	""	""	""	""
"75"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	3	9	"Adverse Event/Serious Adverse Event"	3002462001	"Dry skin"	83	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489605140	""	""	""	NA	"Dry skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Dry skin"	""	""	""	""	""	""	""	""	""	""	""	""
"76"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	3	9	"Adverse Event/Serious Adverse Event"	3054477001	"Eye tearing"	132	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491239880	""	""	""	NA	"Eyes tearing"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"77"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	3	9	"Adverse Event/Serious Adverse Event"	2922962001	"Fatigue"	62	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486497711	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"78"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	3	9	"Adverse Event/Serious Adverse Event"	3176693001	"Left hip weakness"	174	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494436651	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"79"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	3	9	"Adverse Event/Serious Adverse Event"	3176702001	"Left knee muscle weakness"	142	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494436728	""	""	""	NA	"Muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"80"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	3	9	"Adverse Event/Serious Adverse Event"	2922951001	"Left knee muscle weakness"	69	77	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486497586	""	""	""	NA	"Muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"81"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	5	9	"Adverse Event/Serious Adverse Event"	2862051003	"Alopecia"	24	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486500157	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"82"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	3	9	"Adverse Event/Serious Adverse Event"	3214752001	"Cushingoid syndrome"	99	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495056698	""	""	""	NA	"Cushingoid"	"Endocrine disorders"	"Adrenal gland disorders"	"Adrenal cortical hyperfunctions"	"Cushingoid"	""	""	""	""	""	""	""	""	""	""	""	""
"83"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	3	9	"Adverse Event/Serious Adverse Event"	3009118001	"Fatigue"	26	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489955922	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"84"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	3	9	"Adverse Event/Serious Adverse Event"	3214777001	"Fatigue"	116	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495056872	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"85"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	3	9	"Adverse Event/Serious Adverse Event"	3214799001	"Fingernail changes"	81	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495057029	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"86"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	3	9	"Adverse Event/Serious Adverse Event"	3214812001	"Left hand blister"	123	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495057137	""	""	""	NA	"Blister"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Bullous conditions"	"Blister"	""	""	""	""	""	""	""	""	""	""	""	""
"87"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	3	9	"Adverse Event/Serious Adverse Event"	3214732001	"Lower back pain"	108	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495056461	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"88"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	3	9	"Adverse Event/Serious Adverse Event"	3214739001	"Neuropathy in feet"	95	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495056529	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"89"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	3	9	"Adverse Event/Serious Adverse Event"	3214762001	"Sinus congestion"	111	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495056799	""	""	""	NA	"Sinus congestion"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Paranasal sinus disorders (excl infections and neoplasms)"	"Sinus congestion"	""	""	""	""	""	""	""	""	""	""	""	""
"90"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	3	9	"Adverse Event/Serious Adverse Event"	3214727001	"Toe nail changes"	81	115	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495056408	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"91"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	3	9	"Adverse Event/Serious Adverse Event"	3214806001	"Toenail changes"	116	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495057081	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"92"	"DN-101 Protocol No. 011-007"	"002"	"002-0014"	5	9	"Adverse Event/Serious Adverse Event"	3096945003	"Hyperglycemia"	7	7	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494945996	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"93"	"DN-101 Protocol No. 011-007"	"002"	"002-0014"	3	9	"Adverse Event/Serious Adverse Event"	3199997001	"Hyperglycemia-sporadic"	8	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494946064	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"94"	"DN-101 Protocol No. 011-007"	"002"	"002-0014"	3	9	"Adverse Event/Serious Adverse Event"	3199963001	"Scalp tenderness"	23	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494945853	""	""	""	NA	"Scalp tenderness"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Pain of skin"	""	""	""	""	""	""	""	""	""	""	""	""
"95"	"DN-101 Protocol No. 011-007"	"003"	"003-0001"	5	9	"Adverse Event/Serious Adverse Event"	2628807003	"Benign Systolic Murmur"	133	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486236453	""	""	""	NA	"Systolic murmur"	"Investigations"	"Cardiac and vascular investigations (excl enzyme tests)"	"Cardiac auscultatory investigations"	"Cardiac murmur"	""	""	""	""	""	""	""	""	""	""	""	""
"96"	"DN-101 Protocol No. 011-007"	"003"	"003-0001"	3	9	"Adverse Event/Serious Adverse Event"	3004015001	"Bilateral Leg Edema"	NA	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489673170	""	""	""	NA	"Leg edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"97"	"DN-101 Protocol No. 011-007"	"003"	"003-0001"	3	9	"Adverse Event/Serious Adverse Event"	2689633001	"Constipation"	42	50	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474409725	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"98"	"DN-101 Protocol No. 011-007"	"003"	"003-0001"	3	9	"Adverse Event/Serious Adverse Event"	2919996001	"Disturbed Sleep"	71	132	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486421908	""	""	""	NA	"Sleep disturbed"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Sleep disorders NEC"	"Sleep disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"99"	"DN-101 Protocol No. 011-007"	"003"	"003-0001"	3	9	"Adverse Event/Serious Adverse Event"	2826141001	"Dizziness"	117	120	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481821423	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"100"	"DN-101 Protocol No. 011-007"	"003"	"003-0001"	3	9	"Adverse Event/Serious Adverse Event"	2921711001	"Dyspnea"	172	197	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486487194	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"101"	"DN-101 Protocol No. 011-007"	"003"	"003-0001"	3	9	"Adverse Event/Serious Adverse Event"	2712263001	"fatigue"	132	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475789027	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"102"	"DN-101 Protocol No. 011-007"	"003"	"003-0001"	3	9	"Adverse Event/Serious Adverse Event"	2910555001	"Heart Palpitation"	155	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"ECHOCARDIOGRAM - NORMAL REPORT"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486237001	""	""	""	NA	"Palpitation"	"Cardiac disorders"	"Cardiac disorder signs and symptoms"	"Cardiac signs and symptoms NEC"	"Palpitations"	""	""	""	""	""	""	""	""	""	""	""	""
"103"	"DN-101 Protocol No. 011-007"	"003"	"003-0001"	3	9	"Adverse Event/Serious Adverse Event"	2910524001	"Nail Changes"	133	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486234837	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"104"	"DN-101 Protocol No. 011-007"	"003"	"003-0001"	3	9	"Adverse Event/Serious Adverse Event"	2920028001	"Nocturia"	71	132	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486422414	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"105"	"DN-101 Protocol No. 011-007"	"003"	"003-0002"	5	9	"Adverse Event/Serious Adverse Event"	2659202003	"allopecia"	28	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483487206	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"106"	"DN-101 Protocol No. 011-007"	"003"	"003-0002"	3	9	"Adverse Event/Serious Adverse Event"	2908608001	"Constipation"	13	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486057682	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"107"	"DN-101 Protocol No. 011-007"	"003"	"003-0002"	3	9	"Adverse Event/Serious Adverse Event"	2851162001	"fatigue"	21	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483487088	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"108"	"DN-101 Protocol No. 011-007"	"003"	"003-0002"	3	9	"Adverse Event/Serious Adverse Event"	2774891001	"Febrile Neutropenia"	54	63	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479160264	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"109"	"DN-101 Protocol No. 011-007"	"003"	"003-0002"	3	9	"Adverse Event/Serious Adverse Event"	2908472001	"Nail Changes"	84	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486055439	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"110"	"DN-101 Protocol No. 011-007"	"003"	"003-0002"	3	9	"Adverse Event/Serious Adverse Event"	2908461001	"Neutropenia"	72	84	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486055371	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"111"	"DN-101 Protocol No. 011-007"	"003"	"003-0002"	3	9	"Adverse Event/Serious Adverse Event"	2908479001	"Restlessness"	128	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486055536	""	""	""	NA	"Restlessness"	"Psychiatric disorders"	"Changes in physical activity"	"Increased physical activity levels"	"Restlessness"	""	""	""	""	""	""	""	""	""	""	""	""
"112"	"DN-101 Protocol No. 011-007"	"003"	"003-0003"	5	9	"Adverse Event/Serious Adverse Event"	2680128003	"Allopecia"	30	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481495783	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"113"	"DN-101 Protocol No. 011-007"	"003"	"003-0003"	3	9	"Adverse Event/Serious Adverse Event"	3023124001	"Cough"	182	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490288306	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"114"	"DN-101 Protocol No. 011-007"	"003"	"003-0003"	3	9	"Adverse Event/Serious Adverse Event"	2817401001	"Emphysematous Cholecystitis"	87	121	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	3	1	1	NA	""	0	1	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	89	NA	NA	87	91	"CT Scan performed 09 Dec 06 indicated Emphysematous cholecystitis, likely with small amount of portal venous air.  Significant pericholecystic fluid and fluid in the region of the head of the"	"pancreas and hepatoduodenal ligament all consistent with acute inflammation."	""	2	2	2	NA	2	2	NA	2	"Patient presented to the Foothills Medical Centre on morning of 09 Dec 06 after collapsing at his home.  EMS was called and patient presented with significant abdominal pain, weakness and was"	"diaphoretic.  Family member stated that patient was mildly SOB on 08 DEC 06.  Family member also states that patient appears to have a mild facial droop and dysarthria.  Patient was assessed by CT"	"scan to confirm the presence of Emphysematous Cholecystitis.  Patient underwent a laparoscopic cholecytectomy the morning of 10 Dec 06.  At time of this SAE report, Patient is presently stable and"	"admitted to surgical ward at Foothills Medical Centre.;Patient fully recovered from surgery on 12 Jan 06.  Pt. was saw Dr. Eigl on 27 Dec 06 and was assessed and improving but still recovering from"	"surg.  Pt. then seen in surg. clinic on 05 Jan 07 and given ok by the surgeon to cont. with chemo.  Patient returned to TBCC on 12 jan 07 W/Dr. Eigl and was restarted on chemo reduced to dose of 60"	"mg/m2  15 jan 07."	""	""	""	""	""	NA	NA	""	1481480678	""	""	""	NA	"Emphysematous cholecystitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Hepatobiliary and spleen infections"	"Emphysematous cholecystitis"	""	""	""	""	""	""	""	""	""	""	""	""
"115"	"DN-101 Protocol No. 011-007"	"003"	"003-0003"	3	9	"Adverse Event/Serious Adverse Event"	2909052001	"Fatigue"	125	135	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486068838	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"116"	"DN-101 Protocol No. 011-007"	"003"	"003-0003"	3	9	"Adverse Event/Serious Adverse Event"	2818249001	"Fatigue"	12	30	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481495638	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"117"	"DN-101 Protocol No. 011-007"	"003"	"003-0003"	3	9	"Adverse Event/Serious Adverse Event"	3023132001	"Fever"	182	184	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490288417	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"118"	"DN-101 Protocol No. 011-007"	"003"	"003-0003"	3	9	"Adverse Event/Serious Adverse Event"	3116052001	"Leg Edema"	189	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492958994	""	""	""	NA	"Leg edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"119"	"DN-101 Protocol No. 011-007"	"003"	"003-0003"	3	9	"Adverse Event/Serious Adverse Event"	3023142001	"Nasal Discharge"	184	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490288502	""	""	""	NA	"Nasal discharge"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Rhinorrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"120"	"DN-101 Protocol No. 011-007"	"003"	"003-0003"	3	9	"Adverse Event/Serious Adverse Event"	3186156001	"Shortness of breath"	232	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494779816	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"121"	"DN-101 Protocol No. 011-007"	"003"	"003-0004"	5	9	"Adverse Event/Serious Adverse Event"	2753066003	"Alopecia"	48	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483570492	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"122"	"DN-101 Protocol No. 011-007"	"003"	"003-0004"	3	9	"Adverse Event/Serious Adverse Event"	3116133001	"Bilateral Peripheral Edema- lower legs"	153	NA	1	2	0	NA	NA	NA	NA	NA	1	1	NA	4	NA	NA	1	"Treatment stopped, patient off study."	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492960965	""	""	""	NA	"Edema legs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"123"	"DN-101 Protocol No. 011-007"	"003"	"003-0004"	3	9	"Adverse Event/Serious Adverse Event"	2854964001	"Fatigue"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483570058	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"124"	"DN-101 Protocol No. 011-007"	"003"	"003-0004"	3	9	"Adverse Event/Serious Adverse Event"	2854979001	"Insomnia"	36	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483570359	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"125"	"DN-101 Protocol No. 011-007"	"003"	"003-0004"	3	9	"Adverse Event/Serious Adverse Event"	2992537001	"Nail Changes"	132	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489337887	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"126"	"DN-101 Protocol No. 011-007"	"003"	"003-0004"	3	9	"Adverse Event/Serious Adverse Event"	2914814001	"Nocturia"	73	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486332463	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"127"	"DN-101 Protocol No. 011-007"	"003"	"003-0004"	3	9	"Adverse Event/Serious Adverse Event"	2854973001	"Peripheral Edema"	42	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Dexamethasone Reduced"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483570214	""	""	""	NA	"Peripheral edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"128"	"DN-101 Protocol No. 011-007"	"003"	"003-0006"	5	9	"Adverse Event/Serious Adverse Event"	2861156003	"Abscess in right groin (ingrown hair)"	43	51	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488726347	""	""	""	NA	"Ingrown hair"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Pilar disorders NEC"	"Ingrown hair"	""	""	""	""	""	""	""	""	""	""	""	""
"129"	"DN-101 Protocol No. 011-007"	"003"	"003-0006"	3	9	"Adverse Event/Serious Adverse Event"	2907946001	"Allergic Reaction"	3	3	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486047905	""	""	""	NA	"Allergic reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"130"	"DN-101 Protocol No. 011-007"	"003"	"003-0006"	3	9	"Adverse Event/Serious Adverse Event"	3153571001	"Edema (right ankle)"	72	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493730434	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"131"	"DN-101 Protocol No. 011-007"	"003"	"003-0006"	3	9	"Adverse Event/Serious Adverse Event"	2922017001	"Fever"	12	12	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486489988	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"132"	"DN-101 Protocol No. 011-007"	"003"	"003-0006"	3	9	"Adverse Event/Serious Adverse Event"	3019783001	"Infected Sebaceous cyst on back of neck"	65	104	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490205888	""	""	""	NA	"Infected sebaceous cyst"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Skin structures and soft tissue infections"	"Infected sebaceous cyst"	""	""	""	""	""	""	""	""	""	""	""	""
"133"	"DN-101 Protocol No. 011-007"	"003"	"003-0006"	3	9	"Adverse Event/Serious Adverse Event"	3124967001	"Infected Sebaceous cyst on back of neck"	105	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493070683	""	""	""	NA	"Infected sebaceous cyst"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Skin structures and soft tissue infections"	"Infected sebaceous cyst"	""	""	""	""	""	""	""	""	""	""	""	""
"134"	"DN-101 Protocol No. 011-007"	"003"	"003-0006"	3	9	"Adverse Event/Serious Adverse Event"	2907962001	"Myalgia"	4	9	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486048007	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"135"	"DN-101 Protocol No. 011-007"	"003"	"003-0006"	3	9	"Adverse Event/Serious Adverse Event"	2977406001	"Myalgia"	25	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488726443	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"136"	"DN-101 Protocol No. 011-007"	"003"	"003-0007"	5	9	"Adverse Event/Serious Adverse Event"	2878819003	"Alopecia"	117	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494770245	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"137"	"DN-101 Protocol No. 011-007"	"003"	"003-0007"	3	9	"Adverse Event/Serious Adverse Event"	3048496001	"Nail Changes"	77	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490901451	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"138"	"DN-101 Protocol No. 011-007"	"003"	"003-0007"	3	9	"Adverse Event/Serious Adverse Event"	3115313001	"Tenderness in fingertips"	78	88	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492949111	""	""	""	NA	"Pain in fingers"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"139"	"DN-101 Protocol No. 011-007"	"003"	"003-0007"	3	9	"Adverse Event/Serious Adverse Event"	2992602001	"Transient Numbness in fingertips"	48	50	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489338813	""	""	""	NA	"Numbness in fingers"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"140"	"DN-101 Protocol No. 011-007"	"003"	"003-0009"	5	9	"Adverse Event/Serious Adverse Event"	2894198003	"Alopecia"	23	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489939071	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"141"	"DN-101 Protocol No. 011-007"	"003"	"003-0009"	3	9	"Adverse Event/Serious Adverse Event"	3007704001	"Decreased Hemoglobin"	28	91	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489939432	""	""	""	NA	"Decreased hemoglobin"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"142"	"DN-101 Protocol No. 011-007"	"003"	"003-0009"	3	9	"Adverse Event/Serious Adverse Event"	3007715001	"Fatigue"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489939588	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"143"	"DN-101 Protocol No. 011-007"	"003"	"003-0009"	3	9	"Adverse Event/Serious Adverse Event"	3144484001	"Left Leg Edema"	67	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Patient had Doppler Ultrasound"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493575713	""	""	""	NA	"Leg edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"144"	"DN-101 Protocol No. 011-007"	"003"	"003-0009"	3	9	"Adverse Event/Serious Adverse Event"	3007710001	"Muscle Aches"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489939523	""	""	""	NA	"Muscle ache"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"145"	"DN-101 Protocol No. 011-007"	"003"	"003-0009"	3	9	"Adverse Event/Serious Adverse Event"	3007691001	"Nail Changes"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489939266	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"146"	"DN-101 Protocol No. 011-007"	"003"	"003-0009"	3	9	"Adverse Event/Serious Adverse Event"	3202675001	"Right femoral head and neck fracture"	112	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Patient Hospitalised - pending results"	2	0	NA	0	72	NA	NA	NA	1	NA	NA	1	"Patient hospitalised"	112	NA	NA	112	NA	"No information available at this time, will submit when available"	""	""	0	0	0	NA	0	NA	NA	NA	"notified patient was admitted to unit 47 of FMC with fractured hip. No other information available"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494961334	""	""	""	NA	"Femoral neck fracture"	"Injury, poisoning and procedural complications"	"Bone and joint injuries"	"Lower limb fractures and dislocations"	"Femoral neck fracture"	""	""	""	""	""	""	""	""	""	""	""	""
"147"	"DN-101 Protocol No. 011-007"	"003"	"003-0009"	3	9	"Adverse Event/Serious Adverse Event"	3007674001	"Sensory Neuropathy (fingertips of both hands)"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489939168	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"148"	"DN-101 Protocol No. 011-007"	"003"	"003-0010"	5	9	"Adverse Event/Serious Adverse Event"	2901157003	"Anhedonia"	49	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492086979	""	""	""	NA	"Anhedonia"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Mood alterations with depressive symptoms"	"Anhedonia"	""	""	""	""	""	""	""	""	""	""	""	""
"149"	"DN-101 Protocol No. 011-007"	"003"	"003-0010"	3	9	"Adverse Event/Serious Adverse Event"	3151177001	"Decrease in muscle strength"	90	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493666910	""	""	""	NA	"Muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"150"	"DN-101 Protocol No. 011-007"	"003"	"003-0010"	3	9	"Adverse Event/Serious Adverse Event"	3007747001	"Fatigue"	48	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489939907	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"151"	"DN-101 Protocol No. 011-007"	"003"	"003-0010"	3	9	"Adverse Event/Serious Adverse Event"	3007755001	"generalized achiness"	48	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489940095	""	""	""	NA	"General body pain"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Pain"	""	""	""	""	""	""	""	""	""	""	""	""
"152"	"DN-101 Protocol No. 011-007"	"003"	"003-0010"	3	9	"Adverse Event/Serious Adverse Event"	3007762001	"Nail Changes"	48	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489940201	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"153"	"DN-101 Protocol No. 011-007"	"003"	"003-0010"	3	9	"Adverse Event/Serious Adverse Event"	3083660001	"Pain in Right Hip"	13	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492087243	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"154"	"DN-101 Protocol No. 011-007"	"003"	"003-0010"	3	9	"Adverse Event/Serious Adverse Event"	2962729001	"Pain in sternum"	13	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487855784	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"155"	"DN-101 Protocol No. 011-007"	"003"	"003-0010"	3	9	"Adverse Event/Serious Adverse Event"	3151169001	"Peripheral Edema- Bilateral (feet)"	80	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493666846	""	""	""	NA	"Foot edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"156"	"DN-101 Protocol No. 011-007"	"003"	"003-0010"	3	9	"Adverse Event/Serious Adverse Event"	2962726001	"sensory neuropathy"	20	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487855714	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"157"	"DN-101 Protocol No. 011-007"	"003"	"003-0010"	3	9	"Adverse Event/Serious Adverse Event"	3186287001	"Sweats (diaphoresis)"	90	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494780325	""	""	""	NA	"Diaphoresis"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"158"	"DN-101 Protocol No. 011-007"	"003"	"003-0011"	5	9	"Adverse Event/Serious Adverse Event"	2926334003	"Edema- lower limbs"	79	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493045444	""	""	""	NA	"Edema lower limb"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"159"	"DN-101 Protocol No. 011-007"	"003"	"003-0011"	3	9	"Adverse Event/Serious Adverse Event"	3154270001	"Hydronephrosis"	87	95	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	7	1	1	1	"Patient had a right retrograde pyelogram, uretheroscopy and strent placement on 04/27/2007"	0	0	NA	0	104	NA	NA	NA	1	NA	1	1	"Patient required to have a right retrograde pyelogram, an uretheroscopy and a stent placement."	98	NA	NA	87	95	"CT of Abdomen, Right Ureteroscopy on 04/27/2007, Stent inserted on 04/27/2007. Patient given cipro and Tylenol #3. Patient discharged 04/29/2007."	""	""	NA	0	0	NA	1	NA	NA	NA	"Patient being dealyed one week from treatment but still contuning to take prednisone. Patient has not yet been re-introduced with Docetaxel. Scheduled for next week ~ 05/25/2007."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493744326	""	""	""	NA	"Hydronephrosis"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal obstructive disorders"	"Hydronephrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"160"	"DN-101 Protocol No. 011-007"	"003"	"003-0011"	3	9	"Adverse Event/Serious Adverse Event"	2992588001	"Vesicular Rash (left hand)"	33	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489338636	""	""	""	NA	"Rash vesicular"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash vesicular"	""	""	""	""	""	""	""	""	""	""	""	""
"161"	"DN-101 Protocol No. 011-007"	"003"	"003-0011"	3	9	"Adverse Event/Serious Adverse Event"	2992569001	"Vesicular rash (left hand)"	21	33	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489338454	""	""	""	NA	"Rash vesicular"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash vesicular"	""	""	""	""	""	""	""	""	""	""	""	""
"162"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	5	9	"Adverse Event/Serious Adverse Event"	2467135004	"anemia"	99	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468412223	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"163"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	3	9	"Adverse Event/Serious Adverse Event"	2535888001	"Anemia"	27	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"164"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	3	9	"Adverse Event/Serious Adverse Event"	2608706001	"chest pain, cardiac"	30	34	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468414541	""	""	""	NA	"Chest pain - cardiac"	"Cardiac disorders"	"Coronary artery disorders"	"Ischaemic coronary artery disorders"	"Angina pectoris"	""	""	""	""	""	""	""	""	""	""	""	""
"165"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	3	9	"Adverse Event/Serious Adverse Event"	2608695001	"constipation"	35	35	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468413384	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"166"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	3	9	"Adverse Event/Serious Adverse Event"	2608661001	"cough"	92	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468411831	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"167"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	3	9	"Adverse Event/Serious Adverse Event"	2590317001	"Cough"	71	87	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1465738044	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"168"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	3	9	"Adverse Event/Serious Adverse Event"	2608709001	"dyspnea"	137	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468414850	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"169"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	3	9	"Adverse Event/Serious Adverse Event"	2608655001	"erythematous left leg"	113	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468411641	""	""	""	NA	"Erythema"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Erythemas"	"Erythema"	""	""	""	""	""	""	""	""	""	""	""	""
"170"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	3	9	"Adverse Event/Serious Adverse Event"	2608658001	"fatigue"	120	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468411764	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"171"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	3	9	"Adverse Event/Serious Adverse Event"	2584247001	"Fatigue"	93	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1465223061	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"172"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	3	9	"Adverse Event/Serious Adverse Event"	2574325001	"Fatigue"	71	74	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463496026	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"173"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	3	9	"Adverse Event/Serious Adverse Event"	2534342001	"Fatigue"	13	20	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"174"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	3	9	"Adverse Event/Serious Adverse Event"	2584255001	"Frequency of urination intermittent"	71	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1465223202	""	""	""	NA	"Frequency urinary"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Pollakiuria"	""	""	""	""	""	""	""	""	""	""	""	""
"175"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	3	9	"Adverse Event/Serious Adverse Event"	2535823001	"Hypotension"	8	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"176"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	3	9	"Adverse Event/Serious Adverse Event"	2534352001	"Insomnia"	11	20	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"177"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	3	9	"Adverse Event/Serious Adverse Event"	2608664001	"peripheral neuropathy"	148	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468411923	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"178"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	3	9	"Adverse Event/Serious Adverse Event"	2608698001	"phlebitis r fore arm"	44	46	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"ice pack to affected area 3 x day"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468413759	""	""	""	NA	"Phlebitis arm"	"Vascular disorders"	"Vascular inflammations"	"Phlebitis NEC"	"Phlebitis"	""	""	""	""	""	""	""	""	""	""	""	""
"179"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	3	9	"Adverse Event/Serious Adverse Event"	2608667001	"steroid myopathy"	148	NA	1	2	1	1	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468412122	""	""	""	NA	"Steroid myopathy"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Myopathies"	"Myopathy steroid"	""	""	""	""	""	""	""	""	""	""	""	""
"180"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	3	9	"Adverse Event/Serious Adverse Event"	2535844001	"Tachycardia"	8	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"181"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	3	9	"Adverse Event/Serious Adverse Event"	2608673001	"thrombocytopenia"	118	125	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468412303	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"182"	"DN-101 Protocol No. 011-007"	"006"	"006-0001"	5	9	"Adverse Event/Serious Adverse Event"	2532056003	"Acute DVT of the left lower extremity"	180	183	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	286	NA	NA	180	183	"DVT ultrasound 8/22/06 which showed left sided common DVT and a superficial venous thrombosis on th right."	""	""	2	2	2	NA	2	2	NA	2	"Patient was seen by his urologist on the day of admissions to schedule cystoscopy and ureteral stent change. The physician noticed an increased left lower extremity swelling. Patient was admitted to"	"the hospital for management of anticoagulation. The patient was placed on heparin at first pending his stent replacement. Once stent replacement was complete, the patient was instructed on Lovenox"	"injections and coumadin. Patient was discharged."	""	""	""	""	""	""	""	""	NA	NA	""	1481040292	""	""	""	NA	"DVT"	"Vascular disorders"	"Embolism and thrombosis"	"Peripheral embolism and thrombosis"	"Deep vein thrombosis"	""	""	""	""	""	""	""	""	""	""	""	""
"183"	"DN-101 Protocol No. 011-007"	"006"	"006-0001"	3	9	"Adverse Event/Serious Adverse Event"	2567297001	"Blood in urine"	53	78	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481121149	""	""	""	NA	"Blood in urine"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Urinalysis NEC"	"Blood urine present"	""	""	""	""	""	""	""	""	""	""	""	""
"184"	"DN-101 Protocol No. 011-007"	"006"	"006-0001"	3	9	"Adverse Event/Serious Adverse Event"	2809275001	"Neutropenia"	43	50	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481121403	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"185"	"DN-101 Protocol No. 011-007"	"006"	"006-0001"	3	9	"Adverse Event/Serious Adverse Event"	2545415001	"Syncopal episode"	18	20	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	27	NA	NA	18	20	"3/13/06 EKG with normal sinus rhythm; 3/13/06 Basic metabolic panel with BUN 32, Creatinine 1.0, sodium 131; 3/13/06 Hgb 11.4; and 3/13/06 chest x-ray normal."	""	""	2	2	2	2	2	2	2	2	"Patient was at home when he fainted. He presented to the emergency room without chest pain, palpitations or shortness of breath. Patient was admitted to the cardiac floor for monitoring. Patient"	"discharged on 3/15/06."	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Syncope"	"Nervous system disorders"	"Neurological disorders NEC"	"Disturbances in consciousness NEC"	"Syncope"	""	""	""	""	""	""	""	""	""	""	""	""
"186"	"DN-101 Protocol No. 011-007"	"006"	"006-0002"	5	9	"Adverse Event/Serious Adverse Event"	2551328003	"Bone Pain from Prostate Cancer"	203	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481129033	""	""	""	NA	"Metastatic bone pain"	"Neoplasms benign, malignant and unspecified (incl cysts and polyps)"	"Cancer-related morbidities"	"Oncologic complications and emergencies"	"Metastatic pain"	""	""	""	""	""	""	""	""	""	""	""	""
"187"	"DN-101 Protocol No. 011-007"	"006"	"006-0002"	3	9	"Adverse Event/Serious Adverse Event"	2658236001	"Dizziness"	46	67	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472574810	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"188"	"DN-101 Protocol No. 011-007"	"006"	"006-0002"	3	9	"Adverse Event/Serious Adverse Event"	2658148001	"Intermittent Constipation"	13	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472573314	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"189"	"DN-101 Protocol No. 011-007"	"006"	"006-0002"	3	9	"Adverse Event/Serious Adverse Event"	2658208001	"Left Leg Edema"	109	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472574487	""	""	""	NA	"Leg edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"190"	"DN-101 Protocol No. 011-007"	"006"	"006-0002"	3	9	"Adverse Event/Serious Adverse Event"	2658222001	"Lightheaded"	46	67	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472574591	""	""	""	NA	"Lightheadedness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"191"	"DN-101 Protocol No. 011-007"	"006"	"006-0002"	3	9	"Adverse Event/Serious Adverse Event"	2567192001	"Lower Left Back Pain"	22	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"192"	"DN-101 Protocol No. 011-007"	"006"	"006-0002"	3	9	"Adverse Event/Serious Adverse Event"	2658203001	"Neutropenia"	13	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472574433	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"193"	"DN-101 Protocol No. 011-007"	"006"	"006-0002"	3	9	"Adverse Event/Serious Adverse Event"	2567224001	"skin rash"	10	46	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469017955	""	""	""	NA	"Skin rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"194"	"DN-101 Protocol No. 011-007"	"006"	"006-0002"	3	9	"Adverse Event/Serious Adverse Event"	2616287001	"Swelling in both legs"	82	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469041585	""	""	""	NA	"Swelling of legs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"195"	"DN-101 Protocol No. 011-007"	"008"	"008-0001"	5	9	"Adverse Event/Serious Adverse Event"	2877452003	"Constipation"	95	96	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Patient was hydrated"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494794409	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"196"	"DN-101 Protocol No. 011-007"	"009"	"009-0004"	5	9	"Adverse Event/Serious Adverse Event"	2833683003	"Dermatology/Skin-other: peeling, cracking"	80	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489949708	""	""	""	NA	"Skin peeling"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Exfoliative conditions"	"Skin exfoliation"	""	""	""	""	""	""	""	""	""	""	""	""
"197"	"DN-101 Protocol No. 011-007"	"009"	"009-0004"	3	9	"Adverse Event/Serious Adverse Event"	2917463001	"hypersensitive reaction"	45	45	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Patient c/o flushing and lightheadedness 10 min. after docetaxel started.  Docetaxel infusion stopped for 15 min.  Symptoms resolved.  Docetaxel resumed and completed without any further symptoms."	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486397438	""	""	""	NA	"Hypersensitivity reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"198"	"DN-101 Protocol No. 011-007"	"009"	"009-0004"	3	9	"Adverse Event/Serious Adverse Event"	2970643001	"increased frequency of headache"	50	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488306291	""	""	""	NA	"Frequent headaches"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"199"	"DN-101 Protocol No. 011-007"	"009"	"009-0004"	3	9	"Adverse Event/Serious Adverse Event"	3069244001	"intermittent nausea"	67	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491514819	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"200"	"DN-101 Protocol No. 011-007"	"009"	"009-0004"	3	9	"Adverse Event/Serious Adverse Event"	2871064001	"low neutrophils"	10	17	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484495592	""	""	""	NA	"Neutrophil count low"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Neutrophil count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"201"	"DN-101 Protocol No. 011-007"	"009"	"009-0004"	3	9	"Adverse Event/Serious Adverse Event"	2871077001	"nausea"	5	9	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484495873	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"202"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	5	9	"Adverse Event/Serious Adverse Event"	2909829003	"1/6 systolic flow murmur"	47	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495467994	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"203"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	3	9	"Adverse Event/Serious Adverse Event"	2944206001	"bladder obstruction secondary to hematuria"	13	16	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	6	NA	1	1	"ultrasound; catheterization w/ continuous bladder irrigation"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	14	NA	NA	13	16	"2/13/07:  Urinalysis showing gross hematuria; 2/14/07:	Catheterization for continuous bladder irrigation.  02/14/07:  Ultrasound prior to catheterization"	""	""	2	2	2	NA	2	2	NA	2	"2/13/07--Pt in office for routine hematology.  Used restroom after arrival; afterward stated had just urinated blood; had not had this prior.  Collected urine specimen; result gross hematuria. Cipro"	"ordered.  Patient instructed to call office if new or worsening symptoms.  2/14/07 a.m. patient called office with complaint of unable to urinate since he was in our office the previous day.	Dr."	"Mark Hutchins instructed patient to go to hospital ER for examination, catheterization.  BryanLGH West hospital called re: patient's impending arrival.  In the ER, patient catheterized, bladder"	"irrigated; quite a few blood clots irrigated.  Ultrasound performed showing no hydronephrosis; 5mm known calculus lower pole left kidney unchanged; small clot in bladder; good-sized intravesical"	"component of bladder with prostate cancer protuding into bladder.  Patient admitted and 3-way Foley catheter placed for continuous bladder irrigation.	Patient to be re-evaluted on 2/15/07; further"	"reports to follow."	""	""	""	""	""	NA	NA	""	1487169896	""	""	""	NA	"Bladder obstruction"	"Renal and urinary disorders"	"Bladder and bladder neck disorders (excl calculi)"	"Bladder disorders NEC"	"Bladder obstruction"	""	""	""	""	""	""	""	""	""	""	""	""
"204"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	3	9	"Adverse Event/Serious Adverse Event"	3230833001	"bruising"	89	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495468532	""	""	""	NA	"Bruising"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"205"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	3	9	"Adverse Event/Serious Adverse Event"	3230787001	"hematuria"	36	36	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495467585	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"206"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	3	9	"Adverse Event/Serious Adverse Event"	2944233001	"hematuria"	12	16	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487170581	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"207"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	3	9	"Adverse Event/Serious Adverse Event"	3230790001	"hematuria"	76	81	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495467665	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"208"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	3	9	"Adverse Event/Serious Adverse Event"	3230796001	"hypersensitivity reaction"	26	26	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495467860	""	""	""	NA	"Hypersensitivity reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"209"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	3	9	"Adverse Event/Serious Adverse Event"	3230822001	"intermittent heartburn"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495468331	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"210"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	3	9	"Adverse Event/Serious Adverse Event"	3230830001	"intermittent tearing"	89	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495468460	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"211"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	3	9	"Adverse Event/Serious Adverse Event"	3230815001	"mild epitaxis"	33	47	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495468266	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"212"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	3	9	"Adverse Event/Serious Adverse Event"	3230793001	"mucositis"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495467733	""	""	""	NA	"Mucositis"	"General disorders and administration site conditions"	"General system disorders NEC"	"Mucosal findings abnormal"	"Mucosal inflammation"	""	""	""	""	""	""	""	""	""	""	""	""
"213"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	3	9	"Adverse Event/Serious Adverse Event"	3230803001	"worsening sinus congestion"	33	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495468074	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"214"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	2844494003	"Alopecia"	107	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493919850	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"215"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	3	9	"Adverse Event/Serious Adverse Event"	3160671001	"Constipation"	108	118	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493920689	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"216"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	3	9	"Adverse Event/Serious Adverse Event"	3160617001	"Fatigue"	107	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493919937	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"217"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	3	9	"Adverse Event/Serious Adverse Event"	3160667001	"Hematuria"	79	97	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493920581	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"218"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	3	9	"Adverse Event/Serious Adverse Event"	3068999001	"Infection-Select  Renal/Genitourinary   Urinary tract infection"	63	76	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"IV Fluid hydration"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491510405	""	""	""	NA	"Genitourinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Genitourinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"219"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	3	9	"Adverse Event/Serious Adverse Event"	3160625001	"Taste Alteration"	107	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493920026	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"220"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	3	9	"Adverse Event/Serious Adverse Event"	3160661001	"Weight Loss"	107	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493920459	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"221"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	5	9	"Adverse Event/Serious Adverse Event"	2653623003	"Anemia"	84	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479834315	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"222"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	3	9	"Adverse Event/Serious Adverse Event"	2785405001	"Anemia"	83	84	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479834220	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"223"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	3	9	"Adverse Event/Serious Adverse Event"	2707148001	"chest pain-non cardiac"	32	32	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475603378	""	""	""	NA	"Chest pain (non-cardiac)"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Non-cardiac chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"224"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	3	9	"Adverse Event/Serious Adverse Event"	2785372001	"Decrease total WBC"	78	83	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479833833	""	""	""	NA	"WBC decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"White blood cell count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"225"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	3	9	"Adverse Event/Serious Adverse Event"	2761340001	"Decubitus Ulcer"	71	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"duoderm gel dressing"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478187864	""	""	""	NA	"Decubitus ulcer"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Skin injuries and mechanical dermatoses"	"Decubitus ulcer"	""	""	""	""	""	""	""	""	""	""	""	""
"226"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	3	9	"Adverse Event/Serious Adverse Event"	2785452001	"Deep venous thrombosis- left leg"	81	86	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	72	NA	NA	NA	1	NA	NA	1	"Admitted to hospital and found to have DVT left leg. reported initially as PE  and Dehydration. Need to add DVT"	92	NA	NA	81	86	"doppler ultrasound positive for acute thrombosis left leg on 11/12/2006"	""	""	2	2	2	NA	2	2	NA	2	"DVT left leg  and was admitted for anticoagulation"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479834652	""	""	""	NA	"Deep vein thrombosis leg"	"Vascular disorders"	"Embolism and thrombosis"	"Peripheral embolism and thrombosis"	"Deep vein thrombosis"	""	""	""	""	""	""	""	""	""	""	""	""
"227"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	3	9	"Adverse Event/Serious Adverse Event"	2771349001	"Dehydration"	81	86	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"IV Fluids"	0	0	NA	0	72	NA	NA	NA	1	NA	NA	1	"required admission for IV fluids"	83	NA	NA	81	86	"11/11/2006 clinical physical assessment by MD. no labs to support."	""	""	2	2	2	NA	2	0	NA	2	"Pt admitted to Kettering hospital on saturday Nov. 11, 2006 with clinical signs and symptoms of dehydration including weakness, somnolence, dry mouth.	To receive IV fluids to hydrate."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479048587	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"228"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	3	9	"Adverse Event/Serious Adverse Event"	2761312001	"hypoglycemia"	48	69	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478187447	""	""	""	NA	"Hypoglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hypoglycaemic conditions NEC"	"Hypoglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"229"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	3	9	"Adverse Event/Serious Adverse Event"	2761326001	"Irregular heart rate"	64	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"decreased dose of current conmed--Capoten"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478187571	""	""	""	NA	"Heart rate irregular"	"Investigations"	"Cardiac and vascular investigations (excl enzyme tests)"	"Heart rate and pulse investigations"	"Heart rate irregular"	""	""	""	""	""	""	""	""	""	""	""	""
"230"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	3	9	"Adverse Event/Serious Adverse Event"	2690826001	"neuropathy"	15	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474487596	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"231"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	3	9	"Adverse Event/Serious Adverse Event"	2761297001	"Neutropenia"	43	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478187340	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"232"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	3	9	"Adverse Event/Serious Adverse Event"	2785375001	"Neutropenia"	78	83	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479833948	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"233"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	3	9	"Adverse Event/Serious Adverse Event"	2707153001	"prolonged pt/inr"	32	34	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"hold coumadin"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475603504	""	""	""	NA	"PT prolonged"	"Investigations"	"Haematology investigations (incl blood groups)"	"Coagulation and bleeding analyses"	"Prothrombin time prolonged"	""	""	""	""	""	""	""	""	""	""	""	""
"234"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	3	9	"Adverse Event/Serious Adverse Event"	2771386001	"Pulmonary Embolism"	81	86	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	72	NA	NA	NA	1	NA	NA	1	"Pulmonary embolism"	83	NA	NA	81	86	"D.Dimer 2520,  INR 1.3, PTT 29 drawn on 11/11/2006 Ultrasound and CT PE protocol positive for PE"	""	""	2	2	2	NA	2	2	NA	2	"Pt admitted to hospital on 11/11/06 with weakness, dyspnea, and dehydration and was found to have a very high D. Dimer and Pulmonary embolism.	Placed on anticoagulant therapy."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479049298	""	""	""	NA	"Pulmonary embolism"	"Respiratory, thoracic and mediastinal disorders"	"Pulmonary vascular disorders"	"Pulmonary thrombotic and embolic conditions"	"Pulmonary embolism"	""	""	""	""	""	""	""	""	""	""	""	""
"235"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	3	9	"Adverse Event/Serious Adverse Event"	2785389001	"Thrush"	78	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479834038	""	""	""	NA	"Thrush"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"236"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	3	9	"Adverse Event/Serious Adverse Event"	2690822001	"thrush"	14	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474487488	""	""	""	NA	"Thrush"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"237"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	3	9	"Adverse Event/Serious Adverse Event"	2761337001	"Weakness"	62	70	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478187754	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"238"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	3	9	"Adverse Event/Serious Adverse Event"	2707134001	"weakness"	32	36	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475603274	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"239"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	3	9	"Adverse Event/Serious Adverse Event"	2785398001	"Weakness"	81	86	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479834141	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"240"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	5	9	"Adverse Event/Serious Adverse Event"	2624953003	"hyperglycemia"	0	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476381546	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"241"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	3	9	"Adverse Event/Serious Adverse Event"	3013423001	"Neutropenia"	63	76	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490054284	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"242"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	3	9	"Adverse Event/Serious Adverse Event"	3013444001	"Neutropenia"	146	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490054705	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"243"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	3	9	"Adverse Event/Serious Adverse Event"	3013439001	"Neutropenia"	126	139	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490054620	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"244"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	3	9	"Adverse Event/Serious Adverse Event"	3013436001	"Neutropenia"	104	118	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490054529	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"245"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	3	9	"Adverse Event/Serious Adverse Event"	2674607001	"neutropenia"	20	34	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473551931	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"246"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	3	9	"Adverse Event/Serious Adverse Event"	2674610001	"neutropenia"	41	55	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473551998	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"247"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	3	9	"Adverse Event/Serious Adverse Event"	3013449001	"Neutropenia"	167	183	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490054838	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"248"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	3	9	"Adverse Event/Serious Adverse Event"	3013433001	"Neutropenia"	83	97	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490054445	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"249"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	3	9	"Adverse Event/Serious Adverse Event"	3013455001	"Neutropenia"	209	225	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490054931	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"250"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	3	9	"Adverse Event/Serious Adverse Event"	2889470001	"prostatitis"	188	225	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485198005	""	""	""	NA	"Prostatitis"	"Reproductive system and breast disorders"	"Male reproductive tract infections and inflammations"	"Prostate and seminal vesicles infections and inflammations"	"Prostatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"251"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	3	9	"Adverse Event/Serious Adverse Event"	3013470001	"URI"	209	213	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490055401	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"252"	"DN-101 Protocol No. 011-007"	"014"	"014-0002"	5	9	"Adverse Event/Serious Adverse Event"	2840459003	"fatigue"	72	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487282086	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"253"	"DN-101 Protocol No. 011-007"	"014"	"014-0002"	3	9	"Adverse Event/Serious Adverse Event"	3220349001	"R lower leg fluid reetention"	135	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495133491	""	""	""	NA	"Edema lower limb"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"254"	"DN-101 Protocol No. 011-007"	"014"	"014-0002"	3	9	"Adverse Event/Serious Adverse Event"	2951919001	"rash to bilateral arms"	72	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487282238	""	""	""	NA	"Rash over arms"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"255"	"DN-101 Protocol No. 011-007"	"014"	"014-0003"	5	9	"Adverse Event/Serious Adverse Event"	2998949003	"Bone Pain"	27	28	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490297633	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"256"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	2562368003	"anxiety"	15	15	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474465655	""	""	""	NA	"Anxiety"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Anxiety"	""	""	""	""	""	""	""	""	""	""	""	""
"257"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2690009001	"chest pain - non cardiac"	15	15	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474465351	""	""	""	NA	"Chest pain (non-cardiac)"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Non-cardiac chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"258"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2864409001	"compression fracture T9 & T10"	268	320	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"admitted to evaluate for kyphoplasty; immobilization"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	272	NA	NA	268	272	"Thoracic spine x-ray on 1-6-07 finds \"approximate 30-50% compression fracture deformities of T9 & T10\";MRI of thoracic spine on 1-8-07 finds \"compression fractures at T9 & T10 secondary to"	"osteoporosis\""	""	2	2	2	2	2	2	2	2	"pt went to ER on 1-6-07 with back pain.  DX of compression fractures of T9 & T10.  Pt was admitted to evaluate for possible kyphoplasty.;pt was fitted for a turtle brace, discharged home to follow up"	"with neurosurgeon for possible kyphoplasty in the future if needed for pain not controlled by brace.;Not considered a SRE therefore this will not be documented in the SRE pages.;**5-17-07** According"	"to Dr. Craig Berman at Novacea, the determination of osteoporosis etiology for the compression fracture does not qualify as a SRE."	""	""	""	""	""	""	""	""	NA	NA	""	1484082572	""	""	""	NA	"Compression fracture"	"Injury, poisoning and procedural complications"	"Bone and joint injuries"	"Fractures and dislocations NEC"	"Compression fracture"	""	""	""	""	""	""	""	""	""	""	""	""
"259"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2619995001	"dizziness"	42	69	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469385089	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"260"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2620051001	"dizziness"	85	92	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469386422	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"261"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2690068001	"dysguesia"	92	99	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474467012	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"262"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2864933001	"eczema"	236	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484085378	""	""	""	NA	"Eczema"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermatitis and eczema"	"Eczema"	""	""	""	""	""	""	""	""	""	""	""	""
"263"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2690071001	"fatigue"	36	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474467081	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"264"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2619983001	"headache"	15	22	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"lower Kytril dose"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469384808	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"265"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2619979001	"heartburn"	15	36	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469384666	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"266"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2723334001	"leukopenia"	155	162	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476284994	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"267"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2690092001	"leukopenia"	148	155	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474467645	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"268"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2690086001	"leukopenia"	127	134	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474467497	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"269"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2687185001	"leukopenia"	42	50	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"neutropenic precautions"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474317369	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"270"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2687218001	"leukopenia"	85	92	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"neutropenic precautions"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474317628	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"271"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2687083001	"leukopenia"	22	29	NA	3	0	NA	NA	NA	NA	NA	NA	NA	NA	4	NA	NA	1	"neutropenic precautions"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474316834	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"272"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2687271001	"leukopenia"	63	71	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"neutropenic precautions"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474318028	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"273"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2800213001	"nail changes"	162	320	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480883782	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"274"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2690089001	"neutropenia"	148	155	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474467576	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"275"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2723346001	"neutropenia"	155	162	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476285063	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"276"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2690083001	"neutropenia"	127	134	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474467432	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"277"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2620035001	"neutropenia"	22	29	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"neutropenic precautions"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469386056	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"278"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2623935001	"NEUTROPENIA"	63	71	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"NEUTROPENIC PRECAUTIONS"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469561807	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"279"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2620056001	"neutropenia"	85	92	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"neutropenic precautions"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469386591	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"280"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2620043001	"neutropenia"	42	50	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"neutropenic precautions"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469386257	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"281"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2723355001	"nocturia"	141	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476285173	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"282"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2690049001	"orthostatic hypotension"	120	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474466166	""	""	""	NA	"Orthostatic hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Orthostatic hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"283"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	3017194001	"pedal edema"	236	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490129713	""	""	""	NA	"Pedal edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"284"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2690040001	"pedal edema"	120	141	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474466039	""	""	""	NA	"Pedal edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"285"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2690080001	"productive cough with white sputum"	120	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474467345	""	""	""	NA	"Productive cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Productive cough"	""	""	""	""	""	""	""	""	""	""	""	""
"286"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2690077001	"productive cough with yellow sputum"	74	120	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474467248	""	""	""	NA	"Productive cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Productive cough"	""	""	""	""	""	""	""	""	""	""	""	""
"287"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	3017175001	"right rib fracture"	236	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490129539	""	""	""	NA	"Fracture rib"	"Injury, poisoning and procedural complications"	"Bone and joint injuries"	"Thoracic cage fractures and dislocations"	"Rib fracture"	""	""	""	""	""	""	""	""	""	""	""	""
"288"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2619986001	"scalp tenderness"	36	42	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469384949	""	""	""	NA	"Scalp tenderness"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Pain of skin"	""	""	""	""	""	""	""	""	""	""	""	""
"289"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	3	9	"Adverse Event/Serious Adverse Event"	2690032001	"viral URI"	74	78	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474465936	""	""	""	NA	"Upper respiratory tract infection viral NOS"	"Infections and infestations"	"Viral infectious disorders"	"Viral infections NEC"	"Viral upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"290"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	2752242003	"Decreased Mobility"	164	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"MRI L/S ordered for 4-05-07"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491407007	""	""	""	NA	"Mobility decreased"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Mobility decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"291"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	2818665001	"Dizziness"	36	71	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481558313	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"292"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	3238650001	"Fatigue"	207	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495640323	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"293"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	2797912001	"fatigue"	17	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480620676	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"294"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	2798158001	"fever"	37	38	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480622135	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"295"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	3187055001	"Headache"	178	199	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494783085	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"296"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	2799246001	"Hyperglycemia"	39	40	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Sent to Endocrinologist for diabetes management and insulin addition . Does have hx of diabetes which was well-controlled however has increased in grade."	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480866599	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"297"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	2799387001	"Hyperglycemia"	40	49	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480867934	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"298"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	2797989001	"hyperglycemia"	28	29	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"already on oral hyperglycemic agents for hx of diabetes/reported the hyperglycemia since grade has increased"	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480621164	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"299"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	2818662001	"Hyperglycemia"	49	59	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481558243	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"300"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	3118035001	"Hyperglycemia"	178	179	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492974008	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"301"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	2798084001	"infection;blood gram negative rods"	37	44	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480621677	""	""	""	NA	"Gram-negative rod infection"	"Infections and infestations"	"Bacterial infectious disorders"	"Bacterial infections NEC"	"Bacterial infection"	""	""	""	""	""	""	""	""	""	""	""	""
"302"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	3238756001	"Intermittant Hematuria"	92	201	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495640732	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"303"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	3062280001	"Leukopenia"	164	178	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491407223	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"304"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	3138083001	"Leukopenia"	186	199	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493314744	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"305"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	2797956001	"leukopenia"	17	28	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480620916	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"306"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	2799349001	"Lymphopenia"	39	49	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480867364	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"307"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	2798055001	"lymphopenia"	37	39	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480621537	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"308"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	2798141001	"malaise"	37	48	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480622004	""	""	""	NA	"Malaise"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Malaise"	""	""	""	""	""	""	""	""	""	""	""	""
"309"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	2797939001	"neutropenia"	17	28	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480620839	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"310"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	3138098001	"Neutropenia"	186	199	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493314858	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"311"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	2839311001	"neutropenia"	59	71	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482360079	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"312"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	2907135001	"Neutropenia"	101	112	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485980767	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"313"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	3062289001	"Neutropenia"	164	178	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491407309	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"314"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	3002549001	"Neutropenia"	143	154	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489606487	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"315"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	3238725001	"Pain back of both legs (thighs)"	207	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495640583	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"316"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	2895971001	"Pain:Low back pain (buttocks area)"	30	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485376143	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"317"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	2895959001	"Pain:Pain to back of both legs( thighs )"	30	207	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485376041	""	""	""	NA	"Pain in thigh"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"318"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	3066219001	"Spinal Stenosis"	86	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491485820	""	""	""	NA	"Spinal stenosis NOS"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)"	"Spine and neck deformities"	"Spinal column stenosis"	""	""	""	""	""	""	""	""	""	""	""	""
"319"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	2798167001	"sweating"	37	71	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480622236	""	""	""	NA	"Sweating"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"320"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	2797965001	"sweating"	23	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480620991	""	""	""	NA	"Sweating"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"321"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	2799322001	"Taste Alteration"	39	91	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480867188	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"322"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	2989543001	"Taste Alteration"	122	204	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489080460	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"323"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	3238693001	"Taste Alteration"	204	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495640459	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"324"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	3238781001	"Urinary Tract Infection"	210	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495640838	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"325"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	2798105001	"urinary tract infection"	37	44	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480621825	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"326"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	2797924001	"weakness"	17	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480620760	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"327"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	2798124001	"weakness"	37	48	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480621903	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"328"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	3	9	"Adverse Event/Serious Adverse Event"	3238642001	"Weakness"	207	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495640252	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"329"	"DN-101 Protocol No. 011-007"	"019"	"019-0003"	5	9	"Adverse Event/Serious Adverse Event"	2779287003	"alopecia"	20	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481145234	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"330"	"DN-101 Protocol No. 011-007"	"019"	"019-0003"	3	9	"Adverse Event/Serious Adverse Event"	2989374001	"Dizziness"	110	134	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489077917	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"331"	"DN-101 Protocol No. 011-007"	"019"	"019-0003"	3	9	"Adverse Event/Serious Adverse Event"	3176539001	"Fatigue"	176	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494434438	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"332"	"DN-101 Protocol No. 011-007"	"019"	"019-0003"	3	9	"Adverse Event/Serious Adverse Event"	2813465001	"leukopenia"	15	22	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481143952	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"333"	"DN-101 Protocol No. 011-007"	"019"	"019-0003"	3	9	"Adverse Event/Serious Adverse Event"	2813737001	"neutropenia"	22	29	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481146063	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"334"	"DN-101 Protocol No. 011-007"	"019"	"019-0003"	3	9	"Adverse Event/Serious Adverse Event"	2813577001	"neutropenia"	15	22	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481144971	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"335"	"DN-101 Protocol No. 011-007"	"022"	"022-0002"	5	9	"Adverse Event/Serious Adverse Event"	2658742003	"alopecia"	33	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474311359	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"336"	"DN-101 Protocol No. 011-007"	"022"	"022-0002"	3	9	"Adverse Event/Serious Adverse Event"	2730570001	"dysuria"	48	53	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476386068	""	""	""	NA	"Dysuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Dysuria"	""	""	""	""	""	""	""	""	""	""	""	""
"337"	"DN-101 Protocol No. 011-007"	"022"	"022-0002"	3	9	"Adverse Event/Serious Adverse Event"	2731305001	"fatigue"	21	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476389952	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"338"	"DN-101 Protocol No. 011-007"	"022"	"022-0002"	3	9	"Adverse Event/Serious Adverse Event"	2730727001	"leukopenia"	51	56	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476387253	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"339"	"DN-101 Protocol No. 011-007"	"022"	"022-0002"	3	9	"Adverse Event/Serious Adverse Event"	2686505001	"leukopenia"	23	35	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474311279	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"340"	"DN-101 Protocol No. 011-007"	"022"	"022-0002"	3	9	"Adverse Event/Serious Adverse Event"	2730954001	"neutropenia"	51	56	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476388674	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"341"	"DN-101 Protocol No. 011-007"	"022"	"022-0002"	3	9	"Adverse Event/Serious Adverse Event"	2731002001	"thrombocytopenia"	56	58	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476388755	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"342"	"DN-101 Protocol No. 011-007"	"024"	"024-0002"	5	9	"Adverse Event/Serious Adverse Event"	2711709003	"anemia"	91	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486649044	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"343"	"DN-101 Protocol No. 011-007"	"024"	"024-0002"	3	9	"Adverse Event/Serious Adverse Event"	2773044001	"constipation"	22	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479140906	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"344"	"DN-101 Protocol No. 011-007"	"024"	"024-0002"	3	9	"Adverse Event/Serious Adverse Event"	2856003001	"fatigue"	51	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483638499	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"345"	"DN-101 Protocol No. 011-007"	"024"	"024-0002"	3	9	"Adverse Event/Serious Adverse Event"	2927860001	"hair loss"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486648854	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"346"	"DN-101 Protocol No. 011-007"	"024"	"024-0002"	3	9	"Adverse Event/Serious Adverse Event"	2856037001	"hoarseness"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483638826	""	""	""	NA	"Hoarseness"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Dysphonia"	""	""	""	""	""	""	""	""	""	""	""	""
"347"	"DN-101 Protocol No. 011-007"	"024"	"024-0002"	3	9	"Adverse Event/Serious Adverse Event"	2927820001	"nausea"	9	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486648610	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"348"	"DN-101 Protocol No. 011-007"	"024"	"024-0002"	3	9	"Adverse Event/Serious Adverse Event"	2927871001	"neutropenia"	56	63	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486648967	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"349"	"DN-101 Protocol No. 011-007"	"024"	"024-0002"	3	9	"Adverse Event/Serious Adverse Event"	2927849001	"sleeplessness"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486648783	""	""	""	NA	"Sleeplessness"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"350"	"DN-101 Protocol No. 011-007"	"024"	"024-0002"	3	9	"Adverse Event/Serious Adverse Event"	2773037001	"urinary infection"	9	39	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479140815	""	""	""	NA	"Urinary infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"351"	"DN-101 Protocol No. 011-007"	"024"	"024-0002"	3	9	"Adverse Event/Serious Adverse Event"	2856023001	"urinary tract infection"	78	85	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483638692	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"352"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	5	9	"Adverse Event/Serious Adverse Event"	2782142003	"Constipation"	117	121	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490815411	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"353"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	3	9	"Adverse Event/Serious Adverse Event"	3044611001	"Dehydration"	37	38	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"increased PO fluids"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490813350	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"354"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	3	9	"Adverse Event/Serious Adverse Event"	3139423001	"Dehydration - Xerostomia"	140	147	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"encouraged increased po fluids"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493324602	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"355"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	3	9	"Adverse Event/Serious Adverse Event"	3044842001	"Dehydration - Xerostomia"	99	113	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"ecnouraged increased PO fluids"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490814448	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"356"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	3	9	"Adverse Event/Serious Adverse Event"	3044994001	"Dehydration - Xerostomia"	119	133	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"encourage increased PO fluids"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490815551	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"357"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	3	9	"Adverse Event/Serious Adverse Event"	3044581001	"Dysgeusia"	37	39	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490813245	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"358"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	3	9	"Adverse Event/Serious Adverse Event"	3044513001	"Fatigue"	36	43	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490812850	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"359"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	3	9	"Adverse Event/Serious Adverse Event"	3044745001	"Fatigue"	78	81	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490813963	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"360"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	3	9	"Adverse Event/Serious Adverse Event"	3139410001	"Fatigue"	140	142	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493324462	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"361"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	3	9	"Adverse Event/Serious Adverse Event"	3044783001	"Fatigue"	100	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490814130	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"362"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	3	9	"Adverse Event/Serious Adverse Event"	3044649001	"Hand Foot Syndrome"	56	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490813462	""	""	""	NA	"Hand and foot syndrome"	"Skin and subcutaneous tissue disorders"	"Skin and subcutaneous tissue disorders NEC"	"Skin and subcutaneous conditions NEC"	"Palmar-plantar erythrodysaesthesia syndrome"	""	""	""	""	""	""	""	""	""	""	""	""
"363"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	3	9	"Adverse Event/Serious Adverse Event"	2824412001	"Hand-Foot Syndrome"	15	35	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481738785	""	""	""	NA	"Hand and foot syndrome"	"Skin and subcutaneous tissue disorders"	"Skin and subcutaneous tissue disorders NEC"	"Skin and subcutaneous conditions NEC"	"Palmar-plantar erythrodysaesthesia syndrome"	""	""	""	""	""	""	""	""	""	""	""	""
"364"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	3	9	"Adverse Event/Serious Adverse Event"	2995374001	"Mucositis - oral cavity"	15	20	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Magic Mouthwash prn"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489423721	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"365"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	3	9	"Adverse Event/Serious Adverse Event"	3044533001	"Mucositis - oral cavity"	37	39	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Magic Mouthwash"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490812978	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"366"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	3	9	"Adverse Event/Serious Adverse Event"	3178048001	"Nail Changes"	141	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494446057	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"367"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	3	9	"Adverse Event/Serious Adverse Event"	3044973001	"Pain - Bilateral thighs to hips"	139	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490815322	""	""	""	NA	"Painful hips"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"368"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	3	9	"Adverse Event/Serious Adverse Event"	3044870001	"Pain - lt. Hip"	109	139	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490814604	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"369"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	3	9	"Adverse Event/Serious Adverse Event"	3044550001	"Rectal Irritation"	37	39	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490813065	""	""	""	NA	"Discomfort rectal"	"Gastrointestinal disorders"	"Anal and rectal conditions NEC"	"Anal and rectal disorders NEC"	"Anal discomfort"	""	""	""	""	""	""	""	""	""	""	""	""
"370"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	5	9	"Adverse Event/Serious Adverse Event"	2695940003	"alopecia"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488158557	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"371"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	3	9	"Adverse Event/Serious Adverse Event"	2967826001	"anemia"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488160247	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"372"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	3	9	"Adverse Event/Serious Adverse Event"	2967820001	"change in taste of food"	118	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488159997	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"373"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	3	9	"Adverse Event/Serious Adverse Event"	2967787001	"constipation"	49	77	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488158870	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"374"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	3	9	"Adverse Event/Serious Adverse Event"	2967800001	"decreased appetite"	7	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488159256	""	""	""	NA	"Appetite decreased NOS"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Decreased appetite"	""	""	""	""	""	""	""	""	""	""	""	""
"375"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	3	9	"Adverse Event/Serious Adverse Event"	2967809001	"dry eyes"	98	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488159690	""	""	""	NA	"Dry eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Dry eye"	""	""	""	""	""	""	""	""	""	""	""	""
"376"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	3	9	"Adverse Event/Serious Adverse Event"	2967823001	"dry mouth"	118	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488160101	""	""	""	NA	"Dry mouth"	"Gastrointestinal disorders"	"Salivary gland conditions"	"Oral dryness and saliva altered"	"Dry mouth"	""	""	""	""	""	""	""	""	""	""	""	""
"377"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	3	9	"Adverse Event/Serious Adverse Event"	2967803001	"fatigue"	7	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488159352	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"378"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	3	9	"Adverse Event/Serious Adverse Event"	2967773001	"hematuria"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488158730	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"379"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	3	9	"Adverse Event/Serious Adverse Event"	2967839001	"hyperglycemia"	98	139	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488160974	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"380"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	3	9	"Adverse Event/Serious Adverse Event"	2967836001	"hyperglycemia"	77	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488160791	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"381"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	3	9	"Adverse Event/Serious Adverse Event"	2967842001	"hyperglycemia"	139	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488161090	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"382"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	3	9	"Adverse Event/Serious Adverse Event"	2967806001	"insomnia"	7	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488159535	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"383"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	3	9	"Adverse Event/Serious Adverse Event"	2967790001	"night sweat"	7	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488158985	""	""	""	NA	"Night sweat"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Night sweats"	""	""	""	""	""	""	""	""	""	""	""	""
"384"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	3	9	"Adverse Event/Serious Adverse Event"	2967761001	"urinary incontinence"	7	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488158368	""	""	""	NA	"Urinary incontinence"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"385"	"DN-101 Protocol No. 011-007"	"027"	"027-0001"	5	9	"Adverse Event/Serious Adverse Event"	2560687003	"ACUTE DVT OF RIGHT LOWER EXTREMITY"	35	36	NA	3	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	35	NA	NA	35	36	"PT/PTT 05/15, 05/16; CBC W/DIFF 05/15/2006; DIGOXIN LEVEL 05/15/2006; PT/PTT/INR 05/15/2006"	""	""	2	2	2	NA	2	2	NA	2	"75 YEAR OLD MALE WITH COMPLAINTS OF RIGHT LOWER EXTREMITY AND RIGHT THIGH SWELLING THAT HAS BEEN ONGOING SINCE PREVIOUS HOSPITALIZATION ON 05/08/2006. ;;THE SYMPTOMS RIGHT LOWER EXTREMITY AND RIGHT"	"THIGH SWELLING IN ADDITION TO PAIN INCREASED WITH STANDING OR WALKING.	;;PATIENT DENIED SYMPTOMS OF CHEST PAIN, SHORTNESS OF BREATH."	""	""	""	""	""	""	""	""	""	NA	NA	""	1463671885	""	""	""	NA	"DVT"	"Vascular disorders"	"Embolism and thrombosis"	"Peripheral embolism and thrombosis"	"Deep vein thrombosis"	""	""	""	""	""	""	""	""	""	""	""	""
"386"	"DN-101 Protocol No. 011-007"	"027"	"027-0001"	3	9	"Adverse Event/Serious Adverse Event"	2965627001	"anemia"	35	56	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488130367	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"387"	"DN-101 Protocol No. 011-007"	"027"	"027-0001"	3	9	"Adverse Event/Serious Adverse Event"	2965196001	"fatigue"	14	35	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488122574	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"388"	"DN-101 Protocol No. 011-007"	"027"	"027-0001"	3	9	"Adverse Event/Serious Adverse Event"	2576292001	"GROUP G STREPTOCOCCUS SEPTICEMIA"	23	28	NA	4	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	35	NA	NA	23	28	"BLOOD CULTURE 05/03/2006;CBC W/DIFF 05/03/2006, 05/05/2006, 05/06/2006, 05/07/2006, 05/08/2006;URINE CULTURE 05/03/2006;STOOL CULTURE 05/03/2006;CT of ABDOMEN 05/UNK/2006;CT OF PELVIS"	"05/UNK/2006;BONE MARROW BIOPSY 05/UNK/2006;CHEST X-RAY 05/04/2006"	""	2	2	2	NA	2	2	NA	2	"75 YEAR OLD MALE WITH COMPLAINTS OF GENERALIZED WEAKNESS, NAUSEA AND FEVER.; ; ON 05/03/2006 ADMITTED WITH TEMPERATURE OF 101, BLOOD PRESSURE OF 68/30 mmHg."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463669987	""	""	""	NA	"Streptococcal septicemia"	"Infections and infestations"	"Bacterial infectious disorders"	"Streptococcal infections"	"Streptococcal sepsis"	""	""	""	""	""	""	""	""	""	""	""	""
"389"	"DN-101 Protocol No. 011-007"	"027"	"027-0001"	3	9	"Adverse Event/Serious Adverse Event"	2600635001	"HYPOKALEMIA"	25	25	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1467214027	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"390"	"DN-101 Protocol No. 011-007"	"027"	"027-0001"	3	9	"Adverse Event/Serious Adverse Event"	2600632001	"HYPOMAGNESEMIA"	25	25	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1467213946	""	""	""	NA	"Hypomagnesemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Magnesium metabolism disorders"	"Hypomagnesaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"391"	"DN-101 Protocol No. 011-007"	"027"	"027-0001"	3	9	"Adverse Event/Serious Adverse Event"	2583626001	"NEUTROPENIC FEVER"	23	28	NA	4	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	53	NA	NA	23	28	"CBC WITH DIFF 05/03/2006, BLOOD CULTURE 05/03/2005"	""	""	2	2	2	NA	1	2	NA	2	")N 05/03/2006 PT. ADMITTED WITH COMPLAINTS OF GENERALIZED WEAKNESS, NAUSEA AND FEVER OF 101 F. ON DAY OF  WBC 400. PATIENT WAS PLACED ON NEUPOGEN 300 MG SQ QD AS WELL AS IV ANTIBIOTIC THERAPY.  ON"	"05/08/2006 PT WAS DISCHARGED HOME WITH HOME HEALTH SERVICE FOR CONTINUED IV ROCEPHIN QD X 14 DAYS."	""	""	""	""	""	""	""	""	""	NA	NA	""	1465160678	""	""	""	NA	"Neutropenic fever"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"392"	"DN-101 Protocol No. 011-007"	"027"	"027-0001"	3	9	"Adverse Event/Serious Adverse Event"	2583576001	"PAROXYSMAL ATRIAL FIBRILLATION"	23	35	NA	2	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1465159996	""	""	""	NA	"Paroxysmal atrial fibrillation"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Atrial fibrillation"	""	""	""	""	""	""	""	""	""	""	""	""
"393"	"DN-101 Protocol No. 011-007"	"027"	"027-0003"	5	9	"Adverse Event/Serious Adverse Event"	2848095003	"alopecia"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487700984	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"394"	"DN-101 Protocol No. 011-007"	"027"	"027-0003"	3	9	"Adverse Event/Serious Adverse Event"	2958629001	"fatigue"	38	44	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487701432	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"395"	"DN-101 Protocol No. 011-007"	"027"	"027-0003"	3	9	"Adverse Event/Serious Adverse Event"	2958620001	"fatigue"	26	37	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487701194	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"396"	"DN-101 Protocol No. 011-007"	"027"	"027-0003"	3	9	"Adverse Event/Serious Adverse Event"	2958626001	"Insomnia"	38	41	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487701325	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"397"	"DN-101 Protocol No. 011-007"	"027"	"027-0003"	3	9	"Adverse Event/Serious Adverse Event"	3196306001	"nausea"	37	58	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494882673	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"398"	"DN-101 Protocol No. 011-007"	"027"	"027-0003"	3	9	"Adverse Event/Serious Adverse Event"	3195712001	"sore throat"	70	74	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494876979	""	""	""	NA	"Sore throat"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Pharyngolaryngeal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"399"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	5	9	"Adverse Event/Serious Adverse Event"	2557593003	"alopecia"	100	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1467741541	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"400"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	3	9	"Adverse Event/Serious Adverse Event"	2562956001	"dry mouth"	18	121	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469553753	""	""	""	NA	"Dry mouth"	"Gastrointestinal disorders"	"Salivary gland conditions"	"Oral dryness and saliva altered"	"Dry mouth"	""	""	""	""	""	""	""	""	""	""	""	""
"401"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	3	9	"Adverse Event/Serious Adverse Event"	2595161001	"dypsnea"	82	100	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"had 2-view chest x-ray/came out negative"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466439457	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"402"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	3	9	"Adverse Event/Serious Adverse Event"	2578964001	"dysguesia"	58	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1464124789	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"403"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	3	9	"Adverse Event/Serious Adverse Event"	2567429001	"dysuria"	38	100	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466005806	""	""	""	NA	"Dysuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Dysuria"	""	""	""	""	""	""	""	""	""	""	""	""
"404"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	3	9	"Adverse Event/Serious Adverse Event"	2578967001	"fatigue"	40	51	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1464125118	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"405"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	3	9	"Adverse Event/Serious Adverse Event"	2592712001	"fatigue"	61	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466005655	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"406"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	3	9	"Adverse Event/Serious Adverse Event"	2562947001	"fatigue"	19	22	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"407"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	3	9	"Adverse Event/Serious Adverse Event"	2562952001	"intermittent constipation"	21	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"408"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	3	9	"Adverse Event/Serious Adverse Event"	2562959001	"leukopenia"	29	38	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"409"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	3	9	"Adverse Event/Serious Adverse Event"	2578958001	"neuropathy"	58	121	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1464124685	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"410"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	3	9	"Adverse Event/Serious Adverse Event"	2562962001	"neutropenia"	29	38	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"411"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	3	9	"Adverse Event/Serious Adverse Event"	2567423001	"urinary tract infection"	38	121	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466005702	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"412"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	3	9	"Adverse Event/Serious Adverse Event"	2567426001	"urine color change"	37	121	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466005734	""	""	""	NA	"Urine color abnormal"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Urinalysis NEC"	"Urine colour abnormal"	""	""	""	""	""	""	""	""	""	""	""	""
"413"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	3	9	"Adverse Event/Serious Adverse Event"	2602480001	"vertigo-intermittent"	97	121	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1467741446	""	""	""	NA	"Vertigo"	"Ear and labyrinth disorders"	"Inner ear and VIIIth cranial nerve disorders"	"Inner ear signs and symptoms"	"Vertigo"	""	""	""	""	""	""	""	""	""	""	""	""
"414"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	2719549003	"abdominal bloating"	70	91	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482252104	""	""	""	NA	"Abdominal bloating"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Flatulence, bloating and distension"	"Abdominal distension"	""	""	""	""	""	""	""	""	""	""	""	""
"415"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	2748063001	"asthenia"	4	7	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477344551	""	""	""	NA	"Asthenia"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"416"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	2950081001	"dehydration"	126	130	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"hydration"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487263817	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"417"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	2950192001	"diaphoresis"	124	131	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487264370	""	""	""	NA	"Diaphoresis"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"418"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	2967912001	"diarrehea"	124	131	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488168006	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"419"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	2834019001	"dypsnea"	70	91	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482252276	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"420"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	2748071001	"dyspepsia"	14	25	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477344810	""	""	""	NA	"Dyspepsia"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"421"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	2983686001	"elevated ALT"	134	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488913278	""	""	""	NA	"ALT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Alanine aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"422"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	2983652001	"elevated AST"	134	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488913144	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"423"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	2834147001	"elevated BUN"	67	127	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482253974	""	""	""	NA	"Blood urea nitrogen increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood urea increased"	""	""	""	""	""	""	""	""	""	""	""	""
"424"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	2983635001	"elevated BUN"	130	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488913068	""	""	""	NA	"Blood urea nitrogen increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood urea increased"	""	""	""	""	""	""	""	""	""	""	""	""
"425"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	2763783001	"erectile dysfunction"	28	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478472121	""	""	""	NA	"Erectile dysfunction"	"Reproductive system and breast disorders"	"Sexual function and fertility disorders"	"Erection and ejaculation conditions and disorders"	"Erectile dysfunction"	""	""	""	""	""	""	""	""	""	""	""	""
"426"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	2950200001	"fatigue"	126	130	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"hydration"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487264762	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"427"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	2949944001	"fever"	124	128	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"hydration"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487263075	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"428"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	2763765001	"flatus"	15	49	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478471817	""	""	""	NA	"Flatus"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Flatulence, bloating and distension"	"Flatulence"	""	""	""	""	""	""	""	""	""	""	""	""
"429"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	2949998001	"generalized arthalgia"	126	144	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487263303	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"430"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	2950197001	"headache"	126	128	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"hydration"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487264658	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"431"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	2763771001	"hot flashes-intermittent"	15	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478471899	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"432"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	2983615001	"hypoalbuminemia"	130	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488912901	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"433"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	3081848001	"hypokalemia"	127	130	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492032689	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"434"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	3081856001	"hyponatremia"	127	130	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"hydration"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492032748	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"435"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	2950021001	"intermittent abdominal pain/cramping"	124	131	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487263435	""	""	""	NA	"Abdominal crampy pains"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"436"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	2748060001	"jaw pain"	6	8	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477344472	""	""	""	NA	"Jaw pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Pain in jaw"	""	""	""	""	""	""	""	""	""	""	""	""
"437"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	2949964001	"muscle weakness"	126	130	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"hydration"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487263169	""	""	""	NA	"Muscle weakness NOS"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"438"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	2833963001	"right jaw pain intermittent"	63	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482251915	""	""	""	NA	"Jaw pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Pain in jaw"	""	""	""	""	""	""	""	""	""	""	""	""
"439"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	2967890001	"salmonella infection"	133	140	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488167481	""	""	""	NA	"Salmonella infection NOS"	"Infections and infestations"	"Bacterial infectious disorders"	"Salmonella infections"	"Salmonellosis"	""	""	""	""	""	""	""	""	""	""	""	""
"440"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	2748066001	"scrotal pain post tx"	4	6	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477344647	""	""	""	NA	"Scrotal pain"	"Reproductive system and breast disorders"	"Penile and scrotal disorders (excl infections and inflammations)"	"Scrotal disorders NEC"	"Scrotal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"441"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	2942389001	"sinusitis"	91	114	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487110372	""	""	""	NA	"Sinusitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Sinusitis"	""	""	""	""	""	""	""	""	""	""	""	""
"442"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	3	9	"Adverse Event/Serious Adverse Event"	2834004001	"Weight Gain"	70	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482252195	""	""	""	NA	"Weight gain"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight increased"	""	""	""	""	""	""	""	""	""	""	""	""
"443"	"DN-101 Protocol No. 011-007"	"030"	"030-0004"	5	9	"Adverse Event/Serious Adverse Event"	2754380003	"elevated BUN"	57	79	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482256156	""	""	""	NA	"Blood urea nitrogen increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood urea increased"	""	""	""	""	""	""	""	""	""	""	""	""
"444"	"DN-101 Protocol No. 011-007"	"030"	"030-0004"	3	9	"Adverse Event/Serious Adverse Event"	2863286001	"hypoalbuminemia"	36	92	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484068599	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"445"	"DN-101 Protocol No. 011-007"	"030"	"030-0004"	3	9	"Adverse Event/Serious Adverse Event"	2863248001	"hypocalcemia"	57	92	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484068076	""	""	""	NA	"Hypocalcemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Calcium metabolism disorders"	"Hypocalcaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"446"	"DN-101 Protocol No. 011-007"	"030"	"030-0004"	3	9	"Adverse Event/Serious Adverse Event"	2772434001	"hypotension"	21	36	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"held Toprol"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479100752	""	""	""	NA	"Hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"447"	"DN-101 Protocol No. 011-007"	"030"	"030-0004"	3	9	"Adverse Event/Serious Adverse Event"	2772440001	"leukopenia"	21	36	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479100837	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"448"	"DN-101 Protocol No. 011-007"	"030"	"030-0004"	3	9	"Adverse Event/Serious Adverse Event"	2772443001	"neutropenia"	21	36	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479100892	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"449"	"DN-101 Protocol No. 011-007"	"030"	"030-0004"	3	9	"Adverse Event/Serious Adverse Event"	2863298001	"pruritis"	60	72	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484068851	""	""	""	NA	"Pruritis"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Pruritus NEC"	"Pruritus"	""	""	""	""	""	""	""	""	""	""	""	""
"450"	"DN-101 Protocol No. 011-007"	"030"	"030-0004"	3	9	"Adverse Event/Serious Adverse Event"	2784212001	"rash- lower abdomen"	28	36	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479749628	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"451"	"DN-101 Protocol No. 011-007"	"030"	"030-0004"	3	9	"Adverse Event/Serious Adverse Event"	2784206001	"rash-axilla bilateral"	28	36	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479749573	""	""	""	NA	"Localised rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"452"	"DN-101 Protocol No. 011-007"	"030"	"030-0004"	3	9	"Adverse Event/Serious Adverse Event"	2772449001	"teeth pain-intermittent"	14	79	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479101192	""	""	""	NA	"Tooth pain"	"Gastrointestinal disorders"	"Dental and gingival conditions"	"Dental pain and sensation disorders"	"Toothache"	""	""	""	""	""	""	""	""	""	""	""	""
"453"	"DN-101 Protocol No. 011-007"	"030"	"030-0004"	3	9	"Adverse Event/Serious Adverse Event"	2772446001	"vertigo"	21	21	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479100971	""	""	""	NA	"Vertigo"	"Ear and labyrinth disorders"	"Inner ear and VIIIth cranial nerve disorders"	"Inner ear signs and symptoms"	"Vertigo"	""	""	""	""	""	""	""	""	""	""	""	""
"454"	"DN-101 Protocol No. 011-007"	"030"	"030-0005"	5	9	"Adverse Event/Serious Adverse Event"	2888854003	"alopecia"	26	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487101990	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"455"	"DN-101 Protocol No. 011-007"	"030"	"030-0005"	3	9	"Adverse Event/Serious Adverse Event"	2983164001	"constipation"	42	43	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"disimpaction"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488910542	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"456"	"DN-101 Protocol No. 011-007"	"030"	"030-0005"	3	9	"Adverse Event/Serious Adverse Event"	2906075001	"dysguesia"	12	17	NA	2	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485964779	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"457"	"DN-101 Protocol No. 011-007"	"030"	"030-0005"	3	9	"Adverse Event/Serious Adverse Event"	2983240001	"elevated Alkaline Phosphatase"	25	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488910985	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"458"	"DN-101 Protocol No. 011-007"	"030"	"030-0005"	3	9	"Adverse Event/Serious Adverse Event"	2940981001	"fatigue"	17	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487101879	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"459"	"DN-101 Protocol No. 011-007"	"030"	"030-0005"	3	9	"Adverse Event/Serious Adverse Event"	2905982001	"halluciniations"	8	11	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485964044	""	""	""	NA	"Hallucinations"	"Psychiatric disorders"	"Disturbances in thinking and perception"	"Perception disturbances"	"Hallucination"	""	""	""	""	""	""	""	""	""	""	""	""
"460"	"DN-101 Protocol No. 011-007"	"030"	"030-0005"	3	9	"Adverse Event/Serious Adverse Event"	2901361001	"intermittent constipation"	8	17	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485803037	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"461"	"DN-101 Protocol No. 011-007"	"030"	"030-0009"	5	9	"Adverse Event/Serious Adverse Event"	3109940003	"arthalgia hands-intermittent"	13	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493585795	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"462"	"DN-101 Protocol No. 011-007"	"030"	"030-0009"	3	9	"Adverse Event/Serious Adverse Event"	3146511001	"fatigue"	13	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493585838	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"463"	"DN-101 Protocol No. 011-007"	"030"	"030-0009"	3	9	"Adverse Event/Serious Adverse Event"	3197789001	"intermittent vertigo"	17	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494897988	""	""	""	NA	"Vertigo"	"Ear and labyrinth disorders"	"Inner ear and VIIIth cranial nerve disorders"	"Inner ear signs and symptoms"	"Vertigo"	""	""	""	""	""	""	""	""	""	""	""	""
"464"	"DN-101 Protocol No. 011-007"	"030"	"030-0009"	3	9	"Adverse Event/Serious Adverse Event"	3172727001	"leukopenia"	17	27	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494355659	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"465"	"DN-101 Protocol No. 011-007"	"030"	"030-0009"	3	9	"Adverse Event/Serious Adverse Event"	3172766001	"neutropenia"	17	27	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494355997	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"466"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	2536465003	"anemia"	77	111	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470175775	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"467"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	3	9	"Adverse Event/Serious Adverse Event"	2571031001	"constipation"	15	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1462986528	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"468"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	3	9	"Adverse Event/Serious Adverse Event"	2556832001	"dizziness"	11	11	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"469"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	3	9	"Adverse Event/Serious Adverse Event"	2571038001	"dry skin"	48	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1462986655	""	""	""	NA	"Dry skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Dry skin"	""	""	""	""	""	""	""	""	""	""	""	""
"470"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	3	9	"Adverse Event/Serious Adverse Event"	2556819001	"fatigue"	11	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"471"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	3	9	"Adverse Event/Serious Adverse Event"	2629905001	"feet tingling"	133	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470175578	""	""	""	NA	"Tingling feet/hands"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"472"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	3	9	"Adverse Event/Serious Adverse Event"	3205233001	"groin pain"	294	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494969466	""	""	""	NA	"Groin pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Soft tissue disorders NEC"	"Groin pain"	""	""	""	""	""	""	""	""	""	""	""	""
"473"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	3	9	"Adverse Event/Serious Adverse Event"	2556810001	"leukopenia"	14	28	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"474"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	3	9	"Adverse Event/Serious Adverse Event"	2629914001	"leukopenia"	98	111	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470175720	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"475"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	3	9	"Adverse Event/Serious Adverse Event"	2581677001	"leukopenia"	77	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1464887155	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"476"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	3	9	"Adverse Event/Serious Adverse Event"	2556839001	"lower extremity myalgias"	11	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Myalgia of lower extremities"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"477"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	3	9	"Adverse Event/Serious Adverse Event"	2629911001	"nail changes"	133	231	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470175664	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"478"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	3	9	"Adverse Event/Serious Adverse Event"	2556816001	"neutropenia"	14	28	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"479"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	3	9	"Adverse Event/Serious Adverse Event"	2571028001	"thrombocytopenia"	35	56	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1462986439	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"480"	"DN-101 Protocol No. 011-007"	"034"	"034-0001"	5	9	"Adverse Event/Serious Adverse Event"	2663284003	"Allergic Rhinitis"	28	31	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476890757	""	""	""	NA	"Allergic rhinitis"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal congestion and inflammations"	"Rhinitis allergic"	""	""	""	""	""	""	""	""	""	""	""	""
"481"	"DN-101 Protocol No. 011-007"	"034"	"034-0001"	3	9	"Adverse Event/Serious Adverse Event"	2723711001	"Anemia"	14	63	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476288508	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"482"	"DN-101 Protocol No. 011-007"	"034"	"034-0001"	3	9	"Adverse Event/Serious Adverse Event"	3033443001	"Deep Vein Thrombosis"	90	92	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	90	NA	NA	90	92	"none"	""	""	2	2	2	2	2	2	2	2	"Ultrasound showed Acute deep vein thrombosis.  He was admitted and treated with Lovenox and Coumadin."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490631109	""	""	""	NA	"Deep vein thrombosis"	"Vascular disorders"	"Embolism and thrombosis"	"Peripheral embolism and thrombosis"	"Deep vein thrombosis"	""	""	""	""	""	""	""	""	""	""	""	""
"483"	"DN-101 Protocol No. 011-007"	"034"	"034-0001"	3	9	"Adverse Event/Serious Adverse Event"	2753971001	"febrile neutropenia"	57	60	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	40	NA	NA	NA	1	NA	1	NA	""	58	NA	NA	57	65	"WBC- 900-  Manual diff= Bands .02 Neut .25 = ; AGC of 243"	""	""	2	2	2	NA	2	2	NA	2	"ON 10/26/06 patient went to ER with a 101 fever and weakness.  Mild diarrhea.; Grade 4 neutropenia"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477598809	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"484"	"DN-101 Protocol No. 011-007"	"034"	"034-0001"	3	9	"Adverse Event/Serious Adverse Event"	2723880001	"hypocalcemia"	28	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476289962	""	""	""	NA	"Hypocalcemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Calcium metabolism disorders"	"Hypocalcaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"485"	"DN-101 Protocol No. 011-007"	"034"	"034-0001"	3	9	"Adverse Event/Serious Adverse Event"	2773428001	"hypokalemia"	64	65	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479146268	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"486"	"DN-101 Protocol No. 011-007"	"034"	"034-0001"	3	9	"Adverse Event/Serious Adverse Event"	2723797001	"hyponatremia"	28	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476289459	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"487"	"DN-101 Protocol No. 011-007"	"034"	"034-0001"	3	9	"Adverse Event/Serious Adverse Event"	2723774001	"neutropenia"	14	21	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476289147	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"488"	"DN-101 Protocol No. 011-007"	"034"	"034-0001"	3	9	"Adverse Event/Serious Adverse Event"	2723566001	"Pain port placement"	28	35	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476287550	""	""	""	NA	"Catheter site pain"	"General disorders and administration site conditions"	"Administration site reactions"	"Implant and catheter site reactions"	"Catheter site pain"	""	""	""	""	""	""	""	""	""	""	""	""
"489"	"DN-101 Protocol No. 011-007"	"036"	"036-0003"	5	9	"Adverse Event/Serious Adverse Event"	2951765003	"Constipation"	67	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493315730	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"490"	"DN-101 Protocol No. 011-007"	"036"	"036-0003"	3	9	"Adverse Event/Serious Adverse Event"	3093463001	"Edema of Right Ankle"	29	39	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Venous Doppler Ultrasound Right Lower Limb"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492436786	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"491"	"DN-101 Protocol No. 011-007"	"036"	"036-0003"	3	9	"Adverse Event/Serious Adverse Event"	3138193001	"Nausea"	71	75	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493315811	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"492"	"DN-101 Protocol No. 011-007"	"036"	"036-0003"	3	9	"Adverse Event/Serious Adverse Event"	3222746001	"Pain"	94	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495139112	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"493"	"DN-101 Protocol No. 011-007"	"036"	"036-0003"	3	9	"Adverse Event/Serious Adverse Event"	3096552001	"Swelling of both ankles"	46	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492459755	""	""	""	NA	"Ankles swelling"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Joint swelling"	""	""	""	""	""	""	""	""	""	""	""	""
"494"	"DN-101 Protocol No. 011-007"	"036"	"036-0003"	3	9	"Adverse Event/Serious Adverse Event"	3138143001	"Syncope"	58	58	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Patient was taken by ambulance to the Emergency department, assessed and released after determining that the Syncope was caused by an episode of Hypotension"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493315344	""	""	""	NA	"Syncope"	"Nervous system disorders"	"Neurological disorders NEC"	"Disturbances in consciousness NEC"	"Syncope"	""	""	""	""	""	""	""	""	""	""	""	""
"495"	"DN-101 Protocol No. 011-007"	"036"	"036-0003"	3	9	"Adverse Event/Serious Adverse Event"	3138202001	"Vomiting"	74	74	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493315919	""	""	""	NA	"Vomiting"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Vomiting"	""	""	""	""	""	""	""	""	""	""	""	""
"496"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	5	9	"Adverse Event/Serious Adverse Event"	2609204003	"Alopecia"	27	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470755914	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"497"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	3	9	"Adverse Event/Serious Adverse Event"	2654644001	"Constipation"	30	31	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472420167	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"498"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	3	9	"Adverse Event/Serious Adverse Event"	2859573001	"dyspnea on exertion"	148	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483906638	""	""	""	NA	"Dyspnea exertional"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea exertional"	""	""	""	""	""	""	""	""	""	""	""	""
"499"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	3	9	"Adverse Event/Serious Adverse Event"	2631780001	"Edema - Right Lower extremity"	20	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470338883	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"500"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	3	9	"Adverse Event/Serious Adverse Event"	2859531001	"edema bilateral feet"	91	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483906267	""	""	""	NA	"Foot edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"501"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	3	9	"Adverse Event/Serious Adverse Event"	2859594001	"edema left upper extremity"	148	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483906880	""	""	""	NA	"Edema extremity upper"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"502"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	3	9	"Adverse Event/Serious Adverse Event"	2859588001	"edema lower extremities"	148	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483906792	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"503"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	3	9	"Adverse Event/Serious Adverse Event"	2702212001	"Epistaxis"	80	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Stop taking Ansaid"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475183364	""	""	""	NA	"Epistaxis"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"504"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	3	9	"Adverse Event/Serious Adverse Event"	2687330001	"Fatigue"	51	61	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474318984	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"505"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	3	9	"Adverse Event/Serious Adverse Event"	2702107001	"Fatigue"	80	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475181897	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"506"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	3	9	"Adverse Event/Serious Adverse Event"	2687324001	"Generalized myalgia's"	51	61	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474318743	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"507"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	3	9	"Adverse Event/Serious Adverse Event"	2859516001	"generalized pain"	91	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483906182	""	""	""	NA	"General body pain"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Pain"	""	""	""	""	""	""	""	""	""	""	""	""
"508"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	3	9	"Adverse Event/Serious Adverse Event"	2654650001	"Hot flashes"	30	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472420411	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"509"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	3	9	"Adverse Event/Serious Adverse Event"	2656938001	"Inadequate venous access"	10	10	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472501913	""	""	""	NA	"Poor venous access"	"Vascular disorders"	"Vascular disorders NEC"	"Non-site specific vascular disorders NEC"	"Poor venous access"	""	""	""	""	""	""	""	""	""	""	""	""
"510"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	3	9	"Adverse Event/Serious Adverse Event"	2631786001	"Neutropenia"	20	27	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470338993	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"511"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	3	9	"Adverse Event/Serious Adverse Event"	2705230001	"Neutropenia"	83	91	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475516209	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"512"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	3	9	"Adverse Event/Serious Adverse Event"	2631774001	"Neutropenia"	14	20	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470338792	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"513"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	3	9	"Adverse Event/Serious Adverse Event"	2672772001	"Neutropenia"	56	69	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473354409	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"514"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	3	9	"Adverse Event/Serious Adverse Event"	2859548001	"onychosis hands and feet"	148	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483906426	""	""	""	NA	"Onycholysis"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Onycholysis"	""	""	""	""	""	""	""	""	""	""	""	""
"515"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	3	9	"Adverse Event/Serious Adverse Event"	2859562001	"orbital edema"	148	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483906551	""	""	""	NA	"Orbital edema"	"Eye disorders"	"Ocular structural change, deposit and degeneration NEC"	"Orbital structural change, deposit and degeneration"	"Orbital oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"516"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	3	9	"Adverse Event/Serious Adverse Event"	2702118001	"Pain - knees bilaterally"	80	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475182092	""	""	""	NA	"Knee pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"517"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	3	9	"Adverse Event/Serious Adverse Event"	3189742001	"pain bilateral legs"	251	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494794855	""	""	""	NA	"Pain legs"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"518"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	3	9	"Adverse Event/Serious Adverse Event"	2664003001	"Rash - bilaterally axilla"	53	59	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473096517	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"519"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	5	9	"Adverse Event/Serious Adverse Event"	2559571003	"constipation"	231	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482430079	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"520"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	3	9	"Adverse Event/Serious Adverse Event"	2840022001	"constipation"	161	182	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482423069	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"521"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	3	9	"Adverse Event/Serious Adverse Event"	2712213001	"constipation"	147	154	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475787708	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"522"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	3	9	"Adverse Event/Serious Adverse Event"	2840093001	"dysenea with exertion"	210	231	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482424490	""	""	""	NA	"Dyspnea exertional"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea exertional"	""	""	""	""	""	""	""	""	""	""	""	""
"523"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	3	9	"Adverse Event/Serious Adverse Event"	2840320001	"elevated AST"	231	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482429823	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"524"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	3	9	"Adverse Event/Serious Adverse Event"	2840114001	"elevated AST & ALT"	203	217	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482424910	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"525"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	3	9	"Adverse Event/Serious Adverse Event"	2840019001	"elevated creatinine"	154	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482423009	""	""	""	NA	"Creatinine increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"526"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	3	9	"Adverse Event/Serious Adverse Event"	2839936001	"fatigue"	147	182	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482421341	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"527"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	3	9	"Adverse Event/Serious Adverse Event"	2587629001	"Fatigue"	7	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1465404316	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"528"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	3	9	"Adverse Event/Serious Adverse Event"	2840102001	"fatigue"	210	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482424619	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"529"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	3	9	"Adverse Event/Serious Adverse Event"	2567350001	"Fever"	10	11	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1465418605	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"530"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	3	9	"Adverse Event/Serious Adverse Event"	2818822001	"hyperalkaline phosphatase"	28	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481560701	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"531"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	3	9	"Adverse Event/Serious Adverse Event"	2567342001	"Hyperglycemia"	7	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1465151757	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"532"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	3	9	"Adverse Event/Serious Adverse Event"	2840003001	"loss of appetite"	154	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482422753	""	""	""	NA	"Appetite lost"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"533"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	3	9	"Adverse Event/Serious Adverse Event"	2839986001	"neuropathy"	147	154	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482422616	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"534"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	3	9	"Adverse Event/Serious Adverse Event"	2840359001	"paresthesias"	231	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482430200	""	""	""	NA	"Paresthesia"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"535"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	3	9	"Adverse Event/Serious Adverse Event"	2840365001	"weakness"	231	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482430248	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"536"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	3	9	"Adverse Event/Serious Adverse Event"	2840371001	"weight loss/appetite"	231	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482430307	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"537"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	3	9	"Adverse Event/Serious Adverse Event"	2840084001	"weight loss/appetite"	203	210	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482424254	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"538"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	5	9	"Adverse Event/Serious Adverse Event"	2576896003	"Albumin, low"	131	132	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492704976	""	""	""	NA	"Albumin low"	"Investigations"	"Protein and chemistry analyses NEC"	"Protein analyses NEC"	"Blood albumin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"539"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	3	9	"Adverse Event/Serious Adverse Event"	3110895001	"Alkaline Phosphatase"	7	159	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492705026	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"540"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	3	9	"Adverse Event/Serious Adverse Event"	3110914001	"ALT, SGPT elevated"	68	308	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492705115	""	""	""	NA	"ALT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Alanine aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"541"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	3	9	"Adverse Event/Serious Adverse Event"	3110922001	"AST, SGOT"	47	308	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492705176	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"542"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	3	9	"Adverse Event/Serious Adverse Event"	2611430001	"Fatigue"	26	47	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468782013	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"543"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	3	9	"Adverse Event/Serious Adverse Event"	3110936001	"Glucose, high"	7	308	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492705295	""	""	""	NA	"Glucose high"	"Investigations"	"Metabolic, nutritional and blood gas investigations"	"Carbohydrate tolerance analyses (incl diabetes)"	"Blood glucose increased"	""	""	""	""	""	""	""	""	""	""	""	""
"544"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	3	9	"Adverse Event/Serious Adverse Event"	3110838001	"Hemoglobin"	7	180	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492704610	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"545"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	3	9	"Adverse Event/Serious Adverse Event"	3110850001	"Lymphopenia"	130	130	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492704676	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"546"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	3	9	"Adverse Event/Serious Adverse Event"	2683626001	"numbness and tingling"	68	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474212767	""	""	""	NA	"Numbness"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"547"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	3	9	"Adverse Event/Serious Adverse Event"	3110941001	"Phosphate, low"	131	132	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492705384	""	""	""	NA	"Phosphate low"	"Investigations"	"Water, electrolyte and mineral investigations"	"Mineral and electrolyte analyses"	"Blood phosphorus decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"548"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	3	9	"Adverse Event/Serious Adverse Event"	2693955001	"pneumonia"	130	140	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	4	NA	NA	1	"will confirm once I have documentation"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	131	NA	NA	130	132	""	""	""	2	1	2	NA	2	0	NA	0	"Pt called Urgent Care Center reporting a fever of 102.8 and generalized aches, but no localizing symptoms.  He was asked to come in and later admitted with pnuemonia, confirmed on chest x-ray.  Pt is"	"scheduled to receive treatment on 9/27/06, however this will be delayed."	""	""	""	""	""	""	""	""	""	NA	NA	""	1474830699	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"549"	"DN-101 Protocol No. 011-007"	"041"	"041-0006"	5	9	"Adverse Event/Serious Adverse Event"	2576905003	"Anemia"	7	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1464896497	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"550"	"DN-101 Protocol No. 011-007"	"041"	"041-0006"	3	9	"Adverse Event/Serious Adverse Event"	3110990001	"AST, SGOT"	133	196	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492705841	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"551"	"DN-101 Protocol No. 011-007"	"041"	"041-0006"	3	9	"Adverse Event/Serious Adverse Event"	2707911001	"Fatigue"	125	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475619012	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"552"	"DN-101 Protocol No. 011-007"	"041"	"041-0006"	3	9	"Adverse Event/Serious Adverse Event"	3110987001	"Hemoglobin"	7	329	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492705788	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"553"	"DN-101 Protocol No. 011-007"	"041"	"041-0006"	3	9	"Adverse Event/Serious Adverse Event"	2582304001	"Hyperglycemia"	7	329	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1464896597	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"554"	"DN-101 Protocol No. 011-007"	"041"	"041-0006"	3	9	"Adverse Event/Serious Adverse Event"	3110994001	"Potassium, high"	133	196	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492705892	""	""	""	NA	"Potassium high"	"Investigations"	"Water, electrolyte and mineral investigations"	"Mineral and electrolyte analyses"	"Blood potassium increased"	""	""	""	""	""	""	""	""	""	""	""	""
"555"	"DN-101 Protocol No. 011-007"	"041"	"041-0006"	3	9	"Adverse Event/Serious Adverse Event"	3111001001	"Sodium, low"	196	196	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492705961	""	""	""	NA	"Sodium low"	"Investigations"	"Water, electrolyte and mineral investigations"	"Mineral and electrolyte analyses"	"Blood sodium decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"556"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	5	9	"Adverse Event/Serious Adverse Event"	2650456003	"ALT, SGPT elevated"	7	156	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492718485	""	""	""	NA	"ALT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Alanine aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"557"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	3	9	"Adverse Event/Serious Adverse Event"	3112245001	"AST, SGOT elevated"	7	156	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492718530	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"558"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	3	9	"Adverse Event/Serious Adverse Event"	2822260001	"Hemoglobin"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481658862	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"559"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	3	9	"Adverse Event/Serious Adverse Event"	2822253001	"hyperglycemia"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481658799	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"560"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	3	9	"Adverse Event/Serious Adverse Event"	2685569001	"hyperglycemia"	7	49	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474294787	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"561"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	3	9	"Adverse Event/Serious Adverse Event"	2822287001	"hyperkalemia (high potassium)"	70	77	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481659108	""	""	""	NA	"Hyperkalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hyperkalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"562"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	3	9	"Adverse Event/Serious Adverse Event"	2822273001	"hyperkalemia (high potassium)"	28	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481659003	""	""	""	NA	"Hyperkalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hyperkalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"563"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	3	9	"Adverse Event/Serious Adverse Event"	2835863001	"LDH (elevated)"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482271877	""	""	""	NA	"LDH increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood lactate dehydrogenase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"564"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	3	9	"Adverse Event/Serious Adverse Event"	2822267001	"Leukocytes (Total WBC), low"	77	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481658927	""	""	""	NA	"WBC decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"White blood cell count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"565"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	3	9	"Adverse Event/Serious Adverse Event"	2835853001	"neutropenia"	7	77	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482271790	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"566"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	3	9	"Adverse Event/Serious Adverse Event"	2827089001	"nocturia"	7	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481837658	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"567"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	3	9	"Adverse Event/Serious Adverse Event"	2827098001	"nocturia"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481837774	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"568"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	3	9	"Adverse Event/Serious Adverse Event"	3062217001	"Tongue Ulceration"	102	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	6	NA	1	1	"patient seen by Head and Neck MD, biopsy benign"	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491406606	""	""	""	NA	"Tongue ulceration"	"Gastrointestinal disorders"	"Tongue conditions"	"Tongue disorders"	"Tongue ulceration"	""	""	""	""	""	""	""	""	""	""	""	""
"569"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	5	9	"Adverse Event/Serious Adverse Event"	2728478003	"Alkaline phosphatase"	30	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481574358	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"570"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	3	9	"Adverse Event/Serious Adverse Event"	2750702001	"Cardiac Chest Pain"	15	15	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	NA	NA	NA	15	15	"10/24/06:  WBC*=0.5 K/mcL; RBC*=3.87 M/mcL; HGB*=11.6 g/dl; HCT*=34.9%; MCV=90 fl; MCH=30.1 pg; MCHC=33.3%; Platelet=199 K/mcL; RDW*=16.7%; Pro Time=13.2 sec; Pro Time=0.96 inr; APTT=28.1 sec; Na=141"	"mEq/L; K=4.4 mEq/L; Cl=106 mEq/L; Gluc*=144 mg/dl; BUN=11 mg/dl; Creat=0.8 mg/dl; Calcium=9.2 mg/dl; Magnesium=1.8 mEq/L; CPK=48 Units/L; Troponin=<0.06 ng/mL;* indicates values outside normal range"	""	2	2	2	NA	2	2	NA	2	"Pt admitted to Urgent Care Center at MSKCC on 10/24/06 complaining of pain in shoulders and chest tightness.  Urgent Care Center reports chest pain, pain in limb, and neutropenia.  Pt discharged same"	"day. Neutropenia is a known side-effect of the docetaxel.  The chest pain is unlikely related to the docetaxel or the prednisone."	""	""	""	""	""	""	""	""	""	NA	NA	""	1477424340	""	""	""	NA	"Chest pain - cardiac"	"Cardiac disorders"	"Coronary artery disorders"	"Ischaemic coronary artery disorders"	"Angina pectoris"	""	""	""	""	""	""	""	""	""	""	""	""
"571"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	3	9	"Adverse Event/Serious Adverse Event"	2776236001	"Cardiac Chest pain"	36	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"waiting for reports from outside institution"	1	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	37	NA	NA	36	36	"Myocardial Infarction was ruled and. And Echocardiogran weas reviewd and appeared unchanged from previous records"	""	""	2	2	2	NA	2	2	2	2	"Pt was admitted to Monmouth Medical Center on 11/14 with chest pain.  Myocardial Infarction was ruled out.  Echocardiogram was reviewed by dr. McAleer and appears unchanged from previous records. Pt"	"was discharged on 11/14, same day.  We are waiting on the medical reports and discharde summary from Monmouth Medical Center."	""	""	""	""	""	""	""	""	""	NA	NA	""	1479227735	""	""	""	NA	"Chest pain - cardiac"	"Cardiac disorders"	"Coronary artery disorders"	"Ischaemic coronary artery disorders"	"Angina pectoris"	""	""	""	""	""	""	""	""	""	""	""	""
"572"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	3	9	"Adverse Event/Serious Adverse Event"	2827158001	"constipation"	8	30	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481838669	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"573"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	3	9	"Adverse Event/Serious Adverse Event"	2754314001	"Febrile neutropenia"	17	20	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	NA	NA	NA	18	20	"10/27/06 (to 11/8/06): hypoalbuminemia Grade 1;10/26/06: hyperglycemia Grade 2;10/27/06-10/28/06: Hemoglobin Grade 2;10/27/06: INR Grade 1;10/26/06-10/27/06: WBC Grade 3;10/28/06: WBC Grade"	"1;10/26/06-10/27/06: Neutrophils Grade 4;10/27/06: PTT Grade 1;10/26/06: hyponatremia (low sodium): Grade 1;10/27/06: lymphopenia grade 3;10/26/06: hyperglycemia Grade 2"	""	2	1	2	NA	2	2	NA	0	"Thursday 10/26 pt reported \"scratchy throat and runny nose\" w temp 99.5.  Temp rose to 100.6 at 8pm on 10/26, pt was admitted 10/27."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477842334	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"574"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	3	9	"Adverse Event/Serious Adverse Event"	2819273001	"hemoglobin (low)"	18	19	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481569968	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"575"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	3	9	"Adverse Event/Serious Adverse Event"	2819261001	"hyperglycemia (high glucose)"	17	17	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481569736	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"576"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	3	9	"Adverse Event/Serious Adverse Event"	2819265001	"hyperglycemia (high glucose)"	30	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481569820	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"577"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	3	9	"Adverse Event/Serious Adverse Event"	2819285001	"hypoalbuminemia (low albumin)"	51	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481570190	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"578"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	3	9	"Adverse Event/Serious Adverse Event"	2819276001	"Hypoalbuminemia (low albumin)"	18	30	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481570095	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"579"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	3	9	"Adverse Event/Serious Adverse Event"	2819793001	"INR (elevated)"	18	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481574556	""	""	""	NA	"INR increased"	"Investigations"	"Haematology investigations (incl blood groups)"	"Coagulation and bleeding analyses"	"International normalised ratio increased"	""	""	""	""	""	""	""	""	""	""	""	""
"580"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	3	9	"Adverse Event/Serious Adverse Event"	2819979001	"Lymphopenia"	30	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481576738	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"581"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	3	9	"Adverse Event/Serious Adverse Event"	2819946001	"Lymphopenia"	8	20	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481576266	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"582"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	3	9	"Adverse Event/Serious Adverse Event"	2827161001	"nocturia"	8	30	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481838723	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"583"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	3	9	"Adverse Event/Serious Adverse Event"	3161341001	"Pneumonia"	200	NA	1	4	0	NA	NA	NA	NA	NA	NA	NA	NA	4	NA	NA	1	"Hospitalized"	1	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	207	NA	NA	200	NA	"lab tests currently unavailable."	""	""	0	0	2	NA	0	2	NA	0	"Patient AIP was admitted to a local local hospital on 4/27/07. He was septic and hypotensive.  His blood pressure was 90 over 37. He has right and left pneumonia, with a temperature of 102 F and was"	"neutropenic (although exact counts are not yet available). Patient received two blood transfusions to bring his oxygen level up.  He is on dopamine."	""	""	""	""	""	""	""	""	""	NA	NA	""	1493930359	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"584"	"DN-101 Protocol No. 011-007"	"041"	"041-0011"	5	9	"Adverse Event/Serious Adverse Event"	2741939003	"Alkaline Phosphatase"	7	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492718926	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"585"	"DN-101 Protocol No. 011-007"	"041"	"041-0011"	3	9	"Adverse Event/Serious Adverse Event"	3044036001	"cellulitis vs. folliculitis at colectomy incision site"	98	112	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490810585	""	""	""	NA	"Incision site infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Incision site infection"	""	""	""	""	""	""	""	""	""	""	""	""
"586"	"DN-101 Protocol No. 011-007"	"041"	"041-0011"	3	9	"Adverse Event/Serious Adverse Event"	3044123001	"Fatigue"	147	155	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490811125	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"587"	"DN-101 Protocol No. 011-007"	"041"	"041-0011"	3	9	"Adverse Event/Serious Adverse Event"	3064748001	"Fever"	107	108	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491421361	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"588"	"DN-101 Protocol No. 011-007"	"041"	"041-0011"	3	9	"Adverse Event/Serious Adverse Event"	3112319001	"Glucose, high"	7	122	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492718973	""	""	""	NA	"Glucose high"	"Investigations"	"Metabolic, nutritional and blood gas investigations"	"Carbohydrate tolerance analyses (incl diabetes)"	"Blood glucose increased"	""	""	""	""	""	""	""	""	""	""	""	""
"589"	"DN-101 Protocol No. 011-007"	"041"	"041-0011"	3	9	"Adverse Event/Serious Adverse Event"	3112291001	"Hemoglobin"	122	122	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492718880	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"590"	"DN-101 Protocol No. 011-007"	"041"	"041-0011"	3	9	"Adverse Event/Serious Adverse Event"	2827169001	"nocturia"	28	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481838886	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"591"	"DN-101 Protocol No. 011-007"	"041"	"041-0013"	5	9	"Adverse Event/Serious Adverse Event"	2756487003	"ALT, SGPT"	31	73	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492720138	""	""	""	NA	"SGPT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Alanine aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"592"	"DN-101 Protocol No. 011-007"	"041"	"041-0013"	3	9	"Adverse Event/Serious Adverse Event"	3112501001	"Hemoglobin"	10	157	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492720084	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"593"	"DN-101 Protocol No. 011-007"	"041"	"041-0013"	3	9	"Adverse Event/Serious Adverse Event"	2818901001	"hyperglycemia (high glucose)"	10	157	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481561317	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"594"	"DN-101 Protocol No. 011-007"	"041"	"041-0013"	3	9	"Adverse Event/Serious Adverse Event"	2818930001	"hyperkalemia (high potassium)"	31	115	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481561550	""	""	""	NA	"Hyperkalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hyperkalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"595"	"DN-101 Protocol No. 011-007"	"041"	"041-0013"	3	9	"Adverse Event/Serious Adverse Event"	2831471001	"nocturia"	10	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482167835	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"596"	"DN-101 Protocol No. 011-007"	"041"	"041-0018"	5	9	"Adverse Event/Serious Adverse Event"	2870728003	"AST SGOT"	35	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492374715	""	""	""	NA	"SGOT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"597"	"DN-101 Protocol No. 011-007"	"041"	"041-0018"	3	9	"Adverse Event/Serious Adverse Event"	3090302001	"Glucose, high"	35	56	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492374841	""	""	""	NA	"Glucose high"	"Investigations"	"Metabolic, nutritional and blood gas investigations"	"Carbohydrate tolerance analyses (incl diabetes)"	"Blood glucose increased"	""	""	""	""	""	""	""	""	""	""	""	""
"598"	"DN-101 Protocol No. 011-007"	"041"	"041-0018"	3	9	"Adverse Event/Serious Adverse Event"	3090264001	"hemoglobin, low"	35	56	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492374647	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"599"	"DN-101 Protocol No. 011-007"	"041"	"041-0018"	3	9	"Adverse Event/Serious Adverse Event"	3090320001	"Potassium, high"	35	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492374930	""	""	""	NA	"Potassium high"	"Investigations"	"Water, electrolyte and mineral investigations"	"Mineral and electrolyte analyses"	"Blood potassium increased"	""	""	""	""	""	""	""	""	""	""	""	""
"600"	"DN-101 Protocol No. 011-007"	"041"	"041-0018"	3	9	"Adverse Event/Serious Adverse Event"	3029895001	"Rash"	15	NA	1	1	0	NA	NA	NA	NA	NA	1	1	NA	5	1	NA	1	"skin biopsy performed by local dermatologist"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490553821	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"601"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	5	9	"Adverse Event/Serious Adverse Event"	2923710003	"AST, SGOT"	2	2	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492525431	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"602"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	3	9	"Adverse Event/Serious Adverse Event"	3024524001	"Dry Skin"	23	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490301054	""	""	""	NA	"Dry skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Dry skin"	""	""	""	""	""	""	""	""	""	""	""	""
"603"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	3	9	"Adverse Event/Serious Adverse Event"	3099189001	"Glucose, high"	2	65	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492525625	""	""	""	NA	"Glucose high"	"Investigations"	"Metabolic, nutritional and blood gas investigations"	"Carbohydrate tolerance analyses (incl diabetes)"	"Blood glucose increased"	""	""	""	""	""	""	""	""	""	""	""	""
"604"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	3	9	"Adverse Event/Serious Adverse Event"	3099205001	"Potassium, high"	2	2	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492525740	""	""	""	NA	"Potassium high"	"Investigations"	"Water, electrolyte and mineral investigations"	"Mineral and electrolyte analyses"	"Blood potassium increased"	""	""	""	""	""	""	""	""	""	""	""	""
"605"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	3	9	"Adverse Event/Serious Adverse Event"	3024554001	"Urinary dribbling during the day"	23	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490301336	""	""	""	NA	"Dribbling of urine"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"606"	"DN-101 Protocol No. 011-007"	"041"	"041-0022"	5	9	"Adverse Event/Serious Adverse Event"	2965027003	"Alkaline Phosphatase"	7	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492527767	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"607"	"DN-101 Protocol No. 011-007"	"041"	"041-0022"	3	9	"Adverse Event/Serious Adverse Event"	3099502001	"AST, SGOT"	14	14	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492528098	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"608"	"DN-101 Protocol No. 011-007"	"041"	"041-0022"	3	9	"Adverse Event/Serious Adverse Event"	3039254001	"Fatigue"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490726584	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"609"	"DN-101 Protocol No. 011-007"	"041"	"041-0022"	3	9	"Adverse Event/Serious Adverse Event"	3090566001	"fever"	52	52	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492377637	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"610"	"DN-101 Protocol No. 011-007"	"041"	"041-0022"	3	9	"Adverse Event/Serious Adverse Event"	3099514001	"Glucose, high"	7	52	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492528172	""	""	""	NA	"Glucose high"	"Investigations"	"Metabolic, nutritional and blood gas investigations"	"Carbohydrate tolerance analyses (incl diabetes)"	"Blood glucose increased"	""	""	""	""	""	""	""	""	""	""	""	""
"611"	"DN-101 Protocol No. 011-007"	"041"	"041-0022"	3	9	"Adverse Event/Serious Adverse Event"	3099449001	"Hemoglobin"	7	52	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492527561	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"612"	"DN-101 Protocol No. 011-007"	"041"	"041-0022"	3	9	"Adverse Event/Serious Adverse Event"	3099459001	"Leukocytes"	52	52	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492527606	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"613"	"DN-101 Protocol No. 011-007"	"041"	"041-0022"	3	9	"Adverse Event/Serious Adverse Event"	3099463001	"Lymphopenia"	52	52	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492527657	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"614"	"DN-101 Protocol No. 011-007"	"041"	"041-0022"	3	9	"Adverse Event/Serious Adverse Event"	3112817001	"Pulmonary toxicity"	57	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	57	NA	NA	57	62	"4/19/2007 WBC: 3.1, HGB: 9.7, PLT: 228, electrocardiogram: normal"	""	""	2	2	2	NA	2	0	NA	2	"Patient HNH reported malaise, cough and temperature of 101.2F on 4/14/07.  He was prescribed Levaquin 500 mg daily for 7 days.	Patient was seen in UCC and admitted on 4/19/07 with concern for viral"	"pneumonia.  Appears to have docetaxel induced pulmonary toxicity and is responding to steroids."	""	""	""	""	""	""	""	""	""	NA	NA	""	1492723492	""	""	""	NA	"Pulmonary toxicity"	"Respiratory, thoracic and mediastinal disorders"	"Lower respiratory tract disorders (excl obstruction and infection)"	"Parenchymal lung disorders NEC"	"Pulmonary toxicity"	""	""	""	""	""	""	""	""	""	""	""	""
"615"	"DN-101 Protocol No. 011-007"	"041"	"041-0024"	5	9	"Adverse Event/Serious Adverse Event"	2992343003	"Alkaline Phosphatase"	7	7	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492529151	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"616"	"DN-101 Protocol No. 011-007"	"041"	"041-0024"	3	9	"Adverse Event/Serious Adverse Event"	3099633001	"ALT, SGOT"	7	7	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492529446	""	""	""	NA	"ALT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Alanine aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"617"	"DN-101 Protocol No. 011-007"	"041"	"041-0024"	3	9	"Adverse Event/Serious Adverse Event"	3099629001	"ALT, SGPT"	7	7	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492529190	""	""	""	NA	"SGPT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Alanine aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"618"	"DN-101 Protocol No. 011-007"	"041"	"041-0024"	3	9	"Adverse Event/Serious Adverse Event"	3099637001	"Glucose, High"	7	28	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492529485	""	""	""	NA	"Glucose high"	"Investigations"	"Metabolic, nutritional and blood gas investigations"	"Carbohydrate tolerance analyses (incl diabetes)"	"Blood glucose increased"	""	""	""	""	""	""	""	""	""	""	""	""
"619"	"DN-101 Protocol No. 011-007"	"041"	"041-0024"	3	9	"Adverse Event/Serious Adverse Event"	3099641001	"Sodium, low"	7	7	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492529520	""	""	""	NA	"Sodium low"	"Investigations"	"Water, electrolyte and mineral investigations"	"Mineral and electrolyte analyses"	"Blood sodium decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"620"	"DN-101 Protocol No. 011-007"	"041"	"041-0025"	5	9	"Adverse Event/Serious Adverse Event"	3009149003	"Glucose, high"	28	28	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492526258	""	""	""	NA	"Glucose high"	"Investigations"	"Metabolic, nutritional and blood gas investigations"	"Carbohydrate tolerance analyses (incl diabetes)"	"Blood glucose increased"	""	""	""	""	""	""	""	""	""	""	""	""
"621"	"DN-101 Protocol No. 011-007"	"041"	"041-0025"	3	9	"Adverse Event/Serious Adverse Event"	3099255001	"Hemoglobin"	5	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492526094	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"622"	"DN-101 Protocol No. 011-007"	"041"	"041-0029"	5	9	"Adverse Event/Serious Adverse Event"	3079968003	"diverticulitis"	6	12	NA	3	0	NA	NA	NA	NA	NA	NA	NA	NA	4	NA	NA	1	"patient hospitalized"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	8	NA	NA	6	12	"no test results available at this time."	""	""	2	2	2	NA	2	2	NA	2	"Admitted at South Nassau Community Hospital for diverticulitis before first dose of chemotherapy administered."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492459625	""	""	""	NA	"Diverticulitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Abdominal and gastrointestinal infections"	"Diverticulitis"	""	""	""	""	""	""	""	""	""	""	""	""
"623"	"DN-101 Protocol No. 011-007"	"043"	"043-0002"	5	9	"Adverse Event/Serious Adverse Event"	2561688003	"Abdominal Cramps"	76	80	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473353943	""	""	""	NA	"Abdominal cramps"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"624"	"DN-101 Protocol No. 011-007"	"043"	"043-0002"	4	9	"Adverse Event/Serious Adverse Event"	2735355001	"Asthenia"	114	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476706886	""	""	""	NA	"Asthenia"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"625"	"DN-101 Protocol No. 011-007"	"043"	"043-0002"	4	9	"Adverse Event/Serious Adverse Event"	2672698001	"Dehydration"	80	82	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"IV Fluids- Normal Saline"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473353179	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"626"	"DN-101 Protocol No. 011-007"	"043"	"043-0002"	4	9	"Adverse Event/Serious Adverse Event"	2735361001	"Dygeusia"	114	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476707751	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"627"	"DN-101 Protocol No. 011-007"	"043"	"043-0002"	4	9	"Adverse Event/Serious Adverse Event"	2672778001	"Muscle strain right anterior chest"	99	102	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473354933	""	""	""	NA	"Muscle strain"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Muscle, tendon and ligament injuries"	"Muscle strain"	""	""	""	""	""	""	""	""	""	""	""	""
"628"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	5	9	"Adverse Event/Serious Adverse Event"	2582405003	"Abdominal Pain"	41	47	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473686721	""	""	""	NA	"Abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"629"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	3	9	"Adverse Event/Serious Adverse Event"	2626225001	"Anemia"	41	48	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469730220	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"630"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	3	9	"Adverse Event/Serious Adverse Event"	2626200001	"Asthenia"	34	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469729598	""	""	""	NA	"Asthenia"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"631"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	3	9	"Adverse Event/Serious Adverse Event"	2877146001	"Constipation"	200	201	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484664825	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"632"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	3	9	"Adverse Event/Serious Adverse Event"	2735830001	"Edema of Bilateral Ankles"	119	161	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476716473	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"633"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	3	9	"Adverse Event/Serious Adverse Event"	2676873001	"Fatigue"	48	181	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473687328	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"634"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	3	9	"Adverse Event/Serious Adverse Event"	2874477001	"Fatigue"	182	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484589743	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"635"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	3	9	"Adverse Event/Serious Adverse Event"	2602234001	"GI bleed"	40	47	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Hospitalized"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	43	NA	NA	41	47	"Hgb 7.3 on 7/3/2006; Endoscopy done 7/5/06 showed bleeding ulcers; erosive esophagitis; small hiatal hernia; 1 cm Mallory-Weiss tear"	""	""	2	2	2	2	2	2	2	2	"Patient presented to office c/o hematemesis, epigastric abdominal pain and bleeding per rectum.  Hgb 7.3"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1467733706	""	""	""	NA	"GI bleed"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Non-site specific gastrointestinal haemorrhages"	"Gastrointestinal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"636"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	3	9	"Adverse Event/Serious Adverse Event"	2674875001	"GI Bleed Stool"	41	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473603007	""	""	""	NA	"GI bleed"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Non-site specific gastrointestinal haemorrhages"	"Gastrointestinal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"637"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	3	9	"Adverse Event/Serious Adverse Event"	2626300001	"Hematemesis"	41	47	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469732142	""	""	""	NA	"Hematemesis"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Non-site specific gastrointestinal haemorrhages"	"Haematemesis"	""	""	""	""	""	""	""	""	""	""	""	""
"638"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	3	9	"Adverse Event/Serious Adverse Event"	2674878001	"Hiatal Hernia"	41	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473603372	""	""	""	NA	"Hiatal hernia"	"Gastrointestinal disorders"	"Abdominal hernias and other abdominal wall conditions"	"Diaphragmatic hernias"	"Hiatus hernia"	""	""	""	""	""	""	""	""	""	""	""	""
"639"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	3	9	"Adverse Event/Serious Adverse Event"	2877170001	"Hot Flashes"	182	203	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484665734	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"640"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	3	9	"Adverse Event/Serious Adverse Event"	2877073001	"Hyperglycemia"	77	97	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484661896	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"641"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	3	9	"Adverse Event/Serious Adverse Event"	2626210001	"Hyperglycemia"	14	56	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469729917	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"642"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	3	9	"Adverse Event/Serious Adverse Event"	2877091001	"Hyperglycemia"	182	233	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484663483	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"643"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	3	9	"Adverse Event/Serious Adverse Event"	2877082001	"Hyperglycemia"	140	160	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484663381	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"644"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	3	9	"Adverse Event/Serious Adverse Event"	2676809001	"Insomnia"	41	47	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473686608	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"645"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	3	9	"Adverse Event/Serious Adverse Event"	2877159001	"Right Frozen Shoulder"	181	NA	1	4	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"MRI = Torn Rotator Cuff, Patient refused Surgery."	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484665369	""	""	""	NA	"Frozen shoulder"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related disorders NEC"	"Periarthritis"	""	""	""	""	""	""	""	""	""	""	""	""
"646"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	3	9	"Adverse Event/Serious Adverse Event"	2877121001	"Right Shoulder Pain"	181	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484664395	""	""	""	NA	"Shoulder pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Shoulder pain"	""	""	""	""	""	""	""	""	""	""	""	""
"647"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	5	9	"Adverse Event/Serious Adverse Event"	2585220003	"Alopecia"	11	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468154985	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"648"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	3	9	"Adverse Event/Serious Adverse Event"	3036247001	"Anemia"	176	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490706908	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"649"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	3	9	"Adverse Event/Serious Adverse Event"	3036199001	"Left hip pain"	124	133	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490704329	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"650"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	3	9	"Adverse Event/Serious Adverse Event"	3036237001	"Left hip pain"	134	186	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490706314	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"651"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	3	9	"Adverse Event/Serious Adverse Event"	3036266001	"Left hip replacement"	186	186	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490707574	""	""	""	NA	"Hip replacement"	"Surgical and medical procedures"	"Bone and joint therapeutic procedures"	"Joint therapeutic procedures"	"Hip arthroplasty"	""	""	""	""	""	""	""	""	""	""	""	""
"652"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	3	9	"Adverse Event/Serious Adverse Event"	2604533001	"Leg Cramping"	35	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468155049	""	""	""	NA	"Leg cramps"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"653"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	3	9	"Adverse Event/Serious Adverse Event"	3036234001	"Lower leg extremities swelling"	124	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490706185	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"654"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	3	9	"Adverse Event/Serious Adverse Event"	3036326001	"Pain in shoulders"	211	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490708859	""	""	""	NA	"Shoulder pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Shoulder pain"	""	""	""	""	""	""	""	""	""	""	""	""
"655"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	3	9	"Adverse Event/Serious Adverse Event"	2604522001	"Rash"	8	11	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468154817	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"656"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	3	9	"Adverse Event/Serious Adverse Event"	2604525001	"Rash"	12	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468154896	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"657"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	3	9	"Adverse Event/Serious Adverse Event"	2674423001	"Sinus discharge"	84	97	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473536890	""	""	""	NA	"Nasal sinus discharge"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Paranasal sinus disorders (excl infections and neoplasms)"	"Paranasal sinus hypersecretion"	""	""	""	""	""	""	""	""	""	""	""	""
"658"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	3	9	"Adverse Event/Serious Adverse Event"	3036231001	"Taste change"	12	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490706044	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"659"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	3	9	"Adverse Event/Serious Adverse Event"	2674409001	"Toe nail change"	70	145	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473536586	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"660"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	3	9	"Adverse Event/Serious Adverse Event"	3036240001	"Toe nail change"	176	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490706406	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"661"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	5	9	"Adverse Event/Serious Adverse Event"	2655001003	"Alopecia"	22	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477406792	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"662"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	3	9	"Adverse Event/Serious Adverse Event"	2812314001	"Anemia"	78	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481137322	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"663"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	3	9	"Adverse Event/Serious Adverse Event"	2749172001	"Anemia"	22	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477403885	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"664"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	3	9	"Adverse Event/Serious Adverse Event"	2693003001	"Bilateral soles of feet numbness"	22	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474817267	""	""	""	NA	"Numbness in feet"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"665"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	3	9	"Adverse Event/Serious Adverse Event"	2980630001	"Bone Pain"	162	NA	1	1	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488831379	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"666"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	3	9	"Adverse Event/Serious Adverse Event"	2831296001	"Cold Symptoms"	109	112	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482165381	""	""	""	NA	"Cold symptoms"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"667"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	3	9	"Adverse Event/Serious Adverse Event"	2693007001	"Constipation"	10	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474817391	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"668"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	3	9	"Adverse Event/Serious Adverse Event"	2812446001	"Dehydration"	75	78	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"IV Normal Saline  1000mg 11/6/2006; IV Normal Saline 1500 mg 11/8/2006"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481138374	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"669"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	3	9	"Adverse Event/Serious Adverse Event"	2693030001	"Dysgeusia"	24	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474818008	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"670"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	3	9	"Adverse Event/Serious Adverse Event"	2670558001	"Fatigue"	10	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473268887	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"671"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	3	9	"Adverse Event/Serious Adverse Event"	2693123001	"Leukocytosis"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474818664	""	""	""	NA	"Leukocytosis"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukocytoses NEC"	"Leukocytosis"	""	""	""	""	""	""	""	""	""	""	""	""
"672"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	3	9	"Adverse Event/Serious Adverse Event"	2812136001	"Leukopenia"	57	65	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481135815	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"673"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	3	9	"Adverse Event/Serious Adverse Event"	2749438001	"Leukopenia"	22	50	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477404762	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"674"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	3	9	"Adverse Event/Serious Adverse Event"	2980637001	"Leukopenia"	155	162	NA	2	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488831459	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"675"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	3	9	"Adverse Event/Serious Adverse Event"	2812158001	"Leukopenia"	65	71	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481135932	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"676"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	3	9	"Adverse Event/Serious Adverse Event"	2670618001	"Neutropenia"	15	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473269470	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"677"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	3	9	"Adverse Event/Serious Adverse Event"	2980651001	"Neutropenia"	155	162	NA	3	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488831584	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"678"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	3	9	"Adverse Event/Serious Adverse Event"	2812244001	"Neutropenia"	65	71	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481136744	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"679"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	3	9	"Adverse Event/Serious Adverse Event"	2749595001	"Neutropenia"	43	50	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477407206	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"680"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	3	9	"Adverse Event/Serious Adverse Event"	2692996001	"Neutropenia"	22	29	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474816552	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"681"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	3	9	"Adverse Event/Serious Adverse Event"	2812326001	"Reflex Esophagitis"	75	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481137412	""	""	""	NA	"Reflux esophagitis"	"Gastrointestinal disorders"	"Gastrointestinal inflammatory conditions"	"Oesophagitis (excl infective)"	"Reflux oesophagitis"	""	""	""	""	""	""	""	""	""	""	""	""
"682"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	3	9	"Adverse Event/Serious Adverse Event"	2812298001	"Right Arm Bone Pain"	65	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481137229	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"683"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	3	9	"Adverse Event/Serious Adverse Event"	2812096001	"weakness in lower extremities"	57	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481135638	""	""	""	NA	"Lower extremities weakness of"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"684"	"DN-101 Protocol No. 011-007"	"044"	"044-0001"	5	9	"Adverse Event/Serious Adverse Event"	2963408003	"Alopecia"	38	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494772286	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"685"	"DN-101 Protocol No. 011-007"	"045"	"045-0001"	5	9	"Adverse Event/Serious Adverse Event"	2590563003	"alopecia"	80	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474323331	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"686"	"DN-101 Protocol No. 011-007"	"045"	"045-0001"	3	9	"Adverse Event/Serious Adverse Event"	2687370001	"bone pain"	-61	NA	1	2	0	NA	NA	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474322878	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"687"	"DN-101 Protocol No. 011-007"	"045"	"045-0001"	3	9	"Adverse Event/Serious Adverse Event"	2687376001	"fatigue"	17	73	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474323114	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"688"	"DN-101 Protocol No. 011-007"	"045"	"045-0001"	3	9	"Adverse Event/Serious Adverse Event"	2687379001	"insomnia"	24	45	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474323221	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"689"	"DN-101 Protocol No. 011-007"	"045"	"045-0001"	3	9	"Adverse Event/Serious Adverse Event"	2902652001	"lower extremity edema"	178	198	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485812975	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"690"	"DN-101 Protocol No. 011-007"	"045"	"045-0001"	3	9	"Adverse Event/Serious Adverse Event"	2902708001	"nail changes"	234	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485813726	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"691"	"DN-101 Protocol No. 011-007"	"045"	"045-0001"	3	9	"Adverse Event/Serious Adverse Event"	2902674001	"nasal drainage"	126	136	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485813217	""	""	""	NA	"Nasal discharge"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Rhinorrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"692"	"DN-101 Protocol No. 011-007"	"045"	"045-0001"	3	9	"Adverse Event/Serious Adverse Event"	2902698001	"nasal stuffiness"	185	198	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485813629	""	""	""	NA	"Nasal stuffiness"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal congestion and inflammations"	"Nasal congestion"	""	""	""	""	""	""	""	""	""	""	""	""
"693"	"DN-101 Protocol No. 011-007"	"045"	"045-0001"	3	9	"Adverse Event/Serious Adverse Event"	2902726001	"neuropathy motor-weakness"	52	73	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485813919	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"694"	"DN-101 Protocol No. 011-007"	"045"	"045-0001"	3	9	"Adverse Event/Serious Adverse Event"	2687398001	"neuropathy-sensory"	87	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474323518	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"695"	"DN-101 Protocol No. 011-007"	"045"	"045-0001"	3	9	"Adverse Event/Serious Adverse Event"	2902758001	"pain-back"	73	94	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485814285	""	""	""	NA	"Pain back"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"696"	"DN-101 Protocol No. 011-007"	"045"	"045-0001"	3	9	"Adverse Event/Serious Adverse Event"	2687373001	"upper extemity pain"	10	31	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474323001	""	""	""	NA	"Pain in extremity"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"697"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	5	9	"Adverse Event/Serious Adverse Event"	2604584003	"abdominal pain, nonspecific,secondary to partial ileus"	225	230	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	229	NA	NA	225	230	"2/15-EKG-sinus tachy(R=108, K-2.8; Abd series- nonspecific bowel gas pattern which could be due to ileus, no obstruction or performation;Right Rib xray- suspicious for metastatic disease::2/16- GB"	"sonogram- neg, 2/29- CXR-no chg"	""	2	2	2	NA	2	2	NA	2	"The patients wife called the Hope Center to report the patient's condition. After discussiion with Dr. Reddy, she was advised to take him to the ER for evaluation of RUQ Abdominal pain, nausea,"	"anorexia for the past 10 days and poor intake. The patient was in a holding bed overnight and admitted as an inpatient. Prednisone was >20 mg BID, Megace and Lexapro were added and TPN was started. A"	"pulmonologist consult was requested.Blood sugars were monitored and insulin coverage was added.;Potassium dropped to 2.9 and was corrected with TPN. sputum culture was + for pseudomonas. Patient"	"experience some diarrhea which resolved by D/C."	""	""	""	""	""	""	""	NA	NA	""	1487530233	""	""	""	NA	"Gastric ileus"	"Gastrointestinal disorders"	"Gastrointestinal stenosis and obstruction"	"Gastric and pyloric stenosis and obstruction"	"Gastric ileus"	""	""	""	""	""	""	""	""	""	""	""	""
"698"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	3	9	"Adverse Event/Serious Adverse Event"	2924782001	"Acute Bronchitis and Pneumonia"	204	217	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	3	1	1	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486569780	""	""	""	NA	"Bronchial pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Bronchopneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"699"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	3	9	"Adverse Event/Serious Adverse Event"	2900000001	"Acute Exacerbation of Chronic Obstructive Pulmonary Disease"	204	212	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	3	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	208	NA	NA	204	212	"WBC-20.7 (2 weeks post Neulasta), chest per auscultation-scattered wheezes and rales; per patient, CXR was negative for Pneumonia; 1/29-CXR showed resolution of infiltrate in the right costophrenic"	"angle.sputum culture was normal, micro on 2/1 was neg so far"	""	2	2	2	NA	2	2	2	2	"Patients presented to the Pulmonologists office with severe Shortness of Breath, cough, wheezing and rattling. No improvement despite outpatient treatment. Patient was then hospitalized for IV"	"steroids(Solumedrol) and IV antibiotics(Zosyn3.375gm q6hours), oxygen PRN, Pulmonary toilet,and mucomyst. On d/c, he had no distress, good air entry, no rales no wheezes, and was sent home in stable"	"condition"	""	""	""	""	""	""	""	""	NA	NA	""	1485732378	""	""	""	NA	"Chronic obstructive airways disease exacerbated"	"Respiratory, thoracic and mediastinal disorders"	"Bronchial disorders (excl neoplasms)"	"Bronchospasm and obstruction"	"Chronic obstructive pulmonary disease"	""	""	""	""	""	""	""	""	""	""	""	""
"700"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	3	9	"Adverse Event/Serious Adverse Event"	2738518001	"anemia"	1	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476815862	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"701"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	3	9	"Adverse Event/Serious Adverse Event"	3081385001	"Anorexia"	225	230	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492028775	""	""	""	NA	"Anorexia"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"702"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	3	9	"Adverse Event/Serious Adverse Event"	3080567001	"Aspergillus lung infection"	233	268	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492021582	""	""	""	NA	"Aspergillus infection NOS"	"Infections and infestations"	"Fungal infectious disorders"	"Aspergillus infections"	"Aspergillosis"	""	""	""	""	""	""	""	""	""	""	""	""
"703"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	3	9	"Adverse Event/Serious Adverse Event"	2628599001	"Bronchitis"	20	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470079319	""	""	""	NA	"Bronchitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Bronchitis"	""	""	""	""	""	""	""	""	""	""	""	""
"704"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	3	9	"Adverse Event/Serious Adverse Event"	2682366001	"Chronic Obstructive Pulmonary Disease, Exacerbation"	72	76	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"hospitalized for IV steroids and IV antibiotics/per patient will do bronchoscopy on Tuesday if no improvement over the weekend."	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	72	NA	NA	72	76	"Patient was just admitted. No specific information is available at this time"	""	""	2	2	2	NA	2	2	NA	2	"Patient has Chronic Bronchitis with COPD. He has been treated with oral antibiotics and steroids as an outpatient. Patient was assessed by his pulmonologist today and it was felt patient needed to be"	"hospitalized for high dose antibiotics and steroids. No specific information is available at this time"	""	""	""	""	""	""	""	""	""	NA	NA	""	1473965727	""	""	""	NA	"Chronic obstructive airways disease exacerbated"	"Respiratory, thoracic and mediastinal disorders"	"Bronchial disorders (excl neoplasms)"	"Bronchospasm and obstruction"	"Chronic obstructive pulmonary disease"	""	""	""	""	""	""	""	""	""	""	""	""
"705"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	3	9	"Adverse Event/Serious Adverse Event"	2801836001	"Clinical Pneumonia"	153	157	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"Direct admit to Hospital"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	153	NA	NA	153	157	"CBC, CMP, Blood Cultures, CXR, EKG were ordered for 12/5/06; (no results at this time)"	""	""	2	2	2	NA	2	2	2	2	"Patient came to clinic for Follow-up visit , labs and Aranesp.Patient reported he was feeling weak and was chilling. He had a increased amount of phlegm and had vomited this A.M. mostly phlegm."	"T-100.6, BP-178/88, R-24, P-76. Patient was examined by Dr. Bolla and was sent to the hospital for a direct admit: Dx-Clinical Pneumonia;Patient was to start on Solumedrol 80 mg IV Q8H and Levaquin"	"500 mg IV QD and nebulizer treatments."	""	""	""	""	""	""	""	""	NA	NA	""	1480963237	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"706"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	3	9	"Adverse Event/Serious Adverse Event"	2696412001	"Clinical Pneumonia"	72	76	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	72	NA	NA	72	76	"9/15/06- CXR- negative;blood culture- negative;sputum culture showed pseudomonas aeruginosa;wbc-4.4, Hgb-11.6;chemistry was unremarkable"	""	""	2	2	2	NA	2	2	2	2	"Patient was treated as an outpatient with oral antibiotics and steroids. He had a productive cough with increasing shortness of breath and was hospitalized for IV antibiotics and IV steroids. On"	"9/19/06 he was discharged to home with continued IV Tobramycin QD as an outpatient x 10 days and Levaquin po x 7 days"	""	""	""	""	""	""	""	""	""	NA	NA	""	1474919827	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"707"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	3	9	"Adverse Event/Serious Adverse Event"	3080548001	"Cough, Bronchitis"	186	204	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492021342	""	""	""	NA	"Bronchitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Bronchitis"	""	""	""	""	""	""	""	""	""	""	""	""
"708"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	3	9	"Adverse Event/Serious Adverse Event"	3080602001	"Depression"	226	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492021838	""	""	""	NA	"Depression"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"709"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	3	9	"Adverse Event/Serious Adverse Event"	3080557001	"Dizziness"	189	195	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492021455	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"710"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	3	9	"Adverse Event/Serious Adverse Event"	2638653001	"Febrile Neutropenia"	36	39	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"Oxygen @ 2 liters per nasal cannula"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	40	NA	NA	36	39	"8/10/06- WBC=1.6, neuts=42%, ANC=.6,hgb=11.1, chemistry unremarkable except of Glucose =152,; Chest X-ray unremarkable but felt to have clinical pneumonia with fever and cough with productive sputum."	""	""	2	2	2	2	2	2	2	2	"Patient was seen in the clinic on 8/8/06, stated he had Bronchitis and	was on day 3 of 10 days of antibiotics(dicloxacillin).	noted some nausea  no vomiting, has had temp on and off as high as"	"102.5. It was 98.5 in the clinic on 8/8/06. Patient also noted some increase in SOB. Patient was to continue his antibiotics and call if symptoms persist.  WBC was 1.5 and ANC =0.7. chemistry"	"OK.;Patient's wife called on 8/10/06 and reported his worsening condition. Patient was admitted as an inpatient. Temperature on asmission was 101.1, P=112, R=24, BP=129/60.Blood cultures and sputum"	"cultures were drawn. .	Patient was started on Solu-medrol 60 mg IV BID, IV fluids of NS @ 50cc/hr, Rocephin 1 gm IV qd, Levaquin 500 mg IV qd, DuoNeb nebulizers QID,	Oxygen was on at 2 liters per"	"nasal cannula. Patient was given Neupogen 300 mcg qd x 3 for neutropenia. Patient was discharged on 8/13/2006 and to continue Levaquin 500 mg po qd x 7 days, Xopenex 1.25 via nebulizer 4 times a day"	"as needed.  ;."	""	""	""	""	""	NA	NA	""	1471205088	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"711"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	3	9	"Adverse Event/Serious Adverse Event"	2653472001	"fever"	32	32	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472164914	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"712"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	3	9	"Adverse Event/Serious Adverse Event"	2679678001	"hypertension"	48	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473804921	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"713"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	3	9	"Adverse Event/Serious Adverse Event"	3080615001	"hypokalemia"	225	230	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492021998	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"714"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	3	9	"Adverse Event/Serious Adverse Event"	2923003001	"Leukoplakia above supraglottis area"	208	235	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486497959	""	""	""	NA	"Leukoplakia"	"Skin and subcutaneous tissue disorders"	"Cornification and dystrophic skin disorders"	"Skin preneoplastic conditions NEC"	"Leukoplakia"	""	""	""	""	""	""	""	""	""	""	""	""
"715"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	3	9	"Adverse Event/Serious Adverse Event"	2738502001	"neutropenia"	104	111	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Infection precautions"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476815546	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"716"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	3	9	"Adverse Event/Serious Adverse Event"	2924826001	"Pseudomonas Pneumonia"	217	222	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	218	NA	NA	217	222	"2/7/;07- Na-133, K-3.0, CL-92, Glucose-197, BUN-31, WBC-11.9, neuts-88%(H), lymphs-1%(L)"	""	""	2	2	2	NA	2	2	NA	2	"Patient had been discharged from the hospital on 2/2/07 and was evaluated in the Pulmonist's office on 2/7/07. He was sent to the office with the Diagnosis of Pseudomonas Pneumonia."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486570646	""	""	""	NA	"Pneumonia due to Pseudomonas"	"Infections and infestations"	"Bacterial infectious disorders"	"Pseudomonal infections"	"Lung infection pseudomonal"	""	""	""	""	""	""	""	""	""	""	""	""
"717"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	3	9	"Adverse Event/Serious Adverse Event"	3080635001	"Pseudomonos Pneumonia"	225	230	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492022168	""	""	""	NA	"Pneumonia due to Pseudomonas"	"Infections and infestations"	"Bacterial infectious disorders"	"Pseudomonal infections"	"Lung infection pseudomonal"	""	""	""	""	""	""	""	""	""	""	""	""
"718"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	3	9	"Adverse Event/Serious Adverse Event"	3081404001	"rash"	218	222	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492028917	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"719"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	3	9	"Adverse Event/Serious Adverse Event"	2923098001	"Steroid induced hyperglycemia"	188	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486498695	""	""	""	NA	"Hyperglycemia steroid-induced"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"720"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	3	9	"Adverse Event/Serious Adverse Event"	2679684001	"sweating"	49	55	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473805370	""	""	""	NA	"Sweating"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"721"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	3	9	"Adverse Event/Serious Adverse Event"	2869011001	"swelling- left arm"	181	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484244972	""	""	""	NA	"Swelling arm"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"722"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	3	9	"Adverse Event/Serious Adverse Event"	2722093001	"Thrush"	76	86	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476223901	""	""	""	NA	"Thrush"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"723"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	2572447003	"cough"	195	216	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491850782	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"724"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	2600952001	"decreased taste"	43	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1467300625	""	""	""	NA	"Taste diminished"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Hypogeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"725"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	3074528001	"diarrhea"	252	258	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491852393	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"726"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	3074410001	"dyspnea"	174	195	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491850597	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"727"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	3074458001	"eye tearing"	195	216	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491851311	""	""	""	NA	"Eyes tearing"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"728"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	3072596001	"fatigue"	71	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491828971	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"729"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	3074472001	"left shoulder pain"	244	253	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491851609	""	""	""	NA	"Shoulder pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Shoulder pain"	""	""	""	""	""	""	""	""	""	""	""	""
"730"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	3074420001	"lightheadedness"	174	195	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491850687	""	""	""	NA	"Lightheadedness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"731"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	2600939001	"muscle aches"	15	19	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1467300013	""	""	""	NA	"Muscle ache"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"732"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	3072618001	"nail toxicity"	132	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491829307	""	""	""	NA	"Nail toxicity"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail toxicity"	""	""	""	""	""	""	""	""	""	""	""	""
"733"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	3072611001	"nasal drainage"	195	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491829219	""	""	""	NA	"Nasal discharge"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Rhinorrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"734"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	2861545001	"neutroenia"	120	132	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483988685	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"735"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	3070026001	"neutropenia"	202	204	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491752862	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"736"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	3070035001	"neutropenia"	265	272	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491753174	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"737"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	3070029001	"neutropenia"	223	237	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491752958	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"738"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	3070019001	"neutropenia"	160	167	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491752676	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"739"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	2662186001	"neutropenia"	99	102	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472755438	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"740"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	2600936001	"neutropenia"	15	19	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1467299853	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"741"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	3070007001	"neutropenia"	139	141	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491752538	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"742"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	3070038001	"neutropenia"	286	293	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491753282	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"743"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	2662181001	"neutropenia"	78	81	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472755349	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"744"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	3070022001	"neutropenia"	181	183	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491752782	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"745"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	3072584001	"neutropenia"	307	309	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491828814	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"746"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	2662173001	"neutropenia"	56	60	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472755259	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"747"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	3070032001	"neutropenia"	244	253	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491753060	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"748"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	2600942001	"neutropenia"	36	39	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1467300166	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"749"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	3074465001	"red, itchy, edematous hands"	223	225	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491851477	""	""	""	NA	"Erythema edematous"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Erythemas"	"Erythema"	""	""	""	""	""	""	""	""	""	""	""	""
"750"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	3074497001	"unable to void"	244	244	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491852113	""	""	""	NA	"Loss of desire to void"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Micturition disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"751"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	3074438001	"urinary tract infection"	177	194	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491850936	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"752"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	3	9	"Adverse Event/Serious Adverse Event"	3072601001	"weakness"	174	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491829113	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"753"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	5	9	"Adverse Event/Serious Adverse Event"	2580267003	"alopecia"	27	34	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477877549	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"754"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	3	9	"Adverse Event/Serious Adverse Event"	2756338001	"alopecia"	34	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477877631	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"755"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	3	9	"Adverse Event/Serious Adverse Event"	2756384001	"constipation, intermittant"	99	224	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477878971	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"756"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	3	9	"Adverse Event/Serious Adverse Event"	2756341001	"desquamation on palms of hands"	34	57	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477877816	""	""	""	NA	"Desquamation"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Exfoliative conditions"	"Skin exfoliation"	""	""	""	""	""	""	""	""	""	""	""	""
"757"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	3	9	"Adverse Event/Serious Adverse Event"	3195427001	"diarrhea, occasional"	101	203	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494875888	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"758"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	3	9	"Adverse Event/Serious Adverse Event"	3195583001	"diverticulitis"	179	203	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494876330	""	""	""	NA	"Diverticulitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Abdominal and gastrointestinal infections"	"Diverticulitis"	""	""	""	""	""	""	""	""	""	""	""	""
"759"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	3	9	"Adverse Event/Serious Adverse Event"	2756344001	"fatigue"	69	203	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477877892	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"760"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	3	9	"Adverse Event/Serious Adverse Event"	2756399001	"increased INR"	94	95	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477879418	""	""	""	NA	"INR increased"	"Investigations"	"Haematology investigations (incl blood groups)"	"Coagulation and bleeding analyses"	"International normalised ratio increased"	""	""	""	""	""	""	""	""	""	""	""	""
"761"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	3	9	"Adverse Event/Serious Adverse Event"	2756367001	"nail changes"	119	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477878369	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"762"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	3	9	"Adverse Event/Serious Adverse Event"	2756331001	"neuropathy -numbness & tingling of hands & feet"	15	57	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477877444	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"763"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	3	9	"Adverse Event/Serious Adverse Event"	3195606001	"taste alteration"	224	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494876534	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"764"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	3	9	"Adverse Event/Serious Adverse Event"	2756353001	"thrush"	97	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477878118	""	""	""	NA	"Thrush"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"765"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	3	9	"Adverse Event/Serious Adverse Event"	2657412001	"viral gastroenteritis"	94	97	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	103	NA	NA	94	97	"On 8/20/06 WBC of 10.8, protime 50.7, protime INR 4.8, and hemoglobin 12.8.  On 8/23/06, WBC of 5.1, protime 14.8, protime INR 1.4 and hemoglobin 10.7.  Blood culture X 2 was no growth after 5 days,"	"clostridium difficile toxin assay was no clostridium difficile toxin detected by EIA method, UA was WNL."	""	2	2	2	2	2	0	2	0	"(taken from discharge summary);Patient was admitted with fever, diarrhea, nausea, vomiting, and occasional bright red blood per rectum.  His INR was 4.8 upon admission, so he was given a 0/5mg of IV"	"vitamin K, which brought his INR down to 1.4.  His GI bleeding has been much, much less since then.;He has a pre-existing diagnosis of radiation proctitis from seeds for his prostate cancer several"	"years ago.  The patient was just observed.;The patient's fever was assessed with panculturing, and he was placed upon intravenous Levaquin upon admission.  He had no further fever.  His C.difficile"	"toxin titer was negative.  His white count was normal throughout the admission.  He is anticoagulated already for pre-existing atrial fibrillation.  He has been instructed to take 10 mg of Coumadin"	"and will check his protime on 8/24.  He does has thrush and will go home on Nystatin along with Levaquin for about 5 days."	""	""	""	""	""	""	NA	NA	""	1472528214	""	""	""	NA	"Viral gastroenteritis"	"Infections and infestations"	"Viral infectious disorders"	"Viral infections NEC"	"Gastroenteritis viral"	""	""	""	""	""	""	""	""	""	""	""	""
"766"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	3	9	"Adverse Event/Serious Adverse Event"	2756357001	"watery eyes"	119	315	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477878251	""	""	""	NA	"Watering eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"767"	"DN-101 Protocol No. 011-007"	"050"	"050-0004"	5	9	"Adverse Event/Serious Adverse Event"	2647488003	"Abdominal cramping"	115	136	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486341027	""	""	""	NA	"Abdominal cramp"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"768"	"DN-101 Protocol No. 011-007"	"050"	"050-0004"	3	9	"Adverse Event/Serious Adverse Event"	2717857001	"alopecia"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476140911	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"769"	"DN-101 Protocol No. 011-007"	"050"	"050-0004"	3	9	"Adverse Event/Serious Adverse Event"	2717851001	"cold sore"	34	42	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476140731	""	""	""	NA	"Cold sores"	"Infections and infestations"	"Viral infectious disorders"	"Herpes viral infections"	"Herpes simplex"	""	""	""	""	""	""	""	""	""	""	""	""
"770"	"DN-101 Protocol No. 011-007"	"050"	"050-0004"	3	9	"Adverse Event/Serious Adverse Event"	2836022001	"Constipation"	94	157	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482273850	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"771"	"DN-101 Protocol No. 011-007"	"050"	"050-0004"	3	9	"Adverse Event/Serious Adverse Event"	2864721001	"Dizzyness"	98	99	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484083969	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"772"	"DN-101 Protocol No. 011-007"	"050"	"050-0004"	3	9	"Adverse Event/Serious Adverse Event"	2835964001	"Fatigue"	73	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482273142	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"773"	"DN-101 Protocol No. 011-007"	"050"	"050-0004"	3	9	"Adverse Event/Serious Adverse Event"	2915383001	"herpes"	129	135	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486341104	""	""	""	NA	"Herpes NOS"	"Infections and infestations"	"Viral infectious disorders"	"Herpes viral infections"	"Herpes virus infection"	""	""	""	""	""	""	""	""	""	""	""	""
"774"	"DN-101 Protocol No. 011-007"	"050"	"050-0004"	3	9	"Adverse Event/Serious Adverse Event"	2864805001	"Neuropathy"	115	136	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484084424	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"775"	"DN-101 Protocol No. 011-007"	"050"	"050-0004"	3	9	"Adverse Event/Serious Adverse Event"	2836028001	"Upper Respiratory Tract infection"	94	115	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482274035	""	""	""	NA	"Upper respiratory tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"776"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	2659471003	"abdominal pain"	30	43	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475080299	""	""	""	NA	"Abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"777"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	3	9	"Adverse Event/Serious Adverse Event"	2835871001	"Bilateral hip pain"	105	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482271928	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"778"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	3	9	"Adverse Event/Serious Adverse Event"	2699641001	"confusion"	33	36	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475080797	""	""	""	NA	"Confusion"	"Psychiatric disorders"	"Deliria (incl confusion)"	"Confusion and disorientation"	"Confusional state"	""	""	""	""	""	""	""	""	""	""	""	""
"779"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	3	9	"Adverse Event/Serious Adverse Event"	2684949001	"dehydration"	32	36	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"Pt given IV fluids given in the clinic x 2 days...pt ultimately admitted to hospital for hydration"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	40	NA	NA	34	36	"None"	""	""	2	1	2	NA	2	2	NA	0	"Hopitalized for dehydration due to nausea and vomiting"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474238542	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"780"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	3	9	"Adverse Event/Serious Adverse Event"	2926863001	"Ecchymoses"	181	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486598949	""	""	""	NA	"Ecchymoses"	"Skin and subcutaneous tissue disorders"	"Skin vascular abnormalities"	"Purpura and related conditions"	"Ecchymosis"	""	""	""	""	""	""	""	""	""	""	""	""
"781"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	3	9	"Adverse Event/Serious Adverse Event"	2699701001	"edema - extrermities"	33	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475081141	""	""	""	NA	"Edema extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"782"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	3	9	"Adverse Event/Serious Adverse Event"	2709688001	"Electolyte imbalance"	34	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475694654	""	""	""	NA	"Electrolyte imbalance"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Electrolyte imbalance NEC"	"Electrolyte imbalance"	""	""	""	""	""	""	""	""	""	""	""	""
"783"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	3	9	"Adverse Event/Serious Adverse Event"	2699608001	"Fatigue"	43	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475080606	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"784"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	3	9	"Adverse Event/Serious Adverse Event"	2699596001	"generalized weakness"	33	36	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475080460	""	""	""	NA	"Weakness generalized"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"785"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	3	9	"Adverse Event/Serious Adverse Event"	2864315001	"Hypercholesteralemia"	34	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484081653	""	""	""	NA	"Hypercholesteraemia"	"Metabolism and nutrition disorders"	"Lipid metabolism disorders"	"Elevated cholesterol"	"Hypercholesterolaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"786"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	3	9	"Adverse Event/Serious Adverse Event"	2699547001	"Hyperglycemia"	23	40	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475079775	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"787"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	3	9	"Adverse Event/Serious Adverse Event"	2765007001	"Neutropenia"	57	64	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478537531	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"788"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	3	9	"Adverse Event/Serious Adverse Event"	2717624001	"Neutropenia"	33	43	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476137792	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"789"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	3	9	"Adverse Event/Serious Adverse Event"	2699678001	"shortness of breath"	33	36	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475080969	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"790"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	3	9	"Adverse Event/Serious Adverse Event"	2717597001	"Shortness of breath"	33	36	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476137069	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"791"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	3	9	"Adverse Event/Serious Adverse Event"	2869473001	"Spinal stenosis"	155	174	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	155	NA	NA	155	174	"Please see source documentation included in report"	""	""	2	2	2	NA	2	2	NA	2	"Patient fell at home twice due to lower extremity weakness with crumpling of the knees and hips, but no loss of consiousness.  He is also neutropenic and is complaining about pain in his lumbar"	"spine."	""	""	""	""	""	""	""	""	""	NA	NA	""	1484251404	""	""	""	NA	"Spinal stenosis NOS"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)"	"Spine and neck deformities"	"Spinal column stenosis"	""	""	""	""	""	""	""	""	""	""	""	""
"792"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	3	9	"Adverse Event/Serious Adverse Event"	2765001001	"taste disturbances"	64	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478537401	""	""	""	NA	"Taste disturbance"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"793"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	3	9	"Adverse Event/Serious Adverse Event"	2717609001	"Weakness"	43	64	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476137226	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"794"	"DN-101 Protocol No. 011-007"	"050"	"050-0006"	5	9	"Adverse Event/Serious Adverse Event"	2685007003	"Alopecia"	57	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478654400	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"795"	"DN-101 Protocol No. 011-007"	"050"	"050-0006"	3	9	"Adverse Event/Serious Adverse Event"	2719783001	"Anemia"	26	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476205257	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"796"	"DN-101 Protocol No. 011-007"	"050"	"050-0006"	3	9	"Adverse Event/Serious Adverse Event"	2986976001	"Facial edema"	161	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488996354	""	""	""	NA	"Face edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Face oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"797"	"DN-101 Protocol No. 011-007"	"050"	"050-0006"	3	9	"Adverse Event/Serious Adverse Event"	2767994001	"Fatigue"	57	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478654243	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"798"	"DN-101 Protocol No. 011-007"	"050"	"050-0006"	3	9	"Adverse Event/Serious Adverse Event"	2836217001	"Fever"	84	84	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482278557	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"799"	"DN-101 Protocol No. 011-007"	"050"	"050-0006"	3	9	"Adverse Event/Serious Adverse Event"	2719729001	"Leukopenia"	26	36	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476205053	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"800"	"DN-101 Protocol No. 011-007"	"050"	"050-0006"	3	9	"Adverse Event/Serious Adverse Event"	2719766001	"Neutropenia"	26	36	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476205191	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"801"	"DN-101 Protocol No. 011-007"	"050"	"050-0006"	3	9	"Adverse Event/Serious Adverse Event"	2962260001	"Tearing"	119	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487809178	""	""	""	NA	"Lacrimation"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"802"	"DN-101 Protocol No. 011-007"	"050"	"050-0006"	3	9	"Adverse Event/Serious Adverse Event"	2767991001	"Trace bipedal edema"	36	57	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478654173	""	""	""	NA	"Pedal edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"803"	"DN-101 Protocol No. 011-007"	"050"	"050-0007"	5	9	"Adverse Event/Serious Adverse Event"	2693767003	"anorexia"	18	27	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478743432	""	""	""	NA	"Anorexia"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"804"	"DN-101 Protocol No. 011-007"	"050"	"050-0007"	3	9	"Adverse Event/Serious Adverse Event"	2836104001	"Cough"	53	119	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482276578	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"805"	"DN-101 Protocol No. 011-007"	"050"	"050-0007"	3	9	"Adverse Event/Serious Adverse Event"	2710644001	"Dehydration"	20	20	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475709506	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"806"	"DN-101 Protocol No. 011-007"	"050"	"050-0007"	3	9	"Adverse Event/Serious Adverse Event"	2770161001	"diarrhea"	18	23	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478743253	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"807"	"DN-101 Protocol No. 011-007"	"050"	"050-0007"	3	9	"Adverse Event/Serious Adverse Event"	2836065001	"Fatigue"	15	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482275873	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"808"	"DN-101 Protocol No. 011-007"	"050"	"050-0007"	3	9	"Adverse Event/Serious Adverse Event"	2710650001	"leukopenia"	20	27	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475709609	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"809"	"DN-101 Protocol No. 011-007"	"050"	"050-0007"	3	9	"Adverse Event/Serious Adverse Event"	2836125001	"Leukopenia"	48	56	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482277216	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"810"	"DN-101 Protocol No. 011-007"	"050"	"050-0007"	3	9	"Adverse Event/Serious Adverse Event"	2710655001	"Neutropenia"	20	27	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475709761	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"811"	"DN-101 Protocol No. 011-007"	"050"	"050-0007"	3	9	"Adverse Event/Serious Adverse Event"	2836147001	"Neutropenia"	48	56	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482277447	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"812"	"DN-101 Protocol No. 011-007"	"050"	"050-0007"	3	9	"Adverse Event/Serious Adverse Event"	2836111001	"Pneumonitis"	84	119	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482276722	""	""	""	NA	"Pneumonitis"	"Respiratory, thoracic and mediastinal disorders"	"Lower respiratory tract disorders (excl obstruction and infection)"	"Lower respiratory tract inflammatory and immunologic conditions"	"Pneumonitis"	""	""	""	""	""	""	""	""	""	""	""	""
"813"	"DN-101 Protocol No. 011-007"	"050"	"050-0007"	3	9	"Adverse Event/Serious Adverse Event"	2836097001	"Upper Respiratory Infection"	63	90	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482276422	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"814"	"DN-101 Protocol No. 011-007"	"050"	"050-0007"	3	9	"Adverse Event/Serious Adverse Event"	2836108001	"Weakness"	63	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482276647	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"815"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	2798245003	"alopecia"	19	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487803371	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"816"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	3	9	"Adverse Event/Serious Adverse Event"	2893808001	"constipation"	5	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"prune juice"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485288955	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"817"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	3	9	"Adverse Event/Serious Adverse Event"	2962001001	"decreased appetite"	12	19	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487802922	""	""	""	NA	"Appetite decreased NOS"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Decreased appetite"	""	""	""	""	""	""	""	""	""	""	""	""
"818"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	3	9	"Adverse Event/Serious Adverse Event"	2962029001	"dry desquamation fingertips"	26	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"udderly smooth cream, tea tree oil"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487803275	""	""	""	NA	"Desquamation"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Exfoliative conditions"	"Skin exfoliation"	""	""	""	""	""	""	""	""	""	""	""	""
"819"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	3	9	"Adverse Event/Serious Adverse Event"	3019707001	"edema bilateral lower extremities"	110	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490205579	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"820"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	3	9	"Adverse Event/Serious Adverse Event"	2962019001	"epistaxis"	19	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487803090	""	""	""	NA	"Epistaxis"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"821"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	3	9	"Adverse Event/Serious Adverse Event"	2893837001	"fatigue"	5	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485289279	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"822"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	3	9	"Adverse Event/Serious Adverse Event"	2962045001	"increase lacrimentation"	53	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487803479	""	""	""	NA	"Lacrimation increased"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"823"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	3	9	"Adverse Event/Serious Adverse Event"	2961986001	"mucositis"	12	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"salt and soda rinse"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487802769	""	""	""	NA	"Mucositis"	"General disorders and administration site conditions"	"General system disorders NEC"	"Mucosal findings abnormal"	"Mucosal inflammation"	""	""	""	""	""	""	""	""	""	""	""	""
"824"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	3	9	"Adverse Event/Serious Adverse Event"	2962055001	"nail changes"	26	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487803646	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"825"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	3	9	"Adverse Event/Serious Adverse Event"	2962080001	"nuetropenia"	12	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487804323	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"826"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	3	9	"Adverse Event/Serious Adverse Event"	3019673001	"pneumonia"	105	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490205473	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"827"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	3	9	"Adverse Event/Serious Adverse Event"	2961971001	"Taste Changes"	12	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487802536	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"828"	"DN-101 Protocol No. 011-007"	"052"	"052-0001"	5	9	"Adverse Event/Serious Adverse Event"	2554263003	"Alopecia"	25	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463510973	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"829"	"DN-101 Protocol No. 011-007"	"052"	"052-0001"	3	9	"Adverse Event/Serious Adverse Event"	2574884001	"Chills"	26	29	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463509005	""	""	""	NA	"Chills"	"General disorders and administration site conditions"	"Body temperature conditions"	"Body temperature perception"	"Chills"	""	""	""	""	""	""	""	""	""	""	""	""
"830"	"DN-101 Protocol No. 011-007"	"052"	"052-0001"	3	9	"Adverse Event/Serious Adverse Event"	2624455001	"Ear Congestion"	32	115	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469628247	""	""	""	NA	"Ear congestion"	"Ear and labyrinth disorders"	"Aural disorders NEC"	"Ear disorders NEC"	"Ear congestion"	""	""	""	""	""	""	""	""	""	""	""	""
"831"	"DN-101 Protocol No. 011-007"	"052"	"052-0001"	3	9	"Adverse Event/Serious Adverse Event"	2624461001	"Fatigue - intermittent"	11	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469628753	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"832"	"DN-101 Protocol No. 011-007"	"052"	"052-0001"	3	9	"Adverse Event/Serious Adverse Event"	2624812001	"Hypersensitivity to Zometa"	24	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Zometa dose reduced."	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469637703	""	""	""	NA	"Hypersensitivity reaction (NOS)"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"833"	"DN-101 Protocol No. 011-007"	"052"	"052-0001"	3	9	"Adverse Event/Serious Adverse Event"	2574916001	"myalgias"	26	29	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463509775	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"834"	"DN-101 Protocol No. 011-007"	"052"	"052-0001"	3	9	"Adverse Event/Serious Adverse Event"	2630942001	"Nasal Congestion"	32	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470254801	""	""	""	NA	"Nasal congestion"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal congestion and inflammations"	"Nasal congestion"	""	""	""	""	""	""	""	""	""	""	""	""
"835"	"DN-101 Protocol No. 011-007"	"052"	"052-0001"	3	9	"Adverse Event/Serious Adverse Event"	2689313001	"Sty - intermittent"	136	157	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474402364	""	""	""	NA	"Sty"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Eye and eyelid infections"	"Hordeolum"	""	""	""	""	""	""	""	""	""	""	""	""
"836"	"DN-101 Protocol No. 011-007"	"053"	"053-0001"	5	9	"Adverse Event/Serious Adverse Event"	2548656003	"anorexia"	70	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476050616	""	""	""	NA	"Anorexia"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"837"	"DN-101 Protocol No. 011-007"	"053"	"053-0001"	3	9	"Adverse Event/Serious Adverse Event"	2714758001	"Blurred Vision"	175	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476051299	""	""	""	NA	"Blurred vision"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Vision blurred"	""	""	""	""	""	""	""	""	""	""	""	""
"838"	"DN-101 Protocol No. 011-007"	"053"	"053-0001"	3	9	"Adverse Event/Serious Adverse Event"	2714725001	"Bruising"	91	111	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476050843	""	""	""	NA	"Bruising"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"839"	"DN-101 Protocol No. 011-007"	"053"	"053-0001"	3	9	"Adverse Event/Serious Adverse Event"	2717277001	"Fatigue"	175	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476133744	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"840"	"DN-101 Protocol No. 011-007"	"053"	"053-0001"	3	9	"Adverse Event/Serious Adverse Event"	2717251001	"Insomnia"	91	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476133250	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"841"	"DN-101 Protocol No. 011-007"	"053"	"053-0001"	3	9	"Adverse Event/Serious Adverse Event"	2714743001	"Neuropathy - Feet"	91	111	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476051163	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"842"	"DN-101 Protocol No. 011-007"	"053"	"053-0001"	3	9	"Adverse Event/Serious Adverse Event"	2714779001	"Neuropathy - hands and feet"	175	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476051457	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"843"	"DN-101 Protocol No. 011-007"	"053"	"053-0001"	3	9	"Adverse Event/Serious Adverse Event"	2714733001	"Rash"	111	154	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476050953	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"844"	"DN-101 Protocol No. 011-007"	"053"	"053-0001"	3	9	"Adverse Event/Serious Adverse Event"	2714651001	"Trace Right pretibial edema"	28	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476050191	""	""	""	NA	"Pretibial edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"845"	"DN-101 Protocol No. 011-007"	"053"	"053-0001"	3	9	"Adverse Event/Serious Adverse Event"	2714671001	"Urinary Frequency"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476050318	""	""	""	NA	"Urinary frequency"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Pollakiuria"	""	""	""	""	""	""	""	""	""	""	""	""
"846"	"DN-101 Protocol No. 011-007"	"053"	"053-0002"	5	9	"Adverse Event/Serious Adverse Event"	2595732003	"Alopecia"	45	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476136916	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"847"	"DN-101 Protocol No. 011-007"	"053"	"053-0002"	3	9	"Adverse Event/Serious Adverse Event"	2717593001	"Bruising"	45	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476136985	""	""	""	NA	"Bruising"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"848"	"DN-101 Protocol No. 011-007"	"055"	"055-0002"	5	9	"Adverse Event/Serious Adverse Event"	3056995003	"fatigue"	7	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494950259	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"849"	"DN-101 Protocol No. 011-007"	"055"	"055-0002"	3	9	"Adverse Event/Serious Adverse Event"	3200663001	"fever"	38	39	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494950550	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"850"	"DN-101 Protocol No. 011-007"	"055"	"055-0002"	3	9	"Adverse Event/Serious Adverse Event"	3200648001	"sore throat"	35	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494950415	""	""	""	NA	"Sore throat"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Pharyngolaryngeal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"851"	"DN-101 Protocol No. 011-007"	"056"	"056-0003"	5	9	"Adverse Event/Serious Adverse Event"	2830738003	"Rib fracture"	97	113	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493589563	""	""	""	NA	"Rib fracture"	"Injury, poisoning and procedural complications"	"Bone and joint injuries"	"Thoracic cage fractures and dislocations"	"Rib fracture"	""	""	""	""	""	""	""	""	""	""	""	""
"852"	"DN-101 Protocol No. 011-007"	"056"	"056-0004"	5	9	"Adverse Event/Serious Adverse Event"	2889388003	"Back Pain"	-202	16	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492722343	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"853"	"DN-101 Protocol No. 011-007"	"056"	"056-0004"	3	9	"Adverse Event/Serious Adverse Event"	3112757001	"Back Pain"	17	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492722698	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"854"	"DN-101 Protocol No. 011-007"	"056"	"056-0004"	3	9	"Adverse Event/Serious Adverse Event"	3112828001	"Back Pain"	53	76	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492723745	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"855"	"DN-101 Protocol No. 011-007"	"056"	"056-0004"	3	9	"Adverse Event/Serious Adverse Event"	3112778001	"Dizziness"	20	20	NA	1	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492723007	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"856"	"DN-101 Protocol No. 011-007"	"056"	"056-0004"	3	9	"Adverse Event/Serious Adverse Event"	3112809001	"Fatigue"	20	20	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492723356	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"857"	"DN-101 Protocol No. 011-007"	"056"	"056-0004"	3	9	"Adverse Event/Serious Adverse Event"	3112825001	"Knee Pain"	28	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492723655	""	""	""	NA	"Knee pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"858"	"DN-101 Protocol No. 011-007"	"056"	"056-0004"	3	9	"Adverse Event/Serious Adverse Event"	3112815001	"Myalgias"	20	20	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492723457	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"859"	"DN-101 Protocol No. 011-007"	"056"	"056-0004"	3	9	"Adverse Event/Serious Adverse Event"	3112821001	"Myalgias"	28	37	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492723545	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"860"	"DN-101 Protocol No. 011-007"	"056"	"056-0004"	3	9	"Adverse Event/Serious Adverse Event"	3112792001	"Pelvic Pain"	-202	16	NA	2	0	NA	NA	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492723164	""	""	""	NA	"Pelvic pain"	"Reproductive system and breast disorders"	"Reproductive tract disorders NEC"	"Reproductive tract signs and symptoms NEC"	"Pelvic pain"	""	""	""	""	""	""	""	""	""	""	""	""
"861"	"DN-101 Protocol No. 011-007"	"059"	"059-0002"	5	9	"Adverse Event/Serious Adverse Event"	2906857003	"fractured ribs"	75	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493602677	""	""	""	NA	"Fractured ribs"	"Injury, poisoning and procedural complications"	"Bone and joint injuries"	"Thoracic cage fractures and dislocations"	"Rib fracture"	""	""	""	""	""	""	""	""	""	""	""	""
"862"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	2610802003	"arthralgia"	11	212	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469970309	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"863"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	3	9	"Adverse Event/Serious Adverse Event"	2948226001	"Bilateral deep vein thrombosis"	172	178	NA	3	1	1	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	220	NA	NA	172	178	"Bilateral lower extremity venous doppler diagnostic of bilateral deep vein thrombosis."	""	""	2	2	2	NA	2	2	NA	2	"Patient was in the hospital with the diagnosis of bilateral pulmonary emboli when a bilateral venous doppler done on 12/29/06 also showed bilateral deep vein thrombosis."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487196202	""	""	""	NA	"Deep vein thrombosis"	"Vascular disorders"	"Embolism and thrombosis"	"Peripheral embolism and thrombosis"	"Deep vein thrombosis"	""	""	""	""	""	""	""	""	""	""	""	""
"864"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	3	9	"Adverse Event/Serious Adverse Event"	2846918001	"bilateral pulmonary emboli"	172	178	NA	3	1	1	NA	NA	NA	NA	1	1	NA	5	1	NA	1	"hospitalization"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	172	NA	NA	172	178	"CT of chest with contrast on 12/29/06."	""	""	2	2	2	NA	2	2	NA	2	"Patient was found to have bilateral pulmonary emboli on a routine chest CT done today. He denies worsening dyspnea and states has been feeling quite well the past 5 days. He was admitted under the"	"care of his primary physician and will be receiving medication to dissolve the emboli.	Dr Wilcox does not believe this AE is related to the study drugs Taxotere or Prednisone but rather to his"	"underlying prostate cancer."	""	""	""	""	""	""	""	""	NA	NA	""	1483053606	""	""	""	NA	"Embolism pulmonary"	"Respiratory, thoracic and mediastinal disorders"	"Pulmonary vascular disorders"	"Pulmonary thrombotic and embolic conditions"	"Pulmonary embolism"	""	""	""	""	""	""	""	""	""	""	""	""
"865"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	3	9	"Adverse Event/Serious Adverse Event"	2626742001	"constipation"	11	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469969720	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"866"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	3	9	"Adverse Event/Serious Adverse Event"	2949660001	"dyspnea"	184	NA	1	1	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487261075	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"867"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	3	9	"Adverse Event/Serious Adverse Event"	2691681001	"dyspnea"	52	178	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474552260	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"868"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	3	9	"Adverse Event/Serious Adverse Event"	2691693001	"flaccid/numb (r) arm"	63	63	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474552595	""	""	""	NA	"Numbness"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"869"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	3	9	"Adverse Event/Serious Adverse Event"	2801224001	"hematuria"	98	102	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480953347	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"870"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	3	9	"Adverse Event/Serious Adverse Event"	2626768001	"indigestion"	14	212	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469971132	""	""	""	NA	"Indigestion"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"871"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	3	9	"Adverse Event/Serious Adverse Event"	2639283001	"LEUKOPENIA"	18	30	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471269693	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"872"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	3	9	"Adverse Event/Serious Adverse Event"	2728507001	"lymphedema bilateral extremities"	83	114	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476368050	""	""	""	NA	"Lymphedema"	"Vascular disorders"	"Lymphatic vessel disorders"	"Lymphoedemas"	"Lymphoedema"	""	""	""	""	""	""	""	""	""	""	""	""
"873"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	3	9	"Adverse Event/Serious Adverse Event"	2801240001	"mood alteration - anxiety"	97	212	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480953612	""	""	""	NA	"Anxiety"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Anxiety"	""	""	""	""	""	""	""	""	""	""	""	""
"874"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	3	9	"Adverse Event/Serious Adverse Event"	2691684001	"muscle weakness lower extremities"	52	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474552396	""	""	""	NA	"Lower extremities weakness of"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"875"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	3	9	"Adverse Event/Serious Adverse Event"	2626762001	"myalgia"	11	212	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469970859	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"876"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	3	9	"Adverse Event/Serious Adverse Event"	2639307001	"NEUTROPENIA"	18	30	NA	4	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471270272	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"877"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	3	9	"Adverse Event/Serious Adverse Event"	2922900001	"peripheral neuropathy"	156	NA	1	2	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486497159	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"878"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	3	9	"Adverse Event/Serious Adverse Event"	2639325001	"TASTE ALTERATION"	30	212	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471270576	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"879"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	3	9	"Adverse Event/Serious Adverse Event"	2801244001	"tremor"	100	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480953689	""	""	""	NA	"Tremor"	"Nervous system disorders"	"Movement disorders (incl Parkinsonism)"	"Tremor (excl congenital)"	"Tremor"	""	""	""	""	""	""	""	""	""	""	""	""
"880"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	3	9	"Adverse Event/Serious Adverse Event"	2801232001	"watery eye"	51	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480953499	""	""	""	NA	"Watering eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"881"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2645852003	"anemia"	117	139	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491936811	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"882"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	2898271001	"atrial fibrillation"	140	NA	1	2	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485697772	""	""	""	NA	"Atrial fibrillation"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Atrial fibrillation"	""	""	""	""	""	""	""	""	""	""	""	""
"883"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	3077147001	"bruising"	223	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491923502	""	""	""	NA	"Bruising"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"884"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	2949290001	"bruising"	180	223	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487258471	""	""	""	NA	"Bruising"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"885"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	2898256001	"cellulitis (r) foot"	121	182	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485697091	""	""	""	NA	"Cellulitis of foot"	"Infections and infestations"	"Bacterial infectious disorders"	"Bacterial infections NEC"	"Cellulitis"	""	""	""	""	""	""	""	""	""	""	""	""
"886"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	3077122001	"chest congestion"	195	NA	1	2	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491923240	""	""	""	NA	"Pulmonary congestion"	"Respiratory, thoracic and mediastinal disorders"	"Lower respiratory tract disorders (excl obstruction and infection)"	"Pulmonary oedemas"	"Pulmonary congestion"	""	""	""	""	""	""	""	""	""	""	""	""
"887"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	2798868001	"cold-pulmonary"	96	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480857814	""	""	""	NA	"Cold"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"888"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	2728770001	"confusion"	45	45	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476370137	""	""	""	NA	"Confusion"	"Psychiatric disorders"	"Deliria (incl confusion)"	"Confusion and disorientation"	"Confusional state"	""	""	""	""	""	""	""	""	""	""	""	""
"889"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	2898284001	"congestive heart failure"	156	NA	1	2	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485698075	""	""	""	NA	"Congestive heart failure"	"Cardiac disorders"	"Heart failures"	"Heart failures NEC"	"Cardiac failure congestive"	""	""	""	""	""	""	""	""	""	""	""	""
"890"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	3077951001	"degenerative disc disease"	232	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491936682	""	""	""	NA	"Intervertebral disc degeneration NOS"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)"	"Intervertebral disc disorders NEC"	"Intervertebral disc degeneration"	""	""	""	""	""	""	""	""	""	""	""	""
"891"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	2728616001	"dizziness"	45	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476368762	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"892"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	3077991001	"dizziness"	186	186	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491936946	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"893"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	2798865001	"dizziness"	88	88	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480857684	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"894"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	2898310001	"dizziness"	145	160	NA	1	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485698648	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"895"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	2691714001	"dizzness"	20	20	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474553092	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"896"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	2691717001	"dizzness"	27	27	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474553171	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"897"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	2949243001	"dyspnea"	140	161	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487258238	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"898"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	2728746001	"dyspnea"	45	46	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476369979	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"899"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	2949270001	"dyspnea"	161	NA	1	2	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487258380	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"900"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	2898263001	"edema lower extremities"	119	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485697406	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"901"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	2728659001	"fever"	46	49	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476369266	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"902"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	2898299001	"generalized anasarca"	140	161	NA	2	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485698387	""	""	""	NA	"Anasarca"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Generalised oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"903"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	2949218001	"generalized anasarca"	161	NA	1	1	0	NA	NA	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487258039	""	""	""	NA	"Anasarca"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Generalised oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"904"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	2669434001	"hypertension"	7	7	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473256913	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"905"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	2898322001	"insomnia"	145	160	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485699038	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"906"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	2669471001	"muscle spasms"	17	18	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473257321	""	""	""	NA	"Muscle spasms"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"907"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	2949301001	"muscle weakness"	174	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487258586	""	""	""	NA	"Muscle weakness NOS"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"908"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	2949179001	"neutropenia"	169	180	NA	4	0	NA	NA	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487257749	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"909"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	2669464001	"neutropenia"	16	26	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473257154	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"910"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	3	9	"Adverse Event/Serious Adverse Event"	2728696001	"non-cardiac chest pain"	45	46	NA	2	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476369623	""	""	""	NA	"Chest pain (non-cardiac)"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Non-cardiac chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"911"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2741544003	"ACUTE RENAL FAILURE"	43	45	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484749863	""	""	""	NA	"Acute renal failure"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal failure and impairment"	"Renal failure acute"	""	""	""	""	""	""	""	""	""	""	""	""
"912"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2883305001	"anemia"	66	71	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484832300	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"913"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2879821001	"ANEMIA"	43	44	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484750692	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"914"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	3209078001	"anemia"	25	43	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495031201	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"915"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	3208918001	"anorexia"	172	NA	1	1	0	NA	NA	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495030641	""	""	""	NA	"Anorexia"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"916"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2883332001	"anxiety"	66	72	NA	2	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484835672	""	""	""	NA	"Anxiety"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Anxiety"	""	""	""	""	""	""	""	""	""	""	""	""
"917"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2879847001	"AORTIC STENOSIS"	44	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484751578	""	""	""	NA	"Aortic stenosis"	"Vascular disorders"	"Arteriosclerosis, stenosis, vascular insufficiency and necrosis"	"Aortic necrosis and vascular insufficiency"	"Aortic stenosis"	""	""	""	""	""	""	""	""	""	""	""	""
"918"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2879799001	"ATRIAL FIBRILLATION"	43	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484750089	""	""	""	NA	"Atrial fibrillation"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Atrial fibrillation"	""	""	""	""	""	""	""	""	""	""	""	""
"919"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2879834001	"CARDIOMYOPATHY"	44	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484751243	""	""	""	NA	"Cardiomyopathy"	"Cardiac disorders"	"Myocardial disorders"	"Cardiomyopathies"	"Cardiomyopathy"	""	""	""	""	""	""	""	""	""	""	""	""
"920"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2764829001	"chills"	21	21	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478529419	""	""	""	NA	"Chills"	"General disorders and administration site conditions"	"Body temperature conditions"	"Body temperature perception"	"Chills"	""	""	""	""	""	""	""	""	""	""	""	""
"921"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2879881001	"CONGESTIVE HEART FAILURE"	44	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484752736	""	""	""	NA	"Congestive heart failure"	"Cardiac disorders"	"Heart failures"	"Heart failures NEC"	"Cardiac failure congestive"	""	""	""	""	""	""	""	""	""	""	""	""
"922"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2780695001	"constipation"	25	172	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479396807	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"923"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	3209004001	"constipation"	204	NA	1	2	0	NA	NA	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495030907	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"924"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2879805001	"CORONARY ARTERY DISEASE"	43	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484750206	""	""	""	NA	"Coronary artery disease"	"Cardiac disorders"	"Coronary artery disorders"	"Coronary artery disorders NEC"	"Coronary artery disease"	""	""	""	""	""	""	""	""	""	""	""	""
"925"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2879774001	"DEHYDRATION"	43	44	NA	3	0	NA	NA	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484749572	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"926"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	3208956001	"depression"	176	NA	1	2	0	NA	NA	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495030768	""	""	""	NA	"Depression"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"927"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2883298001	"epitaxis"	66	70	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484832172	""	""	""	NA	"Epistaxis"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"928"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2764820001	"facial flushing"	15	16	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478529089	""	""	""	NA	"Facial flushing"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Flushing"	""	""	""	""	""	""	""	""	""	""	""	""
"929"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2879918001	"FEVER"	55	55	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484753929	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"930"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	3209030001	"hemrrhoids"	205	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495031038	""	""	""	NA	"Hemorrhoids"	"Gastrointestinal disorders"	"Gastrointestinal vascular conditions"	"Haemorrhoids and gastrointestinal varices (excl oesophageal)"	"Haemorrhoids"	""	""	""	""	""	""	""	""	""	""	""	""
"931"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2879812001	"HYPOCALCEMIA"	43	46	NA	3	0	NA	NA	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484750372	""	""	""	NA	"Hypocalcemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Calcium metabolism disorders"	"Hypocalcaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"932"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2883347001	"hypokalemia"	69	70	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484835887	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"933"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2879892001	"HYPOKALEMIA"	45	52	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484753060	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"934"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2879943001	"HYPOKALEMIA"	56	56	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484754263	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"935"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2883363001	"hypokalemia"	70	72	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484836045	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"936"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2879986001	"HYPOKALEMIA"	58	63	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484754741	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"937"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2879961001	"HYPOKALEMIA"	57	58	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484754416	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"938"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2879976001	"HYPOMAGNESEMIA"	58	69	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484754612	""	""	""	NA	"Hypomagnesemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Magnesium metabolism disorders"	"Hypomagnesaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"939"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2879760001	"HYPOTENSON"	43	45	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484749292	""	""	""	NA	"Hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"940"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2883315001	"hypoxia"	66	71	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484835251	""	""	""	NA	"Hypoxia"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Conditions associated with abnormal gas exchange"	"Hypoxia"	""	""	""	""	""	""	""	""	""	""	""	""
"941"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2879740001	"insomnia"	43	65	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484748862	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"942"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2879854001	"LEFT ATRIAL ENLARGEMENT"	44	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484751753	""	""	""	NA	"Left atrial enlargement"	"Cardiac disorders"	"Myocardial disorders"	"Myocardial disorders NEC"	"Dilatation atrial"	""	""	""	""	""	""	""	""	""	""	""	""
"943"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2879861001	"LEFT VENTRICULAR ENLARGEMENT"	44	NA	1	1	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484751990	""	""	""	NA	"Left ventricular enlargement"	"Cardiac disorders"	"Myocardial disorders"	"Myocardial disorders NEC"	"Dilatation ventricular"	""	""	""	""	""	""	""	""	""	""	""	""
"944"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2879733001	"leukopenia"	43	44	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484748658	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"945"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2879874001	"MALAISE"	44	73	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484752459	""	""	""	NA	"Malaise"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Malaise"	""	""	""	""	""	""	""	""	""	""	""	""
"946"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2780708001	"neutropenia"	22	35	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479396996	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"947"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2879727001	"neutropenia"	43	45	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484748461	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"948"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2784818001	"sepsis"	43	73	NA	4	1	1	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	43	NA	NA	43	73	"11/21/06 WBC 0.9, ANC 0.1, 11/22/06 Blood cultures show gram negative rods-Escherichia coli"	""	""	2	2	0	NA	1	2	NA	2	"TLM became anorexic on Sunday, November 19, and then began experiencing nausea and vomiting Monday afternoon, November 20. He states he started feeling really bad during the evening and night hours"	"and came to clinic this morning where he was found to have a WBC of 0.9 and ANC of 0.1. His vital signs were BP 64/50, Temp 97, HR 112, Resp 36 and O2 Sat 89% on room air. He initially received a"	"liter bolus of NS and was then hospitalized with the diagnosis of Sepsis. IV Levaquin and Zosyn were started upon hospital arrival. Dr Prakash believes the sepsis was directly related to the"	"docetaxel and not related to the predisone."	""	""	""	""	""	""	""	NA	NA	""	1479762198	""	""	""	NA	"Sepsis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Sepsis, bacteraemia and viraemia"	"Sepsis"	""	""	""	""	""	""	""	""	""	""	""	""
"949"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2879868001	"SINUS TACHYCARDIA"	44	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484752257	""	""	""	NA	"Sinus tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Sinus tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"950"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2883326001	"sinus tachycardia"	66	112	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484835418	""	""	""	NA	"Sinus tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Sinus tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"951"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2879898001	"skin irritation-BUTTOCKS"	57	115	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484753369	""	""	""	NA	"Irritation skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermatitis and eczema"	"Skin irritation"	""	""	""	""	""	""	""	""	""	""	""	""
"952"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2879909001	"THRUSH"	52	86	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484753649	""	""	""	NA	"Thrush"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"953"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2879840001	"TRICUSPID REGURGITATION"	44	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484751357	""	""	""	NA	"Tricuspid regurgitation"	"Cardiac disorders"	"Cardiac valve disorders"	"Tricuspid valvular disorders"	"Tricuspid valve incompetence"	""	""	""	""	""	""	""	""	""	""	""	""
"954"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	3	9	"Adverse Event/Serious Adverse Event"	2879828001	"VENTRICULAR TACHYCARDIA"	44	48	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484751090	""	""	""	NA	"Ventricular tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Ventricular arrhythmias and cardiac arrest"	"Ventricular tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"955"	"DN-101 Protocol No. 011-007"	"063"	"063-0001"	5	9	"Adverse Event/Serious Adverse Event"	2864012003	"Acute respiratory distress syndrome"	4	4	NA	5	0	NA	NA	NA	NA	NA	0	NA	NA	7	1	1	1	"ventilated"	4	0	NA	0	28	NA	NA	1	1	1	NA	NA	""	6	4	1	4	4	"WBC 4.3, abs. grans 3.5 in morning. WBC 1.8, abs. grans 1.3 in afternoon.;Troponin normal;CT negative for PE, but significant bibasilar consolidation consistent with aspiration. All tests done Jan"	"13/06"	""	2	2	2	2	2	2	2	2	"Presented to ER Jan 13/06 @ 5:00 am, c/o neck pain. Patient became acutely hypoxic, tachycardic, moderately hypotensive. Decreased LOC, sats poor, SBP in 80's. Intubated, started on pressors. Expired"	"6:00 pm Jan 13/06. Autopsy to be done Jan 15. Actual diagnosis and causality to be determined after autopsy.;Jan 18/06-autopsy not done as coroner determined it was not necessary. Physician feels"	"cause of death is respiratory failure probably secondary to ARDS, which possibly resulted from aspiration pneumonia, which possibly resulted from depression of level of consciousness stemming from"	"hypernarcosis. Causality not related to prednisone or docetaxel. Hospital discharge summary faxed to Novacea Safety Group; Investigators Assessment and Discharge summary faxed to Lesley Beals"	"Pharmacovigilance this morning, as requested.-Jan Barclay RN/Dr Hotte"	""	""	""	""	""	""	NA	NA	""	1484492604	""	""	""	NA	"Acute respiratory distress syndrome"	"Respiratory, thoracic and mediastinal disorders"	"Lower respiratory tract disorders (excl obstruction and infection)"	"Pulmonary oedemas"	"Acute respiratory distress syndrome"	""	""	""	""	""	""	""	""	""	""	""	""
"956"	"DN-101 Protocol No. 011-007"	"063"	"063-0001"	4	9	"Adverse Event/Serious Adverse Event"	3048904001	"infection documented clinically (oral candidiasis)"	3	4	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490908754	""	""	""	NA	"Oral candidiasis"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Oral candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"957"	"DN-101 Protocol No. 011-007"	"063"	"063-0001"	4	9	"Adverse Event/Serious Adverse Event"	3048918001	"orthostatic hypotension"	3	4	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"instructed to push fluids"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490908917	""	""	""	NA	"Orthostatic hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Orthostatic hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"958"	"DN-101 Protocol No. 011-007"	"063"	"063-0001"	4	9	"Adverse Event/Serious Adverse Event"	3048894001	"pain"	4	4	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490908523	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"959"	"DN-101 Protocol No. 011-007"	"063"	"063-0001"	4	9	"Adverse Event/Serious Adverse Event"	3048925001	"pain - bone - neck"	4	4	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	6	NA	NA	4	4	"CT neg for PE - CT showed bilateral basilar consolidation"	""	""	2	2	2	NA	2	2	NA	2	"-presented to ER complaining of posterior neck pain, developed respiratory distress, became obtunded, expired"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490909342	""	""	""	NA	"Neck pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Neck pain"	""	""	""	""	""	""	""	""	""	""	""	""
"960"	"DN-101 Protocol No. 011-007"	"063"	"063-0001"	4	9	"Adverse Event/Serious Adverse Event"	3048936001	"pain-pulmonary-chest/thorax NOS"	4	4	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490909808	""	""	""	NA	"Thorax pain"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"961"	"DN-101 Protocol No. 011-007"	"063"	"063-0003"	5	9	"Adverse Event/Serious Adverse Event"	2894459003	"allergic reaction/hypersensitivity"	35	36	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491415427	""	""	""	NA	"Hypersensitivity reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"962"	"DN-101 Protocol No. 011-007"	"063"	"063-0003"	3	9	"Adverse Event/Serious Adverse Event"	3133886001	"alopecia"	78	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493234094	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"963"	"DN-101 Protocol No. 011-007"	"063"	"063-0003"	3	9	"Adverse Event/Serious Adverse Event"	2981933001	"fatigue"	15	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488899719	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"964"	"DN-101 Protocol No. 011-007"	"063"	"063-0003"	3	9	"Adverse Event/Serious Adverse Event"	3063432001	"infection-upper respiratory"	49	59	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491415280	""	""	""	NA	"Infection upper respiratory"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"965"	"DN-101 Protocol No. 011-007"	"063"	"063-0003"	3	9	"Adverse Event/Serious Adverse Event"	3064484001	"leukocytes"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491419219	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"966"	"DN-101 Protocol No. 011-007"	"063"	"063-0003"	3	9	"Adverse Event/Serious Adverse Event"	3047462001	"lymphopenia"	35	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490889517	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"967"	"DN-101 Protocol No. 011-007"	"063"	"063-0003"	3	9	"Adverse Event/Serious Adverse Event"	3155095001	"rash"	50	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493754271	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"968"	"DN-101 Protocol No. 011-007"	"063"	"063-0004"	5	9	"Adverse Event/Serious Adverse Event"	3008117003	"facial flushing"	29	30	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494166087	""	""	""	NA	"Facial flushing"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Flushing"	""	""	""	""	""	""	""	""	""	""	""	""
"969"	"DN-101 Protocol No. 011-007"	"063"	"063-0004"	3	9	"Adverse Event/Serious Adverse Event"	3162805001	"low hemoglobin"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494166468	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"970"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	5	9	"Adverse Event/Serious Adverse Event"	3018139003	"alopecia"	19	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492544989	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"971"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	3	9	"Adverse Event/Serious Adverse Event"	3118349001	"diarrhea"	4	6	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492975971	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"972"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	3	9	"Adverse Event/Serious Adverse Event"	3118418001	"fatigue"	3	10	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492976312	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"973"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	3	9	"Adverse Event/Serious Adverse Event"	3118397001	"hypersensitivity reaction"	24	25	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492976238	""	""	""	NA	"Hypersensitivity reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"974"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	3	9	"Adverse Event/Serious Adverse Event"	3201517001	"lymphocytopenia"	3	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494955032	""	""	""	NA	"Lymphocytopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"975"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	3	9	"Adverse Event/Serious Adverse Event"	3171473001	"nausea"	6	6	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494346085	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"976"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	3	9	"Adverse Event/Serious Adverse Event"	3102683001	"pain musculoskeletal-joint"	7	10	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492545177	""	""	""	NA	"Joint pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"977"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	3	9	"Adverse Event/Serious Adverse Event"	3118354001	"proctitis"	6	7	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492976029	""	""	""	NA	"Proctitis"	"Gastrointestinal disorders"	"Gastrointestinal inflammatory conditions"	"Rectal inflammations NEC"	"Proctitis"	""	""	""	""	""	""	""	""	""	""	""	""
"978"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	3	9	"Adverse Event/Serious Adverse Event"	3118381001	"stomatitis/mucositis"	6	8	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492976160	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"979"	"DN-101 Protocol No. 011-007"	"064"	"064-0002"	5	9	"Adverse Event/Serious Adverse Event"	3052754003	"febrile neutropenia"	39	39	NA	5	1	1	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	4	0	NA	1	12	NA	NA	1	1	NA	NA	NA	""	39	39	2	39	39	"WBC 500; Other test results pending or not available at time of this report."	""	""	2	2	2	2	2	2	2	2	"On 04/04/07, patient started Cycle 1, day 1 Prednisone, and on 4/5/07 (day 2), patient received Docetaxel. Patient was on the Control Arm.;On 4/13/07, patient was admitted to hospital after"	"complaining of severe abdominal pain and was found to have febrile neutropenia/sepsis during admission. ;He was put in intensive care and later expired that day."	""	""	""	""	""	""	""	""	""	NA	NA	""	1492119466	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"980"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	5	9	"Adverse Event/Serious Adverse Event"	2563389003	"Constipation"	143	171	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490118289	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"981"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	3	9	"Adverse Event/Serious Adverse Event"	3015735001	"diarrhea"	191	215	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Pt. discontinued use of MiraLax"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490119374	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"982"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	3	9	"Adverse Event/Serious Adverse Event"	2644110001	"Dry Skin"	24	45	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471529525	""	""	""	NA	"Dry skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Dry skin"	""	""	""	""	""	""	""	""	""	""	""	""
"983"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	3	9	"Adverse Event/Serious Adverse Event"	3015537001	"Edema Lower Extremity"	143	171	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490118399	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"984"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	3	9	"Adverse Event/Serious Adverse Event"	3015600001	"eyes tearing"	108	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490118701	""	""	""	NA	"Eyes tearing"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"985"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	3	9	"Adverse Event/Serious Adverse Event"	2644113001	"Fatigue"	45	241	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471529630	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"986"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	3	9	"Adverse Event/Serious Adverse Event"	2644116001	"Infection nephrostomy tube"	71	79	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471530148	""	""	""	NA	"Infection localised"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Localised infection"	""	""	""	""	""	""	""	""	""	""	""	""
"987"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	3	9	"Adverse Event/Serious Adverse Event"	3015669001	"mild parethesia of finger tips"	66	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490118974	""	""	""	NA	"Paresthesia of fingers"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"988"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	3	9	"Adverse Event/Serious Adverse Event"	3015459001	"Onycholysis"	129	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490118090	""	""	""	NA	"Onycholysis"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Onycholysis"	""	""	""	""	""	""	""	""	""	""	""	""
"989"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	3	9	"Adverse Event/Serious Adverse Event"	3015488001	"Pain Left Buttock"	142	363	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490118213	""	""	""	NA	"Buttock pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Buttock pain"	""	""	""	""	""	""	""	""	""	""	""	""
"990"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	3	9	"Adverse Event/Serious Adverse Event"	3015575001	"Papular Lesions Right Foot"	155	171	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490118583	""	""	""	NA	"Skin lesion"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Skin lesion"	""	""	""	""	""	""	""	""	""	""	""	""
"991"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	3	9	"Adverse Event/Serious Adverse Event"	3015636001	"Peri-rectal abcess"	130	182	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490118825	""	""	""	NA	"Rectal abscess"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Abdominal and gastrointestinal infections"	"Rectal abscess"	""	""	""	""	""	""	""	""	""	""	""	""
"992"	"DN-101 Protocol No. 011-007"	"066"	"066-0001"	5	9	"Adverse Event/Serious Adverse Event"	2855324003	"c.difficile colitis"	25	NA	1	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	25	NA	NA	25	29	"2007-01-12-Fecal analysis-clostridium Difficile- positive"	""	""	0	0	0	NA	0	0	NA	0	"Patient presented to emergency room with complaint of diarrhea x 8 days without relieve from medication treatment and has gotten worse.; Patient was admitted to hospital for c/o diarrhea."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484761435	""	""	""	NA	"C.difficile colitis"	"Infections and infestations"	"Bacterial infectious disorders"	"Clostridia infections"	"Clostridium difficile colitis"	""	""	""	""	""	""	""	""	""	""	""	""
"993"	"DN-101 Protocol No. 011-007"	"066"	"066-0001"	3	9	"Adverse Event/Serious Adverse Event"	2909026001	"deep vein thrombosis"	43	NA	1	3	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	1	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	46	NA	NA	43	46	"01-30-2007 Doppler study- positive for DVT in right leg"	""	""	2	2	2	NA	2	2	NA	2	"Patient presented with c/o pain in calf of right leg. Doppler study was done and is positive for DVT.Patient is admitted at the time of testing for treatment of DVT."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486068266	""	""	""	NA	"Deep vein thrombosis"	"Vascular disorders"	"Embolism and thrombosis"	"Peripheral embolism and thrombosis"	"Deep vein thrombosis"	""	""	""	""	""	""	""	""	""	""	""	""
"994"	"DN-101 Protocol No. 011-007"	"066"	"066-0001"	3	9	"Adverse Event/Serious Adverse Event"	2866816001	"diahrrhea"	17	25	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484166062	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"995"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	5	9	"Adverse Event/Serious Adverse Event"	2556619003	"Alopecia"	24	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463418953	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"996"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	3	9	"Adverse Event/Serious Adverse Event"	2688819001	"Anemia"	79	122	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474397557	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"997"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	3	9	"Adverse Event/Serious Adverse Event"	2688832001	"Anemia"	122	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474397700	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"998"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	3	9	"Adverse Event/Serious Adverse Event"	2688811001	"Anemia"	69	71	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474397471	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"999"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	3	9	"Adverse Event/Serious Adverse Event"	2688805001	"Anemia"	17	24	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474397357	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1000"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	3	9	"Adverse Event/Serious Adverse Event"	2688782001	"Ankle edema"	133	143	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474396967	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1001"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	3	9	"Adverse Event/Serious Adverse Event"	2688737001	"Anorexia"	99	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474396443	""	""	""	NA	"Anorexia"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1002"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	3	9	"Adverse Event/Serious Adverse Event"	2688634001	"Constipation"	99	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474395700	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1003"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	3	9	"Adverse Event/Serious Adverse Event"	2688758001	"Fatigue"	133	150	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474396653	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1004"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	3	9	"Adverse Event/Serious Adverse Event"	2688770001	"Fatigue"	150	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474396786	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1005"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	3	9	"Adverse Event/Serious Adverse Event"	2573431001	"Hyperglycemia"	7	8	NA	3	2	NA	1	NA	NA	NA	0	NA	NA	5	1	NA	1	"Insulin given iv, and prednisone held"	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463419425	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1006"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	3	9	"Adverse Event/Serious Adverse Event"	2573438001	"Hyperkalemia"	17	28	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463419595	""	""	""	NA	"Hyperkalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hyperkalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1007"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	3	9	"Adverse Event/Serious Adverse Event"	2573391001	"Leukocytopenia"	17	24	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463419124	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1008"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	3	9	"Adverse Event/Serious Adverse Event"	2688835001	"Neutropenia"	17	24	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474397909	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1009"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	3	9	"Adverse Event/Serious Adverse Event"	2688972001	"Neutropenia"	163	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474399267	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1010"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	3	9	"Adverse Event/Serious Adverse Event"	2688864001	"Neutropenia"	129	133	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474398648	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1011"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	3	9	"Adverse Event/Serious Adverse Event"	2688946001	"Neutropenia"	143	150	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474399163	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1012"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	3	9	"Adverse Event/Serious Adverse Event"	2688899001	"Neutropenia"	133	143	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474398852	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1013"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	3	9	"Adverse Event/Serious Adverse Event"	2688787001	"Pallor"	133	143	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474397096	""	""	""	NA	"Pallor"	"Vascular disorders"	"Vascular disorders NEC"	"Site specific vascular disorders NEC"	"Pallor"	""	""	""	""	""	""	""	""	""	""	""	""
"1014"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	3	9	"Adverse Event/Serious Adverse Event"	2573352001	"Sinus drainage"	7	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463418705	""	""	""	NA	"Nasal discharge"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Rhinorrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1015"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	3	9	"Adverse Event/Serious Adverse Event"	2689004001	"Thrombocytopenia"	122	129	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474399513	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1016"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	3	9	"Adverse Event/Serious Adverse Event"	2689052001	"Thrombocytopenia"	163	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474399823	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1017"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	3	9	"Adverse Event/Serious Adverse Event"	2688991001	"Thrombocytopenia"	92	122	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474399383	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1018"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	3	9	"Adverse Event/Serious Adverse Event"	2689027001	"Thrombocytopenia"	129	133	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474399645	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1019"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	3	9	"Adverse Event/Serious Adverse Event"	2689041001	"Thrombocytopenia"	133	150	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474399743	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1020"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	3	9	"Adverse Event/Serious Adverse Event"	2688607001	"Urinary incontinence"	50	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474395470	""	""	""	NA	"Urinary incontinence"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"1021"	"DN-101 Protocol No. 011-007"	"068"	"068-0006"	5	9	"Adverse Event/Serious Adverse Event"	3177863003	"dysphagia"	16	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495390185	""	""	""	NA	"Dysphagia"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal signs and symptoms NEC"	"Dysphagia"	""	""	""	""	""	""	""	""	""	""	""	""
"1022"	"DN-101 Protocol No. 011-007"	"068"	"068-0006"	3	9	"Adverse Event/Serious Adverse Event"	3227691001	"fatigue"	15	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495390117	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1023"	"DN-101 Protocol No. 011-007"	"069"	"069-0001"	5	9	"Adverse Event/Serious Adverse Event"	2768806003	"fatigue"	78	79	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490628695	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1024"	"DN-101 Protocol No. 011-007"	"069"	"069-0001"	3	9	"Adverse Event/Serious Adverse Event"	3033044001	"fatigue"	99	101	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490628925	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1025"	"DN-101 Protocol No. 011-007"	"069"	"069-0001"	3	9	"Adverse Event/Serious Adverse Event"	2875007001	"fatigue"	39	40	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484592715	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1026"	"DN-101 Protocol No. 011-007"	"069"	"069-0001"	3	9	"Adverse Event/Serious Adverse Event"	3144203001	"fatigue"	142	143	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493574349	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1027"	"DN-101 Protocol No. 011-007"	"069"	"069-0001"	3	9	"Adverse Event/Serious Adverse Event"	3144179001	"fatigue"	121	122	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493574245	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1028"	"DN-101 Protocol No. 011-007"	"069"	"069-0001"	3	9	"Adverse Event/Serious Adverse Event"	3037032001	"intermittent knee pain"	98	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490714511	""	""	""	NA	"Knee pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1029"	"DN-101 Protocol No. 011-007"	"069"	"069-0001"	3	9	"Adverse Event/Serious Adverse Event"	3144227001	"nail changes"	105	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493574446	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"1030"	"DN-101 Protocol No. 011-007"	"069"	"069-0002"	5	9	"Adverse Event/Serious Adverse Event"	2871140003	"Dehydration"	56	56	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"IV Fluids administered"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489100942	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"1031"	"DN-101 Protocol No. 011-007"	"071"	"071-0003"	5	9	"Adverse Event/Serious Adverse Event"	2754585003	"anorexia"	144	151	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494787506	""	""	""	NA	"Anorexia"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1032"	"DN-101 Protocol No. 011-007"	"071"	"071-0003"	3	9	"Adverse Event/Serious Adverse Event"	3188149001	"cough"	144	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494787324	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1033"	"DN-101 Protocol No. 011-007"	"071"	"071-0003"	3	9	"Adverse Event/Serious Adverse Event"	3188174001	"diarrhea"	155	155	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494787451	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1034"	"DN-101 Protocol No. 011-007"	"071"	"071-0003"	3	9	"Adverse Event/Serious Adverse Event"	3188204001	"fingernail changes"	133	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494787578	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"1035"	"DN-101 Protocol No. 011-007"	"071"	"071-0003"	3	9	"Adverse Event/Serious Adverse Event"	2802690001	"insomnia"	21	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480972779	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1036"	"DN-101 Protocol No. 011-007"	"071"	"071-0003"	3	9	"Adverse Event/Serious Adverse Event"	3188227001	"lower back pain"	182	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494787660	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1037"	"DN-101 Protocol No. 011-007"	"071"	"071-0003"	3	9	"Adverse Event/Serious Adverse Event"	3188118001	"respiratory congestion"	144	153	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494787189	""	""	""	NA	"Respiratory tract congestion"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Respiratory tract disorders NEC"	"Respiratory tract congestion"	""	""	""	""	""	""	""	""	""	""	""	""
"1038"	"DN-101 Protocol No. 011-007"	"071"	"071-0004"	5	9	"Adverse Event/Serious Adverse Event"	2787996003	"alopecia"	49	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485808796	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1039"	"DN-101 Protocol No. 011-007"	"071"	"071-0004"	3	9	"Adverse Event/Serious Adverse Event"	3210351001	"chemo induced anemia"	56	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495037677	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1040"	"DN-101 Protocol No. 011-007"	"071"	"071-0004"	3	9	"Adverse Event/Serious Adverse Event"	2902118001	"diarrhea"	21	24	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485808451	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1041"	"DN-101 Protocol No. 011-007"	"071"	"071-0004"	3	9	"Adverse Event/Serious Adverse Event"	3210369001	"dyspnea"	72	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495037753	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1042"	"DN-101 Protocol No. 011-007"	"071"	"071-0004"	3	9	"Adverse Event/Serious Adverse Event"	2902168001	"eye tearing"	21	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485808693	""	""	""	NA	"Eyes tearing"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1043"	"DN-101 Protocol No. 011-007"	"071"	"071-0004"	3	9	"Adverse Event/Serious Adverse Event"	2902208001	"fatigue"	57	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485808930	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1044"	"DN-101 Protocol No. 011-007"	"071"	"071-0004"	3	9	"Adverse Event/Serious Adverse Event"	2902109001	"pain in feet bilaterally"	24	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485808380	""	""	""	NA	"Pain in foot"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"1045"	"DN-101 Protocol No. 011-007"	"071"	"071-0004"	3	9	"Adverse Event/Serious Adverse Event"	2902233001	"pain right arm from chemo infiltration"	35	78	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485809052	""	""	""	NA	"Administration site pain"	"General disorders and administration site conditions"	"Administration site reactions"	"Administration site reactions NEC"	"Administration site pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1046"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	5	9	"Adverse Event/Serious Adverse Event"	2594676003	"Alopecia"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471445275	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1047"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	3	9	"Adverse Event/Serious Adverse Event"	2706296001	"Anemia"	64	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475585820	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1048"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	3	9	"Adverse Event/Serious Adverse Event"	2760170001	"Bone Pain"	130	134	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478119108	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1049"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	3	9	"Adverse Event/Serious Adverse Event"	2899226001	"Bone Pain"	153	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485715713	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1050"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	3	9	"Adverse Event/Serious Adverse Event"	2642333001	"Fatigue"	44	47	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471445438	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1051"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	3	9	"Adverse Event/Serious Adverse Event"	2706307001	"Fatigue"	69	87	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475586060	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1052"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	3	9	"Adverse Event/Serious Adverse Event"	2899220001	"Fatigue"	153	158	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485715605	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1053"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	3	9	"Adverse Event/Serious Adverse Event"	2760131001	"Fatigue"	129	134	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478118901	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1054"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	3	9	"Adverse Event/Serious Adverse Event"	2706304001	"Fatigue"	66	69	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475586002	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1055"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	3	9	"Adverse Event/Serious Adverse Event"	2760144001	"Fatigue"	134	153	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478118966	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1056"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	3	9	"Adverse Event/Serious Adverse Event"	2706317001	"Fatigue"	87	90	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475587508	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1057"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	3	9	"Adverse Event/Serious Adverse Event"	2706286001	"Fatigue"	47	66	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475585339	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1058"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	3	9	"Adverse Event/Serious Adverse Event"	2706326001	"Fatigue"	90	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475587660	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1059"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	3	9	"Adverse Event/Serious Adverse Event"	2899223001	"Fatigue"	158	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485715655	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1060"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	3	9	"Adverse Event/Serious Adverse Event"	2706292001	"Hyperglycemia"	21	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475585491	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1061"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	3	9	"Adverse Event/Serious Adverse Event"	3011350001	"hyperglycemia"	249	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490028532	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1062"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	3	9	"Adverse Event/Serious Adverse Event"	2899240001	"Muscle Aches"	NA	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Encouraged Weight Loss"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485715890	""	""	""	NA	"Muscle ache"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1063"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	3	9	"Adverse Event/Serious Adverse Event"	2706329001	"Sensory Neuropathy"	NA	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475587730	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1064"	"DN-101 Protocol No. 011-007"	"072"	"072-0002"	5	9	"Adverse Event/Serious Adverse Event"	2679177003	"Cough"	182	206	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494949678	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1065"	"DN-101 Protocol No. 011-007"	"072"	"072-0002"	3	9	"Adverse Event/Serious Adverse Event"	2955672001	"Hyperglycemia"	161	182	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487615039	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1066"	"DN-101 Protocol No. 011-007"	"072"	"072-0002"	3	9	"Adverse Event/Serious Adverse Event"	2836962001	"Hyperglycemia"	98	161	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482333189	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1067"	"DN-101 Protocol No. 011-007"	"072"	"072-0002"	3	9	"Adverse Event/Serious Adverse Event"	2836947001	"Hyperglycemia"	35	77	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482332481	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1068"	"DN-101 Protocol No. 011-007"	"072"	"072-0002"	3	9	"Adverse Event/Serious Adverse Event"	3200480001	"Hyperglycemia"	182	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494949216	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1069"	"DN-101 Protocol No. 011-007"	"072"	"072-0002"	3	9	"Adverse Event/Serious Adverse Event"	2836959001	"Hyperglycemia"	77	98	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482333087	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1070"	"DN-101 Protocol No. 011-007"	"072"	"072-0002"	3	9	"Adverse Event/Serious Adverse Event"	2689840001	"Hypergycemia"	14	35	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474457178	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1071"	"DN-101 Protocol No. 011-007"	"072"	"072-0002"	3	9	"Adverse Event/Serious Adverse Event"	3200574001	"Nail Changes"	227	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494949937	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"1072"	"DN-101 Protocol No. 011-007"	"072"	"072-0002"	3	9	"Adverse Event/Serious Adverse Event"	2836950001	"Neutropenia"	21	35	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482332561	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1073"	"DN-101 Protocol No. 011-007"	"072"	"072-0002"	3	9	"Adverse Event/Serious Adverse Event"	3200563001	"Pain - Left inguinal - intermittent"	182	227	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494949849	""	""	""	NA	"Groin pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Soft tissue disorders NEC"	"Groin pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1074"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	5	9	"Adverse Event/Serious Adverse Event"	2615046003	"alopecia"	35	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471795279	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1075"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	3	9	"Adverse Event/Serious Adverse Event"	2851907001	"cardiac arrhythmia"	178	180	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"cardizem drip"	0	0	NA	0	40	NA	NA	NA	1	NA	1	NA	""	178	NA	NA	178	180	"EKG - 1/4/07; transthoracic ECHO - 1/4/07; telemetry monitoring; serial troponins; serial INR monitoring; duplex doppler of bilateral lower extremities; chest x-ray; blood cultures and sensitivity"	""	""	2	2	2	NA	2	2	NA	2	"Patient was admitted with atrial fib with a rapid ventricular response rate. He was monitored with serial troponins and telemetry. Rate control was achieved with a cardizem drip. INR monitoring"	"showed low therapeutic INR (1.12) resulting in anticoagulation with Lovenox. The atrial fib responded to the Cardizem drip. Drip was titrated and discontinued accordingly. Oral Cardizem was"	"prescribed and routine HCTZ and Norvasc were held.  A bilateral lower extremity doppler was performed showing no evidence of DVT.  At discharge, the Cardizem was controlling the patient's heart rate"	"and blood pressure so the HCTZ and Norvasc were discontinued with Cardizem CD 360 mg QD prescribed. Therapeutic INR was 0.98, so Lovenox 90 mg SC every 12 hours and Coumadin 5 mg QD was prescribed"	"for anticoagulation. The patient's study treatment was delayed due to this event. The Investigator considers this event unrelated to study therapy. The patient will receive treatment this week with"	"no dose changes."	""	""	""	""	""	NA	NA	""	1483546735	""	""	""	NA	"Cardiac arrhythmia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Arrhythmia"	""	""	""	""	""	""	""	""	""	""	""	""
"1076"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	3	9	"Adverse Event/Serious Adverse Event"	2711184001	"constipation"	80	81	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475766611	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1077"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	3	9	"Adverse Event/Serious Adverse Event"	2768185001	"constipation"	59	60	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478704089	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1078"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	3	9	"Adverse Event/Serious Adverse Event"	2646068001	"constipation"	15	18	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471794632	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1079"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	3	9	"Adverse Event/Serious Adverse Event"	2666879001	"cough"	53	78	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473168939	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1080"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	3	9	"Adverse Event/Serious Adverse Event"	2666855001	"fatigue"	36	39	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473168656	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1081"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	3	9	"Adverse Event/Serious Adverse Event"	2768453001	"fatigue"	78	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478710300	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1082"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	3	9	"Adverse Event/Serious Adverse Event"	2918430001	"hematuria"	178	247	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486408737	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"1083"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	3	9	"Adverse Event/Serious Adverse Event"	2816709001	"increased bruising"	135	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481468691	""	""	""	NA	"Increased tendency to bruise"	"Skin and subcutaneous tissue disorders"	"Skin vascular abnormalities"	"Purpura and related conditions"	"Increased tendency to bruise"	""	""	""	""	""	""	""	""	""	""	""	""
"1084"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	3	9	"Adverse Event/Serious Adverse Event"	2806798001	"insomnia"	120	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481060291	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1085"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	3	9	"Adverse Event/Serious Adverse Event"	2768229001	"Left thigh pain"	73	99	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478706082	""	""	""	NA	"Pain in thigh"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"1086"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	3	9	"Adverse Event/Serious Adverse Event"	2768449001	"leg cramps"	31	36	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478709829	""	""	""	NA	"Leg cramps"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"1087"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	3	9	"Adverse Event/Serious Adverse Event"	2768441001	"rectal bleeding r/t pre-existing hemorrhoids"	95	96	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478709541	""	""	""	NA	"Hemorrhage rectal"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Intestinal haemorrhages"	"Rectal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"1088"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	3	9	"Adverse Event/Serious Adverse Event"	2977428001	"Right leg pain"	226	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488727514	""	""	""	NA	"Leg pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"1089"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	3	9	"Adverse Event/Serious Adverse Event"	2768282001	"taste disturbance"	88	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478706778	""	""	""	NA	"Taste disturbance"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1090"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	3	9	"Adverse Event/Serious Adverse Event"	2666827001	"taste disturbance"	37	40	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473168502	""	""	""	NA	"Taste disturbance"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1091"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	5	9	"Adverse Event/Serious Adverse Event"	2996186003	"alopecia"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493662922	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1092"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	3	9	"Adverse Event/Serious Adverse Event"	3150770001	"constipation"	29	33	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493663599	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1093"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	3	9	"Adverse Event/Serious Adverse Event"	3027624001	"fever"	14	15	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490541249	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1094"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	3	9	"Adverse Event/Serious Adverse Event"	3027486001	"neutropenia"	15	17	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	18	NA	NA	15	17	"3/23/07 ANC = 320 WBC = 1.1; 3/24/2007 ANC = 290  WBC = 2.1; 3/25/2007 ANC = 592  WBC = 4.2; 3/23/2007 CXR = slight opacity R lung; 3/23/2007 blood cultures = no growth in 24 hours"	""	""	2	2	2	NA	2	2	NA	2	"Docetaxel given (cycle 1) 3/16/2007.  Pt. presented in ER 3/23/2007 evening with c/o productive cough x 3 days and fever spike of 101.5 (f) 3/22.  Temperature in ER = 99.7. Pt  admitted to hospital"	"for emperic Cefipime 2 grams Q 8 hours started immediately.  Blood cultures and sputum cultures were obtained with no growth after 24 hours.  Neupogen 300 mcg was given for neutrophil recovery.  Pt."	"discharged home 3/25/2007 morning.  The investigator considers this event related to Docetaxel."	""	""	""	""	""	""	""	""	NA	NA	""	1490540188	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1095"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	3	9	"Adverse Event/Serious Adverse Event"	3150761001	"sensory neuropathy"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493663484	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1096"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	5	9	"Adverse Event/Serious Adverse Event"	2634760003	"Alteration in taste"	13	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475701316	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1097"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	3	9	"Adverse Event/Serious Adverse Event"	2890512001	"Constipation"	174	174	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	174	NA	NA	174	175	"Pending"	""	""	2	2	2	NA	2	2	NA	2	"Patient experienced constipation not responsive to remedies from home. Was admitted to hospital 23 Jan 07 by on-call physician. Records pending"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485209705	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1098"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	3	9	"Adverse Event/Serious Adverse Event"	2958363001	"Constipation"	154	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487692890	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1099"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	3	9	"Adverse Event/Serious Adverse Event"	2821631001	"Fatigue"	78	81	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481652975	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1100"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	3	9	"Adverse Event/Serious Adverse Event"	2958333001	"Nail Chnages"	120	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487692630	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"1101"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	3	9	"Adverse Event/Serious Adverse Event"	2710215001	"Pain - right lower extremity"	57	79	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475701743	""	""	""	NA	"Pain of lower extremities"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"1102"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	3	9	"Adverse Event/Serious Adverse Event"	2710229001	"Sensory neuropathy"	38	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475701827	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1103"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	3	9	"Adverse Event/Serious Adverse Event"	2821610001	"Shortness of breath"	119	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481652743	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1104"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	3	9	"Adverse Event/Serious Adverse Event"	2732626001	"Taxotere infusion reaction"	8	8	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476404741	""	""	""	NA	"Infusion related reaction"	"General disorders and administration site conditions"	"Administration site reactions"	"Injection and infusion site reactions"	"Infusion related reaction"	""	""	""	""	""	""	""	""	""	""	""	""
"1105"	"DN-101 Protocol No. 011-007"	"081"	"081-0004"	5	9	"Adverse Event/Serious Adverse Event"	2658044003	"Bronchitis"	129	133	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487780072	""	""	""	NA	"Bronchitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Bronchitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1106"	"DN-101 Protocol No. 011-007"	"081"	"081-0004"	3	9	"Adverse Event/Serious Adverse Event"	3056563001	"Candidiasis"	202	209	NA	2	0	NA	NA	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491316274	""	""	""	NA	"Candidiasis"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"1107"	"DN-101 Protocol No. 011-007"	"081"	"081-0004"	3	9	"Adverse Event/Serious Adverse Event"	2960668001	"Dizziness"	173	176	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Told patient to increase fluid intake; monitor BP at home"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487780289	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"1108"	"DN-101 Protocol No. 011-007"	"081"	"081-0004"	3	9	"Adverse Event/Serious Adverse Event"	2960679001	"Dizziness"	177	NA	1	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487780418	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"1109"	"DN-101 Protocol No. 011-007"	"081"	"081-0004"	3	9	"Adverse Event/Serious Adverse Event"	2732286001	"Fatigue"	25	32	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476399850	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1110"	"DN-101 Protocol No. 011-007"	"081"	"081-0004"	3	9	"Adverse Event/Serious Adverse Event"	2960737001	"Fatigue"	152	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487781007	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1111"	"DN-101 Protocol No. 011-007"	"081"	"081-0004"	3	9	"Adverse Event/Serious Adverse Event"	2732293001	"Fatigue"	45	49	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476399956	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1112"	"DN-101 Protocol No. 011-007"	"081"	"081-0004"	3	9	"Adverse Event/Serious Adverse Event"	2732303001	"indigestion"	45	46	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476400163	""	""	""	NA	"Indigestion"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"1113"	"DN-101 Protocol No. 011-007"	"081"	"081-0004"	3	9	"Adverse Event/Serious Adverse Event"	2960768001	"Mucositis"	196	202	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487781339	""	""	""	NA	"Mucositis"	"General disorders and administration site conditions"	"General system disorders NEC"	"Mucosal findings abnormal"	"Mucosal inflammation"	""	""	""	""	""	""	""	""	""	""	""	""
"1114"	"DN-101 Protocol No. 011-007"	"081"	"081-0004"	3	9	"Adverse Event/Serious Adverse Event"	3056586001	"Pain - Bone"	215	NA	1	2	0	NA	NA	NA	NA	NA	1	1	NA	4	NA	NA	1	"New treatment will be started"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491316533	""	""	""	NA	"Pain bone"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1115"	"DN-101 Protocol No. 011-007"	"082"	"082-0001"	5	9	"Adverse Event/Serious Adverse Event"	2609735003	"bilateral ankle edema"	148	176	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Cardiac workup, EKG and CT angiogram all proved negative."	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483905188	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1116"	"DN-101 Protocol No. 011-007"	"082"	"082-0001"	3	9	"Adverse Event/Serious Adverse Event"	2859444001	"fatigue"	176	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483905596	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1117"	"DN-101 Protocol No. 011-007"	"082"	"082-0001"	3	9	"Adverse Event/Serious Adverse Event"	2737552001	"insomnia"	71	92	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476736467	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1118"	"DN-101 Protocol No. 011-007"	"082"	"082-0001"	3	9	"Adverse Event/Serious Adverse Event"	2859429001	"intermittent non-cardiac chest pain"	148	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"cardiac workup, EKG and CT angio all proved negative."	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483905355	""	""	""	NA	"Non-cardiac chest pain"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Non-cardiac chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1119"	"DN-101 Protocol No. 011-007"	"082"	"082-0001"	3	9	"Adverse Event/Serious Adverse Event"	2644776001	"swollen olecranon"	31	32	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"IV antibiotics given for 24 hours in the hospital."	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	38	NA	NA	31	32	"CBC within normal limits, x-ray of left elbow showing swelling at the olecranon"	""	""	2	2	2	2	2	2	NA	2	"Patient admitted to Jefferson Memorial Hospital for 24 hours. Received IV antibiotics for swollen elbow. No decrease or discontinuation of study treatment occurred. The patient recovered"	"uneventfully."	""	""	""	""	""	""	""	""	""	NA	NA	""	1471545590	""	""	""	NA	"Swollen elbows"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Joint swelling"	""	""	""	""	""	""	""	""	""	""	""	""
"1120"	"DN-101 Protocol No. 011-007"	"084"	"084-0001"	5	9	"Adverse Event/Serious Adverse Event"	2843463003	"fatigue"	24	42	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487274598	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1121"	"DN-101 Protocol No. 011-007"	"084"	"084-0001"	3	9	"Adverse Event/Serious Adverse Event"	2872080001	"right upper extremity DVT"	12	42	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	19	NA	NA	12	14	"Ultrasoud of right upper extremity. EKG was done showing normal sinus rhythm without any acute ST-T wave changes.; Labs-WBC=2.1, Hgb=10.5, INR=1.0, and electrolytes normal."	""	""	2	2	2	NA	2	2	NA	2	"Patient had a PICC line in place for receiving vancomycin IV, status post urosepsis. He received his vancomycin from 10:00 to 11:30. At 13:00 he noticed redness and swelling of his right forearm. No"	"other symptoms. Came to ER. Right upper extremity ultrasound was done showing DVT in the right subclavian, basilic, axillary and brachial veins. Patient was given a 100 mg of Lovenox subcutaneous."	"PICC line was removed without any incident. Patient was admitted for further observation."	""	""	""	""	""	""	""	""	NA	NA	""	1484514945	""	""	""	NA	"DVT"	"Vascular disorders"	"Embolism and thrombosis"	"Peripheral embolism and thrombosis"	"Deep vein thrombosis"	""	""	""	""	""	""	""	""	""	""	""	""
"1122"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	2602318003	"alopecia"	29	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473795349	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1123"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	3	9	"Adverse Event/Serious Adverse Event"	2635966001	"fatigue"	8	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470856760	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1124"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	3	9	"Adverse Event/Serious Adverse Event"	2638800001	"Febrile Neutropenia"	37	44	NA	4	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	47	NA	NA	37	44	"August 4/06, Neutrophils=0.1, WBC=0.7. Patient was seen back in clinic on Aug 24/06, Neutrophil = 3.7, and rechallenged with Docetaxel with at a reduced dose of 60 mg/m2."	""	""	2	1	2	NA	2	2	NA	0	"pt felt generally unwell and had a fever of 38.4 C.  He was admitted on Aug 4/06 and treated with IV antibiotics Ceftazidine 500 mg q4h iv.  A blood culture from August 4/06 grew Coagulase Negative"	"Staphylococcus.  Aug 7/06 patients WBC=2.3 and Neutrophils= 1.3.  He slowly improved and was discharged August 11/06.  He went home and continues on antibiotic treatment of Rocephin q 24h iv,"	"starting Aug 12/06 for 5 days.	Rechallenged at a reduced dose of 60 mg/m2 of Docetaxel on August 24/06."	""	""	""	""	""	""	""	""	NA	NA	""	1471209549	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1125"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	3	9	"Adverse Event/Serious Adverse Event"	2636005001	"hypertension"	8	8	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470857678	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"1126"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	3	9	"Adverse Event/Serious Adverse Event"	2635978001	"insomnia"	8	NA	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470857149	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1127"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	3	9	"Adverse Event/Serious Adverse Event"	2635997001	"mood changes"	8	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470857555	""	""	""	NA	"Mood swings"	"Psychiatric disorders"	"Mood disorders and disturbances NEC"	"Fluctuating mood symptoms"	"Mood swings"	""	""	""	""	""	""	""	""	""	""	""	""
"1128"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	3	9	"Adverse Event/Serious Adverse Event"	2679249001	"pneumonia"	37	44	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473796118	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"1129"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	3	9	"Adverse Event/Serious Adverse Event"	2837362001	"Shortness of Breath"	NA	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482338986	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1130"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	3	9	"Adverse Event/Serious Adverse Event"	2837284001	"Shortness of breath"	37	NA	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482338667	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1131"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	3	9	"Adverse Event/Serious Adverse Event"	2635991001	"stomach ache"	12	22	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470857478	""	""	""	NA	"Stomach ache"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain upper"	""	""	""	""	""	""	""	""	""	""	""	""
"1132"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	3	9	"Adverse Event/Serious Adverse Event"	2679220001	"tachycardia"	37	NA	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"increased metropolol"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473795733	""	""	""	NA	"Tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"1133"	"DN-101 Protocol No. 011-007"	"087"	"087-0001"	5	9	"Adverse Event/Serious Adverse Event"	2568036003	"Alopecia"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466602388	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1134"	"DN-101 Protocol No. 011-007"	"087"	"087-0001"	3	9	"Adverse Event/Serious Adverse Event"	2587530001	"Extravasation injury of right hand"	19	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1465402264	""	""	""	NA	"Extravasation"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"Extravasation"	""	""	""	""	""	""	""	""	""	""	""	""
"1135"	"DN-101 Protocol No. 011-007"	"087"	"087-0001"	3	9	"Adverse Event/Serious Adverse Event"	2595626001	"Fatigue"	14	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466523677	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1136"	"DN-101 Protocol No. 011-007"	"087"	"087-0001"	3	9	"Adverse Event/Serious Adverse Event"	2595513001	"Hyperpigmentation of right hand"	19	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466516208	""	""	""	NA	"Hyperpigmentation skin"	"Skin and subcutaneous tissue disorders"	"Pigmentation disorders"	"Hyperpigmentation disorders"	"Skin hyperpigmentation"	""	""	""	""	""	""	""	""	""	""	""	""
"1137"	"DN-101 Protocol No. 011-007"	"087"	"087-0001"	3	9	"Adverse Event/Serious Adverse Event"	2595519001	"Numbness in right hand"	19	36	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466516599	""	""	""	NA	"Numbness in hand"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"1138"	"DN-101 Protocol No. 011-007"	"087"	"087-0001"	3	9	"Adverse Event/Serious Adverse Event"	2595629001	"Urinary Frequency/Urgency"	19	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466524195	""	""	""	NA	"Urinary urgency"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Micturition urgency"	""	""	""	""	""	""	""	""	""	""	""	""
"1139"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	5	9	"Adverse Event/Serious Adverse Event"	2778415003	"Bilateral hip pain"	164	166	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493761295	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1140"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	3	9	"Adverse Event/Serious Adverse Event"	3155957001	"Bilateral wrist pain"	164	166	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493761214	""	""	""	NA	"Wrist pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1141"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	3	9	"Adverse Event/Serious Adverse Event"	2816041001	"Chest Pain, non-cardiac"	12	12	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481240861	""	""	""	NA	"Chest pain (non-cardiac)"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Non-cardiac chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1142"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	3	9	"Adverse Event/Serious Adverse Event"	3070285001	"Constipation"	140	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491758575	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1143"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	3	9	"Adverse Event/Serious Adverse Event"	2939939001	"Fatigue"	86	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487091571	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1144"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	3	9	"Adverse Event/Serious Adverse Event"	2904810001	"Febrile Neutropenia"	82	85	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	84	NA	NA	83	85	"1/30/07- chest xray. 1/30/07, 1/31/07, 2/1/07- Hematology/Coagulation. 1/30/07- Chemisty, Urinalysis, and blood cultures."	""	""	0	0	0	0	0	0	0	0	"Patient was admitted to the hospital with Neutopenic Fever. Patient was cultured and started on broad spectrum antibiotics and supported with fluids. He was dismissed and told to stay on Levaquin for"	"several more days and to follow up with Dr. Bjorling in one week."	""	""	""	""	""	""	""	""	""	NA	NA	""	1485908229	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1145"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	3	9	"Adverse Event/Serious Adverse Event"	2988025001	"Heartburn"	33	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489004649	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"1146"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	3	9	"Adverse Event/Serious Adverse Event"	3070267001	"Hematuria"	104	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Coumadin and ASA discontinued"	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491758199	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"1147"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	3	9	"Adverse Event/Serious Adverse Event"	2816064001	"Leg Pain"	12	12	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481241120	""	""	""	NA	"Leg pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"1148"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	3	9	"Adverse Event/Serious Adverse Event"	3043713001	"Neutropenia"	127	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490806674	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1149"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	3	9	"Adverse Event/Serious Adverse Event"	2862676001	"Neutropenia"	62	68	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Radiation Tx held"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484004142	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1150"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	3	9	"Adverse Event/Serious Adverse Event"	2860267001	"Neutropenia"	40	55	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Held radiation therapy."	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483919268	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1151"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	3	9	"Adverse Event/Serious Adverse Event"	2833063001	"Numbness to legs and abdomen"	33	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482183988	""	""	""	NA	"Numbness"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"1152"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	3	9	"Adverse Event/Serious Adverse Event"	2833041001	"Pain to both sides of lower back"	33	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482183855	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1153"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	3	9	"Adverse Event/Serious Adverse Event"	2963833001	"Paroxysmal Atrial Fibrillation"	103	104	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	107	NA	NA	103	104	"Adenosine Stress Test, Echocardiogram, Hematology/Coagulation, Chemistry, and EKG."	""	""	0	0	0	NA	0	0	NA	0	"Patient presented to the ER with  palpitations and chest pressure, also has history of coronary artery disease. Found to be in atrial fibrillation with rapid ventricular response and spontaneously"	"converted after 20mg of Diltiazam was given IV. Went home and was later sent back to ER due to chest pain and palpitations. He was then admitted for 24 hour observation. Started on Metoprolol and"	"Coumadin. Check serial cardiac enzymes. Discharged the next day 2/20/07."	""	""	""	""	""	""	""	""	NA	NA	""	1487883284	""	""	""	NA	"Paroxysmal atrial fibrillation"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Atrial fibrillation"	""	""	""	""	""	""	""	""	""	""	""	""
"1154"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	3	9	"Adverse Event/Serious Adverse Event"	2862682001	"Sinus Infection"	50	59	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484004277	""	""	""	NA	"Sinus infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Sinusitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1155"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	3	9	"Adverse Event/Serious Adverse Event"	2833026001	"Strep Throat"	25	31	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482183740	""	""	""	NA	"Streptococcal sore throat"	"Infections and infestations"	"Bacterial infectious disorders"	"Streptococcal infections"	"Pharyngitis streptococcal"	""	""	""	""	""	""	""	""	""	""	""	""
"1156"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	3	9	"Adverse Event/Serious Adverse Event"	2988011001	"Urinary Retention"	83	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Catheter"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489004530	""	""	""	NA	"Urinary retention"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary retention"	""	""	""	""	""	""	""	""	""	""	""	""
"1157"	"DN-101 Protocol No. 011-007"	"091"	"091-0002"	5	9	"Adverse Event/Serious Adverse Event"	2819038003	"Alopecia"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484167428	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1158"	"DN-101 Protocol No. 011-007"	"091"	"091-0002"	3	9	"Adverse Event/Serious Adverse Event"	2995292001	"Bloody Nasal Discharge"	71	74	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Instructed patient to use saline nasal spray and humidifer"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489421813	""	""	""	NA	"Nose bleed"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"1159"	"DN-101 Protocol No. 011-007"	"091"	"091-0002"	3	9	"Adverse Event/Serious Adverse Event"	3115529001	"Constipation"	115	121	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492953132	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1160"	"DN-101 Protocol No. 011-007"	"091"	"091-0002"	3	9	"Adverse Event/Serious Adverse Event"	3115588001	"Diarrhea"	122	125	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492953468	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1161"	"DN-101 Protocol No. 011-007"	"091"	"091-0002"	3	9	"Adverse Event/Serious Adverse Event"	3115620001	"epiphora"	115	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492953677	""	""	""	NA	"Epiphora"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1162"	"DN-101 Protocol No. 011-007"	"091"	"091-0002"	3	9	"Adverse Event/Serious Adverse Event"	3115502001	"Fatigue"	113	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492952874	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1163"	"DN-101 Protocol No. 011-007"	"091"	"091-0002"	3	9	"Adverse Event/Serious Adverse Event"	2995317001	"Jaw Tenderness"	71	74	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489422363	""	""	""	NA	"Jaw pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Pain in jaw"	""	""	""	""	""	""	""	""	""	""	""	""
"1164"	"DN-101 Protocol No. 011-007"	"091"	"091-0002"	3	9	"Adverse Event/Serious Adverse Event"	2952845001	"Nail Discoloration"	70	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487510000	""	""	""	NA	"Nail discoloration"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail discolouration"	""	""	""	""	""	""	""	""	""	""	""	""
"1165"	"DN-101 Protocol No. 011-007"	"092"	"092-0001"	5	9	"Adverse Event/Serious Adverse Event"	2791412003	"Constipation"	7	12	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	NA	NA	NA	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483638547	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1166"	"DN-101 Protocol No. 011-007"	"093"	"093-0003"	5	9	"Adverse Event/Serious Adverse Event"	2788383003	"Lower Extremity - Pain/Weakness"	117	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	7	1	1	1	"Imaging, Tordal, Naproxen, Pepci, Morphine, Oxycontin Controlled Release given in the hospital.  Meeting with Ortho Surgeon.  Total Right Knee Replacement done on 3/26/07."	2	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	121	NA	NA	119	128	"03/19  MRI of Lumbar Spine, Two Right Knee Views, Venous Evaluation and Whole Body Scan. Therapy and Surgery Evaluation by Dr. Sydney - Ortho Surgeon; 3/21 PSA 8.2"	""	""	2	2	2	2	2	2	2	2	"Patient came in for a follow up visit with Dr. Heather Mannuel.  His PSA level PSA is 8.2.;MRI of Lumbar Spine -There are diffuse osseous metastatic lessions throughout the T12,L1, L3, L4, L5"	"vertebral bodies.  There is also compression fracture of L4 with slight buckling of posterior cortex of this vertebral body toward the central spinal canal.  Multilevel spondylotic changes"	"throughtout the lumbar spine and diffuse fatty infiltration throughout the bone marrow in lower throacic, lumbar and upper sacral region are noted.Whole Body Bone Scan-;Findings are consistent with"	"osseous metastases at T12 and L3 and L4.  Degenerative changes of knees/shoulders.;Two Views of Right knees -;There are sever degenerative changes noted with joint space narrowing of the medial"	"compartment with small degenerative osteophytes noted.;Lower Extremity Venous Evaluation -;No evidence of venous valvular insufficiency"	""	""	""	""	""	""	NA	NA	""	1490108407	""	""	""	NA	"Lower extremities weakness of"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"1167"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2625246003	"Acute Renal Insufficiency"	245	250	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Hospitalization, IV fluids"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	247	NA	NA	245	250	"3-26-07: Creatinine: 3.9 mg/dL; 3-27-07: Creatinine: 4.2 mg/dL; 3-28-07: Creatinine: 5.1 mg/dL; 3-29-07: Creatinine: 5.2 mg/dL; 3-30-07: Creatinine: 4.9 mg/dL; 3-31-07: Creatinine: 3.9 mg/dL"	""	""	2	2	2	NA	2	2	NA	2	"Subject was admitted to local institution in-patient facility on 3-26-07 due to grade 2 acute renal insufficiency. Subject presented with grade 3 diarrhea, grade 3 dehydration. Diarrhea is thought to"	"be related to docetaxel, which resulted in dehydration, resulting in acute renal insufficiency. ;More information will be provided in a follow up report. Subject received 2 1 L boluses of normal"	"saline in ER and continued to receive aggressive hydration on the floor, 200 cc/hr of normal saline, which was decreased 75 cc/hr after 3 days. Urninalysis did not show eosinophils. Subjects diovan"	"was discontinued at time of discharge secondary to patient's acute renal failure and elavated creatinine."	""	""	""	""	""	""	""	NA	NA	""	1490714835	""	""	""	NA	"Acute renal insufficiency"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal failure and impairment"	"Renal failure acute"	""	""	""	""	""	""	""	""	""	""	""	""
"1168"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2740590001	"Alkaline Phosphatase"	65	86	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476893289	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1169"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2740576001	"Alkaline Phosphatase- Increased"	44	238	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476893163	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1170"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2782204001	"ALT- High"	107	128	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479655711	""	""	""	NA	"ALT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Alanine aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1171"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	3033479001	"Cough"	238	280	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490631317	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1172"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	3037145001	"Dehydration"	245	250	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Hospitalization, IV fluids"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	247	NA	NA	245	250	"Subject had elevated creatinine at time of admission and during in patient stay. Subject's creatinine peaked at 5.2 mg/dL on 3-29-07 but fell to 3.9 mg/dL at time of discharge."	""	""	2	2	2	NA	2	2	NA	2	"Subject was admitted to local institution's in-patient facility on 3-26-07 after presenting with grade 3 diarrhea related to docetaxel, grade 3 dehydration as a result of the diarrhea and grade 2"	"acute renal insufficiency as a result of the dehydration. Subject received 2 1 L boluses of normal saline in the ER and continued to receive aggressive hydration while on the floor, receving 200"	"cc/hour normal saline, which was decreased to 75 cc/hour after 3 days. Subjects po intake improved to greater than 2 L per day. Subject's urine output was greater than 3 L daily during his final 3"	"days of in-patient stay."	""	""	""	""	""	""	""	NA	NA	""	1490715283	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"1173"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	3033549001	"Diarrhea"	245	245	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"IV Fluids; Hospitalization"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	-119	NA	NA	245	250	"3-26-07: Serum creatinine: 3.9 mg/dL; 3-27-07: Serum creatinine: 4.2 mg/dL; 3-26-07: Urinalysis: Protein +1, otherwise normal; 3-26-07: Chest x-ray: Normal; 3-27-07: Renal ultrasound"	""	""	2	2	2	NA	2	2	NA	2	"Subject was admitted to local institution on 3-26-07 for grade 3 diarrhea, grade 3 dehydration, and grade 2 acute renal insufficiency. Subject reported having watery diarrhea 4-5 x/day for the past 3"	"days. Subject received IV fluids. Subject received two 1 L boluses of normal saline in the ER and aggressive hydration on the floor at 200 cc/hr of 0.9% normal saline. This was later decreased to 75"	"cc per hour. Subject received 1 dose of imodium at time of admission which resolved the diarrhea. Subject did not have episodes of diarrhea during hospital stay."	""	""	""	""	""	""	""	""	NA	NA	""	1490632169	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1174"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	3127898001	"Dyspnea"	266	280	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493135080	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1175"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2873455001	"Fatigue"	175	196	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484583331	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1176"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2968121001	"Fatigue"	217	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488207976	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1177"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2780893001	"Fatigue"	107	149	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479402247	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1178"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2873423001	"GGT- High"	175	266	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484583115	""	""	""	NA	"GGT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Gamma-glutamyltransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1179"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2782200001	"GGT-High"	107	128	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479655645	""	""	""	NA	"GGT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Gamma-glutamyltransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1180"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2707071001	"Hair loss/alopecia"	65	280	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475602550	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1181"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2968149001	"Hemoglobin- Low"	217	238	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488208304	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1182"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2740382001	"Hemoglobin-Low"	86	149	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476889629	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1183"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2740367001	"Hemoglobin-Low"	44	65	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476889527	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1184"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2919671001	"Hyperglycemia"	196	238	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486418579	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1185"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2873418001	"Hyperglycemia"	175	196	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484583007	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1186"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	3033419001	"Hyperglycemia"	238	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490630978	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1187"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2740397001	"Hyperglycemia"	44	175	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476889754	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1188"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2740418001	"Hypophosphatemia"	44	65	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476890019	""	""	""	NA	"Hypophosphatemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Phosphorus metabolism disorders"	"Hypophosphataemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1189"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2782188001	"LDH- High"	44	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479655556	""	""	""	NA	"LDH increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood lactate dehydrogenase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1190"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2740432001	"Leukopenia"	53	65	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476890151	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1191"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2740441001	"Leukopenia"	74	86	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476890273	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1192"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2968115001	"Lymphopenia"	217	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488207902	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1193"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2809854001	"Lymphopenia"	128	217	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481126281	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1194"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2780905001	"Neuropathy"	107	196	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479402592	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1195"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2740466001	"Neutropenia"	53	65	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476890680	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1196"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2740451001	"Neutropenia"	74	86	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476890409	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1197"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2739406001	"Pain- Thigh"	44	107	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476825705	""	""	""	NA	"Pain in thigh"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"1198"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2739398001	"Pain-Back"	44	266	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476825594	""	""	""	NA	"Pain back"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1199"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2739403001	"Pain-Rib cage"	44	107	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476825648	""	""	""	NA	"Rib pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1200"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2968146001	"Peripheral Edema"	217	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488208229	""	""	""	NA	"Peripheral edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1201"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	3127894001	"Pleural effusion, non-malignant"	266	280	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493135025	""	""	""	NA	"Pleural effusion"	"Respiratory, thoracic and mediastinal disorders"	"Pleural disorders"	"Pneumothorax and pleural effusions NEC"	"Pleural effusion"	""	""	""	""	""	""	""	""	""	""	""	""
"1202"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	3127918001	"Post-nasal Drip"	266	280	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493135404	""	""	""	NA	"Posterior nasal drip"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Postnasal drip"	""	""	""	""	""	""	""	""	""	""	""	""
"1203"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2626552001	"Spinal Cord Compression"	4	8	NA	3	2	NA	1	NA	NA	NA	2	NA	1	4	NA	NA	1	"Radiation therapy for a total of 10 sessions, receiving a total dose of 3000 cGy"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	4	NA	NA	4	6	"MRI: showed spinal cord compression, positive in T4, T8, and T11 regions"	""	""	2	2	2	NA	2	2	NA	2	"Subject was admitted to hospital for spinal cord compression on the same day he was randomized to this study. Spinal cord compression will be considered a baseline SRE. Subject has not received any"	"protocol treatment prior to SAE. ;;The morning of 7/28/06 subject had severe pain in both legs, right hip, and from the lower back around to the front of the abdomen in a band-like pattern. An MRI of"	"the T and L spine was ordered and showed intrathecal extension of soft tissue at the T8 level with radiographic cord compression. It was decided to start steroid therapy, begin prompt radiation"	"therapy. ;;Subject had 10 sessions of radiation therapy and received dexamethasone 4mg every 6 hours, which was tappered off per radiation oncology."	""	""	""	""	""	""	""	NA	NA	""	1469738883	""	""	""	NA	"Spinal cord compression"	"Nervous system disorders"	"Spinal cord and nerve root disorders"	"Spinal cord and nerve root disorders NEC"	"Spinal cord compression"	""	""	""	""	""	""	""	""	""	""	""	""
"1204"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2780898001	"Taste Alteration"	107	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479402331	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1205"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2968129001	"Thrush"	199	206	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488208077	""	""	""	NA	"Thrush"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"1206"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	3	9	"Adverse Event/Serious Adverse Event"	2982254001	"Thrush"	221	229	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488902534	""	""	""	NA	"Thrush"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"1207"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	2868184003	"Alkaline Phosphatase- High"	19	82	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484584690	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1208"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	2921396001	"Alopecia"	40	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486483152	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1209"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	3076927001	"Arthralgia- Right Thigh"	103	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491921104	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1210"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	2873612001	"BiCarb- Low"	19	103	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484584481	""	""	""	NA	"Blood bicarbonate low"	"Investigations"	"Water, electrolyte and mineral investigations"	"Mineral and electrolyte analyses"	"Blood bicarbonate decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1211"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	3221216001	"Bicarbonate- Low"	124	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495135572	""	""	""	NA	"Blood bicarbonate low"	"Investigations"	"Water, electrolyte and mineral investigations"	"Mineral and electrolyte analyses"	"Blood bicarbonate decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1212"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	3221145001	"Bilirubin-High"	124	145	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495135355	""	""	""	NA	"Raised bilirubin"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Blood bilirubin increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1213"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	2873601001	"BUN- High"	19	61	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484584406	""	""	""	NA	"BUN increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood urea increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1214"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	3034038001	"Cough"	82	103	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490637436	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1215"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	3221884001	"Dry skin"	124	145	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495137056	""	""	""	NA	"Dry skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Dry skin"	""	""	""	""	""	""	""	""	""	""	""	""
"1216"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	2968600001	"Dyspnea"	53	82	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488215301	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1217"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	3034062001	"Edema- bilateral ankles"	82	103	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490637565	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1218"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	2968333001	"Fatigue"	53	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488210982	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1219"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	3221130001	"Hemoglobin- Low"	124	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495135290	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1220"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	2968382001	"Hemoglobin-Low"	50	82	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488211300	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1221"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	3234938001	"Hyperglycemia"	145	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495550645	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1222"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	2873628001	"Hyperglycemia"	19	124	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484584589	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1223"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	3220923001	"Hyperglycemia"	124	145	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495134805	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1224"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	3034007001	"Hypomagnesemia"	82	124	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490636952	""	""	""	NA	"Hypomagnesemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Magnesium metabolism disorders"	"Hypomagnesaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1225"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	3221208001	"Hyponatremia"	124	145	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495135506	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1226"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	3034001001	"Hyponatremia"	82	103	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490636885	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1227"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	3076787001	"Hypophosphatemia"	103	124	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491920134	""	""	""	NA	"Hypophosphatemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Phosphorus metabolism disorders"	"Hypophosphataemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1228"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	3235001001	"Infected carbuncle"	134	145	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495551336	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"1229"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	2873598001	"LDH- High"	19	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484584351	""	""	""	NA	"LDH increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood lactate dehydrogenase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1230"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	2968859001	"Leukopenia"	50	50	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488221441	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1231"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	2968669001	"Leukopenia"	28	28	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488217622	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1232"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	3234951001	"Lymphopenia"	145	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495550779	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1233"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	3221016001	"Lymphopenia"	124	145	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495134999	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1234"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	3076709001	"Lymphopenia"	103	124	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491919678	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1235"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	2873592001	"Lymphopenia"	19	50	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484584298	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1236"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	2921366001	"Lymphopenia"	50	103	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486483059	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1237"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	3076901001	"Nail changes"	103	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491920867	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"1238"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	3221793001	"Neuropathy- Fingertips"	124	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495136843	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1239"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	2968354001	"Neuropathy- Fingertips"	61	82	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488211113	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1240"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	2968864001	"Neutropenia"	50	50	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488221505	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1241"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	2968672001	"Neutropenia"	28	28	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488217687	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1242"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	3076886001	"Oral Mucositis"	85	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491920776	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1243"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	3234988001	"Peripheral edema- bilaterally"	124	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495551233	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"1244"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	2921420001	"Rash: Hyperpigmentation w/ scaling on right medial wrist"	27	61	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486483340	""	""	""	NA	"Hyperpigmentation skin"	"Skin and subcutaneous tissue disorders"	"Pigmentation disorders"	"Hyperpigmentation disorders"	"Skin hyperpigmentation"	""	""	""	""	""	""	""	""	""	""	""	""
"1245"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	3	9	"Adverse Event/Serious Adverse Event"	3076793001	"Tachycardia"	82	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491920197	""	""	""	NA	"Tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"1246"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	5	9	"Adverse Event/Serious Adverse Event"	2653653003	"alopecia"	76	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478547727	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1247"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	3	9	"Adverse Event/Serious Adverse Event"	2765211001	"anemia"	41	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478546662	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1248"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	3	9	"Adverse Event/Serious Adverse Event"	3110493001	"cough"	76	83	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492702309	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1249"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	3	9	"Adverse Event/Serious Adverse Event"	3110588001	"elevated blood sugar"	104	167	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492703104	""	""	""	NA	"Blood sugar increased"	"Investigations"	"Metabolic, nutritional and blood gas investigations"	"Carbohydrate tolerance analyses (incl diabetes)"	"Blood glucose increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1250"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	3	9	"Adverse Event/Serious Adverse Event"	2766426001	"fever"	68	68	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478623096	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1251"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	3	9	"Adverse Event/Serious Adverse Event"	2928079001	"left tibial ORIF"	177	225	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	178	NA	NA	177	185	"not available as of 4/20"	""	""	2	2	2	NA	2	2	NA	2	"patient came to emergency room with severe pain.Xray taken showed possible leg fracture. Admitted to hospital for pain control and evaluation..; Discharge pending as of 4/20"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486654293	""	""	""	NA	"Tibia fracture"	"Injury, poisoning and procedural complications"	"Bone and joint injuries"	"Lower limb fractures and dislocations"	"Tibia fracture"	""	""	""	""	""	""	""	""	""	""	""	""
"1252"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	3	9	"Adverse Event/Serious Adverse Event"	3110468001	"mild erythema left shin"	150	205	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492702106	""	""	""	NA	"Erythema"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Erythemas"	"Erythema"	""	""	""	""	""	""	""	""	""	""	""	""
"1253"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	3	9	"Adverse Event/Serious Adverse Event"	3190072001	"mucositis"	272	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	272	NA	NA	272	NA	""	""	""	0	2	0	NA	0	0	NA	NA	"Patient came to hospital ER with neutropenic fever and mucositis.  Admitted"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494797391	""	""	""	NA	"Mucositis"	"General disorders and administration site conditions"	"General system disorders NEC"	"Mucosal findings abnormal"	"Mucosal inflammation"	""	""	""	""	""	""	""	""	""	""	""	""
"1254"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	3	9	"Adverse Event/Serious Adverse Event"	2765217001	"neutropenia"	48	62	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478546902	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1255"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	3	9	"Adverse Event/Serious Adverse Event"	3190051001	"neutropenic fever"	272	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	272	NA	NA	272	NA	""	""	""	0	2	2	2	2	2	2	2	"patient came to ER at hospital with fever and mucositis.; Admitted with neutropenic fever"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494796965	""	""	""	NA	"Neutropenic fever"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1256"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	3	9	"Adverse Event/Serious Adverse Event"	3110546001	"nosocomial pneumonia w/ neutropenic sepsis"	177	185	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492702719	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"1257"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	3	9	"Adverse Event/Serious Adverse Event"	2765220001	"pain in leg"	48	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478547197	""	""	""	NA	"Pain in leg"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"1258"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	3	9	"Adverse Event/Serious Adverse Event"	3031203001	"swelling left lower leg"	129	237	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490581171	""	""	""	NA	"Swelling of legs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1259"	"DN-101 Protocol No. 011-007"	"097"	"097-0003"	5	9	"Adverse Event/Serious Adverse Event"	2902679003	"erythema, macropapular rash on face and back"	53	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	5	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490587446	""	""	""	NA	"Erythema"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Erythemas"	"Erythema"	""	""	""	""	""	""	""	""	""	""	""	""
"1260"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	2894099003	"Chest pain, non-cardiac"	14	29	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"EKG, Adenosine Stress Test"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492540979	""	""	""	NA	"Chest pain (non-cardiac)"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Non-cardiac chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1261"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	3	9	"Adverse Event/Serious Adverse Event"	3048645001	"Chronic low back pain"	8	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490904803	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1262"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	3	9	"Adverse Event/Serious Adverse Event"	3101472001	"constipation"	14	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492541242	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1263"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	3	9	"Adverse Event/Serious Adverse Event"	3048619001	"cough"	16	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490904494	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1264"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	3	9	"Adverse Event/Serious Adverse Event"	3101416001	"Dyspepsia"	14	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492541120	""	""	""	NA	"Dyspepsia"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"1265"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	3	9	"Adverse Event/Serious Adverse Event"	3048610001	"dyspnea"	8	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490904204	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1266"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	3	9	"Adverse Event/Serious Adverse Event"	3101742001	"Fatigue"	14	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492541969	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1267"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	3	9	"Adverse Event/Serious Adverse Event"	3101680001	"headache"	16	27	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492541768	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"1268"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	3	9	"Adverse Event/Serious Adverse Event"	3048592001	"headache"	8	15	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490903907	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"1269"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	3	9	"Adverse Event/Serious Adverse Event"	3101815001	"headache"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492542210	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"1270"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	3	9	"Adverse Event/Serious Adverse Event"	3101866001	"heart palpitations"	14	16	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"EKG and ER visit"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492542335	""	""	""	NA	"Palpitations"	"Cardiac disorders"	"Cardiac disorder signs and symptoms"	"Cardiac signs and symptoms NEC"	"Palpitations"	""	""	""	""	""	""	""	""	""	""	""	""
"1271"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	3	9	"Adverse Event/Serious Adverse Event"	3101781001	"hypertension"	23	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492542093	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"1272"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	3	9	"Adverse Event/Serious Adverse Event"	3112393001	"neutropenia"	58	72	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492719439	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1273"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	3	9	"Adverse Event/Serious Adverse Event"	3099281001	"night sweats"	8	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492526325	""	""	""	NA	"Night sweats"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Night sweats"	""	""	""	""	""	""	""	""	""	""	""	""
"1274"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	3	9	"Adverse Event/Serious Adverse Event"	3101710001	"Rib cage pain"	14	72	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492541873	""	""	""	NA	"Rib pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1275"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	3	9	"Adverse Event/Serious Adverse Event"	3112361001	"sinus drainage"	37	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492719189	""	""	""	NA	"Nasal discharge"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Rhinorrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1276"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	5	9	"Adverse Event/Serious Adverse Event"	2835018003	"CONSTIPATION"	31	31	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491601320	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1277"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	3	9	"Adverse Event/Serious Adverse Event"	3069463001	"CONSTIPATION"	24	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491599911	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1278"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	3	9	"Adverse Event/Serious Adverse Event"	3069432001	"DECREASED APPETITE"	52	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491598359	""	""	""	NA	"Appetite decreased NOS"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Decreased appetite"	""	""	""	""	""	""	""	""	""	""	""	""
"1279"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	3	9	"Adverse Event/Serious Adverse Event"	3069466001	"DECREASING PAIN"	24	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491600051	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"1280"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	3	9	"Adverse Event/Serious Adverse Event"	3069475001	"DIARRHEA"	31	31	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491600671	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1281"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	3	9	"Adverse Event/Serious Adverse Event"	3069435001	"DYSPNEA"	52	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491598463	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1282"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	3	9	"Adverse Event/Serious Adverse Event"	3069504001	"FATIGUE"	52	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491601651	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1283"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	3	9	"Adverse Event/Serious Adverse Event"	3069469001	"HEARTBURN,REFLUX"	31	31	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491600511	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"1284"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	3	9	"Adverse Event/Serious Adverse Event"	3069457001	"NAUSEA"	24	24	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491599496	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"1285"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	3	9	"Adverse Event/Serious Adverse Event"	3069478001	"NAUSEA"	31	31	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491600889	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"1286"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	3	9	"Adverse Event/Serious Adverse Event"	3069498001	"PEDAL EDEMA"	31	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491601506	""	""	""	NA	"Pedal edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1287"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	3	9	"Adverse Event/Serious Adverse Event"	3069447001	"RHONCHI"	3	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491598962	""	""	""	NA	"Rhonchi"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Lower respiratory tract signs and symptoms"	"Rhonchi"	""	""	""	""	""	""	""	""	""	""	""	""
"1288"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	3	9	"Adverse Event/Serious Adverse Event"	3069460001	"VOMITING"	24	24	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491599692	""	""	""	NA	"Vomiting"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Vomiting"	""	""	""	""	""	""	""	""	""	""	""	""
"1289"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	3	9	"Adverse Event/Serious Adverse Event"	3069488001	"VOMITING"	31	31	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491601190	""	""	""	NA	"Vomiting"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Vomiting"	""	""	""	""	""	""	""	""	""	""	""	""
"1290"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	3	9	"Adverse Event/Serious Adverse Event"	3069441001	"WEIGHT LOSS"	73	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491598602	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1291"	"DN-101 Protocol No. 011-007"	"104"	"104-0002"	5	9	"Adverse Event/Serious Adverse Event"	2707732003	"FATIGUE"	46	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487517156	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1292"	"DN-101 Protocol No. 011-007"	"108"	"108-0002"	5	9	"Adverse Event/Serious Adverse Event"	2939989003	"DYSPNEA ON EXERTION"	NA	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"OXYGEN AT NIGHT"	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490627925	""	""	""	NA	"Dyspnea exertional"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea exertional"	""	""	""	""	""	""	""	""	""	""	""	""
"1293"	"DN-101 Protocol No. 011-007"	"108"	"108-0002"	3	9	"Adverse Event/Serious Adverse Event"	3032850001	"FATIGUE"	4	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"MONITORING LABS AND OXYGEN SATURATION"	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490628211	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1294"	"DN-101 Protocol No. 011-007"	"110"	"110-0002"	5	9	"Adverse Event/Serious Adverse Event"	2604892003	"alopecia"	77	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475780613	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1295"	"DN-101 Protocol No. 011-007"	"110"	"110-0005"	5	9	"Adverse Event/Serious Adverse Event"	2942022003	"Hyperglycemia"	3	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488224973	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1296"	"DN-101 Protocol No. 011-007"	"110"	"110-0005"	3	9	"Adverse Event/Serious Adverse Event"	2969100001	"Leukopenia"	10	14	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488225258	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1297"	"DN-101 Protocol No. 011-007"	"110"	"110-0005"	3	9	"Adverse Event/Serious Adverse Event"	3165841001	"Low grade temps"	46	58	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494197114	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1298"	"DN-101 Protocol No. 011-007"	"110"	"110-0005"	3	9	"Adverse Event/Serious Adverse Event"	2969096001	"Neutropenia"	10	14	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488225166	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1299"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	5	9	"Adverse Event/Serious Adverse Event"	2628998003	"Anemia"	51	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481238237	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1300"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	3	9	"Adverse Event/Serious Adverse Event"	2815741001	"Anemia"	30	42	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481238016	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1301"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	3	9	"Adverse Event/Serious Adverse Event"	2704410001	"Bright Red Blood Per Rectum"	44	51	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475449197	""	""	""	NA	"Hemorrhage rectum"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Intestinal haemorrhages"	"Rectal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"1302"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	3	9	"Adverse Event/Serious Adverse Event"	2704362001	"Fatigue"	13	16	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475447548	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1303"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	3	9	"Adverse Event/Serious Adverse Event"	2704389001	"Fecal Incontinence"	42	83	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475448768	""	""	""	NA	"Fecal incontinence"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal signs and symptoms NEC"	"Faecal incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"1304"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	3	9	"Adverse Event/Serious Adverse Event"	2816121001	"Hyperglycemia"	9	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481241978	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1305"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	3	9	"Adverse Event/Serious Adverse Event"	2640251001	"Neutropenic Fever"	17	21	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	17	NA	NA	17	21	"AUG/11/2006 Hematology"	""	""	0	0	0	NA	0	0	NA	0	"Patient was hospitalized with Neutropenic Fever (Grade 3) on Aug/11/2006 confirmed by blood work and a rectal temperature of 102. Patient hospitalized and given IV fluids with 1000mg Vancomycin and"	"Filgrastim 480 mcg. Additional lab tests and blood cultures pending. Patient will be treated with antibiotics and growth factor."	""	""	""	""	""	""	""	""	""	NA	NA	""	1471291017	""	""	""	NA	"Neutropenic fever"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1306"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	3	9	"Adverse Event/Serious Adverse Event"	2726697001	"Rectovesical Fistula"	64	NA	1	1	2	NA	1	NA	NA	NA	2	NA	1	2	NA	1	NA	""	1	0	NA	0	40	NA	NA	NA	1	NA	1	NA	""	84	NA	NA	83	88	"OCT/16/2006 Sigmoid end-colostomy and suprapubic catheter placement"	""	""	2	2	2	NA	2	0	NA	0	"Pt was admitted OCT/16/2006 for elective diverting sigmoid end-colostomy and suprapubic catheter placement for treatment of his rectovesical fistula, a complication likely related to multiple"	"previous local therapies (cryo, xrt, etc.). The surgeries were performed with no complications."	""	""	""	""	""	""	""	""	""	NA	NA	""	1476313380	""	""	""	NA	"Rectovesical fistula"	"Gastrointestinal disorders"	"Gastrointestinal conditions NEC"	"Gastrointestinal fistulae"	"Enterovesical fistula"	""	""	""	""	""	""	""	""	""	""	""	""
"1307"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	2621127003	"Alopecia"	173	NA	1	1	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	NA	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484271656	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1308"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	3	9	"Adverse Event/Serious Adverse Event"	2841271001	"Cognitive Disturbance"	136	173	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482452397	""	""	""	NA	"Cognitive disturbance"	"Nervous system disorders"	"Mental impairment disorders"	"Mental impairment (excl dementia and memory loss)"	"Cognitive disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"1309"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	3	9	"Adverse Event/Serious Adverse Event"	2841268001	"Cough"	117	152	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482452211	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1310"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	3	9	"Adverse Event/Serious Adverse Event"	2637530001	"Dyspepsia"	7	14	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470961322	""	""	""	NA	"Dyspepsia"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"1311"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	3	9	"Adverse Event/Serious Adverse Event"	2841274001	"Dyspnea"	137	173	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482452467	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1312"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	3	9	"Adverse Event/Serious Adverse Event"	2642694001	"Epistaxis"	17	19	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471452775	""	""	""	NA	"Epistaxis"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"1313"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	3	9	"Adverse Event/Serious Adverse Event"	2642698001	"Fatigue"	19	33	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471452857	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1314"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	3	9	"Adverse Event/Serious Adverse Event"	2717760001	"Fatigue"	47	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	NA	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476139064	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1315"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	3	9	"Adverse Event/Serious Adverse Event"	2667164001	"Flu-like symptoms"	32	35	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473176520	""	""	""	NA	"Flu-like symptoms"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"Influenza like illness"	""	""	""	""	""	""	""	""	""	""	""	""
"1316"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	3	9	"Adverse Event/Serious Adverse Event"	3085015001	"Left Hip Pain"	241	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	NA	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492100255	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1317"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	3	9	"Adverse Event/Serious Adverse Event"	3085012001	"Lower Back Pain"	194	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	NA	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492100183	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1318"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	3	9	"Adverse Event/Serious Adverse Event"	2769622001	"Nail Change"	89	NA	1	1	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	NA	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478730136	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"1319"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	3	9	"Adverse Event/Serious Adverse Event"	2679609001	"Worsened Peripheral edema"	47	54	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473801983	""	""	""	NA	"Edema aggravated"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"1320"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	3	9	"Adverse Event/Serious Adverse Event"	2717863001	"Worsened peripheral edema"	68	110	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476141136	""	""	""	NA	"Edema aggravated"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"1321"	"DN-101 Protocol No. 011-007"	"116"	"116-0001"	5	9	"Adverse Event/Serious Adverse Event"	3017422003	"Hematuria"	38	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492997601	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"1322"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2564548003	"allergic rhinitis"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466607700	""	""	""	NA	"Allergic rhinitis"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal congestion and inflammations"	"Rhinitis allergic"	""	""	""	""	""	""	""	""	""	""	""	""
"1323"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2579486001	"Alopecia"	14	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1464278389	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1324"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2596138001	"anemia"	21	34	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466612014	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1325"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2596141001	"anemia"	41	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466612095	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1326"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2664903001	"Anemia"	84	108	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473101965	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1327"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2721166001	"anemia"	125	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476215076	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1328"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2573653001	"arthralgia"	10	16	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463423817	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1329"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2579490001	"arthralgia"	16	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1464278467	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1330"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2721097001	"crepitus of right wrist"	131	194	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476214797	""	""	""	NA	"Crepitations NOS"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"Crepitations"	""	""	""	""	""	""	""	""	""	""	""	""
"1331"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2817780001	"decreased albumin"	161	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481488249	""	""	""	NA	"Albumin decreased"	"Investigations"	"Protein and chemistry analyses NEC"	"Protein analyses NEC"	"Blood albumin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1332"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2817787001	"decreased globulin"	161	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481488311	""	""	""	NA	"Globulin decreased"	"Investigations"	"Protein and chemistry analyses NEC"	"Protein analyses NEC"	"Globulins decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1333"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2664822001	"dizziness"	76	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473101461	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"1334"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2583525001	"Dry Eyes"	31	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1465157636	""	""	""	NA	"Dry eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Dry eye"	""	""	""	""	""	""	""	""	""	""	""	""
"1335"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2720535001	"edema-pedal"	123	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476210554	""	""	""	NA	"Pedal edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1336"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2664762001	"elevated cholesterol"	70	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473101022	""	""	""	NA	"High cholesterol"	"Investigations"	"Lipid analyses"	"Cholesterol analyses"	"Blood cholesterol increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1337"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2573693001	"fatigue"	10	12	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463424592	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1338"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2596018001	"fatigue"	54	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466607183	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1339"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2596015001	"fatigue"	52	54	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466607115	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1340"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2583491001	"fatigue"	13	52	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1465156942	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1341"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2579511001	"Fever"	15	17	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1464279496	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1342"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2579514001	"groin hernia"	15	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"patient encouraged to wear girdle"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1464279643	""	""	""	NA	"Hernia inguinal"	"Gastrointestinal disorders"	"Abdominal hernias and other abdominal wall conditions"	"Inguinal hernias"	"Inguinal hernia"	""	""	""	""	""	""	""	""	""	""	""	""
"1343"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2573672001	"insomnia"	8	11	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463424330	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1344"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2817751001	"left pedal edema"	132	NA	1	2	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481487828	""	""	""	NA	"Pedal edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1345"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2664880001	"leukopenia"	84	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473101828	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1346"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2664965001	"leukopenia"	98	105	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473102482	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1347"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2664988001	"leukopenia"	105	126	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473102639	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1348"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2596153001	"leukopenia"	55	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466612440	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1349"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2596150001	"leukopenia"	34	41	NA	4	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466612383	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1350"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2596144001	"lymphopenia"	27	41	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466612229	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1351"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2596147001	"lymphopenia"	48	55	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466612294	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1352"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2844466001	"neuropathy"	161	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482946441	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1353"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2573820001	"neutropenia"	13	21	NA	4	0	NA	NA	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463425865	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1354"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2664957001	"neutropenia"	98	105	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473102415	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1355"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2596156001	"neutropenia"	55	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466612530	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1356"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2664975001	"neutropenia"	105	126	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473102563	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1357"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2720416001	"neutropenia"	119	126	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476209802	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1358"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2583529001	"neutropenia"	34	41	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1465157985	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1359"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2664859001	"neutropenia"	77	84	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473101649	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1360"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2721048001	"non-cardiac left chest pain"	132	133	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476214654	""	""	""	NA	"Non-cardiac chest pain"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Non-cardiac chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1361"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2664936001	"nose bleed"	82	82	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473102216	""	""	""	NA	"Nose bleed"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"1362"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2664944001	"nose bleed"	85	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473102297	""	""	""	NA	"Nose bleed"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"1363"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2721079001	"shortness of breath"	132	133	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476214726	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1364"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2817790001	"shortness of breath"	161	194	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481488409	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1365"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2596290001	"skin sensitivity"	42	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466614613	""	""	""	NA	"Increased skin sensitivity"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hyperaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"1366"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2664805001	"taste changes"	70	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473101367	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1367"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2664870001	"thrombocytopenia"	77	84	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473101710	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1368"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	3	9	"Adverse Event/Serious Adverse Event"	2664845001	"weight loss"	77	91	NA	1	0	NA	NA	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473101562	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1369"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2585834003	"anemia"	7	28	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466434378	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1370"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	3	9	"Adverse Event/Serious Adverse Event"	2661500001	"anemia"	32	33	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472743533	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1371"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	3	9	"Adverse Event/Serious Adverse Event"	2661470001	"arthralgia"	8	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472742703	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1372"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	3	9	"Adverse Event/Serious Adverse Event"	2716434001	"chills"	103	104	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476122344	""	""	""	NA	"Chills"	"General disorders and administration site conditions"	"Body temperature conditions"	"Body temperature perception"	"Chills"	""	""	""	""	""	""	""	""	""	""	""	""
"1373"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	3	9	"Adverse Event/Serious Adverse Event"	2661560001	"constipation"	60	63	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472744704	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1374"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	3	9	"Adverse Event/Serious Adverse Event"	2661557001	"cough"	65	65	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472744600	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1375"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	3	9	"Adverse Event/Serious Adverse Event"	2716441001	"fatgue"	105	176	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476122506	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1376"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	3	9	"Adverse Event/Serious Adverse Event"	2661544001	"fatigue"	30	103	NA	1	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472744432	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1377"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	3	9	"Adverse Event/Serious Adverse Event"	2716438001	"fatigue"	103	105	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476122439	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1378"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	3	9	"Adverse Event/Serious Adverse Event"	2661551001	"fever"	65	65	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472744519	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1379"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	3	9	"Adverse Event/Serious Adverse Event"	2661580001	"fever"	81	82	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472744846	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1380"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	3	9	"Adverse Event/Serious Adverse Event"	2603447001	"fever"	31	34	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	36	NA	NA	31	34	"See faxed lab results from 03/JUL/2006 and 05/JUL/2006."	""	""	2	2	2	NA	2	2	NA	2	"Patient presented to ER with fever of 102, etiolgy unknown, on 02/JUL/2006.  He was admitted to hospital for observation.  He recieved levaquin  and two units of blood for his anemia.  He was"	"discharged 05/JUL/2006."	""	""	""	""	""	""	""	""	""	NA	NA	""	1467899346	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1381"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	3	9	"Adverse Event/Serious Adverse Event"	2716431001	"fever"	103	104	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476122250	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1382"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	3	9	"Adverse Event/Serious Adverse Event"	2661538001	"indigestion"	57	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472744272	""	""	""	NA	"Indigestion"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"1383"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	3	9	"Adverse Event/Serious Adverse Event"	2716453001	"leukopenia"	105	119	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476122652	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1384"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	3	9	"Adverse Event/Serious Adverse Event"	2661716001	"leukopenia"	84	119	NA	1	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472747159	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1385"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	3	9	"Adverse Event/Serious Adverse Event"	2661591001	"nasal congestion"	81	84	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472744948	""	""	""	NA	"Nasal congestion"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal congestion and inflammations"	"Nasal congestion"	""	""	""	""	""	""	""	""	""	""	""	""
"1386"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	3	9	"Adverse Event/Serious Adverse Event"	2716444001	"neutropenia"	105	119	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476122577	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1387"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	3	9	"Adverse Event/Serious Adverse Event"	2661627001	"neutropenia"	84	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472745188	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1388"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	3	9	"Adverse Event/Serious Adverse Event"	2661489001	"pain- back"	28	34	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472743195	""	""	""	NA	"Pain back"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1389"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	3	9	"Adverse Event/Serious Adverse Event"	2661541001	"pain- back"	57	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472744358	""	""	""	NA	"Pain back"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1390"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	3	9	"Adverse Event/Serious Adverse Event"	2716428001	"peripheral neutropenia"	98	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476122127	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"1391"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	3	9	"Adverse Event/Serious Adverse Event"	2788572001	"pneumonia"	176	231	NA	3	0	NA	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	179	NA	NA	176	181	"Chest x-ray PA and lateral on 11/24/06 findings: new lilateral bibasilar infiltrates and minimal pleural fluid present bilaterally. 11/24/06 labs: WBC 1.64, RBC 3.64, HGB 11.0, HCT 35.0, sodium 136,"	"BUN 39, and creatinine 1.9  11-26-06 labs: WBC 7.59, RBC 2.77, HGB 8.6, HCT 26.4"	""	2	2	2	NA	2	2	NA	2	"the patient was admitted to the hospital on 11-24-06 for shortness of breath and fever.  chest x-ray showed pneumonia.	He had grade 3 leukopenia and grade 1 anemia.  he recieved 2 units of packed"	"red blood cells.  He currently remains in the hospital.  Patient discharged from hospital 11/29/06.  Per discharge summary, patient also presented with chills and cough.  Patient was started on"	"levaquin and diflucan.	He was also given mild hydration because of his renal toxicity.  Patient was quite weak and required physical therapy. after discharge he will recieve physical therapy."	""	""	""	""	""	""	""	""	NA	NA	""	1480277175	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"1392"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	3	9	"Adverse Event/Serious Adverse Event"	2661475001	"shortness of breath"	9	176	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472742793	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1393"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	3	9	"Adverse Event/Serious Adverse Event"	2661608001	"sweats"	81	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472745120	""	""	""	NA	"Sweating"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"1394"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	3	9	"Adverse Event/Serious Adverse Event"	2661529001	"thrombocytopenia"	57	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472744099	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1395"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	3	9	"Adverse Event/Serious Adverse Event"	2716471001	"thrombocytopenia"	105	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476122805	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1396"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	2614756003	"alopecia"	38	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473002077	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1397"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	3	9	"Adverse Event/Serious Adverse Event"	2731515001	"ambulation difficulty"	73	98	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476391258	""	""	""	NA	"Walking difficulty"	"General disorders and administration site conditions"	"General system disorders NEC"	"Gait disturbances"	"Difficulty in walking"	""	""	""	""	""	""	""	""	""	""	""	""
"1398"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	3	9	"Adverse Event/Serious Adverse Event"	2662904001	"anemia"	31	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473002013	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1399"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	3	9	"Adverse Event/Serious Adverse Event"	2731409001	"balance difficulty"	73	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476390763	""	""	""	NA	"Balance difficulty"	"Nervous system disorders"	"Neurological disorders NEC"	"Cerebellar coordination and balance disturbances"	"Balance disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"1400"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	3	9	"Adverse Event/Serious Adverse Event"	2723816001	"constipation"	41	52	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476289605	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1401"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	3	9	"Adverse Event/Serious Adverse Event"	2723895001	"constipation"	85	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476290054	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1402"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	3	9	"Adverse Event/Serious Adverse Event"	2731360001	"double vision"	73	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476390286	""	""	""	NA	"Double vision"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Diplopia"	""	""	""	""	""	""	""	""	""	""	""	""
"1403"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	3	9	"Adverse Event/Serious Adverse Event"	2723886001	"fatigue"	77	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476289986	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1404"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	3	9	"Adverse Event/Serious Adverse Event"	2662910001	"insomnia"	42	52	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473002145	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1405"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	3	9	"Adverse Event/Serious Adverse Event"	2723830001	"insomnia"	75	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476289665	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1406"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	3	9	"Adverse Event/Serious Adverse Event"	2723863001	"leukopenia"	77	87	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476289845	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1407"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	3	9	"Adverse Event/Serious Adverse Event"	2662901001	"leukopenia"	17	24	NA	2	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473001935	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1408"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	3	9	"Adverse Event/Serious Adverse Event"	2731387001	"malaise"	83	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476390643	""	""	""	NA	"Malaise"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Malaise"	""	""	""	""	""	""	""	""	""	""	""	""
"1409"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	3	9	"Adverse Event/Serious Adverse Event"	2723875001	"neutropenia"	77	87	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476289910	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1410"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	3	9	"Adverse Event/Serious Adverse Event"	2662895001	"neutropenia"	17	24	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473001860	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1411"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	3	9	"Adverse Event/Serious Adverse Event"	2745454001	"neutropenic fever"	103	113	NA	4	1	1	NA	NA	NA	NA	1	1	NA	4	NA	NA	1	"Hospitalized 10/22/06 through 11/1/06.  Patient returned to clinic 1/16/07 no further treatment after hospitalization."	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	104	NA	NA	103	113	"WBC on 10/22/2006 at 660."	""	""	NA	NA	NA	NA	NA	2	2	2	"Pt admitted to hospital 10/22/2006, complaining of abdominal discomfort, fever and chills. Pt presented with tachycardia and hypotension, likely related to underlying neutropenic fever. Pts cardizem"	"was discontinued, he was treated with fluids and placed on neutropenic precautions Pt treated with zithromax 500mg IV qd along with Rocephin 1 gram IV qd.  Pt remains in hospital as of 10/23/2006."	""	""	""	""	""	""	""	""	""	NA	NA	""	1477241048	""	""	""	NA	"Neutropenic fever"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1412"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	3	9	"Adverse Event/Serious Adverse Event"	2662888001	"trigeminal neuralgia"	17	52	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	3	1	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473001698	""	""	""	NA	"Trigeminal neuralgia"	"Nervous system disorders"	"Cranial nerve disorders (excl neoplasms)"	"Trigeminal disorders"	"Trigeminal neuralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1413"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	3	9	"Adverse Event/Serious Adverse Event"	2723798001	"trigeminal neuralgia"	57	73	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476289459	""	""	""	NA	"Trigeminal neuralgia"	"Nervous system disorders"	"Cranial nerve disorders (excl neoplasms)"	"Trigeminal disorders"	"Trigeminal neuralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1414"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	3	9	"Adverse Event/Serious Adverse Event"	2731354001	"weakness"	69	NA	1	1	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	1	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476390199	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1415"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	3	9	"Adverse Event/Serious Adverse Event"	2662892001	"weight loss"	17	38	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473001789	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1416"	"DN-101 Protocol No. 011-007"	"117"	"117-0006"	5	9	"Adverse Event/Serious Adverse Event"	2869305003	"tumor pain"	71	NA	1	1	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491334109	""	""	""	NA	"Tumor pain"	"Neoplasms benign, malignant and unspecified (incl cysts and polyps)"	"Cancer-related morbidities"	"Oncologic complications and emergencies"	"Cancer pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1417"	"DN-101 Protocol No. 011-007"	"117"	"117-0007"	5	9	"Adverse Event/Serious Adverse Event"	2911970003	"fever"	59	61	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"antibiotic Levaquin given"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491403988	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1418"	"DN-101 Protocol No. 011-007"	"117"	"117-0007"	3	9	"Adverse Event/Serious Adverse Event"	3061763001	"thrombocytopenia"	48	55	NA	1	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491403073	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1419"	"DN-101 Protocol No. 011-007"	"117"	"117-0011"	5	9	"Adverse Event/Serious Adverse Event"	3182819003	"Fainting following episodes of nausea and vomiting"	300	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"pt admitted for testing evaluation, MRI brain-negative, given IV fluids for hydration"	2	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	302	NA	NA	300	NA	"MRI brain-negative"	""	""	2	2	2	2	2	2	2	2	"Pt was admitted to hospital after experiencing a couple of episode of fainting after nausea and vomiting."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495486809	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"1420"	"DN-101 Protocol No. 011-007"	"118"	"118-0001"	5	9	"Adverse Event/Serious Adverse Event"	2914029003	"Fever"	33	33	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491247106	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1421"	"DN-101 Protocol No. 011-007"	"118"	"118-0001"	3	9	"Adverse Event/Serious Adverse Event"	3149779001	"Rales at both lung bases"	28	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493648271	""	""	""	NA	"Rales"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Lower respiratory tract signs and symptoms"	"Rales"	""	""	""	""	""	""	""	""	""	""	""	""
"1422"	"DN-101 Protocol No. 011-007"	"118"	"118-0001"	3	9	"Adverse Event/Serious Adverse Event"	3054987001	"Rash on right forearm"	27	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491246942	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"1423"	"DN-101 Protocol No. 011-007"	"118"	"118-0001"	3	9	"Adverse Event/Serious Adverse Event"	3054994001	"Skin breakdown"	28	32	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491247040	""	""	""	NA	"Skin breakdown"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Skin disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"1424"	"DN-101 Protocol No. 011-007"	"118"	"118-0001"	3	9	"Adverse Event/Serious Adverse Event"	3054977001	"Wooziness"	26	26	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491246832	""	""	""	NA	"Wooziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"1425"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	2758073003	"alopecia"	24	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489604208	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1426"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	3	9	"Adverse Event/Serious Adverse Event"	3002582001	"chill"	7	7	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489606641	""	""	""	NA	"Chills"	"General disorders and administration site conditions"	"Body temperature conditions"	"Body temperature perception"	"Chills"	""	""	""	""	""	""	""	""	""	""	""	""
"1427"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	3	9	"Adverse Event/Serious Adverse Event"	3002629001	"dyspnea"	55	148	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489607188	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1428"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	3	9	"Adverse Event/Serious Adverse Event"	3142884001	"fatigue"	129	151	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493567639	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1429"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	3	9	"Adverse Event/Serious Adverse Event"	3002598001	"fatigue"	55	75	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489606826	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1430"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	3	9	"Adverse Event/Serious Adverse Event"	2965215001	"fever"	7	7	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488122916	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1431"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	3	9	"Adverse Event/Serious Adverse Event"	3016867001	"fever"	90	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490127607	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1432"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	3	9	"Adverse Event/Serious Adverse Event"	3016771001	"fungal infection"	55	101	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490127045	""	""	""	NA	"Fungal infection"	"Infections and infestations"	"Fungal infectious disorders"	"Fungal infections NEC"	"Fungal infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1433"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	3	9	"Adverse Event/Serious Adverse Event"	3016828001	"infection (catheter related)"	102	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490127336	""	""	""	NA	"Catheter related infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Catheter related infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1434"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	3	9	"Adverse Event/Serious Adverse Event"	3002624001	"infection (catheter related)"	48	102	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489607085	""	""	""	NA	"Catheter related infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Catheter related infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1435"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	3	9	"Adverse Event/Serious Adverse Event"	3142864001	"infection(cath related)"	74	102	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493567424	""	""	""	NA	"Catheter related infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Catheter related infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1436"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	3	9	"Adverse Event/Serious Adverse Event"	2864160001	"insomnia"	4	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484080251	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1437"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	3	9	"Adverse Event/Serious Adverse Event"	3016735001	"muscle weakness"	76	151	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490126900	""	""	""	NA	"Muscle weakness NOS"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"1438"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	3	9	"Adverse Event/Serious Adverse Event"	3002647001	"myalgias"	40	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489607378	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1439"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	3	9	"Adverse Event/Serious Adverse Event"	3142895001	"nail changes"	151	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493567801	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"1440"	"DN-101 Protocol No. 011-007"	"120"	"120-0001"	5	9	"Adverse Event/Serious Adverse Event"	2788285003	"Abdominal Pain, Diarrhea, Nausea and Vomiting"	40	41	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482173998	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"1441"	"DN-101 Protocol No. 011-007"	"120"	"120-0001"	3	9	"Adverse Event/Serious Adverse Event"	3168287001	"Diverticulitis"	196	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	196	NA	NA	195	NA	"WBC 6.9x10-3, Hemoglobin 14.6g/dl, Hematocrit 44.0g, Creatinine .9mg/dl, glucose 257mg/dl.; Vital sounds: Temp99.1, Pulse 104, BP 116/62 Pain 3."	""	""	2	2	2	2	2	2	2	2	"Patient came on May 6-07 to ER, three days ago started with right lower quadrant pain.	Performed Abdomino Pelvic CT and finding of Diverticulitis."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494264382	""	""	""	NA	"Diverticulitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Abdominal and gastrointestinal infections"	"Diverticulitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1442"	"DN-101 Protocol No. 011-007"	"120"	"120-0001"	3	9	"Adverse Event/Serious Adverse Event"	3023486001	"hyperkalemia"	81	123	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490291499	""	""	""	NA	"Hyperkalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hyperkalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1443"	"DN-101 Protocol No. 011-007"	"120"	"120-0001"	3	9	"Adverse Event/Serious Adverse Event"	3023463001	"leukocytosis"	50	NA	1	1	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490291317	""	""	""	NA	"Leukocytosis"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukocytoses NEC"	"Leukocytosis"	""	""	""	""	""	""	""	""	""	""	""	""
"1444"	"DN-101 Protocol No. 011-007"	"120"	"120-0001"	3	9	"Adverse Event/Serious Adverse Event"	3014502001	"Neuropathy"	109	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490109828	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1445"	"DN-101 Protocol No. 011-007"	"120"	"120-0001"	3	9	"Adverse Event/Serious Adverse Event"	3014521001	"pericecal abcess"	129	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490110033	""	""	""	NA	"Abscess intestinal"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Abdominal and gastrointestinal infections"	"Abscess intestinal"	""	""	""	""	""	""	""	""	""	""	""	""
"1446"	"DN-101 Protocol No. 011-007"	"121"	"121-0001"	5	9	"Adverse Event/Serious Adverse Event"	2576175003	"Constipation"	114	135	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474831718	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1447"	"DN-101 Protocol No. 011-007"	"121"	"121-0001"	3	9	"Adverse Event/Serious Adverse Event"	2621587001	"Fatigue"	35	51	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"IV hydration"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469475985	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1448"	"DN-101 Protocol No. 011-007"	"121"	"121-0001"	3	9	"Adverse Event/Serious Adverse Event"	2654431001	"Fatigue"	93	114	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472415832	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1449"	"DN-101 Protocol No. 011-007"	"121"	"121-0001"	3	9	"Adverse Event/Serious Adverse Event"	2705772001	"Fever"	131	135	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475523424	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1450"	"DN-101 Protocol No. 011-007"	"121"	"121-0001"	3	9	"Adverse Event/Serious Adverse Event"	2833090001	"Hot Flashes"	198	221	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482184160	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"1451"	"DN-101 Protocol No. 011-007"	"121"	"121-0001"	3	9	"Adverse Event/Serious Adverse Event"	2653824001	"Neuropathy- sensory"	93	232	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472403371	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1452"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	2845998003	"alkaline phosphatate increase"	14	56	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485373606	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1453"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	3	9	"Adverse Event/Serious Adverse Event"	3045528001	"anemia"	77	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490824812	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1454"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	3	9	"Adverse Event/Serious Adverse Event"	2896357001	"constipation"	20	21	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485378311	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1455"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	3	9	"Adverse Event/Serious Adverse Event"	2973912001	"cough"	69	77	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488401377	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1456"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	3	9	"Adverse Event/Serious Adverse Event"	2896421001	"decreased hemoglobin"	21	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485378892	""	""	""	NA	"Decreased hemoglobin"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1457"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	3	9	"Adverse Event/Serious Adverse Event"	2896296001	"dehydration"	21	27	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"given I.V. fluids on 01/09/2007 and 01/12/2007."	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485377884	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"1458"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	3	9	"Adverse Event/Serious Adverse Event"	2943721001	"diarrhea"	42	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487163624	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1459"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	3	9	"Adverse Event/Serious Adverse Event"	3154551001	"edema limb"	119	147	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493748669	""	""	""	NA	"Edema limbs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1460"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	3	9	"Adverse Event/Serious Adverse Event"	2896380001	"fatgue"	21	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485378610	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1461"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	3	9	"Adverse Event/Serious Adverse Event"	2895851001	"hypercalcemia"	21	24	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"I.V. FLUIDS ADMINISTERED ON 01/09/2007 AND 01/12/2007 IN THE OUTPATIENT CLINIC."	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485374688	""	""	""	NA	"Hypercalcemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Calcium metabolism disorders"	"Hypercalcaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1462"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	3	9	"Adverse Event/Serious Adverse Event"	2895768001	"hyperglycemia"	14	126	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Instructed to avoid high concentrated sweets and sodas"	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485373116	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1463"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	3	9	"Adverse Event/Serious Adverse Event"	2895798001	"hypoalbuminemia"	14	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"started on oral Ensure supplement for increase caloric intake"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485373371	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1464"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	3	9	"Adverse Event/Serious Adverse Event"	2895848001	"hyponatremia"	14	21	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Instructed patient in increasing fluids by mouth to 6- 8 glasses a day."	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485374397	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1465"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	3	9	"Adverse Event/Serious Adverse Event"	2896117001	"HYPOTENSION"	21	27	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"I.V. fluids administered in out patient clinic on 01/09/2007 and 01/12/2007."	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485376940	""	""	""	NA	"Hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"1466"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	3	9	"Adverse Event/Serious Adverse Event"	2895833001	"increased Creatinine"	14	35	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"I.V. fluids were administered in outpatient treatment on 01/09/2007 and 01/12/2007"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485374000	""	""	""	NA	"Creatinine increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1467"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	3	9	"Adverse Event/Serious Adverse Event"	2896191001	"leukopenia without fever"	21	27	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Instructions on infection control prevention and face masks provided to patient."	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485377299	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1468"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	3	9	"Adverse Event/Serious Adverse Event"	2896217001	"neutropenia without fever"	21	27	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Instructions given to patient and his son on neutorpenic precautions."	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485377456	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1469"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	3	9	"Adverse Event/Serious Adverse Event"	3154530001	"pulmonary infiltrates ( BRONCHITIS)"	119	147	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"chest x-ray PA/LAT"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493748384	""	""	""	NA	"Bronchitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Bronchitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1470"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	3	9	"Adverse Event/Serious Adverse Event"	2973866001	"upper pulmonary sinus congestion"	69	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	5	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488401188	""	""	""	NA	"Sinus congestion"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Paranasal sinus disorders (excl infections and neoplasms)"	"Sinus congestion"	""	""	""	""	""	""	""	""	""	""	""	""
"1471"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	3	9	"Adverse Event/Serious Adverse Event"	2896439001	"Urinary Incontinence"	21	35	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485379052	""	""	""	NA	"Urinary incontinence"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"1472"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	3	9	"Adverse Event/Serious Adverse Event"	2896405001	"weight loss"	21	35	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485378788	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1473"	"DN-101 Protocol No. 011-007"	"123"	"123-0002"	5	9	"Adverse Event/Serious Adverse Event"	2971515003	"alkaline phosphatase"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492383910	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1474"	"DN-101 Protocol No. 011-007"	"123"	"123-0002"	3	9	"Adverse Event/Serious Adverse Event"	3022618001	"altered mental status"	11	11	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490283542	""	""	""	NA	"Mental status changes"	"Psychiatric disorders"	"Psychiatric disorders NEC"	"Mental disorders NEC"	"Mental status changes"	""	""	""	""	""	""	""	""	""	""	""	""
"1475"	"DN-101 Protocol No. 011-007"	"123"	"123-0002"	3	9	"Adverse Event/Serious Adverse Event"	3091239001	"constipation"	45	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492384050	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1476"	"DN-101 Protocol No. 011-007"	"123"	"123-0002"	3	9	"Adverse Event/Serious Adverse Event"	3165935001	"edema limb fluid retention lower legs"	70	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494198796	""	""	""	NA	"Edema lower limb"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1477"	"DN-101 Protocol No. 011-007"	"123"	"123-0002"	3	9	"Adverse Event/Serious Adverse Event"	3091257001	"fatigue"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492384241	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1478"	"DN-101 Protocol No. 011-007"	"123"	"123-0002"	3	9	"Adverse Event/Serious Adverse Event"	3091194001	"hemoglobin"	28	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492383683	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1479"	"DN-101 Protocol No. 011-007"	"123"	"123-0002"	3	9	"Adverse Event/Serious Adverse Event"	3091212001	"hyperglycemia"	28	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492383810	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1480"	"DN-101 Protocol No. 011-007"	"123"	"123-0002"	3	9	"Adverse Event/Serious Adverse Event"	3165938001	"nail changes darking of curticles"	70	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494199045	""	""	""	NA	"Nail discoloration"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail discolouration"	""	""	""	""	""	""	""	""	""	""	""	""
"1481"	"DN-101 Protocol No. 011-007"	"123"	"123-0002"	3	9	"Adverse Event/Serious Adverse Event"	3091247001	"neuropathy sensory feet"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492384146	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1482"	"DN-101 Protocol No. 011-007"	"123"	"123-0003"	5	9	"Adverse Event/Serious Adverse Event"	3149382003	"nasal cavity/paranasal sinus reaction"	20	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494197083	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"1483"	"DN-101 Protocol No. 011-007"	"125"	"125-0001"	5	9	"Adverse Event/Serious Adverse Event"	2614744003	"alopecia"	27	97	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476715510	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1484"	"DN-101 Protocol No. 011-007"	"125"	"125-0001"	3	9	"Adverse Event/Serious Adverse Event"	2831120001	"anxiety"	104	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482160628	""	""	""	NA	"Anxiety"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Anxiety"	""	""	""	""	""	""	""	""	""	""	""	""
"1485"	"DN-101 Protocol No. 011-007"	"125"	"125-0001"	3	9	"Adverse Event/Serious Adverse Event"	3005478001	"insomnia"	202	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489691939	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1486"	"DN-101 Protocol No. 011-007"	"125"	"125-0001"	3	9	"Adverse Event/Serious Adverse Event"	3089261001	"intermittent heartburn"	241	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492367449	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"1487"	"DN-101 Protocol No. 011-007"	"125"	"125-0001"	3	9	"Adverse Event/Serious Adverse Event"	3089308001	"left hip pain"	246	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492368033	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1488"	"DN-101 Protocol No. 011-007"	"125"	"125-0001"	3	9	"Adverse Event/Serious Adverse Event"	3089275001	"low back pain"	246	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492367580	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1489"	"DN-101 Protocol No. 011-007"	"125"	"125-0001"	3	9	"Adverse Event/Serious Adverse Event"	2899582001	"Pain right hip"	175	246	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485720313	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1490"	"DN-101 Protocol No. 011-007"	"125"	"125-0001"	3	9	"Adverse Event/Serious Adverse Event"	2736191001	"right hip numbness"	69	83	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476719439	""	""	""	NA	"Numbness"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"1491"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	5	9	"Adverse Event/Serious Adverse Event"	2696089003	"anemia"	107	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484771025	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1492"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	3	9	"Adverse Event/Serious Adverse Event"	3106517001	"arm pressure/pain"	9	9	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492619434	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"1493"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	3	9	"Adverse Event/Serious Adverse Event"	3106511001	"back pain"	9	9	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492619359	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1494"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	3	9	"Adverse Event/Serious Adverse Event"	3106592001	"fluid retention"	178	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492620268	""	""	""	NA	"Fluid retention"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume increased"	"Fluid retention"	""	""	""	""	""	""	""	""	""	""	""	""
"1495"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	3	9	"Adverse Event/Serious Adverse Event"	3106530001	"hyperglycemia - intermittent"	16	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492619524	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1496"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	3	9	"Adverse Event/Serious Adverse Event"	3106577001	"intermittent cough"	135	157	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492620065	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1497"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	3	9	"Adverse Event/Serious Adverse Event"	3106573001	"intermittent headache"	135	157	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492619979	""	""	""	NA	"Intermittent headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"1498"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	3	9	"Adverse Event/Serious Adverse Event"	3106560001	"left hand extravasation"	93	114	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492619784	""	""	""	NA	"Extravasation"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"Extravasation"	""	""	""	""	""	""	""	""	""	""	""	""
"1499"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	3	9	"Adverse Event/Serious Adverse Event"	3106547001	"lightheadedness"	61	62	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492619663	""	""	""	NA	"Lightheadedness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"1500"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	3	9	"Adverse Event/Serious Adverse Event"	3106581001	"neuropathy in heels"	135	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492620159	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1501"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	3	9	"Adverse Event/Serious Adverse Event"	2881991001	"neutropenia"	58	63	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484770863	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1502"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	3	9	"Adverse Event/Serious Adverse Event"	3106505001	"rib pain"	93	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492619229	""	""	""	NA	"Rib pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1503"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	5	9	"Adverse Event/Serious Adverse Event"	2701470003	"cough"	44	50	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482180360	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1504"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	3	9	"Adverse Event/Serious Adverse Event"	2832404001	"distal testicular pain"	14	16	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482178510	""	""	""	NA	"Testicular pain"	"Reproductive system and breast disorders"	"Testicular and epididymal disorders"	"Testicular and epididymal disorders NEC"	"Testicular pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1505"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	3	9	"Adverse Event/Serious Adverse Event"	3089886001	"drainage rt eye"	127	132	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492372113	""	""	""	NA	"Discharge eye"	"Eye disorders"	"Ocular infections, irritations and inflammations"	"Ocular infections, inflammations and associated manifestations"	"Eye discharge"	""	""	""	""	""	""	""	""	""	""	""	""
"1506"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	3	9	"Adverse Event/Serious Adverse Event"	2832395001	"dull ache anterior thighs"	14	16	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482178428	""	""	""	NA	"Pain in thigh"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"1507"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	3	9	"Adverse Event/Serious Adverse Event"	3089821001	"fatigue"	87	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492371533	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1508"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	3	9	"Adverse Event/Serious Adverse Event"	2832381001	"headache"	10	16	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482178251	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"1509"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	3	9	"Adverse Event/Serious Adverse Event"	2832673001	"hyperglycemia"	17	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482180841	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1510"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	3	9	"Adverse Event/Serious Adverse Event"	3090047001	"intermittent general malaise"	87	174	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492373489	""	""	""	NA	"General malaise"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Malaise"	""	""	""	""	""	""	""	""	""	""	""	""
"1511"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	3	9	"Adverse Event/Serious Adverse Event"	3090027001	"intermittent lower extremity edema"	111	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492373370	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1512"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	3	9	"Adverse Event/Serious Adverse Event"	2832742001	"intermittent mucositis"	55	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482181123	""	""	""	NA	"Mucositis"	"General disorders and administration site conditions"	"General system disorders NEC"	"Mucosal findings abnormal"	"Mucosal inflammation"	""	""	""	""	""	""	""	""	""	""	""	""
"1513"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	3	9	"Adverse Event/Serious Adverse Event"	2832611001	"intermittent neutropenia"	13	98	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482180459	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1514"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	3	9	"Adverse Event/Serious Adverse Event"	3089801001	"intermittent pain rt mid back to rt mid rib"	87	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492371383	""	""	""	NA	"Musculoskeletal pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1515"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	3	9	"Adverse Event/Serious Adverse Event"	2832389001	"lower left side back pain"	13	16	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482178335	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1516"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	3	9	"Adverse Event/Serious Adverse Event"	2832376001	"muscle pain"	10	16	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482178166	""	""	""	NA	"Muscle pain"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1517"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	3	9	"Adverse Event/Serious Adverse Event"	2832418001	"rectal itching"	14	16	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482178579	""	""	""	NA	"Localised itching"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Pruritus NEC"	"Pruritus"	""	""	""	""	""	""	""	""	""	""	""	""
"1518"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	3	9	"Adverse Event/Serious Adverse Event"	3090499001	"URI"	13	17	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492376454	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1519"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	3	9	"Adverse Event/Serious Adverse Event"	3090509001	"URI"	94	98	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492376522	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1520"	"DN-101 Protocol No. 011-007"	"125"	"125-0009"	5	9	"Adverse Event/Serious Adverse Event"	2764999003	"Fatigue"	45	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485354041	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1521"	"DN-101 Protocol No. 011-007"	"125"	"125-0009"	3	9	"Adverse Event/Serious Adverse Event"	2894510001	"mild Alopecia"	85	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485353794	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1522"	"DN-101 Protocol No. 011-007"	"125"	"125-0009"	3	9	"Adverse Event/Serious Adverse Event"	2988663001	"Mild Bone Pain"	106	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489010374	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1523"	"DN-101 Protocol No. 011-007"	"125"	"125-0009"	3	9	"Adverse Event/Serious Adverse Event"	2894559001	"Neutropenia"	50	53	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485354368	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1524"	"DN-101 Protocol No. 011-007"	"125"	"125-0009"	3	9	"Adverse Event/Serious Adverse Event"	2894550001	"Neutropenia"	29	32	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485354171	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1525"	"DN-101 Protocol No. 011-007"	"125"	"125-0011"	5	9	"Adverse Event/Serious Adverse Event"	2828712003	"edema lower extremities"	92	99	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491920307	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1526"	"DN-101 Protocol No. 011-007"	"125"	"125-0011"	3	9	"Adverse Event/Serious Adverse Event"	2895252001	"Neutropenia"	15	22	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485366240	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1527"	"DN-101 Protocol No. 011-007"	"125"	"125-0011"	3	9	"Adverse Event/Serious Adverse Event"	2901273001	"Neutropenia"	36	43	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485802322	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1528"	"DN-101 Protocol No. 011-007"	"125"	"125-0011"	3	9	"Adverse Event/Serious Adverse Event"	3076874001	"urinary tract infection"	92	99	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491920723	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1529"	"DN-101 Protocol No. 011-007"	"125"	"125-0013"	5	9	"Adverse Event/Serious Adverse Event"	2837031003	"Dyspepsia"	30	31	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485803786	""	""	""	NA	"Dyspepsia"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"1530"	"DN-101 Protocol No. 011-007"	"125"	"125-0017"	5	9	"Adverse Event/Serious Adverse Event"	2873046003	"neutropenia"	14	21	NA	4	0	NA	NA	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485707889	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1531"	"DN-101 Protocol No. 011-007"	"125"	"125-0018"	5	9	"Adverse Event/Serious Adverse Event"	2897308003	"anemia"	39	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490286352	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1532"	"DN-101 Protocol No. 011-007"	"125"	"125-0018"	3	9	"Adverse Event/Serious Adverse Event"	3023005001	"anemia"	11	53	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490285563	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1533"	"DN-101 Protocol No. 011-007"	"125"	"125-0018"	3	9	"Adverse Event/Serious Adverse Event"	3022970001	"dry lips"	12	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490285337	""	""	""	NA	"Dry lips"	"Gastrointestinal disorders"	"Salivary gland conditions"	"Oral dryness and saliva altered"	"Lip dry"	""	""	""	""	""	""	""	""	""	""	""	""
"1534"	"DN-101 Protocol No. 011-007"	"125"	"125-0018"	3	9	"Adverse Event/Serious Adverse Event"	3095142001	"fatigue"	60	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492451617	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1535"	"DN-101 Protocol No. 011-007"	"125"	"125-0018"	3	9	"Adverse Event/Serious Adverse Event"	3023002001	"lower abdominal pain-intermittent"	41	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490285474	""	""	""	NA	"Abdominal pain lower"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain lower"	""	""	""	""	""	""	""	""	""	""	""	""
"1536"	"DN-101 Protocol No. 011-007"	"125"	"125-0018"	3	9	"Adverse Event/Serious Adverse Event"	3023024001	"neutropenia"	18	25	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490286082	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1537"	"DN-101 Protocol No. 011-007"	"125"	"125-0018"	3	9	"Adverse Event/Serious Adverse Event"	3023030001	"neutropenia"	25	32	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490286156	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1538"	"DN-101 Protocol No. 011-007"	"125"	"125-0018"	3	9	"Adverse Event/Serious Adverse Event"	3022989001	"taste change"	12	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490285410	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1539"	"DN-101 Protocol No. 011-007"	"125"	"125-0022"	5	9	"Adverse Event/Serious Adverse Event"	2972813003	"Lower Back Pain"	32	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490192339	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1540"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	5	9	"Adverse Event/Serious Adverse Event"	2589083003	"alopecia"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471798998	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1541"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	3	9	"Adverse Event/Serious Adverse Event"	2954187001	"anemia"	162	237	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487535797	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1542"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	3	9	"Adverse Event/Serious Adverse Event"	3043600001	"anxiety"	293	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490805843	""	""	""	NA	"Anxiety"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Anxiety"	""	""	""	""	""	""	""	""	""	""	""	""
"1543"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	3	9	"Adverse Event/Serious Adverse Event"	3171779001	"diverticulosis"	142	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494349667	""	""	""	NA	"Diverticulosis"	"Gastrointestinal disorders"	"Diverticular disorders"	"Diverticula"	"Diverticulum"	""	""	""	""	""	""	""	""	""	""	""	""
"1544"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	3	9	"Adverse Event/Serious Adverse Event"	2852114001	"Fatigue"	135	195	NA	1	2	NA	1	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483548301	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1545"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	3	9	"Adverse Event/Serious Adverse Event"	2646323001	"fatigue"	43	99	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471799217	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1546"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	3	9	"Adverse Event/Serious Adverse Event"	2725398001	"GI Bleed"	135	153	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"patient admitted for work-up"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	135	NA	NA	135	138	"10-12-06 HGB 9.9, HCT 30.6"	""	""	2	2	2	NA	2	2	NA	2	"Seen in clinic, reported excessive alcohol consumption for the last 2 weeks, none in 3 days.  Reports bright red blood in bowels movements intermittently over the course of the past week.  Very"	"unsteady on feet, HR 128, BP 152/94.  Admitted to hospital with possible GI Bleed for further work-up."	""	""	""	""	""	""	""	""	""	NA	NA	""	1476300177	""	""	""	NA	"GI bleed"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Non-site specific gastrointestinal haemorrhages"	"Gastrointestinal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"1547"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	3	9	"Adverse Event/Serious Adverse Event"	2739255001	"GI Bleed"	140	153	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	3	1	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	141	NA	NA	140	142	"10/17/06 HGB 9.3, HCT 27.8.  10/18/06 Colonoscopy showed cecum normal, ascending, transverse, descending, and sigmoid colon were normal except for diverticulosis, the rectum was normal, internal"	"hemorrhoids."	""	2	2	2	NA	2	2	NA	2	"Admitted again on 10-17-06 due to another episode of bright red blood per rectum the morning of 10-17-06.  Denies any abdominal pain, nausea or vomitting.  Denies melena.  Admitted to hospital for"	"evaluation and colonoscopy.  Colonoscopy done on 10-18-06 Showed diverticulosis and internal hemorrhoids.  10-30-06  Patient seen in clinic today, reports no more bleeding note.  To receive cycle 7"	"day 2 docetaxel today."	""	""	""	""	""	""	""	""	NA	NA	""	1476823586	""	""	""	NA	"GI bleed"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Non-site specific gastrointestinal haemorrhages"	"Gastrointestinal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"1548"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	3	9	"Adverse Event/Serious Adverse Event"	2608079001	"hyperglycemia"	14	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Decadron to be decreased to 4mg with start of Cycle 6"	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468354284	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1549"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	3	9	"Adverse Event/Serious Adverse Event"	2608097001	"Insomnia"	17	99	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468355614	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1550"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	3	9	"Adverse Event/Serious Adverse Event"	2852182001	"insomnia"	174	195	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483548723	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1551"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	3	9	"Adverse Event/Serious Adverse Event"	3171793001	"internal hemorrhoids"	142	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494349734	""	""	""	NA	"Internal hemorrhoids"	"Gastrointestinal disorders"	"Gastrointestinal vascular conditions"	"Haemorrhoids and gastrointestinal varices (excl oesophageal)"	"Haemorrhoids"	""	""	""	""	""	""	""	""	""	""	""	""
"1552"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	3	9	"Adverse Event/Serious Adverse Event"	2673640001	"right leg pain"	94	118	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473363624	""	""	""	NA	"Leg pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"1553"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	3	9	"Adverse Event/Serious Adverse Event"	2608087001	"unrinary incontinence"	21	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468354609	""	""	""	NA	"Incontinence urinary"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"1554"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	5	9	"Adverse Event/Serious Adverse Event"	2593558003	"alopecia"	22	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468955958	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1555"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	3	9	"Adverse Event/Serious Adverse Event"	2884826001	"dry cough"	169	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484859251	""	""	""	NA	"Dry cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1556"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	3	9	"Adverse Event/Serious Adverse Event"	2837799001	"edema"	172	175	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482344188	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"1557"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	3	9	"Adverse Event/Serious Adverse Event"	2884851001	"face flush and swollen"	92	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484859558	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"1558"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	3	9	"Adverse Event/Serious Adverse Event"	2884808001	"fatigue"	70	73	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484858715	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1559"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	3	9	"Adverse Event/Serious Adverse Event"	2884819001	"Fatigue"	134	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484858921	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1560"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	3	9	"Adverse Event/Serious Adverse Event"	2884801001	"finger skin infection"	176	192	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484858602	""	""	""	NA	"Skin infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Skin structures and soft tissue infections"	"Skin infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1561"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	3	9	"Adverse Event/Serious Adverse Event"	2884860001	"hearing problem"	7	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484859666	""	""	""	NA	"Hearing impaired"	"Ear and labyrinth disorders"	"Hearing disorders"	"Hearing losses"	"Hearing impaired"	""	""	""	""	""	""	""	""	""	""	""	""
"1562"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	3	9	"Adverse Event/Serious Adverse Event"	2837831001	"neuropathy"	169	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482344799	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1563"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	3	9	"Adverse Event/Serious Adverse Event"	2884765001	"night sweats"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484858094	""	""	""	NA	"Night sweats"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Night sweats"	""	""	""	""	""	""	""	""	""	""	""	""
"1564"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	3	9	"Adverse Event/Serious Adverse Event"	2884836001	"right ankle swelling"	197	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484859381	""	""	""	NA	"Ankle swelling"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Joint swelling"	""	""	""	""	""	""	""	""	""	""	""	""
"1565"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	3	9	"Adverse Event/Serious Adverse Event"	2884789001	"skin rash on neck"	169	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484858402	""	""	""	NA	"Neck rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"1566"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	3	9	"Adverse Event/Serious Adverse Event"	2837804001	"upper respiratory infection"	168	176	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482344346	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1567"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	3	9	"Adverse Event/Serious Adverse Event"	2884776001	"watery eyes"	176	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484858230	""	""	""	NA	"Watering eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1568"	"DN-101 Protocol No. 011-007"	"126"	"126-0003"	5	9	"Adverse Event/Serious Adverse Event"	2693911003	"Alopecia"	57	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484852253	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1569"	"DN-101 Protocol No. 011-007"	"126"	"126-0003"	3	9	"Adverse Event/Serious Adverse Event"	2884210001	"edema right leg"	33	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484851613	""	""	""	NA	"Leg edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1570"	"DN-101 Protocol No. 011-007"	"126"	"126-0003"	3	9	"Adverse Event/Serious Adverse Event"	2796096001	"fatigue"	33	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480536247	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1571"	"DN-101 Protocol No. 011-007"	"126"	"126-0003"	3	9	"Adverse Event/Serious Adverse Event"	2884261001	"hot flashes"	33	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484851891	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"1572"	"DN-101 Protocol No. 011-007"	"126"	"126-0003"	3	9	"Adverse Event/Serious Adverse Event"	2868872001	"insomnia"	57	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484242608	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1573"	"DN-101 Protocol No. 011-007"	"126"	"126-0003"	3	9	"Adverse Event/Serious Adverse Event"	2884394001	"Sinus Drainage"	57	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484854218	""	""	""	NA	"Nasal discharge"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Rhinorrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1574"	"DN-101 Protocol No. 011-007"	"126"	"126-0003"	3	9	"Adverse Event/Serious Adverse Event"	2834595001	"watery eyes"	33	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482260362	""	""	""	NA	"Watering eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1575"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	2871837003	"anemia"	39	40	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488901896	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1576"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	3	9	"Adverse Event/Serious Adverse Event"	2983821001	"anemia"	25	31	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488913779	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1577"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	3	9	"Adverse Event/Serious Adverse Event"	2982208001	"anemia"	42	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488902058	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1578"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	3	9	"Adverse Event/Serious Adverse Event"	2982228001	"anemia"	32	33	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488902191	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1579"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	3	9	"Adverse Event/Serious Adverse Event"	3032866001	"arthritis"	67	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490628274	""	""	""	NA	"Arthritis"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Arthropathies NEC"	"Arthritis"	""	""	""	""	""	""	""	""	""	""	""	""
"1580"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	3	9	"Adverse Event/Serious Adverse Event"	3170315001	"constipation"	2	4	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494337272	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1581"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	3	9	"Adverse Event/Serious Adverse Event"	3032848001	"cough"	67	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490628204	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1582"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	3	9	"Adverse Event/Serious Adverse Event"	3164124001	"Dry Eyes"	88	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494180215	""	""	""	NA	"Dry eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Dry eye"	""	""	""	""	""	""	""	""	""	""	""	""
"1583"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	3	9	"Adverse Event/Serious Adverse Event"	3032839001	"dry mouth"	67	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490628139	""	""	""	NA	"Dry mouth"	"Gastrointestinal disorders"	"Salivary gland conditions"	"Oral dryness and saliva altered"	"Dry mouth"	""	""	""	""	""	""	""	""	""	""	""	""
"1584"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	3	9	"Adverse Event/Serious Adverse Event"	3164020001	"edema"	113	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494179678	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"1585"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	3	9	"Adverse Event/Serious Adverse Event"	3172004001	"elevated BUN"	25	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494351709	""	""	""	NA	"Blood urea nitrogen increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood urea increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1586"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	3	9	"Adverse Event/Serious Adverse Event"	3171994001	"elevated Creatinine"	25	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494351615	""	""	""	NA	"Creatinine increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1587"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	3	9	"Adverse Event/Serious Adverse Event"	2982249001	"fatigue"	39	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488902416	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1588"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	3	9	"Adverse Event/Serious Adverse Event"	3233292001	"hematuria"	131	NA	1	3	0	NA	NA	NA	NA	NA	2	NA	1	3	1	1	NA	""	2	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	131	NA	NA	130	NA	"Admission CBC on 5/21/07- WBC 14.4, Hct 25.3, HGB 7.8; Admission Chemistry on 5/21/07- K 5.5, Crea 2.5"	""	""	2	2	2	2	2	2	2	2	"Patient admitted to the hospital after developing hematuria with clot retention at home resulting in the placement of a Foley catheter.  PAtient was requiring multiple irrigations prior to admission,"	"and therefore was admitted to the hospital for continuous bladder irrigation as well as cystoscopy and clot evacuation with possible cauterization.  Admission orders included continuous IV fluids,"	"contiuation of home medications, continuous bladder irrigation, plans for pending cystoscopy, and the transfusion of two units of packed red blood cells."	""	""	""	""	""	""	""	""	NA	NA	""	1495508942	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"1589"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	3	9	"Adverse Event/Serious Adverse Event"	2983984001	"hot flashes"	25	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488914756	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"1590"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	3	9	"Adverse Event/Serious Adverse Event"	2982146001	"hyperglycemia"	5	8	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488901461	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1591"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	3	9	"Adverse Event/Serious Adverse Event"	3164184001	"mouth sores"	109	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494180471	""	""	""	NA	"Sores mouth"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1592"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	3	9	"Adverse Event/Serious Adverse Event"	2983949001	"night sweats"	25	32	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488914552	""	""	""	NA	"Night sweats"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Night sweats"	""	""	""	""	""	""	""	""	""	""	""	""
"1593"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	3	9	"Adverse Event/Serious Adverse Event"	2983995001	"shortness of breath"	39	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488914838	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1594"	"DN-101 Protocol No. 011-007"	"126"	"126-0005"	5	9	"Adverse Event/Serious Adverse Event"	2939382003	"Constipation"	9	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494187112	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1595"	"DN-101 Protocol No. 011-007"	"126"	"126-0005"	3	9	"Adverse Event/Serious Adverse Event"	3164697001	"fatigue"	9	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494185223	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1596"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	2697091003	"constipation"	7	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487168902	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1597"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	3	9	"Adverse Event/Serious Adverse Event"	2944160001	"edema R lower extremity"	48	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487169512	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1598"	"DN-101 Protocol No. 011-007"	"127"	"127-0006"	5	9	"Adverse Event/Serious Adverse Event"	2703225003	"chest tightness upon exertion"	70	NA	1	NA	NA	NA	NA	NA	NA	NA	2	NA	1	2	NA	1	NA	"CABG"	1	0	NA	0	16	NA	NA	NA	NA	1	NA	NA	""	142	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	"Pt complained of chest tightness on 12/6/06 when exerting himself. Pt went to see cardiologist and eventually underwent triple bypass surgery. Pt is on cardiac rehab at the present time."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487265003	""	""	""	NA	"Chest tightness"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"Chest discomfort"	""	""	""	""	""	""	""	""	""	""	""	""
"1599"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	2994752003	"febrile neutropenia"	77	NA	1	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	78	NA	NA	77	NA	"ANC 0.4(1.5-8.8)grade 4; WBC 1.3(4.0-11.0)grade 3"	""	""	2	2	2	NA	2	2	NA	2	"DS recieved treatment with Taxotere on May 16. In clinic for a CBC check on 5/23/07.  Pt reported that he was week and had a temperature of 100.2 on 5/22/07.  Blood count resulted in hospitaliztion"	"and the start of IV antibiotics and Neupogen.;Pt remains in hospital."	""	""	""	""	""	""	""	""	""	NA	NA	""	1495639460	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1600"	"DN-101 Protocol No. 011-007"	"128"	"128-0001"	5	9	"Adverse Event/Serious Adverse Event"	3039470003	"fatigue"	14	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495034396	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1601"	"DN-101 Protocol No. 011-007"	"128"	"128-0001"	3	9	"Adverse Event/Serious Adverse Event"	3211464001	"Intermittent toe cramps"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495042466	""	""	""	NA	"Cramps"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"1602"	"DN-101 Protocol No. 011-007"	"128"	"128-0001"	3	9	"Adverse Event/Serious Adverse Event"	3211568001	"lymphopenia"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495042874	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1603"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	2590631003	"alkaline phosphatase"	7	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475714872	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1604"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	3	9	"Adverse Event/Serious Adverse Event"	3063481001	"anorexia"	114	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491415476	""	""	""	NA	"Anorexia"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1605"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	3	9	"Adverse Event/Serious Adverse Event"	3063629001	"dizziness, intermittent"	117	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491416044	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"1606"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	3	9	"Adverse Event/Serious Adverse Event"	3190291001	"dyseusia"	130	NA	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	NA	NA	NA	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494798885	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1607"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	3	9	"Adverse Event/Serious Adverse Event"	3063439001	"fatigue"	113	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491415305	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1608"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	3	9	"Adverse Event/Serious Adverse Event"	2710906001	"hemoglobin"	91	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475714762	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1609"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	3	9	"Adverse Event/Serious Adverse Event"	2710897001	"hyperglycemia"	29	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475714411	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1610"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	3	9	"Adverse Event/Serious Adverse Event"	2710900001	"hypoalbuminemia"	91	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475714560	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1611"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	3	9	"Adverse Event/Serious Adverse Event"	2701707001	"hyponatremia"	7	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475174668	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1612"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	3	9	"Adverse Event/Serious Adverse Event"	3063891001	"insomnia"	120	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491417050	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1613"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	3	9	"Adverse Event/Serious Adverse Event"	3190385001	"neuropathy, sensory, lower lip."	298	NA	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	NA	NA	NA	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494799314	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1614"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	3	9	"Adverse Event/Serious Adverse Event"	3063667001	"pain, low back"	204	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491416183	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1615"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	3	9	"Adverse Event/Serious Adverse Event"	3063413001	"pain, R groin to leg"	113	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491415193	""	""	""	NA	"Leg pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"1616"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	3	9	"Adverse Event/Serious Adverse Event"	2710940001	"rash"	97	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475715585	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"1617"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	5	9	"Adverse Event/Serious Adverse Event"	2618792003	"alopecia"	30	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475189769	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1618"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	3	9	"Adverse Event/Serious Adverse Event"	3070695001	"anemia"	122	128	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491766526	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1619"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	3	9	"Adverse Event/Serious Adverse Event"	3070849001	"AST"	122	130	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491768654	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1620"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	3	9	"Adverse Event/Serious Adverse Event"	2702663001	"asthenia-muscle weakness"	19	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475189541	""	""	""	NA	"Asthenia"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1621"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	3	9	"Adverse Event/Serious Adverse Event"	3070686001	"blurred vision"	112	130	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491766353	""	""	""	NA	"Blurred vision"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Vision blurred"	""	""	""	""	""	""	""	""	""	""	""	""
"1622"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	3	9	"Adverse Event/Serious Adverse Event"	3070674001	"hallucinations"	125	125	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491766235	""	""	""	NA	"Hallucinations"	"Psychiatric disorders"	"Disturbances in thinking and perception"	"Perception disturbances"	"Hallucination"	""	""	""	""	""	""	""	""	""	""	""	""
"1623"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	3	9	"Adverse Event/Serious Adverse Event"	3070629001	"headache"	124	130	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491765763	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"1624"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	3	9	"Adverse Event/Serious Adverse Event"	2702653001	"headaches, intermittent"	14	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475189407	""	""	""	NA	"Intermittent headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"1625"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	3	9	"Adverse Event/Serious Adverse Event"	3070765001	"hematuria"	128	130	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491767030	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"1626"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	3	9	"Adverse Event/Serious Adverse Event"	2776566001	"hemorrhage, CNS (subural hematoma)"	124	130	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	7	1	1	1	"hospitalization"	4	0	NA	0	44	NA	NA	1	1	NA	1	NA	""	128	130	0	124	130	"CT of Brain, labs. Operation on 11/13/2006 for left frontoparietal craniotomy for evacuation of subacute subdural hematoma with placement of subdural drain."	""	""	2	2	2	2	2	2	2	2	"patient is in follow up phase.;;by history from neurosurgeon, patient suffered a fall on Saturday nov 11/2006 due to instability from parkinison's diasease (medical history).	Struck head but acutely"	"ok. Later that evening, patient had onset of severe headache. Went to ER here at St Joseph's hospital in Tucson. CT/MRI showed subdural hematoma.  There was progressive alteration of mental status."	"Patient was transfered to Phoenix hospital for treatment. Operation performed. Patient released on 11/17/2006 to home hospice. Patient died at home."	""	""	""	""	""	""	""	""	NA	NA	""	1479228984	""	""	""	NA	"Hematoma subdural"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Cerebral injuries NEC"	"Subdural haematoma"	""	""	""	""	""	""	""	""	""	""	""	""
"1627"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	3	9	"Adverse Event/Serious Adverse Event"	3070861001	"hyperglycemia"	126	127	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491768784	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1628"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	3	9	"Adverse Event/Serious Adverse Event"	3070872001	"hypernatremia"	127	130	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491768967	""	""	""	NA	"Hypernatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hypernatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1629"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	3	9	"Adverse Event/Serious Adverse Event"	3070881001	"hypoalbuminemia"	127	130	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491769075	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1630"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	3	9	"Adverse Event/Serious Adverse Event"	3070903001	"hypokalemia"	127	130	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491769250	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1631"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	3	9	"Adverse Event/Serious Adverse Event"	3070865001	"hypophosphatemia"	127	130	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491768861	""	""	""	NA	"Hypophosphatemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Phosphorus metabolism disorders"	"Hypophosphataemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1632"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	3	9	"Adverse Event/Serious Adverse Event"	3070799001	"neutrophils"	21	34	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491767400	""	""	""	NA	"Neutrophil count decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Neutrophil count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1633"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	3	9	"Adverse Event/Serious Adverse Event"	3070742001	"thrombocytopenia"	122	130	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491766773	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1634"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	3	9	"Adverse Event/Serious Adverse Event"	2702648001	"urininary tract infection"	14	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475189298	""	""	""	NA	"Infection urinary tract"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1635"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	3	9	"Adverse Event/Serious Adverse Event"	2702686001	"vitreous hemorrage"	34	52	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475189917	""	""	""	NA	"Vitreous hemorrhage"	"Eye disorders"	"Retina, choroid and vitreous haemorrhages and vascular disorders"	"Choroid and vitreous haemorrhages and vascular disorders"	"Vitreous haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"1636"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	5	9	"Adverse Event/Serious Adverse Event"	2715083003	"excessive tearing"	85	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491163650	""	""	""	NA	"Excess tears"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1637"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	3	9	"Adverse Event/Serious Adverse Event"	3052197001	"fatigue"	96	154	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491163400	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1638"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	3	9	"Adverse Event/Serious Adverse Event"	2883069001	"fatigue"	18	29	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484778642	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1639"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	3	9	"Adverse Event/Serious Adverse Event"	3052701001	"flushing"	162	166	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491167197	""	""	""	NA	"Flushing"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Flushing"	""	""	""	""	""	""	""	""	""	""	""	""
"1640"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	3	9	"Adverse Event/Serious Adverse Event"	2883057001	"flushing"	17	18	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484778475	""	""	""	NA	"Flushing"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Flushing"	""	""	""	""	""	""	""	""	""	""	""	""
"1641"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	3	9	"Adverse Event/Serious Adverse Event"	2883084001	"flushing"	35	37	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484778742	""	""	""	NA	"Flushing"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Flushing"	""	""	""	""	""	""	""	""	""	""	""	""
"1642"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	3	9	"Adverse Event/Serious Adverse Event"	2883098001	"hematuria"	43	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484778826	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"1643"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	3	9	"Adverse Event/Serious Adverse Event"	3052704001	"hemoglobin"	56	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491167299	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1644"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	3	9	"Adverse Event/Serious Adverse Event"	3052346001	"hemoglobin"	16	35	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491164212	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1645"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	3	9	"Adverse Event/Serious Adverse Event"	3052337001	"hyperglycemia"	16	34	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491164125	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1646"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	3	9	"Adverse Event/Serious Adverse Event"	3052709001	"hyperglycemia"	35	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491167426	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1647"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	3	9	"Adverse Event/Serious Adverse Event"	3190202001	"hyponatremia"	224	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494798197	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1648"	"DN-101 Protocol No. 011-007"	"130"	"130-0005"	5	9	"Adverse Event/Serious Adverse Event"	2754100003	"fatigue"	67	69	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485718017	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1649"	"DN-101 Protocol No. 011-007"	"130"	"130-0005"	3	9	"Adverse Event/Serious Adverse Event"	2899423001	"fatigue"	85	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485718150	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1650"	"DN-101 Protocol No. 011-007"	"130"	"130-0005"	3	9	"Adverse Event/Serious Adverse Event"	2899396001	"fatigue"	44	48	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485717942	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1651"	"DN-101 Protocol No. 011-007"	"130"	"130-0005"	3	9	"Adverse Event/Serious Adverse Event"	2899452001	"hyperglycemia"	22	63	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485718377	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1652"	"DN-101 Protocol No. 011-007"	"130"	"130-0005"	3	9	"Adverse Event/Serious Adverse Event"	2899485001	"hypoalbuminemia"	84	105	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485718649	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1653"	"DN-101 Protocol No. 011-007"	"130"	"130-0005"	3	9	"Adverse Event/Serious Adverse Event"	2899469001	"hypoalbuminemia"	42	63	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485718561	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1654"	"DN-101 Protocol No. 011-007"	"130"	"130-0005"	3	9	"Adverse Event/Serious Adverse Event"	2899496001	"Left foot neuropathy sensory"	97	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485718810	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1655"	"DN-101 Protocol No. 011-007"	"130"	"130-0005"	3	9	"Adverse Event/Serious Adverse Event"	3112914001	"nail changes"	114	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492725068	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"1656"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	5	9	"Adverse Event/Serious Adverse Event"	2825540003	"alopecia"	38	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491340797	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1657"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	3	9	"Adverse Event/Serious Adverse Event"	3059757001	"constipation, intermittent"	50	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491341142	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1658"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	3	9	"Adverse Event/Serious Adverse Event"	3063243001	"creatinine"	82	110	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491414496	""	""	""	NA	"Creatinine increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1659"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	3	9	"Adverse Event/Serious Adverse Event"	3059629001	"creatinine"	19	40	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491340391	""	""	""	NA	"Creatinine increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1660"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	3	9	"Adverse Event/Serious Adverse Event"	3059743001	"fatigue"	62	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491341025	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1661"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	3	9	"Adverse Event/Serious Adverse Event"	3188469001	"flushing"	153	154	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494788573	""	""	""	NA	"Flushing"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Flushing"	""	""	""	""	""	""	""	""	""	""	""	""
"1662"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	3	9	"Adverse Event/Serious Adverse Event"	3059841001	"hematuria"	103	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491342229	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"1663"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	3	9	"Adverse Event/Serious Adverse Event"	3059737001	"hyperglycemia"	40	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491340910	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1664"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	3	9	"Adverse Event/Serious Adverse Event"	3059591001	"hyperglycemia"	19	39	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491340302	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1665"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	3	9	"Adverse Event/Serious Adverse Event"	3059658001	"hypoalbuminemia"	19	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491340541	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1666"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	3	9	"Adverse Event/Serious Adverse Event"	3063195001	"pain, back, 10th rib"	96	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491414325	""	""	""	NA	"Rib pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1667"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	5	9	"Adverse Event/Serious Adverse Event"	2830874003	"akaline phosphatase"	44	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485893726	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1668"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	3	9	"Adverse Event/Serious Adverse Event"	2903822001	"alopecia"	59	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485894315	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1669"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	3	9	"Adverse Event/Serious Adverse Event"	2903704001	"fatigue"	45	60	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485892546	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1670"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	3	9	"Adverse Event/Serious Adverse Event"	2903784001	"hyperglycemia"	44	64	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485893931	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1671"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	3	9	"Adverse Event/Serious Adverse Event"	2903809001	"hyperglycemia"	65	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485894184	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1672"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	3	9	"Adverse Event/Serious Adverse Event"	2903794001	"hypoalbuminemia"	44	88	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485894036	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1673"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	3	9	"Adverse Event/Serious Adverse Event"	2903761001	"hypocalcemia"	65	88	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485893635	""	""	""	NA	"Hypocalcemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Calcium metabolism disorders"	"Hypocalcaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1674"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	3	9	"Adverse Event/Serious Adverse Event"	2903749001	"hyponatremia"	44	65	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485893372	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1675"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	3	9	"Adverse Event/Serious Adverse Event"	3063056001	"nausea"	67	69	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491413604	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"1676"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	3	9	"Adverse Event/Serious Adverse Event"	3063041001	"nausea"	45	47	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491413512	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"1677"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	5	9	"Adverse Event/Serious Adverse Event"	2832712003	"Alopecia"	23	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484254545	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1678"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	3	9	"Adverse Event/Serious Adverse Event"	3065964001	"Bone/Joint pain"	73	136	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491432371	""	""	""	NA	"Joint pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1679"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	3	9	"Adverse Event/Serious Adverse Event"	2869752001	"Bruising"	23	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484254828	""	""	""	NA	"Bruising"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"1680"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	3	9	"Adverse Event/Serious Adverse Event"	3214312001	"Burn"	141	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495054438	""	""	""	NA	"Burn"	"Injury, poisoning and procedural complications"	"Injuries by physical agents"	"Thermal burns"	"Thermal burn"	""	""	""	""	""	""	""	""	""	""	""	""
"1681"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	3	9	"Adverse Event/Serious Adverse Event"	2909415001	"Flu Symptoms"	45	94	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486075292	""	""	""	NA	"Flu symptoms"	"Infections and infestations"	"Viral infectious disorders"	"Influenza viral infections"	"Influenza"	""	""	""	""	""	""	""	""	""	""	""	""
"1682"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	3	9	"Adverse Event/Serious Adverse Event"	3009521001	"Peripheral Neuropathy"	80	NA	1	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489964250	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1683"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	3	9	"Adverse Event/Serious Adverse Event"	3165421001	"Right Paraspinal Soft Tissue Pain"	115	NA	1	4	1	1	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Radiation Therapy to Right Paraspinal Area"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494193484	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"1684"	"DN-101 Protocol No. 011-007"	"133"	"133-0001"	5	9	"Adverse Event/Serious Adverse Event"	2763956003	"Fatigue"	112	116	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489510050	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1685"	"DN-101 Protocol No. 011-007"	"133"	"133-0001"	3	9	"Adverse Event/Serious Adverse Event"	2969548001	"Fatigue"	50	55	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488240255	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1686"	"DN-101 Protocol No. 011-007"	"133"	"133-0001"	3	9	"Adverse Event/Serious Adverse Event"	2969537001	"Fatigue"	29	35	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488240165	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1687"	"DN-101 Protocol No. 011-007"	"133"	"133-0001"	3	9	"Adverse Event/Serious Adverse Event"	2823436001	"Fatigue"	8	11	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481669156	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1688"	"DN-101 Protocol No. 011-007"	"133"	"133-0001"	3	9	"Adverse Event/Serious Adverse Event"	3095572001	"Fatigue"	133	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492453995	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1689"	"DN-101 Protocol No. 011-007"	"133"	"133-0001"	3	9	"Adverse Event/Serious Adverse Event"	2969557001	"Fatigue"	91	95	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488240404	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1690"	"DN-101 Protocol No. 011-007"	"133"	"133-0001"	3	9	"Adverse Event/Serious Adverse Event"	2969552001	"Fatigue"	71	76	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488240332	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1691"	"DN-101 Protocol No. 011-007"	"133"	"133-0001"	3	9	"Adverse Event/Serious Adverse Event"	3095597001	"Nail changes"	134	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492454089	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"1692"	"DN-101 Protocol No. 011-007"	"133"	"133-0001"	3	9	"Adverse Event/Serious Adverse Event"	2969564001	"Upper respiratory tract infection"	103	108	NA	1	2	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488240552	""	""	""	NA	"Upper respiratory tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1693"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	5	9	"Adverse Event/Serious Adverse Event"	2819357003	"Facial redness"	3	4	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488758755	""	""	""	NA	"Redness facial"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Erythemas"	"Erythema"	""	""	""	""	""	""	""	""	""	""	""	""
"1694"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	3	9	"Adverse Event/Serious Adverse Event"	2978860001	"Fatigue"	47	52	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488760379	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1695"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	3	9	"Adverse Event/Serious Adverse Event"	2978829001	"Fatigue"	24	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488759937	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1696"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	3	9	"Adverse Event/Serious Adverse Event"	2978765001	"Hypersensitivity reaction to Docetaxel"	2	2	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488758679	""	""	""	NA	"Hypersensitivity reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"1697"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	3	9	"Adverse Event/Serious Adverse Event"	2978826001	"Hypersensitivity reaction to Docetaxel"	23	23	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488759797	""	""	""	NA	"Hypersensitivity reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"1698"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	3	9	"Adverse Event/Serious Adverse Event"	3137944001	"Hypersensitivity reaction to Docetaxel"	128	128	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493313444	""	""	""	NA	"Hypersensitivity reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"1699"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	3	9	"Adverse Event/Serious Adverse Event"	3137851001	"Hypersensitivity reaction to Docetaxel"	107	107	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493311221	""	""	""	NA	"Hypersensitivity reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"1700"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	3	9	"Adverse Event/Serious Adverse Event"	2978777001	"Upper respiratory tract infection"	10	16	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488758831	""	""	""	NA	"Upper respiratory tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1701"	"DN-101 Protocol No. 011-007"	"133"	"133-0009"	5	9	"Adverse Event/Serious Adverse Event"	2969402003	"Upper respiratory tract infection"	17	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492545977	""	""	""	NA	"Upper respiratory tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1702"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	5	9	"Adverse Event/Serious Adverse Event"	2646040003	"Alopecia"	43	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481242248	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1703"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	3	9	"Adverse Event/Serious Adverse Event"	2816149001	"Blurred vision"	48	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481242310	""	""	""	NA	"Blurred vision"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Vision blurred"	""	""	""	""	""	""	""	""	""	""	""	""
"1704"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	3	9	"Adverse Event/Serious Adverse Event"	3021362001	"Dyspnea"	226	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490218998	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1705"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	3	9	"Adverse Event/Serious Adverse Event"	2816155001	"Fatigue"	51	62	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481242383	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1706"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	3	9	"Adverse Event/Serious Adverse Event"	2816171001	"Fatigue"	83	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481242634	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1707"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	3	9	"Adverse Event/Serious Adverse Event"	2725427001	"Heartburn/Dyspepsia"	26	26	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476300329	""	""	""	NA	"Heartburn-like dyspepsia"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"1708"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	3	9	"Adverse Event/Serious Adverse Event"	3021321001	"Hot flashes"	110	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490218565	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"1709"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	3	9	"Adverse Event/Serious Adverse Event"	2725404001	"Insomnia"	21	22	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476300209	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1710"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	3	9	"Adverse Event/Serious Adverse Event"	2725391001	"Neutrophils (low)"	29	34	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476300128	""	""	""	NA	"Neutrophils reduced"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Neutrophil count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1711"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	3	9	"Adverse Event/Serious Adverse Event"	3021354001	"Neutrophils (low)"	159	167	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490218812	""	""	""	NA	"Neutrophils reduced"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Neutrophil count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1712"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	3	9	"Adverse Event/Serious Adverse Event"	3021365001	"Pain-back"	211	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490219097	""	""	""	NA	"Pain back"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1713"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	3	9	"Adverse Event/Serious Adverse Event"	2725471001	"Pain-NOS"	23	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476300605	""	""	""	NA	"Pain NOS"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1714"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	3	9	"Adverse Event/Serious Adverse Event"	3021357001	"Rhinitis"	208	231	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490218900	""	""	""	NA	"Rhinitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Rhinitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1715"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	3	9	"Adverse Event/Serious Adverse Event"	3021317001	"Taste alteration"	94	125	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490218488	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1716"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	3	9	"Adverse Event/Serious Adverse Event"	3021309001	"Urinary frequency/urgency"	104	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490218379	""	""	""	NA	"Urinary urgency"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Micturition urgency"	""	""	""	""	""	""	""	""	""	""	""	""
"1717"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	3	9	"Adverse Event/Serious Adverse Event"	3021343001	"Vascular-other (vein discoloration on left forearm)"	129	210	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490218708	""	""	""	NA	"Vein discoloration"	"Vascular disorders"	"Vascular disorders NEC"	"Non-site specific vascular disorders NEC"	"Vein discolouration"	""	""	""	""	""	""	""	""	""	""	""	""
"1718"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	5	9	"Adverse Event/Serious Adverse Event"	2758274003	"alopecia"	54	NA	1	1	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	1	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486396727	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1719"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	3	9	"Adverse Event/Serious Adverse Event"	2998279001	"Alopecia"	117	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489517237	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1720"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	3	9	"Adverse Event/Serious Adverse Event"	2984623001	"alopecia"	96	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488919285	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1721"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	3	9	"Adverse Event/Serious Adverse Event"	2919071001	"Alopecia"	54	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486413929	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1722"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	3	9	"Adverse Event/Serious Adverse Event"	2919164001	"Alopecia"	75	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486414805	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1723"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	3	9	"Adverse Event/Serious Adverse Event"	2984657001	"Blurring of Eyes"	96	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488919671	""	""	""	NA	"Blurring of eyes"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Vision blurred"	""	""	""	""	""	""	""	""	""	""	""	""
"1724"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	3	9	"Adverse Event/Serious Adverse Event"	2919172001	"Blurring of Eyes"	75	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486414875	""	""	""	NA	"Blurring of eyes"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Vision blurred"	""	""	""	""	""	""	""	""	""	""	""	""
"1725"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	3	9	"Adverse Event/Serious Adverse Event"	2919116001	"Blurring of Eyes"	33	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Told patient to see his PCP for eye exam"	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486414292	""	""	""	NA	"Blurring of eyes"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Vision blurred"	""	""	""	""	""	""	""	""	""	""	""	""
"1726"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	3	9	"Adverse Event/Serious Adverse Event"	2998331001	"Blurring of eyes"	117	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489517531	""	""	""	NA	"Blurring of eyes"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Vision blurred"	""	""	""	""	""	""	""	""	""	""	""	""
"1727"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	3	9	"Adverse Event/Serious Adverse Event"	2917591001	"Blurring of eyes"	54	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"patient told to see PCP for eye check up"	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486398952	""	""	""	NA	"Blurring of eyes"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Vision blurred"	""	""	""	""	""	""	""	""	""	""	""	""
"1728"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	3	9	"Adverse Event/Serious Adverse Event"	3023830001	"Dehydration"	147	NA	1	2	0	NA	NA	NA	NA	NA	NA	NA	NA	4	NA	NA	1	"Patient was hospitalized"	1	0	NA	0	72	NA	NA	NA	1	NA	NA	1	"patient hospitalized for syncope and dehydration"	148	NA	NA	147	151	"3/22/07 CMP, Ca+, Mg+, P, blood cult, UA/CS, occult blood, D dif., sputum cult; 3/23/07, 3/25/07  CBC with D, basic 7"	""	""	2	2	2	2	2	2	2	2	"Patient was taken to the Emergency Room on 3/22/07 after being noted by son of being dizzy and with unsteady gait.  Admitting diagnosis recorded was syncope and dehydration."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490295177	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"1729"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	3	9	"Adverse Event/Serious Adverse Event"	2919024001	"Gynecomastia"	8	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486413332	""	""	""	NA	"Gynecomastia"	"Reproductive system and breast disorders"	"Breast disorders"	"Breast disorders NEC"	"Gynaecomastia"	""	""	""	""	""	""	""	""	""	""	""	""
"1730"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	3	9	"Adverse Event/Serious Adverse Event"	2919149001	"Gynecomastia"	75	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486414510	""	""	""	NA	"Gynecomastia"	"Reproductive system and breast disorders"	"Breast disorders"	"Breast disorders NEC"	"Gynaecomastia"	""	""	""	""	""	""	""	""	""	""	""	""
"1731"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	3	9	"Adverse Event/Serious Adverse Event"	2998247001	"Gynecomastia"	117	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489517054	""	""	""	NA	"Gynecomastia"	"Reproductive system and breast disorders"	"Breast disorders"	"Breast disorders NEC"	"Gynaecomastia"	""	""	""	""	""	""	""	""	""	""	""	""
"1732"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	3	9	"Adverse Event/Serious Adverse Event"	2917674001	"Gynecomastia"	54	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486399662	""	""	""	NA	"Gynecomastia"	"Reproductive system and breast disorders"	"Breast disorders"	"Breast disorders NEC"	"Gynaecomastia"	""	""	""	""	""	""	""	""	""	""	""	""
"1733"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	3	9	"Adverse Event/Serious Adverse Event"	2979639001	"Gynecomastia"	96	NA	1	2	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488820400	""	""	""	NA	"Gynecomastia"	"Reproductive system and breast disorders"	"Breast disorders"	"Breast disorders NEC"	"Gynaecomastia"	""	""	""	""	""	""	""	""	""	""	""	""
"1734"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	3	9	"Adverse Event/Serious Adverse Event"	2998406001	"Incontenent"	117	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489518037	""	""	""	NA	"Incontinent"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"1735"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	3	9	"Adverse Event/Serious Adverse Event"	2984680001	"Incontinence"	96	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488919962	""	""	""	NA	"Incontinence"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"1736"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	3	9	"Adverse Event/Serious Adverse Event"	2984687001	"Low Back Pain"	96	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488920061	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1737"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	3	9	"Adverse Event/Serious Adverse Event"	2998356001	"Nocturia/Urgency"	117	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489517714	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"1738"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	3	9	"Adverse Event/Serious Adverse Event"	2984672001	"Nocturia/urgency"	96	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488919821	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"1739"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	3	9	"Adverse Event/Serious Adverse Event"	2917639001	"Nocturia/Urgency"	54	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486399289	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"1740"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	3	9	"Adverse Event/Serious Adverse Event"	2919181001	"Nocturia/Urgency"	75	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486414956	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"1741"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	3	9	"Adverse Event/Serious Adverse Event"	2919134001	"Nocturia/Urgency"	33	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486414413	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"1742"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	3	9	"Adverse Event/Serious Adverse Event"	3054834001	"Syncope"	158	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Patient hospitalized"	1	0	NA	0	72	NA	NA	NA	1	NA	NA	1	"Patient admitted to UH for Syncope on 4/2/2007 @ 2016.  Various Tests being performed.  Patient is still in hospital as of 4/5/2007.  At this time, discharge date unknown."	159	NA	NA	158	161	"CBC, Chem 7, Mg+, Phos, TSH, Bl2, Folate, RPR, CT Head"	""	""	2	2	2	2	2	2	2	2	"Patient complaining of weakness.  Son had father brought to ER on 4/2/2007.  Admission diagnosis is Syncope."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491244670	""	""	""	NA	"Syncope"	"Nervous system disorders"	"Neurological disorders NEC"	"Disturbances in consciousness NEC"	"Syncope"	""	""	""	""	""	""	""	""	""	""	""	""
"1743"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	3	9	"Adverse Event/Serious Adverse Event"	3023804001	"Syncope"	147	NA	1	2	0	NA	NA	NA	NA	NA	NA	NA	NA	4	NA	NA	1	"Patient admitted to hospital"	1	0	NA	0	72	NA	NA	NA	1	NA	NA	1	"hospitalized for Syncope and Dehydration"	147	NA	NA	147	151	"CMP, Ca+, Mg+, P, Blood cult, UA/CS, occult blood, C.dif, sputum cult (3/22/07), 3/25/07 cbc with diff, basic 7,"	""	""	2	2	2	2	2	2	2	2	"Patient was taken to ER on 3/22/07 after being noted by son of being dizzy and with unsteady gait. Admitting diagnosis recorded was syncope and dehydration."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490294886	""	""	""	NA	"Syncope"	"Nervous system disorders"	"Neurological disorders NEC"	"Disturbances in consciousness NEC"	"Syncope"	""	""	""	""	""	""	""	""	""	""	""	""
"1744"	"DN-101 Protocol No. 011-007"	"138"	"138-0001"	5	9	"Adverse Event/Serious Adverse Event"	3040262003	"alopecia"	26	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494785116	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1745"	"DN-101 Protocol No. 011-007"	"138"	"138-0001"	3	9	"Adverse Event/Serious Adverse Event"	3137749001	"right eye irritation"	5	6	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493309571	""	""	""	NA	"Eye irritation"	"Eye disorders"	"Ocular infections, irritations and inflammations"	"Ocular infections, inflammations and associated manifestations"	"Eye irritation"	""	""	""	""	""	""	""	""	""	""	""	""
"1746"	"DN-101 Protocol No. 011-007"	"140"	"140-0001"	5	9	"Adverse Event/Serious Adverse Event"	2880562003	"agitation"	11	31	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491366111	""	""	""	NA	"Agitation"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Agitation"	""	""	""	""	""	""	""	""	""	""	""	""
"1747"	"DN-101 Protocol No. 011-007"	"140"	"140-0001"	4	9	"Adverse Event/Serious Adverse Event"	3060706001	"constipation"	11	31	NA	1	0	NA	NA	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491365932	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1748"	"DN-101 Protocol No. 011-007"	"140"	"140-0001"	4	9	"Adverse Event/Serious Adverse Event"	3060650001	"dyspnea"	11	31	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491365357	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1749"	"DN-101 Protocol No. 011-007"	"140"	"140-0001"	4	9	"Adverse Event/Serious Adverse Event"	2961241001	"low hemoglobin"	11	31	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487786848	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1750"	"DN-101 Protocol No. 011-007"	"140"	"140-0001"	4	9	"Adverse Event/Serious Adverse Event"	2907175001	"Muscle weakness - (Patient fall)"	11	31	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"patient hospitalized"	5	1	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	14	NA	NA	11	20	"CBC, Chemistries, Chest x-ray"	""	""	2	2	2	2	2	2	2	2	"Patient developed weakness and fell at home.  Patient was admitted to hospital to evaluate.  No fractures or other injury from fall.  Family and patient considering placement in assisted living"	"situation due to patients weakness.  Plan to continue on study at this time."	""	""	""	""	""	""	""	""	""	NA	NA	""	1485981333	""	""	""	NA	"Muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"1751"	"DN-101 Protocol No. 011-007"	"140"	"140-0001"	4	9	"Adverse Event/Serious Adverse Event"	2961181001	"neutropenia"	11	13	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487785977	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1752"	"DN-101 Protocol No. 011-007"	"140"	"140-0001"	4	9	"Adverse Event/Serious Adverse Event"	2961011001	"prostate cancer (progressive)"	31	31	NA	5	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	4	0	NA	0	4	NA	NA	1	NA	NA	NA	NA	""	35	31	0	NA	NA	"N/A"	""	""	2	2	2	NA	2	2	NA	2	"Patient and family decided to go off study 2/8/2007 after patient continued to become progressively weaker and did not show any signs of improvement.  This lack of improvement suggested progressive"	"cancer per the treating investigator and so the family opted to discontinue treatment.	The patient passed away at home with hospice on 2/18/2007."	""	""	""	""	""	""	""	""	""	NA	NA	""	1487783144	""	""	""	NA	"Prostate cancer metastatic"	"Neoplasms benign, malignant and unspecified (incl cysts and polyps)"	"Reproductive neoplasms male malignant and unspecified"	"Prostatic neoplasms malignant"	"Prostate cancer metastatic"	""	""	""	""	""	""	""	""	""	""	""	""
"1753"	"DN-101 Protocol No. 011-007"	"140"	"140-0001"	4	9	"Adverse Event/Serious Adverse Event"	2961223001	"thrombocytopenia"	12	31	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487786635	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1754"	"DN-101 Protocol No. 011-007"	"140"	"140-0002"	5	9	"Adverse Event/Serious Adverse Event"	2983189003	"taste alteration"	2	5	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491319527	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1755"	"DN-101 Protocol No. 011-007"	"141"	"141-0001"	5	9	"Adverse Event/Serious Adverse Event"	2801848003	"acid reflux"	28	66	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492979432	""	""	""	NA	"Acid reflux (oesophageal)"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Gastrooesophageal reflux disease"	""	""	""	""	""	""	""	""	""	""	""	""
"1756"	"DN-101 Protocol No. 011-007"	"141"	"141-0001"	3	9	"Adverse Event/Serious Adverse Event"	3118868001	"blurred vision"	57	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492979648	""	""	""	NA	"Blurred vision"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Vision blurred"	""	""	""	""	""	""	""	""	""	""	""	""
"1757"	"DN-101 Protocol No. 011-007"	"141"	"141-0001"	3	9	"Adverse Event/Serious Adverse Event"	3118919001	"dry cough"	78	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492980139	""	""	""	NA	"Dry cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1758"	"DN-101 Protocol No. 011-007"	"141"	"141-0001"	3	9	"Adverse Event/Serious Adverse Event"	3118904001	"fatigue"	45	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492980025	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1759"	"DN-101 Protocol No. 011-007"	"141"	"141-0001"	3	9	"Adverse Event/Serious Adverse Event"	3118792001	"Night Sweat"	18	18	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492978942	""	""	""	NA	"Night sweat"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Night sweats"	""	""	""	""	""	""	""	""	""	""	""	""
"1760"	"DN-101 Protocol No. 011-007"	"141"	"141-0001"	3	9	"Adverse Event/Serious Adverse Event"	3118943001	"small sore in lower jaw"	126	150	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492980261	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"1761"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	5	9	"Adverse Event/Serious Adverse Event"	2881904003	"anemia, liver bleed"	118	119	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	4	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	118	119	1	118	119	"hematacrit 16.2, platelets 37 (2007 - 05 - 16)"	""	""	2	2	2	2	2	2	2	2	"The patient presented to the ED this morning with profound fatigue.  Patient found to have hematocrit of 16.2.	Patient is being transfused.; ; The patient died in hospital, 17 May 2007."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494976653	""	""	""	NA	"Hepatic haemorrhage"	"Hepatobiliary disorders"	"Hepatic and hepatobiliary disorders"	"Hepatic vascular disorders"	"Hepatic haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"1762"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	3	9	"Adverse Event/Serious Adverse Event"	3119943001	"fatigue"	2	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492991763	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1763"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	3	9	"Adverse Event/Serious Adverse Event"	3119982001	"fatigue"	73	NA	1	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492992098	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1764"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	3	9	"Adverse Event/Serious Adverse Event"	3119948001	"upset stomach"	2	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492991821	""	""	""	NA	"Upset stomach"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal signs and symptoms NEC"	"Stomach discomfort"	""	""	""	""	""	""	""	""	""	""	""	""
"1765"	"DN-101 Protocol No. 011-007"	"141"	"141-0006"	5	9	"Adverse Event/Serious Adverse Event"	2984907003	"elevated liver function test results"	33	54	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	4	NA	NA	1	"discontinued pravachol; conmed on 2007-03-30"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493595238	""	""	""	NA	"Liver function tests raised"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Liver function test abnormal"	""	""	""	""	""	""	""	""	""	""	""	""
"1766"	"DN-101 Protocol No. 011-007"	"141"	"141-0007"	5	9	"Adverse Event/Serious Adverse Event"	2985011003	"Atrial Fibrillation"	26	27	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"admitted to hospital and observed overnight. spontaneously reverted to normal sinus rhythm and discharged within 23 hours."	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493576506	""	""	""	NA	"Atrial fibrillation"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Atrial fibrillation"	""	""	""	""	""	""	""	""	""	""	""	""
"1767"	"DN-101 Protocol No. 011-007"	"141"	"141-0007"	3	9	"Adverse Event/Serious Adverse Event"	3144812001	"Chest pain"	33	33	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"had an EKG and blood test done...negative for MI. Stress test performed, outcome=negative."	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493576943	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"1768"	"DN-101 Protocol No. 011-007"	"142"	"142-0001"	5	9	"Adverse Event/Serious Adverse Event"	2594462003	"Anemia"	14	NA	1	1	2	NA	1	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472057558	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1769"	"DN-101 Protocol No. 011-007"	"142"	"142-0001"	3	9	"Adverse Event/Serious Adverse Event"	2650805001	"Atrial fibrillation"	16	19	NA	3	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	16	NA	NA	15	20	"Sodium	130 mmol/L; BUN  28 mg/dL; Creatinine 2.1  mg/dL; WBC count  0.9 K/uL; Hemoglobin  12.9 g/dL; Neutrophil ABS.  0.14 K/uL; BNP 262 pg/mL"	""	""	2	2	2	NA	2	2	NA	2	"Subject went to clinic for blood draw on 6/27/2006 per protocol and was found to have a fever.	Subject also complained of weakness and diarrhea for the past 3 days.  Neutrophil, ABS 0.14 K/uL"	"Diagnosed with neutropenia and admitted to hospital for continued observation and hydration.  Patient was also admitted to MICU for atrial fibrillation and tachycardia, which required cardizem drip."	"He was also hypotensive and required NS boluses (totaling 2100 ml), after which the blood pressure responded slowly.  Patient was then diagnosed with acute renal failure in which an ultrasound was"	"done showing bilateral hydronephrosis.	His toxicities resolved and he was discharged on 7/3/2006."	""	""	""	""	""	""	""	NA	NA	""	1472060304	""	""	""	NA	"Atrial fibrillation"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Atrial fibrillation"	""	""	""	""	""	""	""	""	""	""	""	""
"1770"	"DN-101 Protocol No. 011-007"	"142"	"142-0001"	3	9	"Adverse Event/Serious Adverse Event"	2650595001	"Bilateral Hydronephrosis"	14	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Foley catheter placed and changed monthly with follow up to Urology."	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472055202	""	""	""	NA	"Bilateral hydronephrosis"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal obstructive disorders"	"Hydronephrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"1771"	"DN-101 Protocol No. 011-007"	"142"	"142-0001"	3	9	"Adverse Event/Serious Adverse Event"	2650462001	"Dehydration"	14	20	NA	3	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	15	NA	NA	15	20	"Sodium	130 mmol/L; BUN  28 mg/dL; Creatinine 2.1  mg/dL; WBC count  0.9 K/uL; Hemoglobin  12.9 g/dL; Neutrophil ABS.  0.14 K/uL; BNP 262 pg/mL"	""	""	2	1	2	NA	2	2	NA	0	"Subject went to clinic for blood draw on 6/27/2006 per protocol and was found to have a fever.	Subject also complained of weakness and diarrhea for the past 3 days.  Neutrophil, ABS 0.14 K/uL"	"Diagnosed with neutropenia and admitted to hospital for continued observation and hydration.  Patient was also admitted to MICU for atrial fibrillation and tachycardia, which required cardizem drip."	"Patient was then diagnosed with acute renal failure in which an ultrasound was done showing bilateral hydronephrosis.  His toxicities resolved and he was discharged on 7/3/2006."	""	""	""	""	""	""	""	""	NA	NA	""	1472052845	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"1772"	"DN-101 Protocol No. 011-007"	"142"	"142-0001"	3	9	"Adverse Event/Serious Adverse Event"	2650529001	"Elevated Creatinine"	14	17	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472053608	""	""	""	NA	"Creatinine increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1773"	"DN-101 Protocol No. 011-007"	"142"	"142-0001"	3	9	"Adverse Event/Serious Adverse Event"	2599765001	"Febrile Neutropenia"	14	20	NA	4	2	NA	1	NA	NA	NA	2	NA	1	5	1	NA	1	"Subject given IV fluids for hydration and admitted for continued observation.  Subject also given Cefepime 2g IVPB"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	15	NA	NA	15	20	"Sodium	130 mmol/L; BUN  28 mg/dL; Creatinine 2.1  mg/dL; WBC count  0.9 K/uL; Hemoglobin  12.9 g/dL; Neutrophil ABS.  0.14 K/uL; BNP 262 pg/mL"	""	""	2	1	2	NA	2	2	NA	0	"Subject went to clinic for blood draw on 6/27/2006 per protocol and was found to have a fever.	Subject also complained of weakness and diarrhea for the past 3 days.  Neutrophil, ABS 0.14 K/uL"	"Diagnosed with neutropenia and admitted to hospital for continued observation and hydration.  Patient was also admitted to MICU for atrial fibrillation and tachycardia, which required cardizem drip."	"Patient was then diagnosed with acute renal failure in which an ultrasound was done showing bilateral hydronephrosis.  His toxicities resolved and he was discharged on 7/3/2006."	""	""	""	""	""	""	""	""	NA	NA	""	1467128616	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1774"	"DN-101 Protocol No. 011-007"	"142"	"142-0001"	3	9	"Adverse Event/Serious Adverse Event"	2650774001	"Hyponatremia"	14	15	NA	1	2	NA	1	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472057715	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1775"	"DN-101 Protocol No. 011-007"	"142"	"142-0001"	3	9	"Adverse Event/Serious Adverse Event"	2650921001	"Hypotension"	16	16	NA	2	2	NA	1	NA	NA	NA	2	NA	1	5	1	NA	1	"2100 ml NS boluses given."	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472061859	""	""	""	NA	"Hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"1776"	"DN-101 Protocol No. 011-007"	"142"	"142-0001"	3	9	"Adverse Event/Serious Adverse Event"	2650719001	"Leukopenia"	14	17	NA	4	2	NA	1	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472057017	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1777"	"DN-101 Protocol No. 011-007"	"142"	"142-0001"	3	9	"Adverse Event/Serious Adverse Event"	2663119001	"Lower GI Bleeding"	76	NA	1	3	2	NA	1	NA	NA	NA	NA	NA	NA	4	NA	NA	1	"Blood transfusion 2 units of pRBCs.  Colonoscopy performed to evaluate bleeding."	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473083874	""	""	""	NA	"Lower gastrointestinal hemorrhage"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Non-site specific gastrointestinal haemorrhages"	"Lower gastrointestinal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"1778"	"DN-101 Protocol No. 011-007"	"142"	"142-0001"	3	9	"Adverse Event/Serious Adverse Event"	2659029001	"Neutropenia"	75	78	NA	4	2	NA	1	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	78	NA	NA	75	91	"ANC 0.57 K/uL (8/27/2006); 0.24 K/uL (8/28/2006); HGB 8.9 g/dl; WBC 1.1 K/uL; Blood cultures positive for Gram(+) cocci"	""	""	2	2	2	NA	2	2	NA	2	"Patient presented to the Emergency Room on 8/27/2006 complaining of weakness and nausea without vomiting.  He reports being too weak to walk and falling at home while in the bathroom.  Urinalysis"	"done was found abnormal and his ANC was 0.57 K/uL.  He was started on Ciprofloxacin.  On 8/28/2006 he developed a fever and chills, so he was switched to Cefepime and Vancomycin.  He was also started"	"on Neupogen since his ANC dropped to 0.27 K/uL.  ;;Lower GI Bleeding:  On 8/28/2006 patient had an episode of bright red blood per rectum about 100 ml.  His hemoglobin dropped and he was transfused 2"	"units of PRBCs."	""	""	""	""	""	""	""	NA	NA	""	1472585201	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1779"	"DN-101 Protocol No. 011-007"	"142"	"142-0001"	3	9	"Adverse Event/Serious Adverse Event"	2650848001	"Tachycardia"	16	16	NA	3	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	NA	NA	NA	15	20	"Sodium	130 mmol/L; BUN  28 mg/dL; Creatinine 2.1  mg/dL; WBC count  0.9 K/uL; Hemoglobin  12.9 g/dL; Neutrophil ABS.  0.14 K/uL; BNP 262 pg/mL"	""	""	2	2	2	NA	2	2	NA	2	"Subject went to clinic for blood draw on 6/27/2006 per protocol and was found to have a fever.	Subject also complained of weakness and diarrhea for the past 3 days.  Neutrophil, ABS 0.14 K/uL"	"Diagnosed with neutropenia and admitted to hospital for continued observation and hydration.  Patient was also admitted to MICU for atrial fibrillation and tachycardia, which required cardizem drip."	"He was also hypotensive and required NS boluses (totaling 2100 ml), after which the blood pressure responded slowly.  Patient was then diagnosed with acute renal failure in which an ultrasound was"	"done showing bilateral hydronephrosis.	His toxicities resolved and he was discharged on 7/3/2006."	""	""	""	""	""	""	""	NA	NA	""	1472060894	""	""	""	NA	"Tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"1780"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	5	9	"Adverse Event/Serious Adverse Event"	2597835003	"Abdominal Pain"	40	44	NA	2	2	NA	1	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472413869	""	""	""	NA	"Abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1781"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	3	9	"Adverse Event/Serious Adverse Event"	2654282001	"Acute Renal Insufficiency"	40	42	NA	3	2	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472413739	""	""	""	NA	"Acute renal insufficiency"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal failure and impairment"	"Renal failure acute"	""	""	""	""	""	""	""	""	""	""	""	""
"1782"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	3	9	"Adverse Event/Serious Adverse Event"	3225528001	"Back Pain"	245	246	NA	3	NA	NA	NA	NA	NA	NA	NA	NA	NA	5	1	NA	1	"Radiation treatment for pain management."	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	331	NA	NA	245	246	"Hemoglobin 10.4  g/dL"	""	""	2	2	2	2	2	2	2	2	"Patient admitted due to uncontrolled back pain.  Received Morphine and radiation treatment for pain management and discharged."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495204657	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1783"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	3	9	"Adverse Event/Serious Adverse Event"	3225522001	"Back Pain"	218	221	NA	3	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	330	NA	NA	218	221	"Spinal CT showed no spinal cord compression."	""	""	2	2	2	2	2	2	2	2	"Patient presented to the Emergency Room complaining of sever back pain preventing him from moving around.  Patient was admitted and given Oramorph 30 mg PO Q12hr ATC, and morphine sulfate PRN.  Pain"	"controlled by Oramorph and patient discharged on 1/29/2007.  CT of spinal while inpatient showed no spinal cord compression."	""	""	""	""	""	""	""	""	""	NA	NA	""	1495203886	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1784"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	3	9	"Adverse Event/Serious Adverse Event"	2634208001	"Dehydration"	42	44	NA	3	2	NA	1	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	3	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	47	NA	NA	43	44	"Creatinine 1.5 mg/dL; WBC 2.7 K/uL; Neutrophil, ABS. 1.30 K/uL"	""	""	2	2	2	NA	2	2	NA	0	"Patient presents to the Emergency Room complaining of nausea, vomiting and intermittent episodes of diarrhea for several days.	He was seen by his primary oncologist on 8/1/06 and advised that he"	"should be admitted to the hospital, but he refused.  Two days after, with persistent nausea and vomiting, he agrees to hospital admission.  The patient was admitted for dehydration and started on IV"	"fluids with 1 liter bolus of normal saline.  He was also given Phenergan 25 mg IV for his nausea.  All other medications, including Prednisone, were withheld while hospitalized.;;Creatinine 1.5 mg/dL"	"Acute renal insufficiency likely secondary to prostate cancer.	Renal ultrasound showed no hydronephrosis or acute process.  Creatinine improved with IV fluids to 1.1 mg/dL."	""	""	""	""	""	""	""	NA	NA	""	1470686787	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"1785"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	3	9	"Adverse Event/Serious Adverse Event"	2654184001	"Nausea"	40	44	NA	3	2	NA	1	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	47	NA	NA	43	44	"Creatinine 1.5 mg/dL; WBC 2.7 K/uL; Neutrophil, ABS. 1.30 K/uL"	""	""	2	2	2	NA	2	0	NA	0	"Patient presents to the Emergency Room complaining of nausea, vomiting and intermittent episodes of diarrhea for several days.	He was seen by his primary oncologist on 8/1/06 and advised that he"	"should be admitted to the hospital, but he refused.  Two days after, with persistent nausea and vomiting, he agrees to hospital admission.  The patient was admitted for dehydration and started on IV"	"fluids with 1 liter bolus of normal saline.  He was also given Phenergan 25 mg IV for his nausea.  All other medications, including Prednisone, were withheld while hospitalized.;;Creatinine 1.5 mg/dL"	"Acute renal insufficiency likely secondary to prostate cancer.	Renal ultrasound showed no hydronephrosis or acute process.  Creatinine improved with IV fluids to 1.1 mg/dL."	""	""	""	""	""	""	""	NA	NA	""	1472412305	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"1786"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	3	9	"Adverse Event/Serious Adverse Event"	2654240001	"Neutropenia"	11	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472412940	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1787"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	3	9	"Adverse Event/Serious Adverse Event"	3225516001	"Peripheral Neuropathy"	194	NA	1	2	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495203236	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1788"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	3	9	"Adverse Event/Serious Adverse Event"	2654176001	"Vomiting"	40	44	NA	3	2	NA	1	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	47	NA	NA	43	44	"Creatinine 1.5 mg/dL; WBC 2.7 K/uL; Neutrophil, ABS. 1.30 K/uL"	""	""	2	2	2	NA	2	2	NA	0	"Patient presents to the Emergency Room complaining of nausea, vomiting and intermittent episodes of diarrhea for several days.	He was seen by his primary oncologist on 8/1/06 and advised that he"	"should be admitted to the hospital, but he refused.  Two days after, with persistent nausea and vomiting, he agrees to hospital admission.  The patient was admitted for dehydration and started on IV"	"fluids with 1 liter bolus of normal saline.  He was also given Phenergan 25 mg IV for his nausea.  All other medications, including Prednisone, were withheld while hospitalized.;;Creatinine 1.5 mg/dL"	"Acute renal insufficiency likely secondary to prostate cancer.	Renal ultrasound showed no hydronephrosis or acute process.  Creatinine improved with IV fluids to 1.1 mg/dL."	""	""	""	""	""	""	""	NA	NA	""	1472412121	""	""	""	NA	"Vomiting"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Vomiting"	""	""	""	""	""	""	""	""	""	""	""	""
"1789"	"DN-101 Protocol No. 011-007"	"142"	"142-0003"	5	9	"Adverse Event/Serious Adverse Event"	2619306003	"Alopecia"	33	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473163947	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1790"	"DN-101 Protocol No. 011-007"	"142"	"142-0003"	3	9	"Adverse Event/Serious Adverse Event"	2666516001	"Constipation"	21	38	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473163782	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1791"	"DN-101 Protocol No. 011-007"	"142"	"142-0004"	5	9	"Adverse Event/Serious Adverse Event"	2675801003	"Dehydration"	115	117	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	150	NA	NA	115	117	"Neutrophil, ABS.  0.42 K/uL  (2006-12-14);			   0.20 K/uL  (2006-12-15); Hemoglobin	10.1 g/dL (2006-12-14); Positive Urinalysis"	""	""	2	2	2	NA	2	2	NA	2	"The patient was admitted through the Emergency Room after an episode of hypotension (60/40).  IV fluids were given for dehydration.  He had a positive urinalysis, which later grew E. Coli resistant"	"to ampicillin and cipro.  Also, his neutrophil count was 0.42 K/uL.  He was given Bactrim for 7 days and is to follow up with Urology as an outpatient.  He also had one episode of hemorrhoidal"	"bleeding and is to follow up with an appointment in colorectal surgery."	""	""	""	""	""	""	""	""	NA	NA	""	1484768288	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"1792"	"DN-101 Protocol No. 011-007"	"142"	"142-0004"	3	9	"Adverse Event/Serious Adverse Event"	2798968001	"Left hip fracture"	85	NA	1	3	2	NA	1	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	1	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	105	NA	NA	88	93	"X-ray"	""	""	2	2	0	NA	2	2	NA	0	"The patient presented to the emergency room on 11/17/2006 complaining of left hip pain and lower extremity pain.  X-ray revealed left intertrochanteric hip fracture.  Open reduction and internal"	"fixation of left hip fracture performed on 11/18/2006.	Patient discharged on 11/22/2006."	""	""	""	""	""	""	""	""	""	NA	NA	""	1480861371	""	""	""	NA	"Hip fracture"	"Injury, poisoning and procedural complications"	"Bone and joint injuries"	"Lower limb fractures and dislocations"	"Hip fracture"	""	""	""	""	""	""	""	""	""	""	""	""
"1793"	"DN-101 Protocol No. 011-007"	"142"	"142-0004"	3	9	"Adverse Event/Serious Adverse Event"	2881601001	"Neutropenia"	115	127	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	150	NA	NA	115	117	"Neutrophil, ABS.  0.42 K/uL  (2006-12-14);			   0.20 K/uL  (2006-12-15); Hemoglobin	10.1 g/dL (2006-12-14); Positive Urinalysis"	""	""	2	2	2	NA	2	2	NA	2	"The patient was admitted through the Emergency Room after an episode of hypotension (60/40).  IV fluids were given for dehydration.  He had a positive urinalysis, which later grew E. Coli resistant"	"to ampicillin and cipro.  Also, his neutrophil count was 0.42 K/uL.  He was given Bactrim for 7 days and is to follow up with Urology as an outpatient.  He also had one episode of hemorrhoidal"	"bleeding and is to follow up with an appointment in colorectal surgery."	""	""	""	""	""	""	""	""	NA	NA	""	1484768975	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1794"	"DN-101 Protocol No. 011-007"	"142"	"142-0004"	3	9	"Adverse Event/Serious Adverse Event"	2881569001	"Urinary Tract Infection"	115	117	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	150	NA	NA	115	117	"Neutrophil, ABS.  0.42 K/uL  (2006-12-14);			   0.20 K/uL  (2006-12-15); Hemoglobin	10.1 g/dL (2006-12-14); Positive Urinalysis"	""	""	2	2	2	NA	2	2	NA	2	"The patient was admitted through the Emergency Room after an episode of hypotension (60/40).  IV fluids were given for dehydration.  He had a positive urinalysis, which later grew E. Coli resistant"	"to ampicillin and cipro.  Also, his neutrophil count was 0.42 K/uL.  He was given Bactrim for 7 days and is to follow up with Urology as an outpatient.  He also had one episode of hemorrhoidal"	"bleeding and is to follow up with an appointment in colorectal surgery."	""	""	""	""	""	""	""	""	NA	NA	""	1484768774	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1795"	"DN-101 Protocol No. 011-007"	"144"	"144-0001"	5	9	"Adverse Event/Serious Adverse Event"	2684853003	"Alopecia"	22	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480375864	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1796"	"DN-101 Protocol No. 011-007"	"144"	"144-0001"	3	9	"Adverse Event/Serious Adverse Event"	3072176001	"Anemia"	22	217	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491789811	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1797"	"DN-101 Protocol No. 011-007"	"144"	"144-0001"	3	9	"Adverse Event/Serious Adverse Event"	2792214001	"Calf Cramps"	43	50	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480376263	""	""	""	NA	"Cramps calf"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"1798"	"DN-101 Protocol No. 011-007"	"144"	"144-0001"	3	9	"Adverse Event/Serious Adverse Event"	2999597001	"Calf Cramps"	98	100	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489539208	""	""	""	NA	"Cramps calf"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"1799"	"DN-101 Protocol No. 011-007"	"144"	"144-0001"	3	9	"Adverse Event/Serious Adverse Event"	3215497001	"dehydration"	246	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"hospitalization"	1	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	248	NA	NA	246	249	"5/15/07 - Cortrosyn stimul cortisol ; 5/15/07 - Brain MRI; 5/15/07 - CBC and CMP"	""	""	2	2	2	2	2	2	2	2	"Hospital admission on 5/15/07 with N&V, r/o CNS mets, and ? adrenal insufficiency.  Brain MRI revealed extensive mets to skull but no intracranial pathology. Cortisol normal.	Per Dr. Mendelson,"	"event is not related to study drug."	""	""	""	""	""	""	""	""	""	NA	NA	""	1495061193	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"1800"	"DN-101 Protocol No. 011-007"	"144"	"144-0001"	3	9	"Adverse Event/Serious Adverse Event"	2792208001	"Dizzinesss"	43	NA	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480376045	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"1801"	"DN-101 Protocol No. 011-007"	"144"	"144-0001"	3	9	"Adverse Event/Serious Adverse Event"	2722291001	"Hypertension"	9	10	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476227043	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"1802"	"DN-101 Protocol No. 011-007"	"144"	"144-0001"	3	9	"Adverse Event/Serious Adverse Event"	2792285001	"Insomnia"	57	248	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480377988	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1803"	"DN-101 Protocol No. 011-007"	"144"	"144-0001"	3	9	"Adverse Event/Serious Adverse Event"	2999581001	"Lightheadedness"	8	8	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489538194	""	""	""	NA	"Lightheadedness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"1804"	"DN-101 Protocol No. 011-007"	"144"	"144-0001"	3	9	"Adverse Event/Serious Adverse Event"	2999588001	"Moody (Change in Mood)"	86	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489538651	""	""	""	NA	"Mood change"	"Psychiatric disorders"	"Mood disorders and disturbances NEC"	"Emotional and mood disturbances NEC"	"Mood altered"	""	""	""	""	""	""	""	""	""	""	""	""
"1805"	"DN-101 Protocol No. 011-007"	"144"	"144-0002"	5	9	"Adverse Event/Serious Adverse Event"	3107964003	"Alopecia"	26	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495496220	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1806"	"DN-101 Protocol No. 011-007"	"144"	"144-0002"	3	9	"Adverse Event/Serious Adverse Event"	3233161001	"Muscle Cramps"	15	18	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495495356	""	""	""	NA	"Muscle cramps"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"1807"	"DN-101 Protocol No. 011-007"	"144"	"144-0002"	3	9	"Adverse Event/Serious Adverse Event"	3233208001	"Tingling Tops of Feet"	26	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495496607	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"1808"	"DN-101 Protocol No. 011-007"	"145"	"145-0003"	5	9	"Adverse Event/Serious Adverse Event"	2787766003	"blood-low hemoglobin"	94	136	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490023621	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1809"	"DN-101 Protocol No. 011-007"	"145"	"145-0003"	3	9	"Adverse Event/Serious Adverse Event"	2849690001	"bone pain - fingers"	-1	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	"this bone pain was seen at baseline"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483459390	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1810"	"DN-101 Protocol No. 011-007"	"145"	"145-0003"	3	9	"Adverse Event/Serious Adverse Event"	2928533001	"Constitutional - fatigue"	39	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486657862	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1811"	"DN-101 Protocol No. 011-007"	"145"	"145-0003"	3	9	"Adverse Event/Serious Adverse Event"	3010821001	"constitutional-fatigue"	108	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490023725	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1812"	"DN-101 Protocol No. 011-007"	"145"	"145-0003"	3	9	"Adverse Event/Serious Adverse Event"	3010772001	"pulmonary-upper respiratory infection"	91	96	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490023530	""	""	""	NA	"Infection upper respiratory"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1813"	"DN-101 Protocol No. 011-007"	"145"	"145-0003"	3	9	"Adverse Event/Serious Adverse Event"	2928548001	"skin - alopecia"	45	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486658004	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1814"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	2933704003	"arthralgia (intermittent)"	7	7	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491425963	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1815"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	3	9	"Adverse Event/Serious Adverse Event"	3065780001	"bradycardia"	27	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491427924	""	""	""	NA	"Bradycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Bradycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"1816"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	3	9	"Adverse Event/Serious Adverse Event"	3065617001	"constipation"	9	11	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491426365	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1817"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	3	9	"Adverse Event/Serious Adverse Event"	3065737001	"cough"	13	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491427406	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1818"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	3	9	"Adverse Event/Serious Adverse Event"	3065758001	"elevated transaminases (SGOT)"	6	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"stop cozaar"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491427610	""	""	""	NA	"SGOT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1819"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	3	9	"Adverse Event/Serious Adverse Event"	3201262001	"fatigue"	48	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	NA	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494953872	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1820"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	3	9	"Adverse Event/Serious Adverse Event"	3065593001	"heartburn (intermittent)"	12	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"hospital bed  with raised head"	NA	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491426183	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"1821"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	3	9	"Adverse Event/Serious Adverse Event"	3065534001	"insomnia (intermittent)"	6	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	NA	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491425827	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1822"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	3	9	"Adverse Event/Serious Adverse Event"	3065565001	"myalgia (intermittent)"	7	7	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491426057	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1823"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	3	9	"Adverse Event/Serious Adverse Event"	3065664001	"phlebitis"	11	48	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"port implanted"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491426646	""	""	""	NA	"Phlebitis"	"Vascular disorders"	"Vascular inflammations"	"Phlebitis NEC"	"Phlebitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1824"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	3	9	"Adverse Event/Serious Adverse Event"	3065768001	"ventricular bigeminy"	27	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491427745	""	""	""	NA	"Ventricular bigeminy"	"Cardiac disorders"	"Cardiac arrhythmias"	"Ventricular arrhythmias and cardiac arrest"	"Ventricular extrasystoles"	""	""	""	""	""	""	""	""	""	""	""	""
"1825"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	5	9	"Adverse Event/Serious Adverse Event"	2800309003	"constipation"	15	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484231240	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1826"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	3	9	"Adverse Event/Serious Adverse Event"	2982552001	"cough"	64	71	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488906204	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1827"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	3	9	"Adverse Event/Serious Adverse Event"	2982602001	"dehydration"	64	64	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488906529	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"1828"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	3	9	"Adverse Event/Serious Adverse Event"	2868291001	"Depression"	15	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484234498	""	""	""	NA	"Depression"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"1829"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	3	9	"Adverse Event/Serious Adverse Event"	3075236001	"dry mucosa"	111	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491858744	""	""	""	NA	"Mucosal dryness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Mucosal findings abnormal"	"Mucosal dryness"	""	""	""	""	""	""	""	""	""	""	""	""
"1830"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	3	9	"Adverse Event/Serious Adverse Event"	3075230001	"exertional dyspnea"	106	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491858653	""	""	""	NA	"Exertional dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea exertional"	""	""	""	""	""	""	""	""	""	""	""	""
"1831"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	3	9	"Adverse Event/Serious Adverse Event"	3137493001	"Generalized Malaise"	132	139	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493307054	""	""	""	NA	"General malaise"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Malaise"	""	""	""	""	""	""	""	""	""	""	""	""
"1832"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	3	9	"Adverse Event/Serious Adverse Event"	2868258001	"Hair loss"	31	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484233153	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1833"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	3	9	"Adverse Event/Serious Adverse Event"	2982606001	"insomnia"	44	51	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488906674	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1834"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	3	9	"Adverse Event/Serious Adverse Event"	2868221001	"Left leg Swelling"	37	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484232068	""	""	""	NA	"Swelling of legs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1835"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	3	9	"Adverse Event/Serious Adverse Event"	3137487001	"leucocytosis"	147	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493306954	""	""	""	NA	"Leucocytosis NOS"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukocytoses NEC"	"Leukocytosis"	""	""	""	""	""	""	""	""	""	""	""	""
"1836"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	3	9	"Adverse Event/Serious Adverse Event"	2982392001	"leukopenia"	37	71	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488904541	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1837"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	3	9	"Adverse Event/Serious Adverse Event"	3137484001	"neutropenia (pancytopenia)"	139	147	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493306854	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1838"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	3	9	"Adverse Event/Serious Adverse Event"	2982514001	"post nasal drip"	64	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488905922	""	""	""	NA	"Postnasal drip"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Postnasal drip"	""	""	""	""	""	""	""	""	""	""	""	""
"1839"	"DN-101 Protocol No. 011-007"	"154"	"154-0002"	5	9	"Adverse Event/Serious Adverse Event"	3045387003	"Deep Vein Thrombosis - Right Leg"	56	59	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	40	NA	NA	NA	1	NA	1	NA	""	57	NA	NA	-674	59	"2007-05-17;- blood pressure 111/67;- respirations 18;- pulse 85-99;- afebrile;- hemoglobin 11.4, MCV 87;- INR 2 with PTT of 46;- may start anticoagulation anywhere from 9-12 months;- to start"	"amiodarone 200 mg once a day"	""	2	2	2	2	2	2	2	2	"This SAE was reported to me on 5-15-07. I spoke with a family member of the patient and he said the patient experienced right leg swelling on 5-14-07 and subsequently saw his physician. A DVT study"	"ultrasound was completed and the patient was found to have a DVT in the right leg from the proximal SFV to the popliteal vein. The patient was hospitalized on 5-14-07 at around 17:00. The family"	"\"thinks he is receiving heparin\". The family states that the plan is for the patient to be in the hospital for 3-4 days and then discharged on Coumadin for six months.  This is all preliminary"	"information.  Per Dr. Shiba, Principal Investigator, he states that this event is unlikely related to any drug therapy but rather to the patient's underlying disease."	""	""	""	""	""	""	""	NA	NA	""	1494874389	""	""	""	NA	"Deep vein thrombosis leg"	"Vascular disorders"	"Embolism and thrombosis"	"Peripheral embolism and thrombosis"	"Deep vein thrombosis"	""	""	""	""	""	""	""	""	""	""	""	""
"1840"	"DN-101 Protocol No. 011-007"	"155"	"155-0001"	5	9	"Adverse Event/Serious Adverse Event"	2765586003	"creatinine"	161	169	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"CMP WILL BE REPEATED ON 4-16-2007, FAX REPORT TO UROLOGIST AND HE WILL SET UP RENAL SONOGRAM RESULTS OF CMP FOR 4-16-07 WILL BE FAXED TO UROLOGIST"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492098317	""	""	""	NA	"Creatinine increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1841"	"DN-101 Protocol No. 011-007"	"155"	"155-0001"	3	9	"Adverse Event/Serious Adverse Event"	2967105001	"hemorrage, gu,bladder"	98	102	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Cipro 500 mg po daily for 5 days urology"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488143118	""	""	""	NA	"Bladder hemorrhage"	"Renal and urinary disorders"	"Bladder and bladder neck disorders (excl calculi)"	"Bladder disorders NEC"	"Urinary bladder haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"1842"	"DN-101 Protocol No. 011-007"	"155"	"155-0001"	3	9	"Adverse Event/Serious Adverse Event"	2870972001	"insomnia"	67	74	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484494485	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1843"	"DN-101 Protocol No. 011-007"	"155"	"155-0001"	3	9	"Adverse Event/Serious Adverse Event"	2797556001	"Joint Pain"	11	12	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480617542	""	""	""	NA	"Joint pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1844"	"DN-101 Protocol No. 011-007"	"155"	"155-0001"	3	9	"Adverse Event/Serious Adverse Event"	2797532001	"neutropenia"	17	32	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480617318	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1845"	"DN-101 Protocol No. 011-007"	"155"	"155-0001"	3	9	"Adverse Event/Serious Adverse Event"	2967096001	"neutropenia"	102	109	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488142975	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1846"	"DN-101 Protocol No. 011-007"	"155"	"155-0001"	3	9	"Adverse Event/Serious Adverse Event"	2967117001	"obstruction GU"	116	116	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488143316	""	""	""	NA	"Urethral obstruction"	"Renal and urinary disorders"	"Urethral disorders (excl calculi)"	"Structural and obstructive urethral disorders (excl congenital)"	"Urethral obstruction"	""	""	""	""	""	""	""	""	""	""	""	""
"1847"	"DN-101 Protocol No. 011-007"	"155"	"155-0001"	3	9	"Adverse Event/Serious Adverse Event"	2870993001	"obstruction, gu, bladder"	70	73	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484494997	""	""	""	NA	"Bladder obstruction"	"Renal and urinary disorders"	"Bladder and bladder neck disorders (excl calculi)"	"Bladder disorders NEC"	"Bladder obstruction"	""	""	""	""	""	""	""	""	""	""	""	""
"1848"	"DN-101 Protocol No. 011-007"	"155"	"155-0001"	3	9	"Adverse Event/Serious Adverse Event"	2870985001	"pain, sinus"	67	74	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484494648	""	""	""	NA	"Sinus pain"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Sinus headache"	""	""	""	""	""	""	""	""	""	""	""	""
"1849"	"DN-101 Protocol No. 011-007"	"155"	"155-0001"	3	9	"Adverse Event/Serious Adverse Event"	3008760001	"perforation, GU-urethra"	133	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Urologist is managing this problem"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489951906	""	""	""	NA	"Perforated GU"	"Gastrointestinal disorders"	"Gastrointestinal ulceration and perforation"	"Gastric ulcers and perforation"	"Gastric ulcer perforation"	""	""	""	""	""	""	""	""	""	""	""	""
"1850"	"DN-101 Protocol No. 011-007"	"155"	"155-0002"	5	9	"Adverse Event/Serious Adverse Event"	2793723003	"c-diff colitis"	40	56	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"obtain stool specimen, admitted to hoppital, started on flagyl."	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	48	NA	NA	48	56	"1.Positive stool specimen for C-Diff collected 02/01/2007; 2.Abnormal Chemistry Panel 02/01/2007 and on admission 04/01/2007 indicating dehydration; 3.Abnormal U/A indicating uti"	""	""	2	2	2	NA	2	2	NA	2	"Patient was seen by urologist for cystitis on 17/12/2006 and placed on Augmentin 500mg po bid. On 28/12/2006 patient was in clinic for cycle 2 of Docetaxel and had complaints of diarrhea related to"	"abx. Chemo was given according to schedule and orders. Pt started to experience exacerbation of the diarrhea with nausea and fever. He stated he had some blood in stools but that predated the chemo."	"Lab work proved the patient was not neutropenic and the doctor suspected this to be gastroenteritis or c-diff infection. He was placed on Flagyl. Blood Cultures were collected and the stool sample"	"and urine sample were brought to clinic on 03/01/2007. The patient remained somewhat stable at home on po fluids, flagyl, until the morning of 04/01/2007 when he became dizzy and fell. The wife"	"called 911 and the patient was taken to the ER. It was determined that he had dehydration requiring IV fluids and hospitalization. As of 05/01/2007 patient remains inpatient and his records will be"	"obtained."	""	""	""	""	""	NA	NA	""	1483547370	""	""	""	NA	"C.difficile colitis"	"Infections and infestations"	"Bacterial infectious disorders"	"Clostridia infections"	"Clostridium difficile colitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1851"	"DN-101 Protocol No. 011-007"	"155"	"155-0002"	3	9	"Adverse Event/Serious Adverse Event"	2851868001	"cystitis/psudomonas"	30	40	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Patient was seen by urologist on 12/17/2006 for complaints of hematuria, after he had provided a specimen the patient was put on augmentin 500 mg po bid starting on 12/17/06 for 10 days."	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483546589	""	""	""	NA	"Cystitis pseudomonal"	"Infections and infestations"	"Bacterial infectious disorders"	"Pseudomonal infections"	"Cystitis pseudomonal"	""	""	""	""	""	""	""	""	""	""	""	""
"1852"	"DN-101 Protocol No. 011-007"	"155"	"155-0002"	3	9	"Adverse Event/Serious Adverse Event"	3057489001	"hemoglobin"	94	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"lab test iron saturation and ferritin to rule out iron diff anemia vs. renal insufiency"	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491328087	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1853"	"DN-101 Protocol No. 011-007"	"155"	"155-0004"	5	9	"Adverse Event/Serious Adverse Event"	2917064003	"hypokalemia"	72	93	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492121471	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1854"	"DN-101 Protocol No. 011-007"	"155"	"155-0004"	3	9	"Adverse Event/Serious Adverse Event"	2953031001	"neutropenia"	16	23	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487516670	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1855"	"DN-101 Protocol No. 011-007"	"155"	"155-0004"	3	9	"Adverse Event/Serious Adverse Event"	2953025001	"uticaria"	11	30	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487516520	""	""	""	NA	"Urticaria"	"Skin and subcutaneous tissue disorders"	"Angioedema and urticaria"	"Urticarias"	"Urticaria"	""	""	""	""	""	""	""	""	""	""	""	""
"1856"	"DN-101 Protocol No. 011-007"	"156"	"156-0001"	5	9	"Adverse Event/Serious Adverse Event"	2744899003	"Cough"	103	109	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485377126	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1857"	"DN-101 Protocol No. 011-007"	"156"	"156-0001"	3	9	"Adverse Event/Serious Adverse Event"	2945517001	"Mouth Sore"	127	132	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487178701	""	""	""	NA	"Sore mouth"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Oral soft tissue pain and paraesthesia"	"Oral pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1858"	"DN-101 Protocol No. 011-007"	"156"	"156-0001"	3	9	"Adverse Event/Serious Adverse Event"	2972658001	"Mucositis"	140	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488383099	""	""	""	NA	"Mucositis"	"General disorders and administration site conditions"	"General system disorders NEC"	"Mucosal findings abnormal"	"Mucosal inflammation"	""	""	""	""	""	""	""	""	""	""	""	""
"1859"	"DN-101 Protocol No. 011-007"	"156"	"156-0001"	3	9	"Adverse Event/Serious Adverse Event"	2991966001	"Pruritis/Itching"	148	152	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489325622	""	""	""	NA	"Itching"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Pruritus NEC"	"Pruritus"	""	""	""	""	""	""	""	""	""	""	""	""
"1860"	"DN-101 Protocol No. 011-007"	"156"	"156-0001"	3	9	"Adverse Event/Serious Adverse Event"	2896205001	"Upper Respiratory Infection"	103	109	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485377358	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1861"	"DN-101 Protocol No. 011-007"	"156"	"156-0001"	3	9	"Adverse Event/Serious Adverse Event"	2945491001	"Upper Respiratory Infection"	127	140	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487178632	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1862"	"DN-101 Protocol No. 011-007"	"156"	"156-0001"	3	9	"Adverse Event/Serious Adverse Event"	3160989001	"Urinary Retention"	198	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493925033	""	""	""	NA	"Urinary retention"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary retention"	""	""	""	""	""	""	""	""	""	""	""	""
"1863"	"DN-101 Protocol No. 011-007"	"156"	"156-0002"	5	9	"Adverse Event/Serious Adverse Event"	2799095003	"Anemia"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485110687	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1864"	"DN-101 Protocol No. 011-007"	"156"	"156-0002"	3	9	"Adverse Event/Serious Adverse Event"	2886604001	"Anxiety"	49	NA	1	2	2	NA	1	NA	NA	NA	0	NA	NA	5	1	NA	1	"Prednisone decreased to daily on 1/24/2007.  Initial adverse event recorded/initiated on 1/17/2007 when con med added."	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485110751	""	""	""	NA	"Anxiety"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Anxiety"	""	""	""	""	""	""	""	""	""	""	""	""
"1865"	"DN-101 Protocol No. 011-007"	"156"	"156-0002"	3	9	"Adverse Event/Serious Adverse Event"	2854406001	"Fatigue"	34	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Flomax, Norvasc, and ASA discontinued due to dizziness and stomach irritation."	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483565560	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1866"	"DN-101 Protocol No. 011-007"	"156"	"156-0002"	3	9	"Adverse Event/Serious Adverse Event"	2897401001	"Insomnia"	55	70	NA	2	2	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485458135	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1867"	"DN-101 Protocol No. 011-007"	"156"	"156-0002"	3	9	"Adverse Event/Serious Adverse Event"	2897406001	"Labored Breathing"	55	70	NA	2	2	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485458221	""	""	""	NA	"Labored breathing"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1868"	"DN-101 Protocol No. 011-007"	"156"	"156-0002"	3	9	"Adverse Event/Serious Adverse Event"	3139221001	"Nausea"	12	70	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493322770	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"1869"	"DN-101 Protocol No. 011-007"	"156"	"156-0002"	3	9	"Adverse Event/Serious Adverse Event"	3171141001	"Pain/musculoskeletal"	122	NA	1	2	0	NA	NA	NA	NA	NA	NA	NA	NA	4	NA	NA	1	"Patient is on follow-up and is no longer on any study medication due to PI's decision"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494343960	""	""	""	NA	"Musculoskeletal pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1870"	"DN-101 Protocol No. 011-007"	"156"	"156-0002"	3	9	"Adverse Event/Serious Adverse Event"	2886515001	"Pedal/Ankle Edema"	43	57	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485110087	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1871"	"DN-101 Protocol No. 011-007"	"156"	"156-0002"	3	9	"Adverse Event/Serious Adverse Event"	3139236001	"Vomitting"	12	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493322897	""	""	""	NA	"Vomiting"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Vomiting"	""	""	""	""	""	""	""	""	""	""	""	""
"1872"	"DN-101 Protocol No. 011-007"	"156"	"156-0002"	3	9	"Adverse Event/Serious Adverse Event"	2890399001	"Weight Loss"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485207969	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1873"	"DN-101 Protocol No. 011-007"	"161"	"161-0001"	5	9	"Adverse Event/Serious Adverse Event"	2829603003	"Anemia"	49	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485908374	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1874"	"DN-101 Protocol No. 011-007"	"161"	"161-0001"	3	9	"Adverse Event/Serious Adverse Event"	2872541001	"Night sweats"	14	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484522332	""	""	""	NA	"Night sweats"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Night sweats"	""	""	""	""	""	""	""	""	""	""	""	""
"1875"	"DN-101 Protocol No. 011-007"	"161"	"161-0001"	3	9	"Adverse Event/Serious Adverse Event"	2971576001	"Paresthesia, left hand"	58	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488315097	""	""	""	NA	"Paresthesia hand"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"1876"	"DN-101 Protocol No. 011-007"	"161"	"161-0001"	3	9	"Adverse Event/Serious Adverse Event"	2971606001	"Paresthesia, right side of face"	64	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488316052	""	""	""	NA	"Facial paresthesia"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"1877"	"DN-101 Protocol No. 011-007"	"161"	"161-0002"	5	9	"Adverse Event/Serious Adverse Event"	2903639003	"Bilateral leg muscle aches"	22	26	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490045825	""	""	""	NA	"Muscle ache"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1878"	"DN-101 Protocol No. 011-007"	"161"	"161-0002"	3	9	"Adverse Event/Serious Adverse Event"	3140112001	"Fatigue"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493333365	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1879"	"DN-101 Protocol No. 011-007"	"161"	"161-0002"	3	9	"Adverse Event/Serious Adverse Event"	3140191001	"Incontinence-intermittent"	41	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493333763	""	""	""	NA	"Incontinence"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"1880"	"DN-101 Protocol No. 011-007"	"161"	"161-0002"	3	9	"Adverse Event/Serious Adverse Event"	3140075001	"Loss of taste"	27	34	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493333184	""	""	""	NA	"Loss of taste"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Ageusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1881"	"DN-101 Protocol No. 011-007"	"165"	"165-0001"	5	9	"Adverse Event/Serious Adverse Event"	2979987003	"muscle cramping of feet"	31	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493043163	""	""	""	NA	"Cramp muscle"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"1882"	"DN-101 Protocol No. 011-007"	"165"	"165-0001"	3	9	"Adverse Event/Serious Adverse Event"	3181081001	"neutropenia"	63	70	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494519585	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1883"	"DN-101 Protocol No. 011-007"	"165"	"165-0001"	3	9	"Adverse Event/Serious Adverse Event"	3121781001	"urinary retention"	7	7	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"foley catheter insertion for that day"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493042270	""	""	""	NA	"Urinary retention"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary retention"	""	""	""	""	""	""	""	""	""	""	""	""
"1884"	"DN-101 Protocol No. 011-007"	"173"	"173-0001"	5	9	"Adverse Event/Serious Adverse Event"	2961623003	"anorexia"	27	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492367029	""	""	""	NA	"Anorexia"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1885"	"DN-101 Protocol No. 011-007"	"173"	"173-0001"	3	9	"Adverse Event/Serious Adverse Event"	3089372001	"bronchitis"	54	58	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"hospitalized"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	55	NA	NA	54	58	"Sputum sent for culture."	""	""	2	2	2	NA	2	2	NA	2	"Pt presented to ER with cough with plegm.  Admitted to hospital with bronchitis +/- pneumonia."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492368583	""	""	""	NA	"Bronchitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Bronchitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1886"	"DN-101 Protocol No. 011-007"	"173"	"173-0001"	3	9	"Adverse Event/Serious Adverse Event"	3089321001	"fatigue"	48	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492368104	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1887"	"DN-101 Protocol No. 011-007"	"173"	"173-0001"	3	9	"Adverse Event/Serious Adverse Event"	3089330001	"hiccups"	48	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492368176	""	""	""	NA	"Hiccups"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Lower respiratory tract signs and symptoms"	"Hiccups"	""	""	""	""	""	""	""	""	""	""	""	""
"1888"	"DN-101 Protocol No. 011-007"	"173"	"173-0001"	3	9	"Adverse Event/Serious Adverse Event"	3089352001	"insomnia"	48	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492368328	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1889"	"DN-101 Protocol No. 011-007"	"173"	"173-0001"	3	9	"Adverse Event/Serious Adverse Event"	3089406001	"neutropenia"	54	58	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"hospitalized"	0	0	NA	1	40	NA	NA	NA	1	NA	1	NA	""	55	NA	NA	54	58	"CBC 04/15/07  WBC=1.3 ANC=494"	""	""	2	2	2	NA	2	2	NA	2	"Pt presented to ER with cough.	CBC revealed neutropenia.  Pt was hospitalized."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492368939	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1890"	"DN-101 Protocol No. 011-007"	"184"	"184-0001"	5	9	"Adverse Event/Serious Adverse Event"	2858542003	"arthralgias"	10	13	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485192019	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1891"	"DN-101 Protocol No. 011-007"	"184"	"184-0001"	3	9	"Adverse Event/Serious Adverse Event"	3080852001	"fatigue"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492023975	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1892"	"DN-101 Protocol No. 011-007"	"184"	"184-0001"	3	9	"Adverse Event/Serious Adverse Event"	2889164001	"flu- like syndrome"	10	13	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485192287	""	""	""	NA	"Flu syndrome"	"Infections and infestations"	"Viral infectious disorders"	"Influenza viral infections"	"Influenza"	""	""	""	""	""	""	""	""	""	""	""	""
"1893"	"DN-101 Protocol No. 011-007"	"184"	"184-0001"	3	9	"Adverse Event/Serious Adverse Event"	2977818001	"intermittent arthralgias"	31	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488735823	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1894"	"DN-101 Protocol No. 011-007"	"184"	"184-0001"	3	9	"Adverse Event/Serious Adverse Event"	2977815001	"intermittent flu like syndrome"	31	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488735745	""	""	""	NA	"Flu syndrome"	"Infections and infestations"	"Viral infectious disorders"	"Influenza viral infections"	"Influenza"	""	""	""	""	""	""	""	""	""	""	""	""
"1895"	"DN-101 Protocol No. 011-007"	"184"	"184-0001"	3	9	"Adverse Event/Serious Adverse Event"	2977828001	"intermittent myalgias"	31	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488735976	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1896"	"DN-101 Protocol No. 011-007"	"184"	"184-0001"	3	9	"Adverse Event/Serious Adverse Event"	2889155001	"myalgias"	10	13	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485192190	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1897"	"DN-101 Protocol No. 011-007"	"184"	"184-0001"	3	9	"Adverse Event/Serious Adverse Event"	2977801001	"nosebleeds"	31	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488735486	""	""	""	NA	"Nosebleed"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"1898"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	3206029003	"Constipation"	-14	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495155240	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1899"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	3	9	"Adverse Event/Serious Adverse Event"	3225053001	"Discomfort - groin"	-84	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495155602	""	""	""	NA	"Groin discomfort"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal discomfort"	""	""	""	""	""	""	""	""	""	""	""	""
"1900"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	3	9	"Adverse Event/Serious Adverse Event"	3225056001	"Hematuria"	-24	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495155652	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"1901"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	3	9	"Adverse Event/Serious Adverse Event"	3225045001	"Nocturia"	-3051	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495155527	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"1902"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	3	9	"Adverse Event/Serious Adverse Event"	3225038001	"Pain - back lumbar region"	-16	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495155469	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1903"	"DN-101 Protocol No. 011-007"	"501"	"501-0001"	5	9	"Adverse Event/Serious Adverse Event"	2762410004	"Anorexia"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484562277	""	""	""	NA	"Anorexia"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1904"	"DN-101 Protocol No. 011-007"	"501"	"501-0001"	3	9	"Adverse Event/Serious Adverse Event"	2772590001	"constipation"	9	13	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479122508	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1905"	"DN-101 Protocol No. 011-007"	"501"	"501-0001"	3	9	"Adverse Event/Serious Adverse Event"	3013746001	"dyspnoe"	114	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490092420	""	""	""	NA	"Dyspnoea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1906"	"DN-101 Protocol No. 011-007"	"501"	"501-0001"	3	9	"Adverse Event/Serious Adverse Event"	2772593001	"fatigue"	9	13	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479122663	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1907"	"DN-101 Protocol No. 011-007"	"501"	"501-0001"	3	9	"Adverse Event/Serious Adverse Event"	2847091001	"Hemoglobin"	48	55	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"2 erothrycyte concentrates given on 22.12.06"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483352448	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1908"	"DN-101 Protocol No. 011-007"	"501"	"501-0001"	3	9	"Adverse Event/Serious Adverse Event"	3010101001	"nausea"	112	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490010870	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"1909"	"DN-101 Protocol No. 011-007"	"501"	"501-0001"	3	9	"Adverse Event/Serious Adverse Event"	3010096001	"nausea"	91	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490010746	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"1910"	"DN-101 Protocol No. 011-007"	"501"	"501-0001"	3	9	"Adverse Event/Serious Adverse Event"	2808898001	"nausea"	31	32	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481106663	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"1911"	"DN-101 Protocol No. 011-007"	"501"	"501-0001"	3	9	"Adverse Event/Serious Adverse Event"	2847124001	"Nausea"	49	52	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483353240	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"1912"	"DN-101 Protocol No. 011-007"	"501"	"501-0001"	3	9	"Adverse Event/Serious Adverse Event"	3010090001	"nausea"	70	77	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490010607	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"1913"	"DN-101 Protocol No. 011-007"	"503"	"503-0003"	5	9	"Adverse Event/Serious Adverse Event"	2898233003	"Dysgeusia"	15	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489661003	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1914"	"DN-101 Protocol No. 011-007"	"503"	"503-0003"	3	9	"Adverse Event/Serious Adverse Event"	3198056001	"Fatigue"	77	79	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494923226	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1915"	"DN-101 Protocol No. 011-007"	"503"	"503-0003"	3	9	"Adverse Event/Serious Adverse Event"	2974771001	"Fatigue"	35	39	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488447270	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1916"	"DN-101 Protocol No. 011-007"	"503"	"503-0003"	3	9	"Adverse Event/Serious Adverse Event"	3061176001	"Fatigue"	57	61	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491383983	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1917"	"DN-101 Protocol No. 011-007"	"503"	"503-0003"	3	9	"Adverse Event/Serious Adverse Event"	3009966001	"Nykturie"	13	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490008423	""	""	""	NA	"Nycturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"1918"	"DN-101 Protocol No. 011-007"	"505"	"505-0001"	5	9	"Adverse Event/Serious Adverse Event"	2818450003	"fever"	60	60	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484507905	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1919"	"DN-101 Protocol No. 011-007"	"505"	"505-0001"	3	9	"Adverse Event/Serious Adverse Event"	3115748001	"leucopenia"	122	123	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492954602	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1920"	"DN-101 Protocol No. 011-007"	"505"	"505-0001"	3	9	"Adverse Event/Serious Adverse Event"	2999921001	"Leucopenia"	99	114	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489571817	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1921"	"DN-101 Protocol No. 011-007"	"505"	"505-0001"	3	9	"Adverse Event/Serious Adverse Event"	2851775001	"Leucopenia"	37	43	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483545885	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1922"	"DN-101 Protocol No. 011-007"	"505"	"505-0001"	3	9	"Adverse Event/Serious Adverse Event"	2999917001	"Leucopenia"	47	93	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489571645	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1923"	"DN-101 Protocol No. 011-007"	"505"	"505-0001"	3	9	"Adverse Event/Serious Adverse Event"	2871644001	"leucopenia"	60	62	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	62	NA	NA	60	62	"Hb 7.97 mmol/L; Leucocytes 1.1 Gpt/L"	""	""	2	2	2	NA	2	2	2	2	"Patient was admitted to hospital because of episode of fever (max. 38.4 degree centigrade) At hospital Leucopenia was diagnosed and antibiotic therapy initiated."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484507633	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1924"	"DN-101 Protocol No. 011-007"	"505"	"505-0002"	5	9	"Adverse Event/Serious Adverse Event"	3010626003	"leukocytopenia"	19	28	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492943255	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1925"	"DN-101 Protocol No. 011-007"	"505"	"505-0003"	5	9	"Adverse Event/Serious Adverse Event"	3061274003	"Colon diverticulum bleeding"	37	42	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	50	NA	NA	37	42	"Platelets 81 GPt/l (04.05.2007); TPZ 38% (04.05.2007)"	""	""	2	2	2	NA	2	2	NA	2	"Patient was admitted because of rectal bleeding on May 3rd, 2007 to hospital close to his home. A coloscopy was performed which showed diverticula in the colon. Bleeding from a diverticulum was"	"identified as the reason. Also thrombocytopenia was found. Bleeding stopped after thromocytes had risen and medication with coumarine derivatives was stopped and patient received low molecular weight"	"heparine."	""	""	""	""	""	""	""	""	NA	NA	""	1495042868	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"1926"	"DN-101 Protocol No. 011-007"	"505"	"505-0003"	3	9	"Adverse Event/Serious Adverse Event"	3229913001	"Leucopenia"	36	43	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495443104	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1927"	"DN-101 Protocol No. 011-007"	"505"	"505-0003"	3	9	"Adverse Event/Serious Adverse Event"	3229893001	"thrombocytopenia"	38	42	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495442867	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1928"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	5	9	"Adverse Event/Serious Adverse Event"	2780546003	"aching muscles"	64	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489930009	""	""	""	NA	"Muscle ache"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1929"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	3	9	"Adverse Event/Serious Adverse Event"	2879541001	"alopecia"	32	38	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484737781	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1930"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	3	9	"Adverse Event/Serious Adverse Event"	2927478001	"Anaemia"	61	63	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Transfusion of erythrocytes"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	93	NA	NA	61	63	"Haemoglobin 8,4 g/dl (2007-01-08); Erythrocytes 2,7 T/l (2007-01-08); Heamoglobin 10,1 g/dl (2007-01-09)"	""	""	0	0	0	NA	0	0	NA	0	"Chronic anaemia as a result of metastatic tumor disease.; After chemotherapy reduction of Hb-concentration."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486642082	""	""	""	NA	"Anaemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1931"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	3	9	"Adverse Event/Serious Adverse Event"	3007217001	"back pain"	57	57	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489929626	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1932"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	3	9	"Adverse Event/Serious Adverse Event"	2879538001	"emesis"	21	21	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484737587	""	""	""	NA	"Emesis"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Vomiting"	""	""	""	""	""	""	""	""	""	""	""	""
"1933"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	3	9	"Adverse Event/Serious Adverse Event"	2879588001	"epistaxis"	42	43	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484741320	""	""	""	NA	"Epistaxis"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"1934"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	3	9	"Adverse Event/Serious Adverse Event"	2879529001	"herpes simplex"	36	55	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484736560	""	""	""	NA	"Herpes simplex"	"Infections and infestations"	"Viral infectious disorders"	"Herpes viral infections"	"Herpes simplex"	""	""	""	""	""	""	""	""	""	""	""	""
"1935"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	3	9	"Adverse Event/Serious Adverse Event"	2879594001	"joint numbness"	45	55	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484741799	""	""	""	NA	"Numbness"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"1936"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	3	9	"Adverse Event/Serious Adverse Event"	2927485001	"loss of weight"	13	34	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486642337	""	""	""	NA	"Loss of weight"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1937"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	3	9	"Adverse Event/Serious Adverse Event"	2879535001	"myalgia"	32	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484737436	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1938"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	3	9	"Adverse Event/Serious Adverse Event"	3007340001	"neuropathia sensoric"	65	65	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489931893	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1939"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	3	9	"Adverse Event/Serious Adverse Event"	3007076001	"neuropathia sensoric"	97	119	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489924873	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1940"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	3	9	"Adverse Event/Serious Adverse Event"	3007334001	"numbness chest"	60	60	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489931593	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"1941"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	3	9	"Adverse Event/Serious Adverse Event"	3007210001	"numbness total"	57	57	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489929519	""	""	""	NA	"Numbness"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"1942"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	3	9	"Adverse Event/Serious Adverse Event"	3007220001	"pain calf left"	57	63	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489929811	""	""	""	NA	"Calf pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"1943"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	3	9	"Adverse Event/Serious Adverse Event"	2879532001	"pain extremity"	15	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484737267	""	""	""	NA	"Pain in extremity"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"1944"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	3	9	"Adverse Event/Serious Adverse Event"	3007194001	"pain shoulder"	58	59	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489929182	""	""	""	NA	"Shoulder pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Shoulder pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1945"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	3	9	"Adverse Event/Serious Adverse Event"	3007372001	"pain talocalcanean joint and foot"	66	66	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489932676	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"1946"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	3	9	"Adverse Event/Serious Adverse Event"	3007352001	"pain vertebra lumbar"	73	73	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489932080	""	""	""	NA	"Lumbar pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1947"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	3	9	"Adverse Event/Serious Adverse Event"	3007069001	"paraesthesia"	97	119	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489924739	""	""	""	NA	"Paraesthesia"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"1948"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	3	9	"Adverse Event/Serious Adverse Event"	2879526001	"rhagaden in the corner of the mouth"	12	36	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484736314	""	""	""	NA	"Rhagades"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Skin fissures"	""	""	""	""	""	""	""	""	""	""	""	""
"1949"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	3	9	"Adverse Event/Serious Adverse Event"	3007040001	"spinal cord compression"	99	119	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	6	NA	1	1	"radiation of BWS"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	103	NA	NA	99	119	"MRI vertebral column from 16.02.2007"	""	""	0	0	0	NA	0	0	NA	0	"laminectomie 19.02.2007, after surgery clear recovery; radiation of BWS"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489924115	""	""	""	NA	"Spinal cord compression"	"Nervous system disorders"	"Spinal cord and nerve root disorders"	"Spinal cord and nerve root disorders NEC"	"Spinal cord compression"	""	""	""	""	""	""	""	""	""	""	""	""
"1950"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	3	9	"Adverse Event/Serious Adverse Event"	3007178001	"sweeting"	57	57	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489928741	""	""	""	NA	"Sweating"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"1951"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	3	9	"Adverse Event/Serious Adverse Event"	2879605001	"tachykardia"	54	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484741990	""	""	""	NA	"Tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"1952"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	3	9	"Adverse Event/Serious Adverse Event"	2879591001	"xerostomia"	52	55	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484741610	""	""	""	NA	"Xerostomia"	"Gastrointestinal disorders"	"Salivary gland conditions"	"Oral dryness and saliva altered"	"Dry mouth"	""	""	""	""	""	""	""	""	""	""	""	""
"1953"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	2858015003	"absence of appetite"	67	67	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490614621	""	""	""	NA	"Appetite absent"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1954"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	3	9	"Adverse Event/Serious Adverse Event"	2969955001	"anorexia"	19	19	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488293010	""	""	""	NA	"Anorexia"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1955"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	3	9	"Adverse Event/Serious Adverse Event"	2969946001	"bone pain"	17	17	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488292641	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1956"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	3	9	"Adverse Event/Serious Adverse Event"	2969950001	"diarrhoea"	19	19	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488292851	""	""	""	NA	"Diarrhoea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1957"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	3	9	"Adverse Event/Serious Adverse Event"	3076141001	"dry skin"	77	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491912520	""	""	""	NA	"Dry skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Dry skin"	""	""	""	""	""	""	""	""	""	""	""	""
"1958"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	3	9	"Adverse Event/Serious Adverse Event"	3031705001	"fatigue"	75	75	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490615160	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1959"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	3	9	"Adverse Event/Serious Adverse Event"	3076130001	"fatigue"	77	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491912144	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1960"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	3	9	"Adverse Event/Serious Adverse Event"	2969943001	"nausea"	17	17	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488292441	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"1961"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	3	9	"Adverse Event/Serious Adverse Event"	3031670001	"nausea"	62	63	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490614463	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"1962"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	3	9	"Adverse Event/Serious Adverse Event"	2969927001	"nausea"	14	14	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488292152	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"1963"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	3	9	"Adverse Event/Serious Adverse Event"	3075940001	"pain in the back"	95	96	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491907489	""	""	""	NA	"Pain back"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1964"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	3	9	"Adverse Event/Serious Adverse Event"	2972733001	"pain stomach"	37	38	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488384003	""	""	""	NA	"Pain stomach"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain upper"	""	""	""	""	""	""	""	""	""	""	""	""
"1965"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	3	9	"Adverse Event/Serious Adverse Event"	3031690001	"pain stomach"	70	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490614822	""	""	""	NA	"Pain stomach"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain upper"	""	""	""	""	""	""	""	""	""	""	""	""
"1966"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	3	9	"Adverse Event/Serious Adverse Event"	3075988001	"raw nasal mucosa"	98	NA	1	1	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491908894	""	""	""	NA	"Nasal mucosal disorder"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Nasal mucosal disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"1967"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	3	9	"Adverse Event/Serious Adverse Event"	3031666001	"sweating"	58	59	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490614229	""	""	""	NA	"Sweating"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"1968"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	3	9	"Adverse Event/Serious Adverse Event"	2972743001	"taste disorder"	40	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488384230	""	""	""	NA	"Taste abnormality"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1969"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	3	9	"Adverse Event/Serious Adverse Event"	3076013001	"taste disorder"	98	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491909524	""	""	""	NA	"Taste abnormality"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1970"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	3	9	"Adverse Event/Serious Adverse Event"	3076009001	"taste disorder"	77	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491909398	""	""	""	NA	"Taste abnormality"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1971"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	3	9	"Adverse Event/Serious Adverse Event"	3076003001	"taste disorder"	56	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491909259	""	""	""	NA	"Taste abnormality"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1972"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	3	9	"Adverse Event/Serious Adverse Event"	3076135001	"xerostomia"	77	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491912420	""	""	""	NA	"Xerostomia"	"Gastrointestinal disorders"	"Salivary gland conditions"	"Oral dryness and saliva altered"	"Dry mouth"	""	""	""	""	""	""	""	""	""	""	""	""
"1973"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	5	9	"Adverse Event/Serious Adverse Event"	2817051003	"anemia"	3	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486328482	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1974"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	3	9	"Adverse Event/Serious Adverse Event"	3092144001	"asthenia"	87	108	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492415596	""	""	""	NA	"Asthenia"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1975"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	3	9	"Adverse Event/Serious Adverse Event"	2914242001	"bone pain"	24	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486327914	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1976"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	3	9	"Adverse Event/Serious Adverse Event"	3126321001	"dyspnea"	108	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493114445	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1977"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	3	9	"Adverse Event/Serious Adverse Event"	3126289001	"edema"	108	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493114198	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"1978"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	3	9	"Adverse Event/Serious Adverse Event"	2914032001	"hair loss"	3	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486326663	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1979"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	3	9	"Adverse Event/Serious Adverse Event"	2914263001	"hyperglycemia"	45	45	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Cancelation of Dexmthasone 3 hours before Docetaxel"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486328075	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1980"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	3	9	"Adverse Event/Serious Adverse Event"	3126314001	"hyperglycemia"	129	129	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493114353	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1981"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	3	9	"Adverse Event/Serious Adverse Event"	2914068001	"leukopenia"	10	16	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486326968	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1982"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	3	9	"Adverse Event/Serious Adverse Event"	3092201001	"neuropathy"	108	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492416376	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1983"	"DN-101 Protocol No. 011-007"	"507"	"507-0004"	5	9	"Adverse Event/Serious Adverse Event"	2827491003	"bone pain"	45	48	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493126518	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1984"	"DN-101 Protocol No. 011-007"	"507"	"507-0004"	3	9	"Adverse Event/Serious Adverse Event"	2974994001	"Ileus"	58	72	NA	4	0	NA	NA	NA	NA	NA	1	1	NA	2	NA	1	NA	""	4	0	NA	0	12	NA	NA	1	1	NA	NA	NA	""	75	71	0	58	71	"To date we do not have any further information."	""	""	2	2	2	2	2	2	2	2	"Patient was admitted to hospital on 13-02-07 with ileus, on 14.02.07 an operation with building of an artificial anus done. The patient died suddenly on the 26.02.07. To date we do not have any"	"further information because the patient was operated in a different hospital."	""	""	""	""	""	""	""	""	""	NA	NA	""	1488460264	""	""	""	NA	"Ileus"	"Gastrointestinal disorders"	"Gastrointestinal stenosis and obstruction"	"Gastrointestinal stenosis and obstruction NEC"	"Ileus"	""	""	""	""	""	""	""	""	""	""	""	""
"1985"	"DN-101 Protocol No. 011-007"	"507"	"507-0004"	3	9	"Adverse Event/Serious Adverse Event"	3126500001	"pain left shoulder"	22	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493116347	""	""	""	NA	"Shoulder pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Shoulder pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1986"	"DN-101 Protocol No. 011-007"	"507"	"507-0004"	3	9	"Adverse Event/Serious Adverse Event"	3127052001	"subileus, bad general condition"	45	48	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	3	1	1	NA	""	3	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	129	NA	NA	45	48	"x-ray of abdomen: coprostase, no ileus. ; blood test: creatinine 2,21 mg/dl, leucocytes 26.050/mul"	""	""	2	2	2	2	2	2	2	2	"patient was admitted to hospital in bad general condition and suspicion of an ileus. after medical stimulation of the bowels condition improved. Furthermore a permanent venous access was implanted."	"patient was discharged after 3 days with improved general condition"	""	""	""	""	""	""	""	""	""	NA	NA	""	1493126274	""	""	""	NA	"Subileus"	"Gastrointestinal disorders"	"Gastrointestinal stenosis and obstruction"	"Gastrointestinal stenosis and obstruction NEC"	"Subileus"	""	""	""	""	""	""	""	""	""	""	""	""
"1987"	"DN-101 Protocol No. 011-007"	"507"	"507-0006"	5	9	"Adverse Event/Serious Adverse Event"	2867838003	"alopecia"	51	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492430111	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1988"	"DN-101 Protocol No. 011-007"	"507"	"507-0006"	3	9	"Adverse Event/Serious Adverse Event"	2966201001	"anemia"	3	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488136555	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1989"	"DN-101 Protocol No. 011-007"	"507"	"507-0006"	3	9	"Adverse Event/Serious Adverse Event"	2966464001	"high serum alkaline phosphatase"	28	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488137813	""	""	""	NA	"Serum alkaline phosphatase elevated"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1990"	"DN-101 Protocol No. 011-007"	"507"	"507-0007"	5	9	"Adverse Event/Serious Adverse Event"	2883211003	"dry mucosa"	31	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493120406	""	""	""	NA	"Mucosal dryness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Mucosal findings abnormal"	"Mucosal dryness"	""	""	""	""	""	""	""	""	""	""	""	""
"1991"	"DN-101 Protocol No. 011-007"	"507"	"507-0007"	3	9	"Adverse Event/Serious Adverse Event"	3126786001	"hypertension"	66	101	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493120654	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"1992"	"DN-101 Protocol No. 011-007"	"507"	"507-0007"	3	9	"Adverse Event/Serious Adverse Event"	3126665001	"incontinence"	10	17	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"pelvic floor exercises"	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493119416	""	""	""	NA	"Incontinence"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"1993"	"DN-101 Protocol No. 011-007"	"507"	"507-0007"	3	9	"Adverse Event/Serious Adverse Event"	3126755001	"leucopenia"	17	24	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493120332	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1994"	"DN-101 Protocol No. 011-007"	"507"	"507-0007"	3	9	"Adverse Event/Serious Adverse Event"	3126774001	"leucopenia"	59	66	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493120503	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1995"	"DN-101 Protocol No. 011-007"	"507"	"507-0007"	3	9	"Adverse Event/Serious Adverse Event"	3126821001	"nail changes"	80	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"cooling of hands during infusion of docetaxel"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493121104	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"1996"	"DN-101 Protocol No. 011-007"	"507"	"507-0007"	3	9	"Adverse Event/Serious Adverse Event"	3126661001	"rash"	10	11	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493119304	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"1997"	"DN-101 Protocol No. 011-007"	"507"	"507-0007"	3	9	"Adverse Event/Serious Adverse Event"	3126671001	"tasting disorder"	10	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493119499	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1998"	"DN-101 Protocol No. 011-007"	"507"	"507-0011"	5	9	"Adverse Event/Serious Adverse Event"	2991875003	"diarrhoe"	10	31	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	NA	0	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494148823	""	""	""	NA	"Diarrhoea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1999"	"DN-101 Protocol No. 011-007"	"507"	"507-0011"	3	9	"Adverse Event/Serious Adverse Event"	3237319001	"Edema"	71	NA	1	4	1	1	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	2	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	73	NA	NA	71	NA	""	""	""	2	2	2	2	2	2	2	2	"Patient was admitted to hospital with edeme of the legs, scrotum and penis. He was unable to void. Furthermore he complains about bone pain. ; Therefore treatment was discontinued for unknown time."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495601466	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"2000"	"DN-101 Protocol No. 011-007"	"507"	"507-0011"	3	9	"Adverse Event/Serious Adverse Event"	3233391001	"edema"	32	NA	NA	3	NA	NA	NA	NA	NA	NA	2	NA	1	4	NA	NA	1	"Patient was hospitalized on May 22nd 2007"	2	0	0	0	8	NA	NA	NA	1	NA	NA	NA	""	NA	NA	NA	71	NA	""	""	""	NA	NA	NA	NA	0	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495525858	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"2001"	"DN-101 Protocol No. 011-007"	"507"	"507-0011"	3	9	"Adverse Event/Serious Adverse Event"	3162245001	"loss of appetite"	3	31	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	NA	0	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494148705	""	""	""	NA	"Appetite lost"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"2002"	"DN-101 Protocol No. 011-007"	"507"	"507-0011"	3	9	"Adverse Event/Serious Adverse Event"	3162241001	"nausea"	3	31	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	NA	0	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494148587	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"2003"	"DN-101 Protocol No. 011-007"	"507"	"507-0011"	3	9	"Adverse Event/Serious Adverse Event"	3162257001	"neuropathie"	10	NA	1	1	NA	NA	NA	0	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	NA	0	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494148994	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"2004"	"DN-101 Protocol No. 011-007"	"507"	"507-0011"	3	9	"Adverse Event/Serious Adverse Event"	3233402001	"ulcer cruris"	32	NA	1	3	NA	NA	NA	NA	NA	NA	2	NA	1	NA	NA	NA	NA	"Patient was hospitalized on May 22nd 2007"	2	0	0	0	8	NA	NA	NA	1	NA	NA	NA	""	NA	NA	NA	71	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495526028	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"2005"	"DN-101 Protocol No. 011-007"	"507"	"507-0011"	3	9	"Adverse Event/Serious Adverse Event"	3162254001	"vomiting"	10	31	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	NA	0	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494148911	""	""	""	NA	"Vomiting"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Vomiting"	""	""	""	""	""	""	""	""	""	""	""	""
"2006"	"DN-101 Protocol No. 011-007"	"507"	"507-0012"	5	9	"Adverse Event/Serious Adverse Event"	3009691003	"appetite loss"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493222104	""	""	""	NA	"Appetite lost"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"2007"	"DN-101 Protocol No. 011-007"	"507"	"507-0012"	3	9	"Adverse Event/Serious Adverse Event"	3132643001	"hair loss"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493222056	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2008"	"DN-101 Protocol No. 011-007"	"507"	"507-0012"	3	9	"Adverse Event/Serious Adverse Event"	3132653001	"tasting disorder"	0	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493222150	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"2009"	"DN-101 Protocol No. 011-007"	"507"	"507-0013"	5	9	"Adverse Event/Serious Adverse Event"	3035957003	"bone pain"	11	12	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493222952	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2010"	"DN-101 Protocol No. 011-007"	"507"	"507-0013"	3	9	"Adverse Event/Serious Adverse Event"	3132789001	"hair loss"	8	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493222901	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2011"	"DN-101 Protocol No. 011-007"	"507"	"507-0013"	3	9	"Adverse Event/Serious Adverse Event"	3132810001	"polyneuropathy"	8	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493223031	""	""	""	NA	"Polyneuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Acute polyneuropathies"	"Polyneuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"2012"	"DN-101 Protocol No. 011-007"	"507"	"507-0015"	5	9	"Adverse Event/Serious Adverse Event"	3118213003	"Gastrointestinal toxicity"	21	NA	1	3	2	NA	1	NA	NA	NA	2	NA	1	5	1	NA	1	"Patient was admitted to another hospital"	2	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	31	NA	NA	21	NA	"We were informed by another hospital that the patient was admitted with acute diarrhea, nause, vomitting and worsening of general condition. Up to now we only know that ulcers of the rectum were"	"diagnosed. We do not have any additional information so far."	""	2	2	2	NA	2	2	NA	2	"We were informed by another hospital that the patient was admitted with acute diarrhea, nause, vomitting and worsening of general condition. Up to now we only know that ulcers of the rectum were"	"diagnosed. We do not have any additional information so far."	""	""	""	""	""	""	""	""	""	NA	NA	""	1495219661	""	""	""	NA	"Gastrointestinal toxicity"	"Gastrointestinal disorders"	"Gastrointestinal inflammatory conditions"	"Gastrointestinal inflammatory disorders NEC"	"Gastrointestinal toxicity"	""	""	""	""	""	""	""	""	""	""	""	""
"2013"	"DN-101 Protocol No. 011-007"	"509"	"509-0001"	5	9	"Adverse Event/Serious Adverse Event"	2943359003	"Leukopenia"	24	30	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492422511	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2014"	"DN-101 Protocol No. 011-007"	"509"	"509-0001"	3	9	"Adverse Event/Serious Adverse Event"	3092671001	"Leukopenia"	45	51	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492422910	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2015"	"DN-101 Protocol No. 011-007"	"509"	"509-0005"	5	9	"Adverse Event/Serious Adverse Event"	3061079003	"Radius fracture (operation 03.05.2007)"	26	39	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	3	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	NA	NA	NA	35	39	"not jet available"	""	""	0	0	0	NA	0	0	NA	0	"Patient tumbled on his way home. By falling down he leaned on his left arm. Result of this aktion, was an fracture of his left radius ."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493810611	""	""	""	NA	"Radius fracture"	"Injury, poisoning and procedural complications"	"Bone and joint injuries"	"Upper limb fractures and dislocations"	"Radius fracture"	""	""	""	""	""	""	""	""	""	""	""	""
"2016"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	5	9	"Adverse Event/Serious Adverse Event"	3141707003	"allergic reaction, face redness"	8	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	16	NA	NA	8	10	"no tests"	""	""	2	2	2	NA	2	2	NA	2	"Patient got redness on his face 8 hours after the end of infusion. Pat. got Dimetinden 2x 1 mg per day"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494405643	""	""	""	NA	"Redness of face"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Erythemas"	"Erythema"	""	""	""	""	""	""	""	""	""	""	""	""
"2017"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	3	9	"Adverse Event/Serious Adverse Event"	3179750001	"burning flank pain i. the evening when patient lies in bed"	11	21	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494489372	""	""	""	NA	"Flank pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Flank pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2018"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	3	9	"Adverse Event/Serious Adverse Event"	3237415001	"dysphagia"	19	21	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495614279	""	""	""	NA	"Dysphagia"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal signs and symptoms NEC"	"Dysphagia"	""	""	""	""	""	""	""	""	""	""	""	""
"2019"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	3	9	"Adverse Event/Serious Adverse Event"	3179687001	"leukopenia"	16	21	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494488612	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2020"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	3	9	"Adverse Event/Serious Adverse Event"	3237412001	"pain in the neck"	19	21	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495614091	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"2021"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	3	9	"Adverse Event/Serious Adverse Event"	3179723001	"polymyalgia"	11	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494489023	""	""	""	NA	"Polymyalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Polymyalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2022"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	3	9	"Adverse Event/Serious Adverse Event"	3237421001	"prickel in hands and legs at night"	19	21	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495614444	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"2023"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	3	9	"Adverse Event/Serious Adverse Event"	3237407001	"vesicular eczema face, neck and hands"	17	21	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495613303	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"2024"	"DN-101 Protocol No. 011-007"	"515"	"515-0001"	5	9	"Adverse Event/Serious Adverse Event"	2910083003	"hypertension with RR 209/108 mmHg HF:108"	90	90	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Nitrendipin 5 mg- ; 20 min post Nitrendipinr- RR: 152/82 HF: 95"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494356250	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"2025"	"DN-101 Protocol No. 011-007"	"515"	"515-0001"	3	9	"Adverse Event/Serious Adverse Event"	3187456001	"inflammation of bladder"	83	88	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494784689	""	""	""	NA	"Bladder inflammation"	"Renal and urinary disorders"	"Bladder and bladder neck disorders (excl calculi)"	"Bladder infections and inflammations"	"Cystitis noninfective"	""	""	""	""	""	""	""	""	""	""	""	""
"2026"	"DN-101 Protocol No. 011-007"	"515"	"515-0001"	3	9	"Adverse Event/Serious Adverse Event"	3187415001	"inflammation of bladder"	48	50	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494784569	""	""	""	NA	"Bladder inflammation"	"Renal and urinary disorders"	"Bladder and bladder neck disorders (excl calculi)"	"Bladder infections and inflammations"	"Cystitis noninfective"	""	""	""	""	""	""	""	""	""	""	""	""
"2027"	"DN-101 Protocol No. 011-007"	"515"	"515-0003"	5	9	"Adverse Event/Serious Adverse Event"	2964464003	"caugh,hyposalivation"	12	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493119928	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"2028"	"DN-101 Protocol No. 011-007"	"515"	"515-0003"	3	9	"Adverse Event/Serious Adverse Event"	3126734001	"diminuation of taste"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493120157	""	""	""	NA	"Taste diminished"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Hypogeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"2029"	"DN-101 Protocol No. 011-007"	"515"	"515-0003"	3	9	"Adverse Event/Serious Adverse Event"	3113205001	"Leukopenia"	57	58	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492771254	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2030"	"DN-101 Protocol No. 011-007"	"515"	"515-0003"	3	9	"Adverse Event/Serious Adverse Event"	3168679001	"loss of hair"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494271067	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2031"	"DN-101 Protocol No. 011-007"	"515"	"515-0004"	5	9	"Adverse Event/Serious Adverse Event"	2964470003	"loss of hair"	15	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494261572	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2032"	"DN-101 Protocol No. 011-007"	"515"	"515-0005"	5	9	"Adverse Event/Serious Adverse Event"	3026451003	"paroxysmal atrium arrhythmia"	10	15	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	20	NA	NA	10	15	"ECG,atrium-flutter"	""	""	2	2	2	NA	2	2	NA	2	"paroxysmal atrium arrhythmia"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491861200	""	""	""	NA	"Paroxysmal arrhythmia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Paroxysmal arrhythmia"	""	""	""	""	""	""	""	""	""	""	""	""
"2033"	"DN-101 Protocol No. 011-007"	"521"	"521-0002"	5	9	"Adverse Event/Serious Adverse Event"	2883225003	"Alopecia"	27	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493043576	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2034"	"DN-101 Protocol No. 011-007"	"521"	"521-0002"	3	9	"Adverse Event/Serious Adverse Event"	2920971001	"constipation"	15	18	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486478258	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2035"	"DN-101 Protocol No. 011-007"	"521"	"521-0002"	3	9	"Adverse Event/Serious Adverse Event"	3122633001	"cuchingoid habitus"	90	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493047430	""	""	""	NA	"Cushingoid"	"Endocrine disorders"	"Adrenal gland disorders"	"Adrenal cortical hyperfunctions"	"Cushingoid"	""	""	""	""	""	""	""	""	""	""	""	""
"2036"	"DN-101 Protocol No. 011-007"	"521"	"521-0002"	3	9	"Adverse Event/Serious Adverse Event"	2920951001	"Urinary incontinence intermittend"	7	48	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486477938	""	""	""	NA	"Incontinence urinary"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"2037"	"DN-101 Protocol No. 011-007"	"521"	"521-0003"	5	9	"Adverse Event/Serious Adverse Event"	2911848003	"Alopecia"	25	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493034777	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2038"	"DN-101 Protocol No. 011-007"	"521"	"521-0003"	3	9	"Adverse Event/Serious Adverse Event"	3121394001	"Fever"	20	24	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493034533	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"2039"	"DN-101 Protocol No. 011-007"	"521"	"521-0003"	3	9	"Adverse Event/Serious Adverse Event"	3121388001	"grippal infection (with unknown ANC)"	20	24	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493034059	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2040"	"DN-101 Protocol No. 011-007"	"521"	"521-0003"	3	9	"Adverse Event/Serious Adverse Event"	3121379001	"Myalgia"	10	12	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493033838	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2041"	"DN-101 Protocol No. 011-007"	"522"	"522-0001"	5	9	"Adverse Event/Serious Adverse Event"	2977156003	"calf cramp"	44	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492603461	""	""	""	NA	"Cramps calf"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"2042"	"DN-101 Protocol No. 011-007"	"522"	"522-0001"	3	9	"Adverse Event/Serious Adverse Event"	3105076001	"obstipation"	31	53	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492603308	""	""	""	NA	"Obstipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2043"	"DN-101 Protocol No. 011-007"	"522"	"522-0004"	5	9	"Adverse Event/Serious Adverse Event"	3006719003	"diarrhea"	8	15	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490697839	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2044"	"DN-101 Protocol No. 011-007"	"522"	"522-0004"	3	9	"Adverse Event/Serious Adverse Event"	3035986001	"oral candidosis"	8	15	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490698144	""	""	""	NA	"Oral candidiasis"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Oral candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"2045"	"DN-101 Protocol No. 011-007"	"524"	"524-0001"	5	9	"Adverse Event/Serious Adverse Event"	2935622003	"bad cold"	34	38	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494258160	""	""	""	NA	"Cold"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2046"	"DN-101 Protocol No. 011-007"	"524"	"524-0001"	3	9	"Adverse Event/Serious Adverse Event"	3167419001	"dysgeusia"	44	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494258914	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"2047"	"DN-101 Protocol No. 011-007"	"524"	"524-0001"	3	9	"Adverse Event/Serious Adverse Event"	3167387001	"heartburn"	44	44	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494258749	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"2048"	"DN-101 Protocol No. 011-007"	"524"	"524-0002"	5	9	"Adverse Event/Serious Adverse Event"	2943304003	"bad cold"	40	58	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494259550	""	""	""	NA	"Cold"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2049"	"DN-101 Protocol No. 011-007"	"524"	"524-0002"	3	9	"Adverse Event/Serious Adverse Event"	3036217001	"COPD"	42	NA	1	NA	NA	NA	NA	1	1	NA	1	1	NA	4	NA	NA	1	"Hospitalisation"	NA	0	0	0	8	NA	NA	NA	1	NA	NA	NA	""	NA	NA	NA	42	NA	""	""	""	0	0	0	0	0	0	0	0	"Yesterday a flu, this morning  symptoms like a COPD ad hospitalisation at once."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490705271	""	""	""	NA	"COPD"	"Respiratory, thoracic and mediastinal disorders"	"Bronchial disorders (excl neoplasms)"	"Bronchospasm and obstruction"	"Chronic obstructive pulmonary disease"	""	""	""	""	""	""	""	""	""	""	""	""
"2050"	"DN-101 Protocol No. 011-007"	"524"	"524-0002"	3	9	"Adverse Event/Serious Adverse Event"	3167561001	"Fever"	40	55	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494259845	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"2051"	"DN-101 Protocol No. 011-007"	"524"	"524-0002"	3	9	"Adverse Event/Serious Adverse Event"	3167488001	"Stomach trauble"	12	12	NA	1	0	NA	NA	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494259315	""	""	""	NA	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"2052"	"DN-101 Protocol No. 011-007"	"525"	"525-0002"	5	9	"Adverse Event/Serious Adverse Event"	2954979003	"Alopezia"	NA	34	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	NA	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490860838	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2053"	"DN-101 Protocol No. 011-007"	"525"	"525-0002"	3	9	"Adverse Event/Serious Adverse Event"	3045845001	"loss of oral taste perception"	13	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	NA	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490860732	""	""	""	NA	"Taste loss"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Ageusia"	""	""	""	""	""	""	""	""	""	""	""	""
"2054"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	5	9	"Adverse Event/Serious Adverse Event"	3025966003	"abdominal pain intermittend"	9	NA	1	1	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492944522	""	""	""	NA	"Abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2055"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	3	9	"Adverse Event/Serious Adverse Event"	3114986001	"agitation"	6	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492944181	""	""	""	NA	"Agitation"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Agitation"	""	""	""	""	""	""	""	""	""	""	""	""
"2056"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	3	9	"Adverse Event/Serious Adverse Event"	3115109001	"cough"	11	12	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492945366	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"2057"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	3	9	"Adverse Event/Serious Adverse Event"	3114916001	"Dizziness"	6	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492943292	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"2058"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	3	9	"Adverse Event/Serious Adverse Event"	3114955001	"dyspnea intermittend"	5	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492943681	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2059"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	3	9	"Adverse Event/Serious Adverse Event"	3115082001	"fatigue"	13	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492945197	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2060"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	3	9	"Adverse Event/Serious Adverse Event"	3114942001	"headaches intermittend"	6	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492943514	""	""	""	NA	"Intermittent headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"2061"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	3	9	"Adverse Event/Serious Adverse Event"	3115125001	"leucopenia"	13	19	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492945559	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2062"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	3	9	"Adverse Event/Serious Adverse Event"	3198626001	"leucopenia"	55	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494935225	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2063"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	3	9	"Adverse Event/Serious Adverse Event"	3198614001	"lost of hair"	13	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494935028	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2064"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	3	9	"Adverse Event/Serious Adverse Event"	3114991001	"muscle-and bonepain"	9	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492944374	""	""	""	NA	"Musculoskeletal pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2065"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	3	9	"Adverse Event/Serious Adverse Event"	3114887001	"Nausea"	8	13	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492943052	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"2066"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	3	9	"Adverse Event/Serious Adverse Event"	3114966001	"urticaria intermittend"	6	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492943811	""	""	""	NA	"Urticaria"	"Skin and subcutaneous tissue disorders"	"Angioedema and urticaria"	"Urticarias"	"Urticaria"	""	""	""	""	""	""	""	""	""	""	""	""
